Generic Name,Company Name, Contact Info, Presentation, Type of Update,Date of Update, Availability Information, Related Information, Resolved Note, Reason for Shortage, Therapeutic Category, Status, Change Date, Date Discontinued, Initial Posting Date, Generic Name Note, Generic Name Link , Company Info Link, Availability Link, Related Info Link,   Resolved Note Link, Discontinued Note Link
Abacavir Sulfate (Ziagen) Tablets,GlaxoSmithKline (ViiV Healthcare),888-825-5249,300 mg tablet 60 count (NDC 49702-221-18),New,1/3/23,,"The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024.  Ziagen Oral Solution (49702-222-48) will still be available.",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Abacavir Sulfate; Lamivudine (Epzicom) Tablets,GlaxoSmithKline (ViiV Healthcare),888-825-5249,600 mg; 300 mg tablets 30 count (NDC 49702-206-13),New,1/3/23,,"The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024.",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Abacavir Sulfate; Lamivudine; Zidovudine (Trizivir) Tablets,GlaxoSmithKline (ViiV Healthcare),888-825-5249,300 mg; 150 mg; 300 mg tablets 60 count (NDC 49702-217-18),New,1/3/23,,"The anticipated date that GSK will cease distribution of the product is approximately November 27, 2023.",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Abiraterone Acetate Tablets,"Janssen Research and Development, LLC",800-526-7736,250 mg tablets (NDC 57894-155-12),New,6/5/20,,,,,Oncology,To be Discontinued,,,6/5/20,,,,,,,
Acetaminophen (Ofirmev) Injection,Mallinckrodt,800-325-8888,"OFIRMEV® (Acetaminophen) Injection 1 g/100 mL (10 mg/mL), (NDC 43825-102-01, 43825-102-03)",New,6/9/22,,,,,Analgesia/Addiction,To be Discontinued,,,6/9/22,,,,,,,
Acetazolamide Injection,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,500 mg (NDC 23155-313-31),Revised,6/17/22,Available,,,,Cardiovascular;Ophthalmology,Resolved,,,12/2/20,,,,,,,
Acetazolamide Injection,"Mylan Institutional, a Viatris company",800-796-9526,"500 mg, Lyophilisate in Single Dose Vials 1PK (NDC 67457-853-50)",Revised,6/17/22,Available,,,,Cardiovascular;Ophthalmology,Resolved,,,12/2/20,,,,,,,
Acetazolamide Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg per vial (NDC 0143-9503-01),Revised,6/17/22,This presentation is temporarily on backorder.,,,,Cardiovascular;Ophthalmology,Resolved,,,12/2/20,,,,,,,
Acetazolamide Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,500mg per vial (NDC 39822-0190-1),Revised,6/17/22,Available,,,,Cardiovascular;Ophthalmology,Resolved,,,12/2/20,,,,,,,
Acetic Acid Otic Solution,Wockhardt Bio A.G.,847-410-6929,"2% 15ml, (NDC 60432-741-15)",New,6/22/22,,,,,Anti-infective,To be Discontinued,,,6/22/22,,,,,,,
Acrivastine and Pseudoephedrine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.",800-462-3636,"Semprex-D Capsules, 8 mg/ 60mg , 100 capsules, (NDC 52244-404-10)",New,6/2/20,,,,,Pulmonary/Allergy,To be Discontinued,,,6/2/20,,,,,,,
Adalimumab (Humira) Pre-filled Syringe,Abbvie,800-255-5162,10 mg/0.2 mL pre-filled syringe (NDC 0074-6347-02),New,7/27/20,,,,,Dermatology;Gastroenterology;Ophthalmology;Rheumatology,To be Discontinued,,,7/27/20,,,,,,,
Adalimumab (Humira) Pre-filled Syringe,Abbvie,800-255-5162,20 mg/0.4 mL pre-filled syringe (NDC 0074-9374-02),New,7/27/20,,,,,Dermatology;Gastroenterology;Ophthalmology;Rheumatology,To be Discontinued,,,7/27/20,,,,,,,
Adefovir Dipivoxil Tablets,"Gilead Sciences, Inc.",800-445-3235,10mg  (NDC 61958-0501-1),New,8/1/22,,,,,Antiviral,To Be Discontinued,8/1/22,8/1/22,8/1/22,,,,,,,
Adenosine Injection,Hospira,844-646-4398,60 mg/20 mL (3 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1932-01),New,9/12/22,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,9/12/22,9/12/22,6/28/22,,,,,,,
Adenosine Injection,Hospira,844-646-4398,90 mg/30 mL (3 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1932-02),New,6/28/22,,,,,Cardiovascular,To be Discontinued,,,6/28/22,,,,,,,
Adenosine Injection,Teva,800-545-8800,NDC 0703-8776-01 (60 mg/20 mL (3 mg/mL)),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Cardiovascular,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Adenosine Injection,Teva,800-545-8800,NDC 0703-8777-01 (90 mg/30 mL (3 mg/mL)),New,8/11/22,,Product is  available with an expected supply duration until JUL 2022.  No future production expected for an extended period.,,,Cardiovascular,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
"Albuterol Sulfate Aerosol, Metered","Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",90 mcg  (NDC 0254-1007-52),New,7/6/21,,,,,Pulmonary/Allergy,To be Discontinued,,,7/6/21,,,,,,,
"Albuterol Sulfate Inhalation Solution, 0.5%",Akorn Pharmaceuticals,800-932-5676,0.5%; 20mL (NDC 50383-741-20),Revised,3/16/23,Not available,No new manufacturing of product,,,Pulmonary/Allery; Pediatric,Current,,,10/25/22,,,,,,,
"Albuterol Sulfate Inhalation Solution, 0.5%",Nephron Pharmaceuticals,800-443-4313,0.5%; 0.5mL (NDC 0487-9901-30),Revised,3/16/23,On allocation,,,Other,Pulmonary/Allery; Pediatric,Current,,,10/25/22,,,,,,,
Alclometasone Dipropionate Ointment,Sandoz,800-525-8747,"0.05% (NDCs 0168-0264-15, 0168-0264-45, and 0168-0264-60)",New,3/16/23,,,,,Dermatology,To be Discontinued,3/16/23,3/16/23,3/16/23,,,,,,,
Aliskiren and Hydrochlorothiazide Tablets,Noden Pharma,844-399-5701,150 mg / 12.5 mg (NDC 70839-112-30),New,12/16/21,,,,,Cardiovascular,To be Discontinued,,,12/16/21,,,,,,,
Aliskiren and Hydrochlorothiazide Tablets,Noden Pharma,844-399-5701,150 mg / 25 mg (NDC 70839-125-30),New,12/16/21,,,,,Cardiovascular,To be Discontinued,,,12/16/21,,,,,,,
Aliskiren and Hydrochlorothiazide Tablets,Noden Pharma,844-399-5701,300 mg / 12.5 mg (NDC 70839-312-30),New,12/16/21,,,,,Cardiovascular,To be Discontinued,,,12/16/21,,,,,,,
Aliskiren and Hydrochlorothiazide Tablets,Noden Pharma,844-399-5701,300 mg / 25 mg; (NDC 70839-325-30),New,12/16/21,,,,,Cardiovascular,To be Discontinued,,,12/16/21,,,,,,,
Alprostadil (Muse) Suppository,"Mylan, a Viatris company",800-796-9526,250mcg Suppository 6s (NDC 0037-8120-06),Reverified,3/28/23,Out of stock; Estimated release dates to be determined,Resupply TBD; open investigation,,Other,Urology,Current,,,10/18/22,,,,,,,
Alprostadil (Muse) Suppository,"Mylan, a Viatris company",800-796-9526,500mcg Suppository 6s (NDC 0037-8130-06),Reverified,3/28/23,Out of stock; Estimated release dates to be determined,Resupply TBD; open investigation,,Other,Urology,Current,,,10/18/22,,,,,,,
Alprostadil (Muse) Suppository,"Mylan, a Viatris company",800-796-9526,1000mcg Suppository 6s (NDC 0037-8140-06),Reverified,3/28/23,Out of stock; Estimated release dates to be determined,Resupply TBD; open investigation,,Other,Urology,Current,,,10/18/22,,,,,,,
Alprostadil Injection,Teva,800-545-8800,NDC 0703-1501-02 (500 mcg/mL 1 mL Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Pediatric; Cardiovascular,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Alprostadil Suppository,"Mylan Specialty, a Viatris Company",800-796-9526,125 mcg (NDC 0037-8110-06),New,6/14/21,,,,,Urology,To be Discontinued,,,6/14/21,,,,,,,
Aluminum Hydroxide and Magnesium Carbonate (Gaviscon Regular Strength),GlaxoSmithKline,888-367-6471,"Gaviscon Liquid Regular Strength, 95 mg/15mL, 358 mg/15mL, Mint 12oz, (NDC 0135-0094-41)",New,8/6/21,,,,,Gastroenterology,To be Discontinued,,,8/6/21,,,,,,,
Aluminum Hydroxide and Magnesium Carbonate (Gaviscon Regular Strength),GlaxoSmithKline,888-367-6471,"Gaviscon Liquid Regular Strength, 95 mg/15mL, 358 mg/15mL, Mint 6oz, (NDC 0135-0094-42)",New,8/6/21,,,,,Gastroenterology,To be Discontinued,,,8/6/21,,,,,,,
Aluminum Hydroxide and Magnesium Carbonate (Gaviscon Regular Strength),GlaxoSmithKline,888-367-6471,"Gaviscon Chewable Tablet, Regular Strength, 80 mg/1, 14.2 mg/1, 100ct Bottle, (NDC 0135-0096-26)",New,8/6/21,,,,,Gastroenterology,To be Discontinued,,,8/6/21,,,,,,,
Alvimopan Capsules,Merck Sharp & Dohme LLC,800-672-6372,12 mg (NDC 67919-020-10),New,3/2/23,,"To be discontinued May 31, 2023",,,Gastroenterology,To be Discontinued,3/2/23,3/2/23,3/2/23,,,,,,,
Amantadine Hydrochloride Capsules,Sandoz,800-525-8747,100 mg capsules  (NDCs 0781-2320-01 and 0781-2320-05),New,7/16/20,,,,,Antiviral;Neurology,To be Discontinued,,,7/16/20,,,,,,,
Ambrisentan Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","5 mg (NDC 49884-353-11, 49884-353-62 )",New,12/23/21,,,,,Cardiovascular,To be Discontinued,,,12/23/21,,,,,,,
Ambrisentan Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","10 mg (NDC 49884-354-11, 49884-354-62)",New,12/23/21,,,,,Cardiovascular,To be Discontinued,,,12/23/21,,,,,,,
Amifostine Injection,"Clinigen, Inc.",877-776-5385,ETHYOL® (amifostine) for injection: 3 x 500 mg vials (NDC 76310-017-50),Reverified,5/16/22,Shortage anticipated from June 2020; Estimated shortage duration:  Unknown,,,Other,Oncology;Other,Current,,,5/21/20,,,,,,,
Amikacin Sulfate Injection,Teva,800-545-8800,"NDC 0703-9032-03 (500 mg/2 mL (250 mg/mL), 10 x 2 mL Single Dose Vials)",New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Anti-infective,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Amikacin Sulfate Injection,Teva,800-545-8800,"NDC 0703-9040-03  (1 g/4 mL (250 mg/mL), 10 x 4 mL Vials)",New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Anti-infective,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Amino Acids,B. Braun Medical Inc.,800-227-2862,"Plenamine 15% Amino Acids Injection 2,000mL S4505 (NDC 00264-4500-05)",New,6/8/22,Available,,,,Gastroenterology,Current,,,12/8/20,,,,,,,
Amino Acids,B. Braun Medical Inc.,800-227-2862,"Plenamine 15% Amino Acids Injection 1,000mL S4500 (NDC 00264-4500-00)",Revised,6/8/22,Available,,,,Gastroenterology,Current,,,12/8/20,,,,,,,
Amino Acids,"ICU Medical, Inc.",877-976-7747,Aminosyn II 15% Sulfite-Free BLK PK 2000 mL (Legacy Hospira NDC 0409-7171-17)(ICU Medical NDC 0990-7171-17),Reverified,3/31/23,Unavailable,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Gastroenterology,Current,,,12/8/20,,,,,,,
Amino Acids,"ICU Medical, Inc.",877-946-7747,Aminosyn II 10% Sulfite-Free BLK PK 2000 mL (Legacy Hospira NDC 0409-7172-17) (ICU Medical NDC 0990-7172-17),Reverified,3/31/23,Unavailable,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Gastroenterology,Current,,,12/8/20,,,,,,,
Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN™-PF 7%, Sulfite-Free, 500 mL (Legacy Hospira NDC 0409-4178-03) (ICU Medical NDC 0990-4178-03)",Reverified,3/31/23,Unavailable,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Gastroenterology,Current,,,12/8/20,,,,,,,
Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN-PF 10%, Sulfite-Free, (Pediatric Formula) 1000 mL  (Legacy Hospira NDC 0409-4179-05) (ICU Medical NDC 0990-4179-05)",Reverified,3/31/23,Unavailable,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Gastroenterology,Current,,,12/8/20,,,,,,,
Amino Acids,Baxter Healthcare,888-229-0001,"15% CLINISOL - sulfite-free (Amino Acid) Injection in VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion. Product Codes: 2B6189 15% 2000 mL (NDC 0338-0502-06), 2B6187 15% 500 mL (NDC 0338-0502-03)",Reverified,3/29/23,Available,,,,Gastroenterology,Current,,,12/8/20,,,,,,,
Aminocaproic Acid Oral Solution,VistaPharm,727-530-1633,"0.25 grams/mL, 8 fl oz (NDC 66689-330-08)",New,3/8/23,,,,,Hematology,To be Discontinued,3/8/23,3/8/23,3/8/23,,,,,,,
Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 60 count bottle (NDC 0185-0144-60)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 90 count bottle (NDC 0185-0144-09)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 500 count bottle (NDC 0185-0144-05)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 500 count bottle (NDC 0245-0145-15)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 30 count bottle (NDC 0245-0145-30)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2","10mg (NDCs 0603-2212-02, 0603-2212-16, 0603-2212-21, and 0603-2212-32)",New,12/16/21,,,,,Psychiatry,To be Discontinued,,,12/16/21,,,,,,,
Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2","25mg (NDCs 0603-2213-02, 0603-2213-21, 0603-2213-30, and 0603-2213-32)",New,12/16/21,,,,,Psychiatry,To be Discontinued,,,12/16/21,,,,,,,
Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",50mg (NDCs 0603-2214-21 and 0603-2214-32),New,12/16/21,,,,,Psychiatry,To be Discontinued,,,12/16/21,,,,,,,
Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",75mg (NDCs 0603-2215-21 and 0603-2215-25),New,12/16/21,,,,,Psychiatry,To be Discontinued,,,12/16/21,,,,,,,
Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",100mg (NDCs 0603-2216-21 and 0603-2216-25),New,12/16/21,,,,,Psychiatry,To be Discontinued,,,12/16/21,,,,,,,
Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",150mg (NDC 0603-2217-21),New,12/16/21,,,,,Psychiatry,To be Discontinued,,,12/16/21,,,,,,,
Amitriptyline Hydrochloride Tablets,"Mylan Specialty, a Viatris Company",800-796-9526,10 mg (NDCs 0378-2610-01 and 0378-2610-10),New,8/2/21,,,,,Psychiatry,To be Discontinued,,,8/2/21,,,,,,,
Amitriptyline Hydrochloride Tablets,"Mylan Specialty, a Viatris Company",800-796-9526,25 mg (NDCs 0378-2625-01 and 0378-2625-10),New,8/2/21,,,,,Psychiatry,To be Discontinued,,,8/2/21,,,,,,,
Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 tablets (NDC 0591-5714-01)",Reverified,4/5/23,Available,,,,Psychiatry,Current,,,3/9/20,,,,,,,
Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 tablets (NDC 0591-5713-01)",Reverified,4/5/23,Available,,,,Psychiatry,Current,,,3/9/20,,,,,,,
Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"100 mg, 100 tablets (NDC 0591-5715-01)",Reverified,4/5/23,Available,Recovery expected TBD,,Other,Psychiatry,Current,,,3/9/20,,,,,,,
Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"150 mg, 100 tablets (NDC 0591-5716-01)",Reverified,4/5/23,Available,,,,Psychiatry,Current,,,3/9/20,,,,,,,
Amoxicillin Oral Powder for Suspension,"Aurobindo, USA",866-850-2876,"125 mg/5mL (NDCs 65862-706-01, 65862-706-55, and 65862-706-80)",Reverified,1/11/23,On allocation.,,,Demand increase for drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,"Aurobindo, USA",866-850-2876,"200 mg/5mL (NDCs 65862-070-01, 65862-070-50, and 65862-070-75)",Reverified,1/11/23,On allocation.,,,Demand increase for drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,"Aurobindo, USA",866-850-2876,"250 mg/5mL (NDCs 65862-707-01, 65862-707-55, and 65862-707-80)",Reverified,1/11/23,On allocation.,,,Demand increase for drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,"Aurobindo, USA",866-850-2876,"400 mg/5mL (NDCs 65862-071-01, 65862-071-50, and 65862-071-75)",Reverified,1/11/23,On allocation.,,,Demand increase for drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Hikma Pharmaceuticals,800-631-2174,"125 mg/5mL (NDCs 0143-9888-01, 0143-9888-15, and 0143-9888-80)",Reverified,3/31/23,Available for current customers.,,,Demand increase for drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Hikma Pharmaceuticals,800-631-2174,"200 mg/5mL (NDCs 0143-9886-01, 0143-9886-50, and 0143-9886-75)",Reverified,3/31/23,Available for current customers.,,,Demand increase for drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Hikma Pharmaceuticals,800-631-2174,"250 mg/5mL (NDCs 0143-9889-01, 0143-9889-15, and 0143-9889-80)",Reverified,3/31/23,Available for current customers.,,,Demand increase for drug,Anti-infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Hikma Pharmaceuticals,800-631-2174,"400 mg/5mL (NDCs 0143-9887-01, 0143-9887-50, and 0143-9887-75)",Reverified,3/31/23,Available for current customers.,,,Demand increase for drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,125mg/5mL 100 mL (NDC 0781-60-3946),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,125mg/5mL 150 mL (NDC 0781-60-3955),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,250 mg/5 mL 80 mL (NDC 0781-60-3958),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,200 mg/5 mL 100 mL (NDC 0781-61-5646),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,200 mg/5 mL 50 mL (NDC 0781-61-5652),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,200 mg/5 mL 75 mL (NDC 0781-61-5657),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,400 mg/5 mL 100 mL (NDC 0781-61-5746),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,400 mg/5 mL 50 mL (NDC 0781-61-5752),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-545-8747,400 mg/5 mL 75 mL (NDC 0781-61-5757),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,250mg/5mL 100 mL (NDC 0781-60-4146),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,250mg/5mL 150 mL (NDC 0781-60-4155),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Sandoz,800-525-8747,250mg/5mL 80 mL (NDC 0781-60-4158),Reverified,4/5/23,Limited Availability,,,Other,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Teva Pharmaceuticals,800-545-8800,"200 mg/5mL (NDCs 0093-4160-73, 0093-4160-76, and 0093-4160-78)",Revised,4/5/23,"(NDC 0093-4160-73) - Allocation, Recovery expected May 2023; (NDC 0093-4160-76) - Allocation, Recovery expected July 2023;  (NDC 0093-4160-78) - Available

;",,,Demand increase for the drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Teva Pharmaceuticals,800-545-800,"250 mg/5mL (NDCs 0093-4155-73, 0093-4155-80, and 0093-4155-79)",Revised,4/5/23,"(NDC 0093-4155-73) - Allocation, Recovery expected May 2023; (NDC 0093-4155-80) - Allocation,  Recovery expected July 2023; (NDC 0093-4155-79) - Allocation, Recovery expected May 2023",,,Demand increase for the drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amoxicillin Oral Powder for Suspension,Teva Pharmaceuticals,800-545-8800,"400 mg/5mL (NDCs 0093-4161-73, 0093-4161-76, and 0093-4161-78)",Revised,4/5/23,"(NDC 0093-4161-73) - Allocation, Recovery expected June 2023; (NDC 0093-4161-76) - Allocation, Recovery expected June 2023; (NDC 0093-4161-78) - Allocation, Recovery expected August 2023",,,Demand increase for the drug,Anti-Infective; Pediatric,Current,,,10/28/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,SpecGX LLC,800-325-8888,7.5 mg 100 TABLET in 1 BOTTLE (NDC 0406-8884-01),Revised,3/9/23,Backorder until April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,SpecGX LLC,800-325-8888,15 mg 100 TABLET in 1 BOTTLE (NDC 0406-8885-01),Revised,3/9/23,Backorder until April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,SpecGX LLC,800-325-8888,5 mg 100 TABLET in 1 BOTTLE (NDC 0406-8891-01),Revised,3/9/23,Supply constraints through April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,SpecGX LLC,800-325-8888,10 mg 100 TABLET in 1 BOTTLE (NDC 0406-8892-01),Revised,3/9/23,Supply constraints through April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,SpecGX LLC,800-325-8888,20 mg 100 TABLET in 1 BOTTLE (NDC 0406-8893-01),Revised,3/9/23,Supply constraints through April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,SpecGX LLC,800-325-8888,30 mg 100 TABLET in 1 BOTTLE (NDC 0406-8894-01),Revised,3/9/23,Supply constraints through April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Epic Pharma, LLC",(718) 276-8600 ext. 3,Amphetamine Salts 20mg C2 100 Tab (NDC 42806-344-01),Reverified,3/8/23,Allocation to existing customers only,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Epic Pharma, LLC",(718) 276-8600 ext. 3,Amphetamine Salts10mg C2 100 Tab (NDC 42806-341-01),Reverified,3/8/23,Allocation to existing customers only,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Epic Pharma, LLC",(718) 276-8600 ext. 3,Amphetamine Salts 15mg C2 100 Tab (NDC 42806-343-01),Reverified,3/8/23,Allocation to existing customers only,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Epic Pharma, LLC",(718) 276-8600 ext. 3,Amphetamine Salts 30mg C2 100 Tab (NDC 42806-345-01),Reverified,3/8/23,Allocation to existing customers only,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Epic Pharma, LLC",(718) 276-8600 ext. 3,Amphetamine Salts 5mg C2 100 Tab (NDC 42806-339-01),Reverified,3/8/23,Allocation to existing customers only,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Alvogen,844-842-8672 and email: CustomerService-US@alvogen.com,5mg 100 ct (NDC 47781-174-01),Revised,3/31/23,Available,Supporting contracted business only,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Alvogen,844-842-8672 and email: CustomerService-US@alvogen.com,10mg 100 ct (NDC 47781-176-01),Revised,3/31/23,Available,Supporting contracted business only,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Alvogen,844-842-8672 and email: CustomerService-US@alvogen.com,15mg 100 ct (NDC 47781-178-01),Revised,3/31/23,Unavailable. Next delivery: early April 2023; Estimated recovery: mid-May 2023,Supporting contracted business only,,Demand increase,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Alvogen,844-842-8672 and email: CustomerService-US@alvogen.com,20mg 100 ct (NDC 47781-179-01),Revised,3/31/23,Unavailable. Next delivery: mid-April 2023; Estimated recovery: April 2023,Supporting contracted business only,,Demand increase,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Alvogen,844-842-8672 and email: CustomerService-US@alvogen.com,30 mg 100 ct (NDC 47781-180-01),Revised,3/31/23,Unavailable. Next delivery: mid-April 2023; Estimated recovery mid-May 2023,Supporting contracted business only,,Demand increase,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Sunrise Pharmaceutical, Inc.",732-382-6085 Monday to Friday 9 am to 3:45 pm,"Amphetamine Mixed Salts Tablets C-II 5 mg, 100 (NDC 11534-190-01)",New,10/12/22,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Sunrise Pharmaceutical, Inc.",732-382-6085 Monday to Friday 9 am to 3:45 pm,"Amphetamine Mixed Salts Tablets C-II 10 mg, 100 (NDC 11534-192-01)",New,10/12/22,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Sunrise Pharmaceutical, Inc.",732-382-6085 Monday to Friday 9 am to 3:45 pm,"Amphetamine Mixed Salts Tablets C-II 7.5 mg, 100 (NDC 11534-191-01)",New,10/12/22,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Sunrise Pharmaceutical, Inc.",732-382-6085 Monday to Friday 9 am to 3:45 pm,"Amphetamine Mixed Salts Tablets C-II 12.5 mg, 100 (NDC 11534-193-01)",New,10/12/22,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Sunrise Pharmaceutical, Inc.",732-382-6085 Monday to Friday 9 am to 3:45 pm,"Amphetamine Mixed Salts Tablets C-II 15 mg, 100 (NDC 11534-194-01)",New,10/12/22,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Sunrise Pharmaceutical, Inc.",732-382-6085 Monday to Friday 9 am to 3:45 pm,"Amphetamine Mixed Salts Tablets C-II 20 mg, 100 (NDC 11534-195-01)",New,10/12/22,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Sunrise Pharmaceutical, Inc.",732-382-6085 Monday to Friday 9 am to 3:45 pm,"Amphetamine Mixed Salts Tablets C-II 30 mg, 100 (NDC 11534-196-01)",New,10/12/22,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"5 mg, 100 count (NDC 0527-1500-37)",Reverified,3/10/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"7.5 mg, 100 count (NDC 0527-1501-37)",Reverified,3/10/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"10 mg, 100 count (NDC 0527-1502-37)",Reverified,3/10/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"12.5 mg, 100 count (NDC 0527-1503-37)",Reverified,3/10/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"15 mg, 100 count (NDC 0527-1504-37)",Reverified,3/10/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"20 mg, 100 count (NDC 0527-1505-37)",Reverified,3/10/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"30 mg, 100 count (NDC 0527-1506-37)",Reverified,3/10/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"5 mg, 100 Count Bottle (NDC 68382-950-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,,9/12/19,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"7.5 mg, 100 Count Bottle (NDC 68382-951-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,,9/12/19,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"10 mg, 100 Count Bottle (NDC 68382-952-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,,9/12/19,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"12.5 mg, 100 Count Bottle (NDC 68382-953-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,,9/12/19,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"15 mg, 100 Count Bottle (NDC 68382-954-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,,9/12/19,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"20 mg, 100 Count Bottle (NDC 68382-955-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,,9/12/19,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"30 mg, 100 Count Bottle (NDC 68382-956-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,,9/12/19,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"30 mg, 100 Count Bottle (NDC 0185-2099-01)",Reverified,4/5/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"20 mg, 100 Count Bottle (NDC 0185-0853-01)",Reverified,4/5/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"10 mg, 100 Count Bottle (NDC 0185-0842-01)",Reverified,4/5/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"5 mg, 100 Count Bottle (NDC 0185-2098-01)",Reverified,4/5/23,Available,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 10mg 100 (NDC 57844-110-01),Revised,4/5/23,Available,"Product is available, however Teva continues to experience unprecedented increase in demand.",,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 12.5mg 100 (NDC 57844-112-01),Revised,4/5/23,Available,"Product is available, however Teva continues to experience unprecedented increase in demand.",,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 15mg 100 (NDC 57844-115-01),Revised,4/5/23,Available,"Product is available, however Teva continues to experience unprecedented increase in demand.",,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 20mg 100 (NDC 57844-120-01),Revised,4/5/23,"Limited Supply Available, Recovery TBD","Product is available, however Teva continues to experience unprecedented increase in demand.",,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 30mg 100 (NDC 57844-130-01),Revised,4/5/23,"Limited Supply Available, Recovery TBD","Product is available, however Teva continues to experience unprecedented increase in demand.",,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 5mg 100 (NDC 57844-105-01),Revised,4/5/23,Available,"Product is available, however Teva continues to experience unprecedented increase in demand.",,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 7.5mg 100 (NDC 57844-117-01),Revised,4/5/23,Available,"Product is available, however Teva continues to experience unprecedented increase in demand.",,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,12.5  mg 100 count (NDC 0555-0776-02),Revised,4/5/23,"Allocating Limited Supply, Recovery May 2023",Unprecedented increase in demand being experienced for the product.  Supplying at or above demand currently at low inventory.,,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,15  mg 100 count (NDC 0555-0777-02),Revised,4/5/23,Product Under Allocation,Unprecedented increase in demand being experienced for the product.  Supplying at or above demand currently at low inventory.,,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,7.5  mg 100 count (NDC 0555-0775-02),Revised,4/5/23,Product Under Allocation,Unprecedented increase in demand being experienced for the product.  Supplying at or above demand currently at low inventory.,,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,10  mg 100 count (NDC 0555-0972-02),Revised,4/5/23,Product Under Allocation,"Unprecedented increase in demand being experienced for the product.  Supplying at or above demand currently at low inventory. 
Intermittent supply interruption may be experienced.",,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,20 mg 100 count (NDC 0555-0973-02),Revised,4/5/23,Product Under Allocation,Unprecedented increase in demand being experienced for the product.  Supplying at or above demand currently at low inventory.,,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,30 mg 100 count (NDC 0555-0974-02),Revised,4/5/23,Product Under Allocation,"Unprecedented increase in demand being experienced for the product.  Supplying at or above demand currently at low inventory. 
Intermittent supply interruption may be experienced.",,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,5 mg 100 count (NDC 0555-0971-02),Revised,4/5/23,"Allocating Limited Supply, Recovery April 2023",Unprecedented increase in demand being experienced for the product.  Supplying at or above demand currently at low inventory.,,Demand increase for the drug,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,USPHARMA WINDLAS,855-257-0292,"Amphetamine Mixed Salts Tablets C-II 5 mg, 100 (NDC 72516-016-01)",New,3/9/23,Unavailable.  Estimated recovery: end of June 2023,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,USPHARMA WINDLAS,855-257-0292,"Amphetamine Mixed Salts Tablets C-II 10 mg, 100 (NDC 72516-014-01)",New,3/9/23,Unavailable.  Estimated recovery: end of June 2023,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,USPHARMA WINDLAS,855-257-0292,"Amphetamine Mixed Salts Tablets C-II 15 mg, 100 (NDC 72516-013-01)",New,3/9/23,Unavailable.  Estimated recovery: end of June 2023,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,USPHARMA WINDLAS,855-257-0292,"Amphetamine Mixed Salts Tablets C-II 20 mg, 100 (NDC 72516-012-01)",New,3/9/23,Unavailable.  Estimated recovery: end of June 2023,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,USPHARMA WINDLAS,855-257-0292,"Amphetamine Mixed Salts Tablets C-II 30 mg, 100 (NDC 72516-011-01)",New,3/9/23,Unavailable.  Estimated recovery: end of June 2023,,,Shortage of active ingredient,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma USA,(866) 850-2876 or CustomerService@AurobindoUSA.com,"Amphetamine Mixed Salts Tablets C-II 5 mg, 100 (NDC 13107-0068-01)",New,3/14/23,Estimated availability April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma USA,(866) 850-2876 or CustomerService@AurobindoUSA.com,"Amphetamine Mixed Salts Tablets C-II 7.5 mg, 100 (NDC 13107-0069-01)",New,3/14/23,Estimated availability April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma USA,(866) 850-2876 or CustomerService@AurobindoUSA.com,"Amphetamine Mixed Salts Tablets C-II 10 mg, 100 (NDC 13107-0070-01)",New,3/14/23,Estimated availability April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma USA,(866) 850-2876 OR CustomerService@AurobindoUSA.com,"Amphetamine Mixed Salts Tablets C-II 15 mg, 100 (NDC 13107-0072-01)",New,3/14/23,Estimated availability April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma USA,(866) 850-2876 or CustomerService@AurobindoUSA.com,"Amphetamine Mixed Salts Tablets C-II 20 mg, 100 (NDC 13107-0073-01)",New,3/14/23,Estimated availability April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma USA,(866) 850-2876 OR CustomerService@AurobindoUSA.com,"Amphetamine Mixed Salts Tablets C-II 30 mg, 100 (NDC 13107-0074-01)",New,3/14/23,Estimated availability April 2023,,,,Psychiatry,Current,,,10/12/22,,,,,,,
"Amphetamine Oral Suspension, Extended Release","Tris Pharma, Inc.",732-940-0358,Amphetamine (Dyanavel XR) EQ 2.5MG BASE/ML (NDC 27808-102-01),Revised,8/26/22,,,,,Psychiatry,Resolved,8/26/22,,11/30/21,,,,,,,
Ampicillin for Injection,"Mylan Institutional, a Viatris company",800-796-9526,250 mg (NDC 67457-353-10),New,9/23/21,,,,,Anti-Infective,To be Discontinued,,,9/23/21,,,,,,,
Ampicillin for Injection,"Mylan Institutional, a Viatris company",800-796-9526,500 mg (NDC 67457-350-10),New,9/23/21,,,,,Anti-Infective,To be Discontinued,,,9/23/21,,,,,,,
Ampicillin for Injection,Pfizer,844-646-4398,1 g; Single Dose Vial (Powder) (NDC 0409-3726-01),New,7/29/22,,Supply expected to exhaust 01Aug2022; Discontinuation of the manufacture of the drug.,,,,To Be Discontinued,7/29/22,7/29/22,7/29/22,,,,,,,
Ampicillin for Injection,Pfizer,844-646-4398,2 g; Single Dose Vial (Powder) (NDC 0409-3720-01,New,7/29/22,,Discontinuation of the manufacture of the drug.,,,,To Be Discontinued,7/29/22,7/29/22,7/29/22,,,,,,,
Ampicillin for Injection,Pfizer,844-646-4398,500 mg; Single Dose Vial (Powder) (NDC 0409-3718-01),New,6/22/22,,,,,Antibiotic,To be Discontinued,,,6/22/22,,,,,,,
Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,1 MG 100 Capsules (NDC 0172-5240-60),Revised,7/20/21,,,,,Hematology,Resolved,,,10/29/19,,,,,,,
Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,0.5 MG 100 Capsules (NDC 0172-5241-60),Revised,7/20/21,,,,,Hematology,Resolved,,,10/29/19,,,,,,,
Anagrelide Hydrochloride Capsules,Takeda Pharmaceuticals USA Inc.,877-825-3327,"AGRYLIN 0.5 mg Capsule,100 capsules in 1 bottle (NDC 54092-063-01)",Revised,7/20/21,,,Available,,Hematology,Resolved,,,10/29/19,,,,,,,
Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,0.5 mg per capsule Bottles of 100 (NDC 13668-453-01),Revised,7/20/21,,,Available,,Hematology,Resolved,,,10/29/19,,,,,,,
Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,"1 mg per capsule, Bottles of 100 (NDC 13668-462-01)",Revised,7/20/21,,,Available,,Hematology,Resolved,,,10/29/19,,,,,,,
Argatroban Injection,Pfizer,844-646-4398,250 mg/2.5 mL (100 mg/mL); Single Dose Vial (NDC 0409-1140-01),New,11/30/22,,Supply expected to exhaust February 2023; Discontinuation of the manufacture of the drug.,,,Anesthesia,To be Discontinued,11/30/22,11/30/22,11/30/22,,,,,,,
Aspirin/Dipyridamole (Aggrenox) Extended Release Capsules,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,25mg/200mg capsules (NDC 0597-0001-60),New,5/26/20,,,,,Cardiovascular,To be Discontinued,,,5/26/20,,,,,,,
Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC  0517-1004-25) (old NDC 0517-0401-25)",Reverified,3/28/23,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,8 mg per 20 mL (0.4 mg per mL); MDV; (NDC 63323-580-20),Reverified,3/31/23,8 month expiry (11/30/2023 expiry) dating available by request.,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,0.1 mg/mL; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3340-1),Reverified,4/6/23,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,1 mg/10 mL (0.1 mg/mL); Ansyr Plastic Syringe(NDC 0409-1630-10),Reverified,3/31/23,Next Delivery: May 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Neurology;Pediatric,Current,,,,,,,,https://www.fda.gov/media/165564/download,,
Atropine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,0.25 mg/5 mL (0.05 mg/mL); Ansyr Plastic Syringe(NDC 0409-9630-05),Reverified,3/31/23,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,https://www.fda.gov/media/165564/download,,
Atropine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,0.5 mg/5 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4910-34),Reverified,3/31/23,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,https://www.fda.gov/media/165564/download,,
Atropine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4911-34, pack of 10; NDC 0409-4911-11, individual)",Reverified,3/31/23,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,https://www.fda.gov/media/165564/download,,
Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 0517-1001-25) (old NDC 0517-1010-25)",Reverified,3/28/23,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.4 mg/mL, 20 mL vial (NDC 0641-6006-10)",Reverified,3/23/23,Inventory is currently available.,Additional lots are scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.4 mg/mL, 1 mL single dose vial, pack of 25 (NDC 16729-525-08)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.4 mg/mL, 20 mL multi-dose vial, pack of 10 (NDC 16729-512-43)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","1 mg/mL, 1 mL single dose vial, pack of 25 (NDC 16729-526-08)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.05 mg/mL, 5 mL prefilled syringe, pack of 10 (NDC 16729-483-03)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.1 mg/mL, 10 mL prefilled syringe, pack of 10 (NDC 16729-484-45)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.1 mg/mL, 5 mL prefilled syringe, pack of 10 (NDC 16729-484-90)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,,,,,,,,,
Azacitidine for Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,100 mg per vial (NDC 71288-115-30),Reverified,2/13/23,Available,,,,Oncology,Current,,,12/18/20,,,,,,,
Azacitidine for Injection,Cipla Limited,844-247-5287,100 mg per vial (NDC 69097-805-40),Revised,6/8/21,Available,,,Demand increase for the drug,Oncology,Current,,,12/22/20,,,,,,,
Azacitidine for Injection,Teva Pharmaceuticals,800-545-8800,100 mg/vial Lyophilized Powder (NDC 68001-0313-56),Reverified,4/5/23,MADE TO ORDER PRODUCT,Product is manufactured and labeled  for Blue Point Laboratories on a made to order basis,,,Oncology,Current,,,12/22/20,,,,,,,
Azacitidine for Injection,Breckenridge Pharmaceutical,860-828-8140,100 mg per vial (NDC 51991-797-98),Revised,1/13/23,Unavailable,No longer marketed. Expiry of last lot marketed: 01/31/2024,,Discontinue of manufacture of drug for distribution in Breckenridge label,Oncology,Current,,,12/22/20,,,,,,,
Azacitidine for Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,100mg/vial (NDC 55150-393-01),Reverified,4/4/23,Available,Check wholesalers for inventory,,,Oncology,Current,,,12/22/20,,,,,,,
Azacitidine for Injection,Celgene Corporation,1-888-423-5436,"100 mg single-dose vial in cartons of 1 vial, (NDC 0781-3253-94)",Revised,10/1/21,Available,,,,Oncology,Current,,,12/18/20,,,,,,,
Azacitidine for Injection,Celgene Corporation,1-888-423-5436,"100 mg single-dose vial in cartons of 1 vial, (NDC 0781-9253-94)",Revised,10/1/21,Available,,,,Oncology,Current,,,12/18/20,,,,,,,
Azacitidine for Injection,Celgene Corporation,1-888-423-5436,"VIDAZA, , 100 mg single-dose vial in cartons of 1 vial, (NDC 59572-102-01)",Revised,10/1/21,Available,,,,Oncology,Current,,,12/18/20,,,,,,,
Azacitidine for Injection,"Fresenius Kabi USA, LLC",1-888-386-1300,"100 mg per vial, single dose vial, PF, (NDC 63323-771-39)",Reverified,3/31/23,Available,,,Demand increase for the drug,Oncology,Current,,,12/18/20,,,,,,,
Azacitidine for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",1-800-631-2174,"100 mg per vial, (NDC 0143-9606-01)",Revised,10/13/22,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology,Current,,,12/18/20,,,,,,,
Azacitidine for Injection,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"100 mg per vial, (NDC 43598-305-62)",Reverified,1/24/23,Available,,,,Oncology,Current,,,12/18/20,,,,,,,
Azacitidine for Injection,Armas Pharmaceuticals Inc,1-732-637-1971,100 mg per vial (NDC 72485-201-01),Revised,1/4/23,Available,,,,Oncology,Current,,,12/18/20,,,,,,,
Azacitidine for Injection,Accord Healthcare Inc.,"866-941-7875, option 2",100 mg per vial (NDC 16729-306-10),Revised,6/10/21,Limited availability.,,,Shortage of an active ingredient,Oncology,Current,,,12/21/20,,,,,,,
Azacitidine for Injection,"Mylan Institutional, a Viatris company",800-796-9526,100 mg per vial (NDC 67457-254-30),Reverified,3/28/23,Presentation discontinued,,,,Oncology,Current,,,12/22/20,,,,,,,
Azithromycin (Azasite) Ophthalmic Solution 1%,Thea Pharma Inc.,781-832-3667,"Azasite (Azithromycin Ophthalmic Solution) 1% (NDC 82584-307-03), 2.5mL",Revised,1/26/23,Available,,,,Ophthalmology,Current,,,2/22/22,,,,,,,
Azithromycin for Suspension,Pfizer,800-533-4535,1 g: 1 x 10 packets (NDC 00069-3051-07),New,12/22/22,,,,,Anti-Infective,To be Discontinued,12/22/22,12/22/22,12/22/22,,,,,,,
Azithromycin Tablets,Pfizer,800-533-4535,500 mg: 5 x 10 blister pack (NDC 00069-3070-86),New,12/22/22,,,,,Anti-Infective,To be Discontinued,12/22/22,12/22/22,12/22/22,,,,,,,
Bacteriostatic 0.9% Sodium Chloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"0.9% (90 mg per 10 mL), (9mg/mL), Multiple Dose Plastic Vial, 30 mL (NDC 63323-924-30)",Reverified,3/31/23,Available,Check wholesaler inventory,,Increase in demand,Gastroenterology;Other;Pediatric,Current,,,12/8/21,,,,,,,
Bacteriostatic 0.9% Sodium Chloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"0.9% (90 mg per 10 mL), (9mg/mL), Multiple Dose Plastic Vial, 10 mL, (NDC 63323-924-10)",Reverified,3/31/23,Available,Check wholesaler inventory,,Increase in demand,Gastroenterology;Other;Pediatric,Current,,,12/8/21,,,,,,,
Bacteriostatic 0.9% Sodium Chloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,10 mL Multiple Dose LifeShield™ Plastic Fliptop Vial (NDC 00409-1966-12),Revised,3/17/23,Next Delivery: June 2023; Estimated Recovery: December 2023,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,,12/8/21,,,,,,,
Bacteriostatic 0.9% Sodium Chloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,20 mL Multiple Dose Plastic Fliptop Vial (NDC 00409-1966-05),Revised,3/31/23,Next Delivery and Estimated Recovery: June 2023,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,,12/8/21,,,,,,,
Bacteriostatic 0.9% Sodium Chloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,30 mL Multiple Dose Plastic Fliptop Vial (NDC 00409-1966-07),Revised,3/31/23,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/8/21,,,,,,,
Bacteriostatic Water for Injection,"Hospira, Inc., a Pfizer company",844-646-4398,30 mL Multiple Dose Plastic Fliptop Vial (NDC 00409-3977-03),Reverified,3/31/23,Available,,,Other,Other,Current,,,12/3/21,,,,,,,
"Belantamab Mafodotin Injection, Powder for Solution",GlaxoSmithKline,888-825-5249,Blenrep 100 mg powder solution for infusion (NDC 0173-0896-01),New,2/10/23,,The product is no longer available as the BLA has been withdrawn.,,,Oncology,To be Discontinued,2/10/23,2/10/23,2/10/23,,,,,,,
Belatacept (Nulojix) Lyophilized Powder for Injection,Bristol Myers Squibb Co.,800-721-5072 ; 877-417-1523,20cc vial 250mg lyophilized powder per vial for IV infusion (NDC 0003-0371-13),Revised,11/28/22,"No disruption to existing patients is anticipated. Until further notice, BMS will continue to limit distribution to appropriate patients via the US NULOJIX Distribution Program. For further information, contact BMS Medical Information.",,,Demand increase for the drug,Transplant,Current,,,3/6/17,,,,,,,
Belladonna and Opium Suppositories,Padagis USA LLC,866-634-9120,16.2mg/60 mg suppository (NDC 0574-7040),New,12/2/22,,Discontinuation of the manufacture of the drug substance.,,,Urology,To be Discontinued,12/2/22,12/2/22,12/2/22,,,,,,,
Belladonna and Opium Suppositories,Padagis USA LLC,866-634-9120,16.2mg/30 mg suppository (NDC 0574-7045),New,12/2/22,,Discontinuation of the manufacture of the drug substance.,,,Urology,To be Discontinued,12/2/22,12/2/22,12/2/22,,,,,,,
Belladonna and Opium Suppositories,Padagis US LLC,866-634-9120,16.2mg/60 mg suppository (NDC 0574-7040),Revised,12/2/22,Currently out of stock. No estimated release date available.,,,Discontinuation of the manufacture of the drug substance,Urology,Current,,,8/3/22,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Belladonna+and+Opium+Suppositories&st=d&tab=tabs-4&panels=0,,
Belladonna and Opium Suppositories,Padagis US LLC,866-634-9120,16.2mg/30 mg suppository (NDC 0574-7045),Revised,12/2/22,Currently out of stock. No estimated release date available.,,,Discontinuation of the manufacture of the drug substance,Urology,Current,,,8/3/22,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Belladonna+and+Opium+Suppositories&st=d&tab=tabs-4&panels=0,,
Benzonatate Capsules,Pfizer Pharmaceuticals,800-533-4535,Tessalon 100 mg perles; Bottle of 100 (NDC 0069-0122-01),New,6/8/21,,,,,Pulmonary/Allergy,To be Discontinued,,,6/8/21,,,,,,,
Betamethasone Dipropionate Cream,Sandoz,800-525-8747,0.05% (0168-0265-15 and 0168-0265-50),New,3/16/23,,,,,Dermatology,To be Discontinued,3/16/23,3/16/23,3/16/23,,,,,,,
Betamethasone Valerate Topical Foam,Ingenus Pharmaceuticals LLC,866-321-5031,0.12% (NDCs 50742-315-01 and 50742-315-50),New,11/30/21,,,,,Dermatology,To be Discontinued,,,11/30/21,,,,,,,
Bivalirudin in 0.9% Sodium Chloride Injection,Baxter,888-229-0001,250 mg/50 mL (NDC 0338-9572-24),New,7/12/22,,Discontinuation of the manufacture of the drug.,,,Hematology,To be Discontinued,7/12/22,7/12/22,7/12/22,,,,,,,
Bivalirudin in 0.9% Sodium Chloride Injection,Baxter,888-229-0001,500 mg/100 mL (NDC 0338-9576-12),New,7/12/22,,Discontinuation of the manufacture of the drug.,,,Hemtology,To be Discontinued,7/12/22,7/12/22,7/12/22,,,,,,,
Bleomycin Injection,Teva,800-545-8800,NDC 0703-3154-01 (15 Units/Single Dose Vial),New,8/11/22,,Product is available with an expected supply duration until SEPT 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Bleomycin Injection,Teva,800-545-8800,NDC 0703-3155-01 (30 Units/Single Dose Vial),New,8/11/22,,Product is available with an expected supply duration until AUG 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Bosentan Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",62.5mg (NDC 49884-058-02),New,10/27/22,,,,,Cardiovascular,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,
Bosentan Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",125mg  (NDC 49884-059-02),New,10/27/22,,,,,Cardiovascular,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Oral Syrup",Wockhardt Bio A.G.,847-410-6929,4 Fl Oz (118ml) (NDC 60432-275-04),New,8/26/22,,Discontinuing the manufacture of the product due to business reasons,,,Pulmonary/Allergy; Gastroenterology,To be Discontinued,8/26/22,8/26/22,8/26/22,,,,,,,
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Oral Syrup",Wockhardt Bio A.G.,847-410-6929,1 pint (475ml) (NDC 60432-275-16),New,8/26/22,,Discontinuing the manufacture of the product due to business reasons,,,Pulmonary/Allergy; Gastroenterology,To be Discontinued,8/26/22,8/26/22,8/26/22,,,,,,,
Budesonide Capsules,Teva Pharmaceuticals,800-545-8800,3 mg capsules (NDC 0093-7445-01),New,12/23/19,,,,,Gastroenterology,To be Discontinued,,,12/23/19,,,,,,,
Budesonide Inhalational Suspension,Sandoz,800-525-8747,Budesonide 0.5 mg/2mL (NDC 0781-7516-87),New,12/19/22,,,,,Pulmonary/Allergy,To be Discontinued,12/19/22,12/19/22,12/19/22,,,,,,,
Budesonide Inhalational Suspension,Sandoz,800-525-8747,Budesonide 0.25 mg/2 mL (NDC 0781-7515-87),New,12/19/22,,,,,Pulmonary/Allergy,To be Discontinued,12/19/22,12/19/22,12/19/22,,,,,,,
Budesonide Inhalational Suspension,Sandoz,800-525-8747,Budesonide 1 mg/2 mL (NDC 0781-7517-87),New,12/19/22,,,,,Pulmonary/Allergy,To be Discontinued,12/19/22,12/19/22,12/19/22,,,,,,,
Bumetanide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg per 4 mL (0.25 mg per mL), single-dose vial, (NDC 65219-570-04)",Reverified,3/31/23,Available,Check wholesalers for inventory,,Demand increase,Cardiovascular,Current,,,1/31/18,,,,,,,
Bumetanide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2.5 mg per 10 mL (0.25 mg per mL), multiple-dose vial, (NDC 65219-572-10)",Reverified,3/31/23,Available,Check wholesalers for inventory,,Demand increase,Cardiovascular,Current,,,1/31/18,,,,,,,
Bumetanide Injection,Pfizer,844-646-4398,1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1412-04),New,7/19/22,,Stock anticipated to be available through September 2022,,,Cardiology; Renal,To be Discontinued,7/19/22,7/19/22,7/19/22,,,,,,,
Bumetanide Injection,Pfizer,844-646-4398,2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 0409-1412-10),New,7/19/22,,Stock anticipated to be available through August 2022,,,Cardiology; Renal,To be Discontinued,7/19/22,7/19/22,7/19/22,,,,,,,
Bumetanide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,1mg/4mL vial (NDC 70860-405-04),Reverified,3/24/23,Available,,,,Cardiovascular,Current,,,1/31/18,,,,,,,
Bumetanide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,2.5mg/10mL vial (NDC 70860-406-10),Reverified,3/24/23,Available,,,,Cardiovascular,Current,,,1/31/18,,,,,,,
Bumetanide Injection,"Hospira, Inc.",844-646-4398,1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1412-04),Reverified,11/28/22,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,,12/13/17,,,,,,,
Bumetanide Injection,"Hospira, Inc.",844-646-4398,2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1412-10),Reverified,11/28/22,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,,12/13/17,,,,,,,
Bumetanide Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 4 mL vial (NDC 0641-6008-10)",Reverified,3/10/23,Inventory is currently available,Additional lots are scheduled for manufacturing and will be available. Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,,1/31/18,,,,,,,
Bumetanide Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 10 mL vial (NDC 0641-6007-10)",Reverified,3/10/23,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,,1/31/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-461-57),Revised,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-463-57),Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.25% (25 mg per 10 mL) (2.5 mg per mL) SDV (NDC 63323-468-17),Revised,3/31/23,Backordered. Next release May 2023.,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI .25% (75 mg per 30 mL) (2.5 mg per mL) SDV (NDC 63323-468-37),Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (50 mg per 10 mL) (5 mg per mL) SDV (NDC 63323-462-17),Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) SDV (NDC 63323-462-37),Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) Sterile-Pak, SDV (NDC 63323-462-31)",Revised,3/31/23,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.75% (225 mg per 30 mL) (7.5 mg per mL)  SDV  (NDC 63323-460-37),Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-01),Revised,3/31/23,Next Delivery: February 2024; Estimated Recovery: March 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-17),Revised,3/31/23,Next Delivery: February 2024; Estimated Recovery: March 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9043-01),Revised,3/31/23,Next Delivery: February 2024; Estimated Recovery: March 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-01),Revised,3/31/23,Next Delivery: February 2024; Estimated Recovery: March 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-17),Revised,3/31/23,Next Delivery: February 2024; Estimated Recovery: March 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9046-01),Revised,3/31/23,Next Delivery: February 2024; Estimated Recovery: March 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-10)",Revised,3/31/23,Next Delivery: August 2023; Estimated Recovery: June 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-30)",Revised,3/31/23,Next Delivery: August 2023; Estimated Recovery: June 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-10)",Revised,3/31/23,Next Delivery: August 2023; Estimated Recovery: June 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-29)",Revised,3/31/23,Next Delivery: September 2023; Estimated Recovery: June 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1752-50)",Revised,3/31/23,Next Delivery and Estimated Recovery: March 2024,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1755-50)",Revised,3/31/23,Limited Supply Available. Next Delivery and Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-465-57),Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-467-57),Revised,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (25 mg per 10 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-17)",Revised,3/31/23,Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-37)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF,             Sterile-Pak, SDV (NDC 63323-464-31)",Revised,3/31/23,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (50 mg per 10 mL) (5 mg per mL)  MPF,                 SDV  (NDC 63323-466-17)",Revised,3/31/23,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF, SDV (NDC 63323-466-37)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF, Sterile-Pak, SDV (NDC 63323-466-31)",Revised,3/31/23,Backordered. Next release not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (75 mg per 10 mL) (7.5 mg per mL) MPF, SDV (NDC 63323-472-17)",Revised,3/31/23,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (225 mg per 30 mL) (7.5 mg per mL) MPF, SDV (NDC 63323-472-37)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.25% 10 mL Single Dose Vials (NDC 55150-167-10),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.25% 30 mL Single Dose Vials (NDC 55150-168-30),Revised,4/4/23,Currently on backorder - next shipment in April,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 10 mL Single Dose Vials (NDC 55150-169-10),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-170-30),Revised,4/4/23,Available,,,Available,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.75% 10 mL Single Dose Vials (NDC 55150-171-10),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.75% 30 mL Single Dose Vials (NDC 55150-172-30),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.25% 50 mL Multiple Dose Vials (NDC 55150-249-50),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 50 mL Multiple Dose Vials (NDC 55150-250-50),Revised,4/4/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-01),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: December 2023,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-02),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1160-01),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-01),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-02),Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: September 2023,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1163-01),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,75 mg/10 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-01),Revised,3/31/23,Next Delivery: July 2023; Estimated Recovery: March 2024,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,225 mg/30 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-02),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: September 2023,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose); Glass Ampul (NDC 00409-3613-01),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: September 2023,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Marcaine 25 mg/10 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-10),Revised,3/31/23,Next Delivery: August 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Marcaine 75 mg/30 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-30),Revised,3/31/23,Next Delivery: October 2023; Estimated Recovery: March 2024,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Marcaine 125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1587-50),Revised,3/31/23,Next Delivery: September 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Marcaine 50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-10),Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Marcaine 150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-29),Revised,3/31/23,Next Delivery: August 2023; Estimated Recovery: December 2023,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Marcaine 250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1610-50),Revised,3/31/23,Limited Supply Available. Next Delivery: June 2023; Estimated Recovery: March 2024,,,Other,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Marcaine 75 mg/10 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-10),Revised,3/31/23,Available,,,Other,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Marcaine 225 mg/30 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-29),Revised,3/31/23,Next Delivery: July 2023; Estimated Recovery: September 2023,,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/128550/download,,
Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 5 mL single-dose ampules (NDC 59923-717-05),Revised,10/19/22,Available,,,,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/162424/download,,
Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 10 mL single-dose ampules (NDC 59923-719-10),Revised,10/19/22,Available,,,,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/162424/download,,
Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 5 mL single-dose ampules (NDC 59923-718-05),Revised,10/19/22,Available,,,,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/162424/download,,
Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 10 mL single-dose ampules (NDC 59923-720-10),Revised,10/19/22,Available,,,,Anesthesia,Current,,,2/20/18,,,,,https://www.fda.gov/media/162424/download,,
Bupivacaine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"Bupivacaine Spinal, USP (7.5 mg/mL in 8.25% dextrose) 2 mL Single Dose Ampule (10 x 2 mL)(NDC 36000-092-10)",Reverified,3/29/23,Stocked out - recovery TBD,,,Manufacturing Delay,Anesthesia,Current,,,2/20/18,,,,,,,
Bupivacaine Hydrochloride Injection,"Huons Co., Ltd",+82-2-854-4700 or via email intbiz@huons.com,"HCl 0.75% & Dextrose 8.25%, Injectable spinal (NDC 73293-0002-2)",Revised,11/15/22,Available,,,,Anesthesia,Current,,,2/20/18,,,,,,,
Busulfan Injection,American Regent/Luitpold,800-645-1706,6 mg/mL  (NDC 0517-0920-08),New,8/6/21,,,,,Hematology,To be Discontinued,,,8/6/21,,,,,,,
Busulfan Injection,Apotex Corp.,800-706-5575,6mg/mL (NDCs 60505-6177-0 and 60505-6177-8),New,10/15/21,,,,,Hematology,To be Discontinued,,,10/15/21,,,,,,,
Butenafine Hydrochloride Cream,"Mylan, A Viatris company",800-796-9526,"Mentax® (butenafine HCl) Cream, 1% 15g Tube; (NDC 0378-6151-46)",New,11/2/22,,Discontinuance of the manufacture of the drug,,,Anti-Infective; Dermatology,To be Discontinued,11/2/22,11/2/22,11/2/22,,,,,,,
Butenafine Hydrochloride Cream,"Mylan, a Viatris company",800-796-9526,"Mentax® (butenafine HCl) Cream, 1% 30g Tube; (NDC 0378-6151-49)",New,11/2/22,,Discontinuance of the manufacture of the drug,,,Anti-Infective; Dermatology,To be Discontinued,11/2/22,11/2/22,11/2/22,,,,,,,
Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment,"Tolmar, Inc.",800-525-8747,Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment (NDC 0781-7165-35 and 0781-7165-95),New,3/2/23,,,,,Dermatology,To be Discontinued,3/2/23,3/2/23,3/2/23,,,,,,,
Calcitonin Salmon Nasal Spray,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",200 IU/spray (NDC 49884-161-11),New,8/29/22,,,,,Musculoskeletal,To be Discontinued,8/29/22,8/29/22,8/29/22,,,,,,,
Calcium Acetate Oral Solution,Fresenius Medical Care North America,800-323-5188,667mg/5mL (NDC 49230-643-31),New,4/5/23,,,,,Renal,To be Discontinued,4/5/23,4/5/23,4/5/23,,,,,,,
Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 mg calcium gluconate per 50 mL (20 mg/mL), single-dose bag (NDC 65219-162-01, 1 bag; NDC 65219-162-10, 24 bags)",Reverified,3/31/23,Available,,,Available,Cardiovascular; Endocrinology/Metabolism; Gastroenterology; Other; Pediatric; Pulmonary/Allergy,Current,,,3/24/21,,,,,,,
Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1800,"2,000 mg calcium gluconate per 100 mL (20 mg/mL), single-dose bag (NDC 65219-164-01, 1 bag; NDC 65219-164-50, 24 bags)",Reverified,3/31/23,Available,,,Available,Cardiovascular; Endocrinology/Metabolism; Gastroenterology; Other; Pediatric; Pulmonary/Allergy,Current,,,3/24/21,,,,,,,
Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 mg calcium gluconate per 10 mL (100 mg/mL), single-dose vial (NDC 63323-360-01, 1 vial; NDC 63323-360-19, 25 vials)",Reverified,3/31/23,Available,,,Available,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,,3/24/21,,,,,,,
Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5,000 mg calcium gluconate per 50 mL (100 mg/mL), single-dose vial (NDC 63323-360-03, 1 vial; NDC 63323-360-59, 25 vials)",Reverified,3/31/23,Available,Check wholesaler inventory,,Available,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,,3/24/21,,,,,,,
Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10,000 mg calcium gluconate per 100 mL (100 mg/mL), pharmacy bulk package vial (NDC 63323-360-05, 1 vial; NDC 63323-360-61, 20 vials)",Reverified,3/31/23,Available,,,Available,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,,3/24/21,,,,,,,
Calcium Gluconate Injection,HQ Specialty Pharma,888-493-0861,"1,000 mg/50 mL (20 mg/mL) single-dose bag (NDC 44567-620-01, 1 bag; NDC 44567-620-24, 24 bags)",Revised,10/17/22,Available,"Manufactured for WG Critical Care, LLC",,,Cardiovascular; Endocrinology/Metabolism; Gastroenterology; Other; Pediatric; Pulmonary/Allergy,Current,,,3/24/21,,,,,,,
Calcium Gluconate Injection,HQ Specialty Pharma,888-493-0861,"2,000 mg/100 mL (20 mg/mL) single-dose bag (NDC 44567-621-01, 1 bag; NDC 44567-621-24, 24 bags)",Revised,10/17/22,Available,"Manufactured for WG Critical Care, LLC",,,Cardiovascular; Endocrinology/Metabolism; Gastroenterology; Other; Pediatric; Pulmonary/Allergy,Current,,,3/24/21,,,,,,,
Calcium Gluconate Injection,HQ Specialty Pharma,888-493-0861,"1,000 mg/100 mL (10 mg/mL) single-dose bag (NDC 44567-622-01, 1 bag; NDC 44567-622-24, 24 bags)",Revised,10/17/22,Available,"Manufactured for WG Critical Care, LLC",,,Cardiovascular; Endocrinology/Metabolism; Gastroenterology; Other; Pediatric; Pulmonary/Allergy,Current,,,3/24/21,,,,,,,
Capecitabine Tablets,Teva Pharmaceuticals,800-545-8800,"150 mg, 60 count (NDC 0093-7473-06)",Revised,4/5/23,Available,,,Demand increase for the drug,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, 120 count (NDC 0093-7474-89)",Revised,4/5/23,Available,,,Demand increase for the drug,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"150 mg, 60 ct (NDC 59651-204-60)",Reverified,3/17/23,On allocation,Intermittent availability expected,,Demand increase for the drug,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"150 mg, 1x10 unit (NDC 59651-204-10)",Reverified,3/17/23,Not Marketed,,,,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"500 mg, 120 ct (NDC 59651-205-08)",Reverified,3/17/23,On allocation,Intermittent availability expected,,Demand increase for the drug,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"500 mg, 1x10 unit (NDC 59651-205-10)",Reverified,3/17/23,Not Marketed,,,,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,"Dr. Reddy’s Laboratories, Inc",866-732-3952,150 mg 60's USA (NDC 55111-496-60),New,2/17/23,Available,,,,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,"Dr. Reddy’s Laboratories, Inc",866-732-3952,500 mg 120's USA (NDC 55111-497-04),New,2/17/23,Available,,,,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","500 mg, 120 count (NDC 16729-073-29)",Revised,2/17/23,Unavailable,Blue Point (NDC 680010-488-07) and NorthStar (NDC 16714-468-01) manufactured by Accord - Unavailable,,Other,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Genentech,800-551-2231,Xeloda 150 mg tablets (NDC 0004-1100-20),Revised,2/10/23,Limited supply available,,,,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Genentech,800-551-2231,Xeloda 500 mg tablets (NDC 0004-1101-50),Revised,2/10/23,Available,,,,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Novadoz Pharmaceuticals LLC,848-200-1906 ,"500 mg, 120 count (NDC 72205-007-92)",Revised,2/10/23,Available,Manufactured by MSN Laboratories Private Limited (Formulation Division),,,Oncology,Current,,,2/9/23,,,,,,,
Capecitabine Tablets,Novadoz Pharmaceuticals LLC,848-200-1906,"150 mg, 60 count (NDC 72205-006-60)",Revised,2/10/23,Available,Manufactured by MSN Laboratories Private Limited (Formulation Division),,,Oncology,Current,,,2/9/23,,,,,,,
Capreomycin Injection,Akorn Pharmaceuticals,800-932-5676,"Capastat Sulfate (Capreomycin for Injection USP) Eq to 1 g Capreomycin activity, 10mL (NDC 17478-080-50)",Revised,5/5/21,,,,,Anti-Infective,To be Discontinued,,,5/21/19,,,,,,,
Captopril Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,12.5mg; 25mg; 50mg; 100mg (NDC 0378-3007-10; 0378-3007-01; 0378-3012-10; 0378-3012-01; 0378-3017-10; 0378-3017-01; 0378-3022-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,,8/9/21,,,,,,,
Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 25mg/15mg 100s Tabs (NDC 00378-0081-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,,8/9/21,,,,,,,
Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 25mg/25mg 100s Tabs (NDC 00378-0083-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,,8/9/21,,,,,,,
Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 50mg/15mg 100s Tabs (NDC 00378-0084-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,,8/9/21,,,,,,,
Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 50mg/25mg 100s Tabs (NDC 00378-0086-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,,8/9/21,,,,,,,
Carbamazepine Oral Suspension,Wockhardt Bio A.G.,847-410-6929,"100mg/5ml 450mL, (NDC 60432-129-16)",New,6/22/22,,,,,Neurology; Pediatric,To be Discontinued,,,6/22/22,,,,,,,
Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose,"Chiesi USA, Inc.",888-466-6505 x6511,Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose (NDC 10122-326-10),New,3/20/18,,,,,Cardiovascular,To be Discontinued,,,3/20/18,,,,,,,
Caspofungin Acetate Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,50 mg (NDC 67457-831-50),New,7/23/20,,,,,Anti-Infective;Pediatric,To be Discontinued,,,7/23/20,,,,,,,
Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single-dose ADD-Vantage Vial (NDC 00409-2585-01,Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 10 g (10 vials) (NDC 60505-6143-04),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,100 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1100-1),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,12/17/18,,,,,,,
Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,300 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1300-1),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,12/17/18,,,,,,,
Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 1 g (25 vials) (NDC 60505-6142-05),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,10g 10 vials (NDC 25021-102-99),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,500mg 25 vials (NDC 25021-100-10),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 2 gram/50 mL in DUPLEX Catalog 3105-11 (NDC 00264-3105-11),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 1 gram/50 mL in DUPLEX Catalog 3103-11 (NDC 0264-3103-11),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,WG Critical Care,888-493-0861,500mg SDV (NDC 44567-706-25),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,WG Critical Care,888-493-0861,1g SDV (NDC 44567-707-25),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,WG Critical Care,888-493-0861,10g PBP (NDC 44567-708-10),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single Dose Glass Fliptop Vial (NDC 00409-0805-01),Revised,12/1/22,,,,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9923-90),Revised,12/1/22,,Product will be made available as it is released.,Available,,Anti-Infective,Resolved,12/1/22,,12/3/18,,,,,,,
Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9924-90),Revised,12/1/22,,Product will be made available as it is released.,Available,,Anti-Infective,Resolved,12/1/22,,12/3/18,,,,,,,
Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 mg/ 100 mL vial (NDC 0143-9983-03),Revised,12/1/22,,Product will be made available as it is released.,Available,,Anti-Infective,Resolved,12/1/22,,12/3/08,,,,,,,
Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 500 mg (NDC 0781-3450-95),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,12/3/18,,,,,,,
Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 1 g (NDC 0781-3451-96),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,12/3/18,,,,,,,
Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 10 g (NDC 0781-3452-95),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,12/3/18,,,,,,,
Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,1g 25 vials (NDC 25021-101-10),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 1 gram/50 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3503)(NDC 0338-3503-41)",Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,12/17/18,,,,,,,
Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 2 gram/100 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3508)(NDC 0338-3508-41)",Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,12/17/18,,,,,,,
Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 2 g (25 vials) (NDC 60505-6231-05),Revised,12/1/22,,,Available,,Anti-Infective,Resolved,12/1/22,,11/30/18,,,,,,,
Cefdinir Capsules,Sandoz,800-525-8747,300 mg capsules  (NDC 0781-2176-60),New,7/9/20,,,,,Anti-Infective,To be Discontinued,,,7/9/20,,,,,,,
Cefdinir Powder for Suspension,Sandoz,800-525-8747,125 mg/5 mL (NDCs 0781-6077-46 and 0781-6077-61),New,10/29/21,,,,,Anti-Infective,To be Discontinued,,,10/29/21,,,,,,,
Cefdinir Powder for Suspension,Sandoz,800-525-8747,250 mg/5 mL (NDCs 0781-6078-46 and 0781-6078-61),New,10/29/21,,,,,Anti-Infective,To be Discontinued,,,10/29/21,,,,,,,
Cefixime Oral Capsules,Ascend Laboratories LLC.,201-326-9004,400 mg (50’s HDPE Bottle pack)(NDC 67877-584-50),Revised,11/30/22,Available,,,Requirements related to complying with good manufacturing practices,Anti-Infective,Current,,,1/21/22,,,,,,,
Cefixime Oral Capsules,Lupin,866-587-4617,400 mg Bottle of 50 capsules (NDC 68180-423-08),Reverified,11/18/22,"Limited availability, Manufacturing and distribution is ongoing.",,,Demand increase for the drug,Anti-Infective,Current,,,1/21/22,,,,,,,
Cefixime Oral Capsules,Lupin,866-587-4617,400 mg Unit dose Package of 10 (1 blister of 10 capsules) (NDC 68180-423-11),Reverified,11/18/22,"Limited availability, Manufacturing and distribution is ongoing.",,,Demand increase for the drug,Anti-Infective,Current,,,1/21/22,,,,,,,
Cefotaxime Sodium Injection,"SteriMax, Inc.",800-881-3550,"2g/vial, (NDC 21586-012-2)",Reverified,10/14/21,Available,,,Other,Anti-Infective;Pediatric,Current,,,2/17/15,,,,,https://www.fda.gov/media/152896/download,,
Cefotaxime Sodium Injection,"SteriMax, Inc.",800-881-3550,"1g/vial, (NDC 21586-011-2)",Reverified,10/14/21,Available,,,Other,Anti-Infective;Pediatric,Current,,,2/17/15,,,,,https://www.fda.gov/media/152896/download,,
Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9930-10),Revised,10/13/22,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,,2/17/15,,,,,,,
Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9931-25),Revised,10/13/22,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,,2/17/15,,,,,,,
Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2 g/ 10 mL vial (NDC 0143-9933-25),Revised,10/13/22,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,,2/17/15,,,,,,,
Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 g/ 100 mL vial (NDC 0143-9935-01),Revised,10/13/22,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,,2/17/15,,,,,,,
Cefotetan Disodium Injection,"Teligent Pharma, Inc.",856-697-1441,Cefotan 2g Vial 10 (NDC 52565-0053-10),Reverified,10/13/21,Discontinued,,,,Anti-Infective,Current,,,12/17/15,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Cefotetan+Disodium+Injection&st=d&tab=tabs-2,,
Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,1 gram/50 mL in DUPLEX (NDC 00264-3173-11),Revised,6/9/22,,,,,Anti-Infective,To be Discontinued,,,8/14/14,,,,,,,
Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,2 gram/50 mL in DUPLEX (NDC 00264-3175-11),Revised,6/9/22,,,,,Anti-Infective,To be Discontinued,,,8/14/14,,,,,,,
Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,1 g SDV (NDC 63323-0385-10),Reverified,3/31/23,Available,Check wholesaler for inventory,,Manufacturing delay,Anti-Infective,Current,,,8/14/14,,,,,,,
Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,2 g SDV (NDC 63323-0386-20),Reverified,3/31/23,Available,Check wholesaler for inventory,,Manufacturing delay,Anti-Infective,Current,,,8/14/14,,,,,,,
Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 g PBP (NDC 63323-0396-61),Reverified,3/31/23,No release date available at this time.,,,Manufacturing delay,Anti-Infective,Current,,,8/14/14,,,,,,,
Cefoxitin for Injection,Apotex Corp.,800-706-5575,1 g (25 vials) (NDC 60505-0759-05),Revised,11/18/21,,,,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,Apotex Corp.,800-706-5575,2 g (25 vials) (NDC 60505-0760-05),Revised,11/18/21,,,,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,Apotex Corp.,800-706-5575,10 g (10 vials) (NDC 60505-0761-04),Revised,11/18/21,,,,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,1 g per vial; SDV; (NDC 63323-341-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,2 grams per vial; SDV; (NDC 63323-342-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,Sagent Pharmaceuticals,866-625-1618,"10 g, package of 10 vials (NDC 25021-111-99)",Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,Sagent Pharmaceuticals,866-625-1618,"1 g, package of 10 vials (NDC 25021-109-10)",Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,Sagent Pharmaceuticals,866-625-1618,"2 g, package of 10 vials (NDC 25021-110-20)",Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,WG Critical Care,888-493-0861,1 g (NDC 44567-245-25),Revised,11/18/21,Available,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,WG Critical Care,888-493-0861,2 g (NDC 44567-246-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,WG Critical Care,888-493-0861,10 g (NDC 44567-247-10),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1g vial (NDC 0143-9878-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2g vial (NDC 0143-9877-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10g vial (NDC 0143-9876-10),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,B. Braun Medical Inc.,800-227-2862,Cefoxitin Injection 2 gram/50 mL in DUPLEX Catalog 3125-11 (NDC NDC 00264-3125-11),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Cefoxitin for Injection,B. Braun Medical Inc.,800-227-2862,Cefoxitin Injection 1 gram/50 mL in DUPLEX Catalog 3123-11 (NDC 0264-3123-11),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,,5/3/19,,,,,,,
Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 1g Bag 24 x 50mL (NDC 24987-0412-00),New,3/20/18,,,,,Anti-Infective;Pediatric,To be Discontinued,,,3/20/18,,,,,,,
Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 2g Bag 24 x 50mL (NDC 24987-0413-00),New,3/20/18,,,,,Anti-Infective;Pediatric,To be Discontinued,,,3/20/18,,,,,,,
"Ceftazidime and Avibactam (AVYCAZ®) for Injection, 2 grams/0.5 grams",Allergan Sales LLC,800-678-1605,"2 g/1, .5 g/1 powder for solution 1 Single-use vials (NDC 0456-2700-01)",Revised,2/7/22,,,Available,,Anti-Infective,Resolved,,,2/26/20,,,,,,,
"Ceftazidime and Avibactam (AVYCAZ®) for Injection, 2 grams/0.5 grams",Allergan Sales LLC,800-678-1605,"2 g/1, .5 g/1 powder for solution Carton containing 10 vials  (NDC 0456-2700-10)",Revised,2/7/22,,,Available,,Anti-Infective,Resolved,,,2/26/20,,,,,,,
Ceftolozane and Tazobactam (Zerbaxa) Injection,Merck Sharp & Dohme Corp.,800-672-6372,Supplied in single-dose vials containing ceftolozane 1 g (equivalent to 1.147 g of ceftolozane sulfate) and tazobactam 0.5 g (equivalent to 0.537 g of tazobactam sodium) per vial. Vials are supplied in cartons containing 10 vials (NDC 67919-030-01),Revised,3/14/22,,,Available,,Anti-Infective,Resolved,,,1/4/21,,,,,,,
Cefuroxime Sodium (Zinacef) Injection,"Teligent Pharma, Inc.",856-697-1441,Cefuroxime Sodium (Zinacef) Premix Sol Frozen 1.5g Bag 24 x 50mL (NDC 24987-0425-00),New,3/20/18,,,,,Anti-Infective;Pediatric,To be Discontinued,,,3/20/18,,,,,,,
Cetirizine Hydrochloride Solution,Torrent Pharma Inc.,908-280-3333,"Oral Solution, 1 mg/mL 120 mL (NDC 1366859607) and 480 mL (NDC 1366859611)",New,6/9/22,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,,6/9/22,,,,,,,
Chloramphenicol Sodium Succinate Injection,Fresenius Kabi USA,888-386-1300,"1 gram per vial, (NDC 63323-011-15)",New,4/5/23,Backordered. Next release May 2023.,,,Manufacturing delay,Anti-Infective,Current,,,4/5/23,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,Chartwell Pharma,845-268-5000 Ext. 510,"5 mg, 60 count (NDC 62135-220-60)",Revised,10/25/22,,,Available,,Neurology; Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,Chartwell Pharma,845-268-5000 Ext. 510,"10 mg, 60 count (NDC 62135-221-60)",Revised,10/25/22,,,Available,,Neurology; Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,Chartwell Pharma,845-268-5000 Ext. 510,"25 mg, 60 count (NDC 62135-222-60)",Revised,10/25/22,,,Available,,Neurology; Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,"Epic Pharma, LLC",888-374-2791,"5mg, 100ct (NDC 42806-564-01)",Revised,10/25/22,,,Available,,Neurology;Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"10 mg, 1000 count (NDC 0555-0033-05)",Revised,10/25/22,,,Available,,Neurology;Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"10 mg, 100 count (NDC 0555-0033-02)",Revised,10/25/22,,,Available,,Neurology;Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 count (NDC 0555-0159-02)",Revised,10/25/22,,,Available,,Neurology;Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 500 count (NDC 0555-0158-04)",Revised,10/25/22,,,Available,,Neurology;Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 500 count (NDC 0555-0159-04)",Revised,10/25/22,,,Available,,Neurology;Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count (NDC 0555-0158-02)",Revised,10/25/22,,,Available,,Neurology;Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,"Epic Pharma, LLC",888-374-2791,"10mg, 100ct (NDC 42806-562-01)",Revised,10/25/22,,,Available,,Neurology;Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
Chlordiazepoxide Hydrochloride Capsules,"Epic Pharma, LLC",888-374-2791,"25mg, 100ct (NDC 42806-563-01)",Revised,10/25/22,,,Available,,Neurology;Psychiatry,Resolved,10/25/22,,3/30/21,,,,,,,
"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,5 mg (NDC 43547-251-10),New,11/19/19,,,,,Neurology;Psychiatry,To be Discontinued,,,11/19/19,,,,,,,
"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,10 mg (NDC 43547-252-10),New,11/19/19,,,,,Neurology;Psychiatry,To be Discontinued,,,11/19/19,,,,,,,
Chloroprocaine Hydrochloride Injection,B. Braun Medical Inc.,800-227-2862,"Clorotekal® (Chloroprocaine HCl Injection, USP) 5mL ampules 50 mg/5 mL (10 mg/mL) Catalog D7055 (NDC 0264-7055-05)",New,5/17/21,Product available,,,Other,Anesthesia,Current,,,5/17/21,,,,,,,
Chloroprocaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,Nescacaine 1% (300 mg per 30 mL) (10 mg per mL); MDV; (NDC 63323-475-37),Revised,3/31/23,Available,Check wholesaler for inventory,,,Anesthesia,Current,,,5/17/21,,,,,,,
Chloroprocaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,Nescacaine 2% (600 mg per 30 mL) (20 mg per mL); MDV; (NDC 63323-476-37),Revised,3/31/23,Available,,,,Anesthesia,Current,,,5/17/21,,,,,,,
Chloroprocaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,Nesacaine 2% (400 mg per 20 mL) (20 mg per mL); SDV; (NDC 63323-477-27),Revised,3/31/23,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,,5/17/21,,,,,,,
Chloroprocaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,Nesacaine 3% (600 mg per 20 mL) (30 mg per mL); SDV; (NDC 63323-478-27),Revised,3/31/23,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,,5/17/21,,,,,,,
Chloroprocaine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% (20 mg/mL), 20 mL vial (NDC 0143-9209-10)",Revised,10/13/22,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,,5/17/21,,,,,,,
Chloroprocaine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"3% (30 mg/mL), 20 mL vial (NDC 0143-9210-10)",Revised,10/13/22,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,,5/17/21,,,,,,,
Chlorothiazide Oral Suspension,"Salix Pharmaceuticals, Inc.",800-321-4576,250 mg/5 mL (NDC 65649-311-12),New,12/20/22,Currently unavailable. Estimated dhortage duration: TBD,,,Other,Cardiovascular,Current,,,12/20/22,,,,,,,
Ciprofloxacin in Dextrose (5%) Injection,Baxter,888-229-0001,200 mg/100 mL (NDC 36000-008-24),New,1/31/23,,Discontinuation of the manufacture of the drug,,,Anti-Infective,To be Discontinued,1/31/23,1/31/23,1/31/23,,,,,,,
Ciprofloxacin in Dextrose (5%) Injection,Baxter,888-229-0001,400 mg/200 mL (NDC 36000-009-24),New,1/31/23,,Discontinuation of the manufacture of the drug,,,Anti-Infective,To be Discontinued,1/31/23,1/31/23,1/31/23,,,,,,,
Cisatracurium Besylate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"10 mg/5 mL Single Dose Vial, Package of 10 vials (NDC 55150-284-10)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,200 mg/20 mL (10 mg/mL) Single-dose vials (NDC 0703-2045-03),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,20 mg/10 mL (2 mg/mL) Multiple-dose vials (NDC 0703-2056-03),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,10 mg/5 mL (2 mg/mL) Single-dose vials (NDC 0703-2033-03),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,2mg/mL 10 vials (NDC 70069-141-10),Revised,7/27/21,,,,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,2mg/ml 10 vials (NDC 70069-161-10),Revised,7/27/21,,,,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,10mg/mL 10 vials (NDC 70069-151-10),Revised,7/27/21,,,,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,10 mg per 5 mL single dose vial (NDC 71288-712-06),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,200 mg per 20 mL single dose vial (NDC 71288-713-21),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,20 mg per 10 mL  multi dose vial (NDC 71288-712-11),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg (base) per 5 mL (2 mg per mL), Single dose vial, PF, (NDC 63323-416-05)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 10 mL (2 mg per mL), Multiple dose vial, (NDC 63323-417-10)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL (10 mg per mL), Single dose vial, PF, (NDC 63323-418-20)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,Sandoz,800-525-8747,2mg/ml; 5mL (NDC 0781-3150-95),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,Sandoz,800-525-8747,2mg/mL; 10mL (NDC 0781-3152-95),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,Sandoz,800-525-8747,1-mg/mL; 20mL (NDC 0781-3153-95_,Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,10mg/5mL (2mg/mL) Single Dose Vial (NDC 00409-1098-02),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Dose Vial (NDC 00409-1103-01),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,20mg/10mL (2mg/mL) Multi-Dose Vial (NDC 00409-1208-01),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,Abbvie,800-255-5162,"2 mg/mL, 5 mL Single-dose vial (NDC 0074-4378-05, 0074-4378-24, 0074-4378-36)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,Abbvie,800-255-5162,"2 mg/mL, 10 mL Multiple-dose vial (NDC 0074-4380-10, 0074-4380-79, 0074-4380-81)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,Abbvie,800-255-5162,"10 mg/mL, 20 mL Single-dose vial (NDC 0074-4382-20, 0074-4382-91, 0074-4382-93)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisatracurium Besylate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"20 mg / 10 mL Multiple-Dose Vial, Package of 10 vials (ndc 55150-286-10)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,,4/8/20,,,,,,,
Cisplatin Injection,Accord Healthcare Inc.,"866-941-7875, option 2","1 mg/mL, 50 mL, multi-dose vial (NDC 16729-288-11)",New,2/10/23,Not available,Marketed by Accord Healthcare. Inventory on hold pending further assessment.,,Other,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,Accord Healthcare Inc.,"866-941-7875, option 2","1 mg/mL, 100 mL, multi-dose vial (NDC 16729-288-38)",New,2/10/23,Not available,Marketed by Accord Healthcare. Inventory on hold pending further assessment.,,Other,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,Accord Healthcare Inc.,"866-941-7875, option 2","1 mg/mL, 50 mL, multi-dose vial (NDC 68001-283-27)",New,2/10/23,Not available,Marketed by BluePoint Laboratories. Inventory on hold pending further assessment.,,Other,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,Accord Healthcare Inc.,"866-941-7875, option 2","1 mg/mL, 100 mL, multi-dose vial (NDC 68001-283-32)",New,2/10/23,Not available,Marketed by BluePoint Laboratories. Inventory on hold pending further assessment.,,Other,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 50 mL, multi-dose vial (NDC 63323-103-51)",Reverified,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 100 mL, multi-dose vial (NDC 63323-103-65)",Reverified,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 200 mL, multi-dose vial (NDC 63323-103-64)",Reverified,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,Hikma Pharmaceuticals,800-631-2174,"1 mg/mL, 50 mL, multi-dose vial (NDC 0143-9504-01)",Revised,3/22/23,This presentation is temporarily on backorder.,Additional lots will be available in the April - May 2023 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,Hikma Pharmaceuticals,800-631-2174,"1 mg/mL, 100 mL, multi-dose vial (NDC 0143-9505-01)",Revised,3/22/23,This presentation is temporarily on backorder.,Additional lots will be available in the March - April 2023 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,HQ Specialty Pharma,WG Critical Care 888-493-0861,"1 mg/mL, 200 mL, multi-dose vial (NDC 44567-511-01)",Revised,3/9/23,Available,Marketed by WG Critical Care,,Demand increase for the drug,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,HQ Specialty Pharma,WG Critical Care 888-493-0861,"50 mg, vial (NDC 44567-530-01)",Revised,3/9/23,Available,Marketed by WG Critical Care,,,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,Teva Pharmaceuticals,800-545-8800,"1 mg/mL, 50 mL, multi-dose vial (NDC 0703-5747-11)",Reverified,4/5/23,Recovery expected Q3,,,Demand increase for the drug,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cisplatin Injection,Teva Pharmaceuticals,800-545-8800,"1 mg/mL, 100 mL, multi-dose vial (NDC 0703-5748-11)",Reverified,4/5/23,Recovery expected Q3,,,Demand increase for the drug,Oncology; Pediatric,Current,,,2/10/23,,,,,,,
Cladribine Injection,Mylan Laboratories Ltd.,800-796-9526,1 mg/mL (NDC 67457-450-10),New,5/20/22,,,,,Oncology,To be Discontinued,,,5/20/22,,,,,,,
"Clindamycin and Benzoyl Peroxide Gel, 1%/5%","Tolmar Pharmaceuticals, Inc.",877-986-5627,45g jar (NDC 0781-7263-68); 35g pump (NDC 0781-7275-43); 50g jar (NDC 0781-7287-50); 50g pump (NDC 0781-7291-46),New,9/30/21,,,,,Dermatology,To be Discontinued,,,9/30/21,,,,,,,
"Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%","Tolmar Pharmaceuticals, Inc.",877-986-5627,45 g tube (NDC 0781-7161-19),New,9/30/21,,,,,Dermatology,To be Discontinued,,,9/30/21,,,,,,,
Clindamycin Phosphate Injection,Pfizer Pharmaceuticals,800-533-4535,Cleocin Phosphate 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26),New,3/21/23,Next Delivery and Estimated Recovery: April 2023,Shortage per Manufacturer: Manufacturing Delays,,Other,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Pfizer Pharmaceuticals,800-533-4535,Cleocin Phosphate 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26),New,3/21/23,Next Delivery and Estimated Recovery:  April 2023,Shortage per Manufacturer: Manufacturing Delays,,Other,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Pfizer Pharmaceuticals,800-533-4535,Cleocin Phosphate 9 g/60 mL (150 mg/mL) Pharmacy Bulk Package (NDC 0009-0728-09),New,3/21/23,Next Delivery and Estimated Recovery:  July 2023,Shortage per Manufacturer: Manufacturing Delays,,Other,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Pfizer Pharmaceuticals,800-533-4535,Cleocin Phosphate 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18),New,3/21/23,Next Delivery: April 2023; Estimated Recovery:  June 2023,Shortage per Manufacturer: Manufacturing Delays,,Other,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Sagent Pharmaceuticals,866-625-1618,"150mg/mL, 25X2mL (NDC 25021-115-02)",Revised,3/22/23,Backorder. Estimated availability TBD,,,Manufacturing delay,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Sagent Pharmaceuticals,866-625-1618,"150mg/mL, 25X4mL (NDC 25021-115-04)",Revised,3/22/23,Backorder. Estimated availability TBD,,,Manufacturing delay,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Sagent Pharmaceuticals,866-625-1618,"150mg/mL, 25x6mL (NDC 25021-115-06)",Revised,3/22/23,Backorder. Estimated availability TBD,,,Manufacturing delay,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Baxter Healthcare,888-229-0001,"Clindamycin in 0.9% Sodium Chloride Injection, 300mg/50mL in GALAXY Plastic Container. Liquid Premix. Product Code 2G3455 (NDC 0338-9545-50)",Revised,3/29/23,Available on allocation,,,Manufacturing delay,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Baxter Healthcare,888-229-0001,"Clindamycin in 0.9% Sodium Chloride Injection, 600mg/50mL in GALAXY Plastic Container. Liquid Premix. Product Code 2G3456 (NDC 0338-9549-50)",Revised,3/29/23,Available on allocation,,,Manufacturing delay,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Baxter Healthcare,888-229-0001,"Clindamycin in 0.9% Sodium Chloride Injection, 900mg/50mL in GALAXY Plastic Container. Liquid Premix. Product Code 2G3457 (NDC 0338-9553-50)",Revised,3/29/23,Available on allocation. Recovery Q2,,,Manufacturing delay,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Baxter Healthcare,888-229-0001,"Clindamycin in 5% Dextrose Injection, 300mg /50mL in GALAXY Plastic Container. Liquid Premix. Product Code 2G3452 (NDC 0338-3410-50)",Revised,3/29/23,Limited supply on allocation. Recovery Q2,,,Manufacturing delay,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Baxter Healthcare,888-229-0001,"Clindamycin in 5% Dextrose Injection, 600mg/50mL in GALAXY Plastic Container. Liquid Premix Product Code 2G3453 (NDC 0338-3612-50)",Revised,3/29/23,Limited supply on allocation. Recovery Q2,,,Manufacturing delay,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Baxter Healthcare,888-229-0001,"Clindamycin in 5% Dextrose Injection, 900mg/50mL in GALAXY Plastic Container. Liquid Premix.  Product Code 2G3454 (NDC 0338-3814-50)",Revised,3/29/23,Limited supply on allocation. Recovery Q2,,,Manufacturing delay,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Sandoz,800-525-8747,300mg/50 mL; pkg of 24 (NDC 0781-3288-09),Revised,4/5/23,Limited Availability,,,Other,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Sandoz,800-525-8747,600mg/50mL; pkg of 24 (NDC 0781-3289-09),Revised,4/5/23,Limited Availability,,,Other,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Sandoz,800-525-8747,900mg/50mL; pkg of 24 (NDC 0781-3290-09),Revised,4/5/23,Limited Availability,,,Other,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Sandoz,800-525-8747,600mg/50mL; pkg of 24 (NDC 72572-074-24),Revised,4/5/23,Unavailable,Civica Label,,Other,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Injection,Sandoz,800-525-8747,900mg/50mL; pkg of 24 (NDC 72572-076-24),Revised,4/5/23,Unavailable,Civica Label,,Other,Anti-Infective,Current,,,3/21/23,,,,,,,
Clindamycin Phosphate Topical Solution 1%,"Teligent Pharma, Inc.",856-697-1441,30mL (NDC 52565-018-29),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Clindamycin Phosphate Topical Solution 1%,"Teligent Pharma, Inc.",856-697-1441,60mL (NDC 52565-018-59),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Clobazam Tablets,"Breckenridge Pharmaceutical, Inc.",860-828-8140,20mg CIV (NDC 51991-901-01),New,2/17/23,,Business decision to discontinue product from the commercial market,,,Neurology,To be Discontinued,2/17/23,2/17/23,2/17/23,,,,,,,
Clobetasol Propionate Ointment,Sandoz,800-525-8747,0.05% 15g (NDC 0168-0162-15),New,10/26/22,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,10/26/22,10/26/22,10/26/22,,,,,,,
Clobetasol Propionate Ointment,Sandoz,800-525-8747,0.05%  30g (NDC 0168-0162-30),New,10/26/22,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,10/26/22,10/26/22,10/26/22,,,,,,,
Clobetasol Propionate Ointment,Sandoz,800-525-8747,0.05% 45g (NDC 0168-0162-46),New,10/26/22,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,10/26/22,10/26/22,10/26/22,,,,,,,
Clobetasol Propionate Ointment,Sandoz,800-525-8747,0.05%  60g (NDC 0168-0162-60),New,10/26/22,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,10/26/22,10/26/22,10/26/22,,,,,,,
Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-039-15),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-039-30),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,45g (NDC 52565-039-45),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-039-60),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Clobetasol Propionate Topical Foam,Ingenus Pharmaceuticals LLC,866-321-5031,0.05% (NDCs 50742-304-01 and 50742-304-50),New,11/16/21,,,,,Dermatology,To be Discontinued,,,11/16/21,,,,,,,
Clobetasol Propionate Topical Solution 0.05%,Wockhardt,800-346-6854,25 mL (NDC 6432-133-25) || 50 mL (NDC 60432-133-50),New,6/13/22,,,,,Dermatology,To be Discontinued,,,6/13/22,,,,,,,
"Clobetasol Propionate Topical Solution, 0.05%","Tolmar Pharmaceuticals, Inc.",877-986-5627,25 mL bottle (NDC 63646-500-25),New,11/1/21,,,,,Dermatology,To be Discontinued,,,11/1/21,,,,,,,
"Clobetasol Propionate Topical Solution, 0.05%","Tolmar Pharmaceuticals, Inc.",877-986-5627,50 mL bottle (NDC 63646-500-50),New,11/1/21,,,,,Dermatology,To be Discontinued,,,11/1/21,,,,,,,
Clomipramine Capsules,Sandoz,800-525-8747,25 mg 100 ct (NDC 0781-2027-01),New,2/14/23,,,,,Psychiatry,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
Clomipramine Capsules,Sandoz,800-525-8747,50 mg 100 ct (NDC 0781-2037-01),New,2/14/23,,,,,Psychiatry,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg  (90s)(NDC 0378-1910-77),New,5/8/18,,,,,Neurology;Pediatric,To be Discontinued,,,5/8/18,,,,,,,
Clonazepam Tablets,Rubicon Research Private Limited,sales@advagenpharma.com,"0.5 mg, 30 count (NDC 72888-152-30)",New,3/27/23,Available from April 3rd 2023,Marketed by Advagen Pharma Ltd.,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Rubicon Research Private Limited,sales@advagenpharma.com,"0.5 mg, 100 count (NDC 72888-152-01)",New,3/27/23,Available from April 3rd 2023,Marketed by Advagen Pharma Ltd.,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Rubicon Research Private Limited,sales@advagenpharma.com,"0.5 mg, 500 count (NDC 72888-152-05)",New,3/27/23,Available from April 3rd 2023,Marketed by Advagen Pharma Ltd.,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Rubicon Research Private Limited,sales@advagenpharma.com,"1 mg, 30 count (NDC 72888-153-30)",New,3/27/23,Available from April 3rd 2023,Marketed by Advagen Pharma Ltd.,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Rubicon Research Private Limited,sales@advagenpharma.com,"1 mg, 100 count (NDC 72888-153-01)",New,3/27/23,Available from April 3rd 2023,Marketed by Advagen Pharma Ltd.,,,Neurology; Pediatric; Psychiatry,Current,,,3/27/23,,,,,,,
Clonazepam Tablets,Rubicon Research Private Limited,sales@advagenpharma.com,"1 mg, 500 count (NDC 72888-153-05)",New,3/27/23,Available from April 3rd 2023,Marketed by Advagen Pharma Ltd.,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Rubicon Research Private Limited,sales@advagenpharma.com,"2 mg, 30 count (NDC 72888-154-30)",New,3/27/23,Available from April 3rd 2023,Marketed by Advagen Pharma Ltd.,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Rubicon Research Private Limited,sales@advagenpharma.com,"2 mg, 100 count (NDC 72888-154-01)",New,3/27/23,Available from April 3rd 2023,Marketed by Advagen Pharma Ltd.,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Rubicon Research Private Limited,sales@advagenpharma.com,"2 mg, 500 count (NDC 72888-154-05)",New,3/27/23,Available from April 3rd 2023,Marketed by Advagen Pharma Ltd.,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Accord Healthcare, Inc.","866-941-7875, option 2","0.5 mg, 100 count (NDC 16729-136-00)",New,3/10/23,Not available. Shortage duration not available.,Inventory on hold pending further assessment.,,Other,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Accord Healthcare, Inc.","866-941-7875, option 2","0.5 mg, 500 count (NDC 16729-136-16)",New,3/10/23,Not available. Shortage duration not available.,Inventory on hold pending further assessment.,,Other,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Accord Healthcare, Inc.","866-941-7875, option 2","1 mg, 100 count (NDC 16729-137-00)",New,3/10/23,Not available. Shortage duration not available.,Inventory on hold pending further assessment.,,Other,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Accord Healthcare, Inc.","866-941-7875, option 2","1 mg, 500 count (NDC 16729-137-16)",New,3/10/23,Not available. Shortage duration not available.,Inventory on hold pending further assessment.,,Other,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Accord Healthcare, Inc.","866-941-7875, option 2","2 mg, 100 count (NDC 16729-138-00)",New,3/10/23,Not available. Shortage duration not available.,Inventory on hold pending further assessment.,,Other,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Accord Healthcare, Inc.","866-941-7875, option 2","2 mg, 500 count (NDC 16729-138-16)",New,3/10/23,Not available. Shortage duration not available.,Inventory on hold pending further assessment.,,Other,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Cheplapharm Arzneimittel GmbH,orders@h2-pharma.com,"0.5 mg, 100 count (NDC 61269-605-10)",New,3/10/23,Available,Marketed by H2-Pharma,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Cheplapharm Arzneimittel GmbH,orders@h2-pharma.com,"1 mg, 100 count (NDC 61269-610-10)",New,3/10/23,Available,Marketed by H2-Pharma,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Cheplapharm Arzneimittel GmbH,orders@h2-pharma.com,"2 mg, 100 count (NDC 61269-620-10)",New,3/10/23,Available,Marketed by H2-Pharma,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Prinston Pharmaceutical, Inc.","For orders, Solco Healthcare 866-931-9829","0.5 mg, 100 count (NDC 43547-406-10)",New,3/10/23,Available,Marketed by Solco Healthcare,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Prinston Pharmaceutical, Inc.","For orders, Solco Healthcare 866-931-9829","0.5 mg, 1000 count (NDC 43547-406-11)",New,3/10/23,Available,Marketed by Solco Healthcare,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Prinston Pharmaceutical, Inc.","For orders, Solco Healthcare 866-931-9829","0.5 mg, 500 count (NDC 43547-406-50)",New,3/10/23,Available,Marketed by Solco Healthcare,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Prinston Pharmaceutical, Inc.","For orders, Solco Healthcare 866-931-9829","1 mg, 100 count (NDC 43547-407-10)",New,3/10/23,Available,Marketed by Solco Healthcare,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Prinston Pharmaceutical, Inc.","For orders, Solco Healthcare 866-931-9829","1 mg, 1000 count (NDC 43547-407-11)",New,3/10/23,Available,Marketed by Solco Healthcare,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Prinston Pharmaceutical, Inc.","For orders, Solco Healthcare 866-931-9829","1 mg, 500 count (NDC 43547-407-50)",New,3/10/23,Available,Marketed by Solco Healthcare,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Prinston Pharmaceutical, Inc.","For orders, Solco Healthcare 866-931-9829","2 mg, 100 count (NDC 43547-408-10)",New,3/10/23,Available,Marketed by Solco Healthcare,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,"Prinston Pharmaceutical, Inc.","For orders, Solco Healthcare 866-931-9829","2 mg, 500 count (NDC 43547-408-50)",New,3/10/23,Available,Marketed by Solco Healthcare,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Teva Pharmaceuticals,800-545-8800,"0.5 mg, 100 count (NDC 0093-0832-01)",Revised,4/5/23,Available,,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Teva Pharmaceuticals,800-545-8800,"0.5 mg, 500 count (NDC 0093-0832-05)",Revised,4/5/23,Available,,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Teva Pharmaceuticals,800-545-8800,"1 mg, 100 count (NDC 0093-3212-01)",Revised,4/5/23,"Limited Supply Available, Recovery April 2023",,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Teva Pharmaceuticals,800-545-8800,"1 mg, 500 count (NDC 0093-3212-05)",Revised,4/5/23,Limited Supply Available,,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Teva Pharmaceuticals,800-545-8800,"2 mg, 100 count (NDC 0093-3213-01)",Revised,4/5/23,"Limited Supply Available, Recovery May 2023",,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonazepam Tablets,Teva Pharmaceuticals,800-545-8800,"2 mg, 500 count (NDC 0093-3213-05)",Revised,4/5/23,Available,,,,Neurology; Pediatric; Psychiatry,Current,,,3/10/23,,,,,,,
Clonidine Hydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",0.1mg  (NDC 10370-257-02),New,11/30/21,,,,,Psychiatry,To be Discontinued,,,11/30/21,,,,,,,
Clonidine Hydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",0.1mg  (NDC 10370-257-02),New,3/22/22,,,,,Cardiovascular,To be Discontinued,,,3/22/22,,,,,,,
Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"12.5 mg tablet, 100 CT Bottle (NDC 18860-101-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,,11/22/19,,,,,,,
Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablets, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-102-01)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,,11/22/19,,,,,,,
Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablet, 100  CT bottle (NDC 18860-102-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,,11/22/19,,,,,,,
Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-104-01)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,,11/22/19,,,,,,,
Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-105-01)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,,11/22/19,,,,,,,
Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 100 CT Bottle (NDC 18860-105-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,,11/22/19,,,,,,,
Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-106-01)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,,11/22/19,,,,,,,
Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablets, 100 CT Bottle (NDC 18860-106-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,,11/22/19,,,,,,,
Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg Tablet, 100 CT Bottle (NDC 18860-104-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,,11/22/19,,,,,,,
Codeine Polistirex and Chlorpheniramine Polistirex Extended-Release Oral Suspension,Aytu BioPharma,855-298-8246,"14.7 mg of codeine (equivalent to 20 mg codeine phosphate); and chlorpheniramine polistirex, which contains 2.8 mg of chlorpheniramine (equivalent to 4 mg chlorpheniramine maleate) per 5 mL (NDCs 69654-480-01 and 69654-480-02)",New,6/13/22,,,,,Pulmonary/Allergy,To be Discontinued,,,6/13/22,,,,,,,
Colestipol Hydrochloride Granules,Pfizer Pharmaceuticals,800-533-4535,"Colestid  5g Granule, For Suspension; 30 x 5 g Blister (NDC 0009-0260-01)",New,3/30/23,,Supply expected to exhaust late May 2023; Discontinuation of the manufacture of the drug.,,,Endocrinology/Metabolism,To be Discontinued,3/30/23,3/30/23,3/30/23,,,,,,,
Collagenase Ointment,"Smith & Nephew, Inc",800-876-1261,Santyl Ointment NDC 50484-010-30 (30g Tube),Reverified,3/1/23,Product is available.,,,,Dermatology,Current,11/21/22,,11/21/22,,,,,,,
Collagenase Ointment,"Smith & Nephew, Inc",800-876-1261,Santyl Ointment NDC 50484-010-90 (90g Tube),Reverified,3/1/23,Product is currently on back order with Smith and Nephew. Shortage duration is unknown at this time.,,,Other,Dermatology,Current,11/21/22,,11/21/22,,,,,,,
Conivaptan Hydrochloride (Vaprisol) in 5% Dextrose Plastic Container,Cumberland Pharmaceuticals Inc.,615-255-0068,20 mg/100 mL (NDC 66220-160-10),New,3/14/22,Next delivery April 2022.  Estimated recovery 3Q 2022.,,,Other,Cardiovascular,Current,,,3/14/22,,,,,,,
"Conjugated Estrogens/Bazedoxifene (DUAVEE) Tablet, Film Coated",Pfizer Pharmaceuticals,800-533-4535,Conjugated estrogens 0.45 mg/bazedoxifene 20 mg; 2 blisters of 15 each (NDC 0008-1123-12),Reverified,3/31/23,Next Delivery and Estimated Recovery: Q4 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Reproductive,Current,,,9/21/22,,,,,,,
"Conjugated Estrogens/Bazedoxifene (DUAVEE) Tablet, Film Coated",Pfizer Pharmaceuticals,800-533-4535,Conjugated estrogens 0.45 mg/bazedoxifene 20 mg; blister of 7 each (US Sample) (NDC 63539-122-07),Reverified,3/31/23,Next Delivery and Estimated Recovery: Q4 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Reproductive,Current,,,9/21/22,,,,,,,
Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BK0/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON-PVC. (NDC 24571-113-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,,4/22/20,,,,,,,
Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK0/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-108-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,,4/22/20,,,,,,,
Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK4/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (DC 24571-114-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,,4/22/20,,,,,,,
Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-105-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,,4/22/20,,,,,,,
Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK2/3.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-103-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,,4/22/20,,,,,,,
Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK2/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-102-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,,4/22/20,,,,,,,
Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol B22GK4/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-111-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,,4/22/20,,,,,,,
Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,PHOXILLUM BK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-116-06),Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,,4/22/20,,,,,,,
Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,PHOXILLUM B22K4/0 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-117-06),Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,,4/22/20,,,,,,,
Cortisone Acetate Tablets,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg, bottles of 100 (NDC 0143-9700-01)",Revised,10/12/22,,Business decision to discontinue manufacture of this product.,,,Endocrinology/Metabolism;Rheumatology,To be Discontinued,10/12/22,10/12/22,3/26/21,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,"CYCLOMYDRIL 0.2%, 1% 2ML (NDC 0065-0359-02)",New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,"CYCLOMYDRIL 0.2%, 1% 5ML (NDC 0065-0359-05)",New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 0.5% 15ML (NDC 0065-0395-15),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 1% 2ML (NDC 0065-0396-02),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 1% 5ML (NDC 0065-0396-05),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 2ML (NDC 0065-0397-02),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 5ML (NDC 0065-0397-05),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 15ML (NDC 0065-0397-15),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOPENTOLATE HCL 1% 15ML (NDC 61314-396-01),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOPENTOLATE HCL 1% 2ML (NDC 61314-396-03),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Bausch & Lomb Incorporated,800-321-4576,"Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, 2 mL bottle (NDC 24208-735-01) and 15 mL bottle (NDC 24208-735-06)",Revised,6/24/21,On backorder. Estimated availability: Mid-September 2021,,,Other,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 15mL 1 Bottle (NDC 17478-097-12)",Revised,3/1/23,Not available,No new manufacturing of product,,,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 2mL, 1 Bottle (NDC 17478-097-02)",Revised,3/1/23,Not available,No new manufacturing of product,,,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 5mL 1 Bottle/EA (NDC 17478-097-10)",Revised,3/1/23,Not available,No new manufacturing of product,,,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl Opht Sol 1% 10mg/mL, 2mL, 1 Bottle (NDC 17478-100-02)",Revised,3/1/23,Not available,No new manufacturing of product,,,Ophthalmology,Current,,,11/9/20,,,,,,,
Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl Ophth 1% 10mg/mL, 15mL, 1 Bottle (NDC 17478-100-12)",Revised,3/1/23,Not available,No new manufacturing of product,,,Ophthalmology,Current,,,11/9/20,,,,,,,
Cysteamine Hydrochloride Ophthalmic Solution,"Leadiant Biosciences, Inc.",866-634-2765,"0.44%, 15 mL bottle (old NDC 54482-020-01) (NEW NDC 54482-020-02)",Revised,6/8/22,,,"NDC 54482-020-01 has been discontinued and replaced by NDC 54482-020-02, which is available.",,Ophthalmology,Resolved,,,10/27/20,,,,,,,
Cysteine Hydrochloride Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154 or 230,Elcys (Cysteine Hydrochloride injection) 500mg/10ml Single-dose vials (NDC 51754-1007-1) Packaged as 10 per carton (NDC 51754-1007-3),Revised,9/3/19,,,Available,,Other;Pediatric,Resolved,,,7/19/16,,,,,,,
Cytarabine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 g/20 mL (100 mg/mL), single dose vial (NDC 63323-120-20)",Reverified,3/31/23,Available,Check wholesalers for inventory,,Manufacturing delay,Oncology;Pediatric,Current,,,9/24/21,,,,,,,
Cytarabine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"100 mg/5 mL (20 mg/mL), single dose vial (NDC 61703-305-38)",Reverified,3/31/23,Available,,,Other,Oncology;Pediatric,Current,,,9/24/21,,,,,,,
Cytarabine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"2 g/20 mL (100 mg/mL), single dose vial (NDC 61703-319-22)",Reverified,3/31/23,Available,,,Other,Oncology;Pediatric,Current,,,9/24/21,,,,,,,
Cytarabine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"500 mg/25 mL (20 mg/mL), multiple dose vial (NDC 61703-304-36)",Reverified,3/31/23,Available,,,Other,Oncology;Pediatric,Current,,,9/24/21,,,,,,,
Cytarabine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"1,000 mg/50 mL (20 mg/mL), pharmacy bulk vial (NDC 61703-303-46)",Reverified,3/31/23,Available,,,Other,Oncology;Pediatric,Current,,,9/24/21,,,,,,,
Cytarabine Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,"2 g/20 mL (100 mg/mL), single dose vial (NDC 71288-109-20)",Reverified,2/13/23,Available.,Check wholesalers for inventory. Next release not determined at this time due to shortage of stoppers.,,,Oncology;Pediatric,Current,,,9/24/21,,,,,,,
Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"2 g/20 mL (100 mg/mL), single dose vial (NDC 67457-452-20)",Reverified,3/28/23,Unavailable,,,,Oncology;Pediatric,Current,,,9/24/21,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Cytarabine+Injection&st=d&tab=tabs-2,,
Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"100 mg/5 mL (20 mg/mL), single dose vial (NDC 67457-455-52)",Reverified,3/28/23,Unavailable,,,,Oncology;Pediatric,Current,,,9/24/21,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Cytarabine+Injection&st=d&tab=tabs-2,,
Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"1000 mg/50 mL (20 mg/mL), pharmacy bulk vial (NDC 67457-454-50)",Reverified,3/28/23,Unavailable,,,,Oncology;Pediatric,Current,,,9/24/21,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Cytarabine+Injection&st=d&tab=tabs-2,,
Cytotec (Misoprostol) Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 120 (NDC 0025-1451-20),New,6/11/21,,,,,Gastroenterology,To be Discontinued,,,6/11/21,,,,,,,
Dacarbazine Injection,Teva Pharmaceuticals,800-545-8800,200 mg 10x20mL (NDC 00703-5075-03),Revised,1/9/23,Unavailable,Recovery TBD,,Demand increase for the drug,Oncology,Current,,,10/20/21,,,,,,,
Dacarbazine Injection,Teva Pharmaceuticals,800-545-8800,200 mg 1x20mL (NDC 00703-5075-01),Revised,1/9/23,Unavailable,Recovery TBD,,Demand increase for the drug,Oncology,Current,,,10/20/21,,,,,,,
Dacarbazine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per vial, Single Dose Amber Vial (NDC 63323-127-10)",Revised,3/31/23,Available,,,Available,Oncology,Current,,,10/20/21,,,,,,,
Dacarbazine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per vial, Single Dose Amber Vial (NDC 63323-128-20)",Revised,3/31/23,Available,Check wholesaler inventory,,Available,Oncology,Current,,,10/20/21,,,,,,,
Dacarbazine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,200 mg/vial (NDC 0143-9245-10),Revised,10/13/22,Inventory is currently available.,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Oncology,Current,,,10/20/21,,,,,,,
Dacarbazine Injection,Teva,800-545-8800,NDC 0703-5075-03 (200 mg 10 X 20 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Dacarbazine Injection,Teva,800-545-8800,NDC 0703-5075-01 (200 mg 1 X 20 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Daptomycin Injection,Pfizer,844-646-4398,350 mg lyophilized; 15 mL Single-dose vial (NDC 0409-5933-01),New,7/26/22,,Supply expected to exhaust 01Sep2022; Replaced with NDC 0409-0120-01; Discontinuation of the manufacture of the drug.,,,Anti-Infective,To Be Discontinued,7/26/22,7/26/22,7/26/22,,,,,,,
Daptomycin Injection,Pfizer,844-646-4398,500 mg lyophilized; 15 mL Single-dose vial (NDC 0409-2757-01),New,7/26/22,,Supply expected to exhaust 01Oct2022; Replaced with NDC 0409-0122-01; Discontinuation of the manufacture of the drug.,,,Anti-Infective,To Be Discontinued,7/26/22,7/26/22,7/26/22,,,,,,,
Daptomycin Injection,"Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc.",800-672-6372,500 mg (NDC 67919-012-01),New,8/2/22,,,,,Anti-Infective,To Be Discontinued,8/2/22,8/2/22,8/2/22,,,,,,,
Daptomycin Injection,Merck Sharp & Dohme Corp.,800-672-6372,500 mg (NDC 67919-011-01),New,10/8/21,,,,,Anti-Infective,To be Discontinued,,,10/8/21,,,,,,,
Daptomycin Injection,"Fresenius Kabi USA, LLC",888-386-1300,350mg (NDC 63323-585-15),New,5/17/22,,,,,Anti-Infective,To be Discontinued,,,5/17/22,,,,,,,
Daptomycin Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500mg (NDCs 63323-371-10, 63323-371-19, and 63323-871-15)",New,5/17/22,,,,,Anti-Infective,To be Discontinued,,,5/17/22,,,,,,,
Darifenacin Hydrobromide Tablets,Teva Pharmaceuticals,800-545-8800,"Extended release, 7.5 mg, 90 count bottle (NDC 0591-4375-19)",New,6/17/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Darifenacin Hydrobromide Tablets,Teva Pharmaceuticals,800-545-8800,"15 mg, 30 count bottle (NDC: 0591-4380-30)",New,6/17/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of 30 (NDC 0430-0171-15)",New,6/4/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of  90 (NDC 0430-0171-23)",New,6/4/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg , 337500 TABLETS in 1 DRUM (NDC 0430-0171-00)",New,6/4/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of 7 (NDC 0430-0171-96)",New,6/4/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg Bottle of 30 (NDC 0430-0170-15)",New,6/4/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg Bottle of  90 (NDC 0430-0170-23)",New,6/4/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg, 337500 TABLETS in 1 DRUM (NDC 0430-0170-00)",New,6/4/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg, Bottle of 7 (NDC 0430-0170-96)",New,6/4/20,,,,,Urology,To be Discontinued,,,6/4/20,,,,,,,
Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir (Viekira XR) Tablets,Abbvie,800-255-5162,"200mg; 8.33mg; 50mg; 33.33 tablets, (NDC 0074-0063-28)",New,5/22/18,,,,,Antiviral,To be Discontinued,,,5/22/18,,,,,,,
Daunorubicin Hydrochloride Injection,Teva,800-545-8800,"20 mg/4 mL, 10 Single Dose Vial Tray (NDC 0703-5233-13)",New,8/11/22,,Product is temporarily unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Daunorubicin Hydrochloride Injection (Novaplus®* Label),Teva Pharmaceuticals,800-545-8800,"5 mg/mL, 20 mg 4 mL/Vial x 10 (NDC 0703-5233-93)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Oncology,To be Discontinued,9/13/22,9/13/22,9/13/22,,,,,,,
Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,180 mg/1 (NDC 00093-3516-56),New,7/20/20,,,,,Hematology,To be Discontinued,,,7/20/20,,,,,,,
Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,90 mg/1 (NDC 00093-3517-56),New,7/20/20,,,,,Hematology,To be Discontinued,,,7/20/20,,,,,,,
Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,360 mg/1 (NDC 00093-3515-56),New,7/20/20,,,,,Hematology,To be Discontinued,,,7/20/20,,,,,,,
DesipramineTablets,Sandoz,800-525-8747,10 mg 100 ct (NDC 0781-8218-01),New,2/14/23,,,,,Psychiatry,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
DesipramineTablets,Sandoz,800-525-8747,25 mg 100 ct (NDC 0781-8972-01),New,2/14/23,,,,,Psychiatry,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
DesipramineTablets,Sandoz,800-525-8747,50 mg 100 ct (NDC 0781-8973-01),New,2/14/23,,,,,Psychiatry,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
DesipramineTablets,Sandoz,800-525-8747,75 mg 100 ct (NDC 0781-8974-01),New,2/14/23,,,,,Psychiatry,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
DesipramineTablets,Sandoz,800-525-8747,100 mg 100 ct (NDC 0781-8975-01),New,2/14/23,,,,,Psychiatry,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
DesipramineTablets,Sandoz,800-525-8747,150 mg 50 ct (NDC 0781-8976-50),New,2/14/23,,,,,Psychiatry,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
Desmopressin Acetate Injection,Teva,800-545-8800,NDC 0703-5051-03 (4 mcg/mL 10 x 1 mL  Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Hematology; Endocrinology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Desmopressin Acetate Injection,Teva,800-545-8800,NDC 0703-5054-01 (4 mcg/mL 10 mL Muti Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Hematology; Endocrinology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Desmopressin Acetate Nasal Spray,Ferring,888-337-7464,"1.5 mg/mL, (NDC 0053-6871-00)",Revised,5/14/21,Unavailable,,,Other,Hematology,Current,,,3/12/21,,,,,,,
Desmopressin Acetate Nasal Spray,Ferring,888-337-7464,10 mcg/0.1mL (NDCs 55566-2500-0 and 69918-501-05),New,5/14/21,Unavailable,,,Other,Hematology,Current,,,3/12/21,,,,,,,
Desmopressin Acetate Nasal Spray,Apotex Corp.,800-706-5575,10 mcg/0.1mL (NDC 60505-0815-0),Reverified,2/15/23,Available,,,,Hematology,Current,,,3/12/21,,,,,,,
Desmopressin Acetate Tablets,"Teva Pharmaceuticals USA, Inc.",800-545-8800,0.1 mg  (NDC 0591-2464-01),New,3/14/23,,,,,Gastroenterology,To be Discontinued,3/14/23,3/14/23,3/14/23,,,,,,,
Desmopressin Acetate Tablets,"Teva Pharmaceuticals USA, Inc.",800-545-8800,0.2 mg  (NDC 0591-2465-01),New,3/14/23,,,,,Gastroenterology,To be Discontinued,3/14/23,3/14/23,3/14/23,,,,,,,
Desogestrel and Ethinyl Estradiol Tablets (ORTHO-CEPT),Janssen Pharmaceuticals,800-526-7736,ORTHO-CEPT (NDC 50458-196-15),Revised,10/8/14,,,,Discontinuation of the manufacture of the drug.,,To Be Discontinued,,,10/8/14,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection SDV [4 mg / 1 ml] 25PK (NDC 67457-423-12),Reverified,3/28/23,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [20 mg / 5 ml] 25PK (NDC 67457-422-54),Reverified,3/28/23,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [120 mg / 30 ml] 25 PK (NDC 67457-421-30),Reverified,3/28/23,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [100 mg / 10 ml] 10PK (NDC 67457-420-10),Reverified,3/28/23,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,4 mg/1 mL SDV (NDC 55150-237-01),Revised,4/4/23,On long-term backorder,Check wholesalers for inventory,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,20 mg/5 mL MDV  (NDC 55150-238-05),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,120 mg/30 mL MDV (NDC 55150-239-30),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Somerset Therapeutics, LLC",732-554-1019,"Dexamethasone Sodium Phosphate Injection USP, 10 mg/mL, 1 mL Single Dose Vial (Preservative Free)(NDC 70069-021-25)",Reverified,4/20/22,Available,,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,20 mg per 5 mL (4 mg per mL); MDV;  Amber vial (NDC 63323-165-05),Revised,3/31/23,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mg per 10 mL (10 mg per mL); MDV;  Amber Vial (NDC 63323-516-10),Revised,3/31/23,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,120 mg per 30 mL (4 mg per mL); MDV; Amber Vial (NDC 63323-165-30),Revised,3/31/23,Backordered. Next release April 2023.,,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,4 mg per mL (4 mg per mL); SDV; Amber Vial (NDC 63323-165-01),Revised,3/31/23,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 mg per mL (10 mg per mL); SDV; Preservative Free; Amber Vial (NDC 63323-506-01),Revised,3/31/23,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6145-25)",Revised,10/13/22,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 5 mL vial (NDC 0641-6146-25)",Revised,10/13/22,Inventory is currently available.,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-0367-25)",Revised,10/13/22,Inventory is currently available,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,10 mg/1 mL SDV (NDC 55150-304-25),Revised,4/4/23,Currently on backorder - next shipment end of March 2023,Check wholesalers for inventory,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,100 mg/10 mL MDV (contains preservative)(NDC 55150-305-10),Revised,4/4/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-106-10)",Revised,3/31/23,7 month expiry (10/31/2023 expiry) dating available by request.,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-109-10)",Revised,3/31/23,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,,2/8/19,,,,,,,
Dexmedetomidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"0.2 mg / 50 ml (Solution in Single Use Vials/Bottles), 20PK (NDC 67457-924-50)",Reverified,3/28/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"0.4 mg / 100 ml (Solution in Single Use Vials/Bottles), 10PK (NDC 67457-925-10)",Reverified,3/28/23,Available,,,Demand increase for the drug,,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"200 mcg/50 mL (4 mcg/mL), 50 mL single dose vial, box of 25 (NDC 42023-186-20)",Reverified,9/21/22,Par Product Available – Please Check Wholesalers,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"400 mcg/100 mL (4 mcg/mL), 100 mL single dose vial, box of 10 (NDC 42023-187-10)",Reverified,9/21/22,Par Product Available – Please Check Wholesalers,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mcg/mL, 2 mL vial (NDC 0143-9532-25)",Revised,10/13/22,Inventory is currently available,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Accord Healthcare Inc.,"866-941-7875, option 2","200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 16729-239-93)",Reverified,4/21/22,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Accord Healthcare Inc.,"866-941-7875, option 2","200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 16729-432-93), Novaplus",Reverified,4/21/22,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 55150-209-02)",Reverified,3/17/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 24 (NDC 0338-9555-24)",Reverified,3/29/23,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 12 (NDC 0338-9557-12)",Reverified,3/29/23,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 24 (NDC 43066-555-24), Novaplus",Reverified,3/29/23,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 12 (NDC 43066-557-12), Novaplus",Reverified,3/29/23,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"80 mcg/20 mL (4 mcg/mL) in 0.9% sodium chloride, single dose vial, box of 10 (NDC 63323-671-20)",Reverified,3/31/23,Available,Check wholesaler inventory,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 25 (NDC 63323-671-50)",Reverified,3/31/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 63323-671-00)",Reverified,3/31/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 63323-421-02)",Reverified,3/31/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"400 mcg/4 mL (100 mcg/mL), multi-dose vial, box of 4 (NDC 44567-600-04)",Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"1000 mcg/10 mL (100 mcg/mL), multi-dose vial, box of 4 (NDC 44567-601-04)",Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"200 mcg/50 mL (4 mcg/mL), single dose bag, box of 24 (NDC 44567-602-24)",Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"400 mcg/100 mL (4 mcg/mL), box of 24 (NDC 44567-603-24)",Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Jiangsu Hengrui Medicine Co. Ltd.,Athenex: 855-273-0154,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 70860-605-03)",Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 67457-251-02)",Reverified,3/28/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"100 mcg/mL, 2 mL single dose vial, box of 25 (NDC 42023-146-25)",Reverified,9/21/22,Par Product Available – Please Check Wholesalers,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"80 mcg/20 mL (4 mcg/mL) in 0.9% sodium chloride, single dose vial, box of 10 (NDC 0409-1660-20)",Reverified,3/31/23,Available,,,Other,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 20 (NDC 0409-1660-50)",Reverified,3/31/23,Available,,,Other,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 0409-1660-10)",Reverified,3/31/23,Available,,,Other,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 0409-1638-02)",Reverified,3/31/23,Available,,,Other,Anesthesia,Current,,,4/10/20,,,,,https://www.fda.gov/drugs/drug-shortages/search-list-extended-use-dates-assist-drug-shortages,,
Dexmedetomidine Injection,Slayback Pharma,844-566-2505,"4 mcg/mL in 0.9% sodium chloride, 50 mL single dose bottle, box of 20 (NDC 71225-126-05)",Reverified,12/28/22,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Slayback Pharma,844-566-2505,"4 mcg/mL in 0.9% sodium chloride, 100 mL single dose bottle, box of 10 (NDC 71225-126-06)",Reverified,12/28/22,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Amneal Pharmaceutical,866-525-7270,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single-dose bottle (NDC 70121-1388-8 box of 20; NDC 70121-1388-1 individual)",Reverified,3/17/23,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Amneal Pharmaceutical,866-525-7270,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single-dose bottle (NDC 70121-1389-7 box of 10; NDC 70121-1389-1 individual)",Reverified,3/17/23,Available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"200mcg/50mL, single dose bag (NDC 55150-296-10)",Revised,3/17/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"400mcg/100mL, single dose bag (NDC 55150-297-10)",Reverified,3/17/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Gland Pharma Limited,866-733-3952,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 43598-976-58)",Reverified,3/10/23,Inventory available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,Gland Pharma Limited,866-733-3952,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 43598-975-58)",Reverified,3/10/23,Inventory available,,,,Anesthesia,Current,,,4/10/20,,,,,,,
Dexmedetomidine Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,"200 mcg/2 mL (100 mcg/mL) single dose vial, box of 25 (NDC 71288-505-03)",Revised,2/13/23,Available on allocation.,,,Demand increase of drug,Anesthesia,Current,,,4/10/21,,,,,,,
Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100s (NDC 0378-1070-01)",New,5/8/18,,,,,Neurology;Pediatric;Psychiatry,To be Discontinued,,,5/8/18,,,,,,,
Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100s (NDC 0378-1071-01)",New,5/8/18,,,,,Neurology;Pediatric;Psychiatry,To be Discontinued,,,5/8/18,,,,,,,
Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-1072-01)",New,5/8/18,,,,,Neurology;Pediatric;Psychiatry,To be Discontinued,,,5/8/18,,,,,,,
Dextrose 10% Injection,Baxter Healthcare,888-229-0001,"10% Dextrose Injection, 250 mL Viaflex Plastic Container. Product Code 2B0162Q (NDC 0338-0023-02)",Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,Baxter Healthcare,888-229-0001,"10% Dextrose Injection, 500 mL Viaflex Plastic Container. Product Code 2B0163Q (NDC 0338-0023-03)",Reverified,3/29/23,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,Baxter Healthcare,888-229-0001,"10% Dextrose Injection, 1000 mL Viaflex Plastic Container. Product Code 2B0164X (NDC 0338-0023-04)",Reverified,3/29/23,Available,,,Manufacturing Delay,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,B. Braun Medical Inc.,800-227-2862,10% 1000 mL Excel Bag L5200 (NDC 0264-7520-00),New,3/1/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,B. Braun Medical Inc.,800-227-2862,10% 500 mL Excel Bag L5201 (NDC 0264-7520-10),New,3/1/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,B. Braun Medical Inc.,800-227-2862,10% 250 mL Excel Bag L5202 (NDC 0264-7520-20),New,3/1/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10% Dextrose Injection, Single dose freeflex bag, (100 mg per mL), (25 grams per 250 mL) (NDC 63323-824-74)",Reverified,3/31/23,Available,Check wholesalers for inventory.,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10% Dextrose Injection, Single dose freeflex bag, (100 mg per mL), (50 grams per 500 mL) (NDC 63323-824-75)",Reverified,3/31/23,Available,Check wholesalers for inventory.,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10% Dextrose Injection, Single dose freeflex bag, (100 mg per mL), (100 grams per 1,000 mL) (NDC 63323-824-76)",Reverified,3/31/23,Available,Check wholesalers for inventory.,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,"ICU Medical, Inc.",877-946-7747,"10% Dextrose Injection, USP, 250 mL (Legacy Hospira NDC 0409-7930-02), (ICU Medical NDC 0990-7930-02)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,"ICU Medical, Inc.",877-946-7747,"10% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7930-03), (ICU Medical NDC 0990-7930-03)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,"ICU Medical, Inc.",877-946-7747,"10% Dextrose Injection, USP, 1000 mL (Legacy Hospira NDC 0409-7930-09), (ICU Medical NDC 0990-7930-09)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 10% Injection,"ICU Medical, Inc.",877-946-7747,"10% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7938-19) (ICU Medical NDC 0990-7938-19)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,3/1/22,,,,,,,
Dextrose 25% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"2.5 g/10 mL (250 mg/mL), plastic syringe, 10 per bundle (NDC 0409-1775-10)",Reverified,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,2/7/22,,,,,https://www.fda.gov/media/165564/download,,
Dextrose 5% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-66),Reverified,3/31/23,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,https://www.fda.gov/media/158041/download,,
Dextrose 5% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-67),Reverified,3/31/23,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,https://www.fda.gov/media/158041/download,,
Dextrose 5% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mL; ADD-Vantage Flexible Container (Case of 24)(NDC 0409-7100-02),Reverified,3/31/23,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,https://www.fda.gov/media/158041/download,,
Dextrose 5% Injection,Fresenius Kabi USA,888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (5 grams per 100 mL) (NDC 63323-624-61)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesaler inventory,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Fresenius Kabi USA,888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (12.5 grams per 250 mL) (NDC 63323-624-74)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesaler inventory,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Fresenius Kabi USA,888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (25 grams per 500 mL) (NDC 63323-624-75)",Revised,3/31/23,Backordered. Next release April 2023.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Fresenius Kabi USA,888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (50 grams per 1,000 mL) (NDC 63323-624-10)",Revised,3/31/23,Available,Check wholesaler inventory,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Fresenius Kabi USA,888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (2.5 grams per 50 mL) (NDC 63323-624-50)",Revised,3/31/23,Backordered. Next release April 2023.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 250 mL (Legacy Hospira NDC 0409-7922-02) (ICU Medical NDC 0990-7922-02)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 150 mL (Legacy Hospira NDC 0409-7922-61) (ICU Medical NDC 0990-7922-61)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 50 mL (Legacy Hospira NDC 0409-7923-13) (ICU Medical NDC 0990-7923-13)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 25 mL 4-1 (Legacy Hospira NDC 0409-7923-20) (ICU Medical NDC 0990-7923-20)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 100 mL (Legacy Hospira NDC 0409-7923-23) (ICU Medical NDC 0990-7923-23)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 50 mL 4-1 (Legacy Hospira NDC 0409-7923-36) (ICU Medical NDC 0990-7923-36)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 100 mL 4-1 (Legacy Hospira NDC 0409-7923-37) (ICU Medical NDC 0990-7923-37)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 25 mL VIAFLEX Plastic Container Quad Pack, Product Code 2B0080, (NDC 0338-0017-10)",Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Product Code 2B0086, (NDC 0338-0017-41)",Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0081, (NDC 0338-0017-11)",Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0088, (NDC 0338-0017-31)",Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Product Code 2B0087, (NDC 0338-0017-48)",Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0082, (NDC 0338-0017-18)",Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0089, (NDC 0338-0017-38)",Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container. Quad Pack, Product Code 2B0040, (NDC 0338-0551-11)",Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container, Product Code EZPB0040, (NDC 0338-9143-30)",Reverified,3/29/23,Available on allocation,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code EZPB0041, (NDC 0338-9147-30)",Reverified,3/29/23,Available on allocation,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code 2B0041, (NDC 0338-0551-18)",Reverified,3/1/23,Available,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 1000 mL VIAFLO Plastic Container, Product Code UE0064D, (NDC 0338-0070-10)",Reverified,3/1/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL VIAFLEX Plastic Container, Product Code 2B0062Q, (NDC 0338-0017-02)",Reverified,3/1/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL VIAFLO Plastic Container, Product Code UE0062D, (NDC 0338-0062-30)",Reverified,3/1/23,"Limited Supply, Recovery Q2",,,Third-party Supplier Issue,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL VIAFLEX Plastic Container, Product Code 2B0063Q, (NDC 0338-0017-03)",Reverified,3/1/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL VIAFLO Plastic Container, Product Code UE0063D, (NDC 0338-0066-20)",Reverified,3/1/23,Limited supply; Recovery Q2,,,Third-party Supplier Issue,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 500 mL Excel Bag L5101 (NDC 0264-7510-10),New,2/16/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 1000 mL Excel Bag L5100 (NDC 0264-7510-00),New,2/16/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 250 mL Excel Bag L5102 (NDC 0264-7510-20),New,2/16/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 100 mL PAB Bag S5104-5264 (NDC 0264-1510-32),New,2/16/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 50 mL PAB Bag S5104-5364 (NDC 0264-1510-31),New,2/16/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,10% 1000 mL Excel Bag L5200 (NDC 0264-7520-00),New,2/16/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,10% 500 mL Excel Bag L5201 (NDC 0264-7520-10),New,2/16/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,10% 250 mL Excel Bag L5202 (NDC 0264-7520-20),New,2/16/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-03) (ICU Medical NDC 0990-7922-03)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-55) (ICU Medical NDC 0990-7922-55)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 1000 mL (Legacy Hospira NDC 0409-7922-09) (ICU Medical NDC 0990-7922-09)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,,2/14/22,,,,,,,
Dextrose 50% Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"25 g/50 mL (0.5 g/mL), syringe, 10 per carton (NDC 76329-3302-1) (old NDC 76329-3301-1)",Reverified,4/6/23,Backorder due to increase in demand,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,1/13/22,,,,,,,
Dextrose 50% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"25 g/50 mL (0.5 g/mL), plastic syringe, 10 per bundle (NDC 0409-7517-16)",Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,1/13/22,,,,,https://www.fda.gov/media/165564/download,,
Dextrose 50% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"25 g/50 mL (0.5 g/mL), glass syringe, 10 per bundle (NDC 0409-4902-34)",Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,1/13/22,,,,,https://www.fda.gov/media/165564/download,,
Dextrose 50% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"25 g/50 mL (0.5 g/mL), single dose vial, 25 per tray (NDC 0409-6648-02)",Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,1/13/22,,,,,,,
Diazepam Oral Solution (Concentrate),"Lannett Company, Inc.",215-333-9300,5 mg/mL (NDC 0527-1768-36),New,1/5/22,,,,,Neurology,To be Discontinued,,,1/5/22,,,,,,,
Diazepam Rectal Gel,Bausch Health,908-927-1400,"Diazepam Rectal Gel - 10mg 2 Syrg per pack, (NDC 68682-652-20)",Revised,9/22/22,Available,Estimated availability September 2022,,,Neurology,Current,,,6/15/22,,,,,,,
Diazepam Rectal Gel,Bausch Health,908-927-1400,"Diazepam Rectal Gel – 2.5mg 2 Syrg per pack, (NDC 68682-650-20)",Revised,9/22/22,Currently unavailable,Estimated availability: TBD,,,Neurology,Current,,,6/15/22,,,,,,,
Diazepam Rectal Gel,Bausch Health,908-927-1400,Diastat Rectal Gel 2.5mg (NDC  66490-650-20),Revised,9/22/22,No longer available,No plans to manufacture.  All volumes converted to generic version,,,Neurology,Current,,,6/15/22,,,,,,,
Diazepam Rectal Gel,Bausch Health,908-927-1400,Diastat Acudial 10 mg (NDC 0187-0658-20),Revised,9/22/22,No longer available,No plans to manufacture.  All volumes converted to generic version,,,Neurology,Current,,,6/15/22,,,,,,,
Diazepam Rectal Gel,Bausch Health,908-927-1400,Diastat Acudial 20 mg (NDC 0187-0659-20),Revised,9/22/22,No longer available,No plans to manufacture.  All volumes converted to generic version,,,Neurology,Current,,,6/15/22,,,,,,,
Diazepam Rectal Gel,Bausch Health,908-927-1400,"Diazepam Rectal Gel - 20mg 2 Syrg per pack, (NDC 68682-655-20)",Revised,9/22/22,Available,,,,Neurology,Current,,,6/15/22,,,,,,,
Diclofenac Sodium Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg (NDC 0378-0355-01),New,4/4/18,,,,,Analgesia/Addiction;Rheumatology,To be Discontinued,,,4/4/18,,,,,,,
Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 200 mg, 30 count bottles (NDC 0555-0588-01)",New,5/9/18,,,,,Antiviral,To be Discontinued,,,5/9/18,,,,,,,
Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 250 mg, 30 count bottles (NDC 0555-0589-01)",New,5/9/18,,,,,Antiviral,To be Discontinued,,,5/9/18,,,,,,,
Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 400 mg, 30 count bottles (NDC 0555-0590-01)",New,5/9/18,,,,,Antiviral,To be Discontinued,,,5/9/18,,,,,,,
"Diflorasone Diacetate Ointment, 0.05%","Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-063-15),New,7/6/21,,,,,Dermatology,To be Discontinued,,,7/6/21,,,,,,,
"Diflorasone Diacetate Ointment, 0.05%","Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-063-30),New,7/6/21,,,,,Dermatology,To be Discontinued,,,7/6/21,,,,,,,
"Diflorasone Diacetate Ointment, 0.05%","Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-063-60),New,7/6/21,,,,,Dermatology,To be Discontinued,,,7/6/21,,,,,,,
Diflunisal Tablets,Avet Pharmaceuticals Inc,855-228-9470,"500 mg, Bottle of 60 (NDC 14539-673-06)",Revised,10/31/22,"Product is available, on allocation",,,Demand increase for the drug,Analgesia/Addiction,Current,,,2/25/22,,,,,,,
Diflunisal Tablets,Avet Pharmaceuticals Inc,855-228-9470,"500 mg, Bottle of 100 (NDC 14539-673-01)",Revised,10/31/22,"Product is available, on allocation",,,Demand increase for the drug,Analgesia/Addiction,Current,,,2/25/22,,,,,,,
Diflunisal Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, Bottle of 100 (NDC 0093-9222-01)",Reverified,4/5/23,Available,,,Other,Analgesia/Addiction,Current,,,2/25/22,,,,,,,
Diflunisal Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, Bottle of 500 (NDC 0093-9222-05)",Reverified,4/5/23,Available,,,Other,Analgesia/Addiction,Current,,,2/25/22,,,,,,,
Diflunisal Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, Bottle of 60 (NDC 0093-9222-06)",Reverified,4/5/23,Available,,,Other,Analgesia/Addiction,Current,,,2/25/22,,,,,,,
Difluprednate Ophthalmic Emulsion,Amneal,866-525-7270,"Difluprednate Ophthalmic Emulsion, 0.05% (5 mL), single-dose bottle (NDC 69238-1380-3)",New,12/21/22,Available,,,,Ophthalmology,Current,,,12/21/22,,,,,,,
Difluprednate Ophthalmic Emulsion,Novartis Pharmaceuticals Corporation,888-669-6682,DUREZOL® (difluprednate ophthalmic emulsion) 0.05% 5mL in 1 bottle (NDC 0065-9240-07),Revised,3/31/23,Availability at wholesalers: Not available; Estimated Shortage Duration: 1 month,There are therapeutic equivalents available for this product.,,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,,12/21/22,,,,,,,
Difluprednate Ophthalmic Emulsion,Novartis Pharmaceuticals Corporation,,Difluprednate ophthalmic emulsion 0.05% 5mL in 1 bottle (NDC 0781-6000-78),Revised,3/31/23,Availability at wholesalers: Not available; Estimated Shortage Duration: 1 month,There are therapeutic equivalents available for this product.,,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,,12/21/22,,,,,,,
Difluprednate Ophthalmic Emulsion,Cipla Limited,844-247-5287,5ml bottle (NDC 69097-341-35),New,12/21/22,Currently unavailable,,,,Ophthalmology,Current,,,12/21/22,,,,,,,
Digoxin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"250 mcg/mL, 2 mL  (NDC 0641-1410-35)",Reverified,4/8/22,Inventory is currently available,,,Other,Cardiovascular,Current,,,6/4/21,,,,,,,
Digoxin Injection,Sandoz,800-525-8747,500mcg/2 mL; 10 ampules (NDC 0781-3059-95),Reverified,4/5/23,"Unavailable, resupply Aug 2023",,,Shortage of an active ingredient,Cardiovascular,Current,,,6/4/21,,,,,,,
Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Adult (500mcg in 2ml) Ampule (NDC 0515-260-10),Revised,2/23/23,Available,,,Delay in shipping of the drug,Cardiovascular,Current,,,6/4/21,,,,,,,
Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Adult (500mcg in 2ml) vial (NDC 70515-261-10),Revised,2/23/23,Available,,,,Cardiovascular,Current,,,6/4/21,,,,,,,
Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Pediatric (100mcg in 1ml) ampoule (NDC 70515-262-10),Revised,2/23/23,Available,,,,Cardiovascular,Current,,,6/4/21,,,,,,,
Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Pediatric (100mcg in 1ml) vial (NDC 70515-263-10),Revised,2/23/23,Available,,,,Cardiovascular,Current,,,6/4/21,,,,,,,
Diltiazem Hydrochloride Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1171-02),New,6/8/21,,,,,Cardiovascular,To be Discontinued,,,2/21/18,,,,,,,
Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 1 vial (NDC 17478-0937-25)",New,4/8/22,,,,,Cardiovascular,To be Discontinued,,,4/8/22,,,,,,,
Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 10 vials (NDC 17478-0937-26)",New,4/8/22,,,,,Cardiovascular,To be Discontinued,,,4/8/22,,,,,,,
Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 5 mL, 10 vials (NDC 17478-0937-05)",New,4/8/22,,,,,Cardiovascular,To be Discontinued,,,4/8/22,,,,,,,
Diltiazem Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 10 mL vial (NDC 0641-6014-10)",Revised,10/13/22,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,,3/1/18,,,,,,,
Diltiazem Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 30 mL vial (NDC 0641-6015-10)",Revised,10/13/22,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,,3/1/18,,,,,,,
Diltiazem Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg; Single Dose ADD-Vantage Vial (NDC 00409-4350-03),Reverified,3/31/23,Available,,,Other,Cardiovascular,Current,,,2/21/18,,,,,,,
Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 10 mL, 10 vials (NDC 17478-0937-10)",Revised,3/1/23,Not available,No new manufacturing of product,,,Cardiovascular,Current,,,2/21/18,,,,,,,
Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 1 vial (NDC 17478-0937-25)",Revised,3/1/23,Not available,No new manufacturing of product,,,Cardiovascular,Current,,,2/21/18,,,,,,,
Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 10 vials (NDC 17478-0937-26)",Revised,3/1/23,Not available,No new manufacturing of product,,,Cardiovascular,Current,,,2/21/18,,,,,,,
Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 5 mL, 10 vials (NDC 17478-0937-05)",Revised,3/1/23,Not available,No new manufacturing of product,,,Cardiovascular,Current,,,2/21/18,,,,,,,
Diltiazem Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 5 mL vial  (NDC 0641-6013-10)",Revised,10/13/22,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,,3/1/18,,,,,,,
Diltiazem Hydrochloride Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,25 mg/5mL vial (NDC 70860-301-05),Reverified,3/24/23,On backorder.,Next shipment TBD,,,Cardiovascular,Current,,,2/21/18,,,,,,,
Diltiazem Hydrochloride Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,50 mg/10mL vial (NDC 70860-301-10),Reverified,3/24/23,On backorder.,Next shipment TBD,,,Cardiovascular,Current,,,2/21/18,,,,,,,
Diltiazem Hydrochloride Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,125 mg/25mL vial (NDC 70860-301-25),Reverified,3/24/23,On backorder.,Next shipment TBD,,,Cardiovascular,Current,,,2/21/18,,,,,,,
Dimercaprol (Bal in Oil) Injection,Akorn Pharmaceuticals,800-932-5676,"3 mL (100 mg/mL) ampules, box of 10 (NDC 17478-526-03)",Revised,3/3/23,Not available,No new manufacturing of product.,,,Hematology;Other,Current,,,3/3/23,,,,,,,
Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace CR, 100 mg capsules, bottle of 100 (NDC 0025-2732-31)",Revised,3/31/23,Available,,,Other,Cardiovascular,Current,,,3/19/21,,,,,,,
Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace CR, 150 mg capsules, bottle of 100 (NDC 0025-2742-31)",Revised,3/31/23,Available,,,Other,Cardiovascular,Current,,,3/19/21,,,,,,,
Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"100 mg capsules, bottle of 100 (NDC 59762-0386-1)",Revised,3/31/23,Available,,,Other,Cardiovascular,Current,,,3/19/21,,,,,,,
Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"150 mg capsules, bottle of 100 (NDC 59762-0400-1)",Revised,3/31/23,Next Delivery & Estimated Recovery: June 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,,3/19/21,,,,,,,
Disopyramide Phosphate (Norpace) Capsules,Teva Pharmaceuticals,800-545-8800,"100 mg capsules, bottle of 100 (NDC 0093-3127-01)",Reverified,4/5/23,Available,,,,Cardiovascular,Current,,,3/19/21,,,,,,,
Disopyramide Phosphate (Norpace) Capsules,Teva Pharmaceuticals,800-545-8800,"150 mg capsules, bottle of 100 (NDC 0093-3129-01)",Reverified,4/5/23,Available,,,,Cardiovascular,Current,,,3/19/21,,,,,,,
Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace IR, 100 mg capsules; bottle of 100 (NDC 0025-2752-31)",Revised,3/31/23,Available,,,Other,Cardiovascular,Current,,,3/19/21,,,,,,,
Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace IR, 150 mg capsules; bottle of 100 (NDC 0025-2762-31)",Revised,3/31/23,Next Delivery and Estimated Recovery: June 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,,3/19/21,,,,,,,
Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100s (NDC 0378-4140-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100s (NDC 0378-4141-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Dobutamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"250 mg/250 mL (NDC 0338-1073-02) Product code 2B0791, 500 mg/250 mL (NDC 0338-1075-02) Product code 2B0792, 1000 mg/250 mL (NDC 0338-1077-02) Product code 2B0793",Reverified,3/29/23,Available,,,Third-Party Supplier Issue,Cardiovascular;Pediatric;Renal,Current,,,11/6/17,,,,,,,
Dobutamine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mg/250 mL (1 mg/mL); Flexible Container (NDC 00409-2346-32),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,,11/6/17,,,,,https://www.fda.gov/media/160654/download,,
Dobutamine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,500 mg/250 mL (2 mg/mL); Flexible Container (NDC 00409-2347-32),Revised,3/31/23,Limited Supply Available. Next Delivery: June 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,,11/6/17,,,,,https://www.fda.gov/media/160654/download,,
Dobutamine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,1000 mg/250 mL (4 mg/mL); Flexible Container (NDC 00409-3724-32),Revised,3/31/23,Available,,,Other,Cardiovascular;Pediatric;Renal,Current,,,11/6/17,,,,,https://www.fda.gov/media/160654/download,,
Dobutamine Hydrochloride Injection,Next Delivery: April 2023; Estimated Recovery: June 2023,844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-01),Revised,3/6/23,Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,,11/6/17,,,,,,,
Dobutamine Hydrochloride Injection,Next Delivery: April 2023; Estimated Recovery: June 2023,844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-02),Revised,3/6/23,Limited Supply Available. Next Delivery and Estimated Recovery: March 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,,11/6/17,,,,,,,
Dobutamine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-2344-88),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular; Pediatric; Renal,Current,,,11/6/17,,,,,,,
Dobutamine Hydrochloride Injection,"Hainan Poly Pharm. Co., Ltd.",-7752,250mg/20ml (NDC 70436-203-80),New,2/22/23,"Estimated Delivery: available in late March 2023 if air freight, otherwise in May 2023 through ocean.","Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988",,Other,Cardiovascular; Pediatric; Renal,Current,,,11/6/17,,,,,,,
Dobutamine Hydrochloride Injection,"Hainan Poly Pharm. Co., Ltd.",-7752,500mg/40ml (NDC 70436-204-80),New,2/22/23,Currently unavailable,,,Other,Cardiovascular; Pediatric; Renal,Current,,,11/6/17,,,,,,,
Dofetilide Capsules,Pfizer Pharmaceuticals,800-533-4353,125 mcg (0.125 mg) capsules; Bottle of 60 (NDC 59762-0037-2),New,5/21/21,,,,,Cardiovascular,To be Discontinued,,,5/21/21,,,,,,,
Dofetilide Capsules,Pfizer Pharmaceuticals,800-533-4353,250 mcg (0.25 mg) capsules; Bottle of 60 (NDC 59762-0038-2),New,5/21/21,,,,,Cardiovascular,To be Discontinued,,,5/21/21,,,,,,,
Dofetilide Capsules,Pfizer Pharmaceuticals,800-533-4535,500 mcg (0.5 mg) capsules; Bottle of 60 (NDC 59762-0039-2),New,5/21/21,,,,,Cardiovascular,To be Discontinued,,,5/21/21,,,,,,,
Dolutegravir Sodium (Tivicay) Tablets,GlaxoSmithKline (ViiV Healthcare),888-825-5249,10 mg tablet 30 count (NDC 49702-226-13),New,1/3/23,,"The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024.  Tivicay 50 mg tablets (49702-228-13) will still be available as well as Tivicay PD 5 mg (49702-255-37).",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Dolutegravir Sodium (Tivicay) Tablets,GlaxoSmithKline (ViiV Healthcare),888-825-5249,25 mg tablet 30 count (NDC 49702-227-13),New,1/3/23,,"The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024.  Tivicay 50 mg tablets (49702-228-13) will still be available as well as Tivicay PD 5 mg (49702-255-37).",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Dopamine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"400 mg/250 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-22)",Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,,11/6/17,,,,,https://www.fda.gov/media/160872/download,,
Dopamine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"800 mg/500 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-24)",Revised,3/31/23,Available,,,Other,Cardiovascular,Current,,,11/6/17,,,,,https://www.fda.gov/media/160872/download,,
Dopamine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"800 mg/250 mL (3,200 mcg/mL); Flexible Container (NDC 00409-7810-22)",Revised,3/31/23,Available,,,Other,Cardiovascular,Current,,,11/6/17,,,,,https://www.fda.gov/media/160872/download,,
Dopamine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,200 mg/5 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-5820-01),Revised,3/31/23,Next Delivery and Estimated Recovery: April 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,,11/6/17,,,,,,,
Dopamine Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,400 mg/10 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9104-20),Revised,3/31/23,Next Delivery and Estimated Recovery: May 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,,11/6/17,,,,,,,
Dopamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"800 mcg/mL (250 mL bag) Product code 2B0832 (NDC 0338-1005-02), 800 mcg/mL (500 mL bag)  Product code 2B0833 (NDC 0338-1005-03), 1600 mcg/mL (250 mL bag) Product code 2B0842 (NDC 0338-1007-02), 1600 mcg/mL (500 mL bag) Product code 2B0843 (NDC 0338-1007-0",Reverified,3/29/23,Available,,,,Cardiovascular,Current,,,11/6/17,,,,,,,
Dopamine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg/mL, 5 mL vial (NDC 0143-9252-25)",Revised,10/13/22,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing and will be available in the November 2022 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,,11/6/17,,,,,,,
Dopamine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg/mL, 10 mL vial (NDC 0143-9254-25)",Revised,10/13/22,Inventory is currently available.,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,,11/6/17,,,,,,,
Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 17478-605-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,1/24/18,,,,,,,
Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 50383-233-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,1/24/18,,,,,,,
Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt-PF® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 0.2 mL single use, 60 count (NDC 17478-604-30)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,1/24/18,,,,,,,
Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 61314-030-02)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,1/24/18,,,,,,,
Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 24208-486-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,1/24/18,,,,,,,
Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 0591-2482-79)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,1/24/18,,,,,,,
Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride and Timolol Maleate 20 mg and 5 mg/mL, 10 mL (0591-2482-79)",New,4/20/18,,,,,Ophthalmology,To be Discontinued,,,4/20/18,,,,,,,
Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Aurobindo Pharma,866-850-2876,"Dorzolamide HCl and Timolol Maleate (Cosopt® PF) Ophthalmic Solution 2%/0.5% Preservative Free, 2mL single use container (NDC 65862-0947-60)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,9/28/18,,,,,,,
Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0591-2481-79)",New,4/20/18,,,,,Ophthalmology,To be Discontinued,,,4/20/18,,,,,,,
Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0093-7618-43)",New,4/20/18,,,,,Ophthalmology,To be Discontinued,,,4/20/18,,,,,,,
Dorzolamide Hydrochloride Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 61314-019-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,1/25/18,,,,,,,
Dorzolamide Hydrochloride Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 50383-232-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,1/24/18,,,,,,,
Dorzolamide Hydrochloride Ophthalmic Solution,Merck Sharp & Dohme Corp.,800-637-2579,"Trusopt® Dorzolamide hydrochloride ophthalmic solution 2%, for topical ophthalmic use 10ml, (NDC 0006-3519-36)",New,4/11/22,,,,,Ophthalmology,To be Discontinued,,,4/11/22,,,,,,,
Dorzolamide Hydrochloride Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride USP 2%, 10 mL (NDC 24208-485-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,,1/24/18,,,,,,,
Doxepin Hydrochloride Oral Solution,Wockhardt Bio A.G.,847-410-6929,"10gm/mL, 118 mL (NDC 60432-651-04)",New,7/26/22,,Discontinuing the manufacture of the product due to business reasons,,,Neurology,To Be Discontinued,7/26/22,7/26/22,7/26/22,,,,,,,
Doxercalciferol Injection,Hospira,844-646-4398,4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vial (NDC 00409-1330-01),New,9/12/22,,Discontinuation of the manufacture of the drug,,,Endocrinology/Metabolism,To be Discontinued,9/12/22,9/12/22,9/12/22,,,,,,,
Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",50mg  (NDC 49884-726-01),New,6/28/22,,,,,Anti-Infective,To be Discontinued,,,6/28/22,,,,,,,
Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",100mg  (NDCs 49884-0727-03 and 49884-0727-04),New,6/28/22,,,,,Anti-Infective,To be Discontinued,,,6/28/22,,,,,,,
Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",150mg  (NDC 49884-0305-02),New,6/28/22,,,,,Anti-Infective,To be Discontinued,,,6/28/22,,,,,,,
Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",50mg (NDC 49884-726-01),New,1/31/22,,,,,Anti-Infective,To be Discontinued,,,1/31/22,,,,,,,
Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",100mg (NDCs 49884-727-03 and 49884-727-04),New,1/31/22,,,,,Anti-Infective,To be Discontinued,,,1/31/22,,,,,,,
Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",150mg (NDC 49884-305-02),New,1/31/22,,,,,Anti-Infective,To be Discontinued,,,1/31/22,,,,,,,
Doxycycline Hyclate Powder for Suspension,"Hospira, Inc.",844-646-4398,25mg/5mL (NDC 0069-0970-65),New,11/15/21,,,,,Anti-Infective,To be Discontinued,,,11/15/21,,,,,,,
Doxycycline Hyclate Tablets,Teva Pharmaceuticals,800-545-8800,"75 mg tablets, 60 count (NDC 0591-6100-60)",Revised,6/22/22,,,,,Anti-Infective,To be Discontinued,,,6/21/22,,,,,,,
Doxycycline Hyclate Tablets,Teva Pharmaceuticals,800-545-8800,150mg  (NDC 0591-6125-60),New,6/21/22,,,,,Anti-Infective,To be Discontinued,,,6/21/22,,,,,,,
Dulaglutide (Trulicity) Injection,Eli Lilly and Company,800-545-5979,Trulicity 0.75mg/0.5mL (NDC 0002-1433-80),Reverified,3/22/23,Available,,,,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Dulaglutide (Trulicity) Injection,Eli Lilly and Company,800-545-5979,Trulicity 1.5 mg/0.5mL (NDC 0002-1434-80),Reverified,3/22/23,Available,,,,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Dulaglutide (Trulicity) Injection,Eli Lilly and Company,800-545-5979,Trulicity 3 mg/0.5mL (NDC 0002-2236-80),Reverified,3/22/23,"Available, though pharmacies may experience delays in receiving full shipments through April 2023",Shipments of 3mg are continuing to occur however due to high demand there may be intermittent periods of backorder.,,Demand increase for the drug,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Dulaglutide (Trulicity) Injection,Eli Lilly and Company,800-545-5979,Trulicity 4.5 mg/0.5mL (NDC 0002-3182-80),Reverified,3/22/23,"Available, though pharmacies may experience delays in receiving full shipments through April 2023",Shipments of 4.5mg are continuing to occur however due to high demand there may be intermittent periods of backorder.,,Demand increase for the drug,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Echothiophate Iodide (Phospholine Iodide) Ophthalmic Solution,Fera Pharmaceuticals,516-277-1448,Phospholine Iodide 0.125% echothiophate iodide for ophthalmic solution 5ml (NDC 48102-053-05),Revised,6/1/22,"Available starting June 1st, 2022 through limited distribution by AllianceRx Walgreens Prime Specialty Pharmacy.",,,Delay in manufacturing,Ophthalmology,Current,,,9/24/19,,,,,https://www.fda.gov/media/158838/download,,
Edetate Calcium Disodium Injection,Bausch Health,800-321-4576,Calcium Disodium Versenate 1000 mg/5 mL (200 mg/mL) (NDC 99207-240-05),Revised,11/30/22,Not currently available. Estimated Shortage duration TBD,,,Requirements related to complying with good manufacturing practices,Other,Current,,,2/2/21,,,,,,,
Edetate Calcium Disodium Injection,BTG International Inc.,844-293-0007,Calcium Edetate de Sodium 500 mg/ampule (NDC 50633-320-10),Revised,11/30/22,Available,,,,Other,Current,,,2/2/21,,,,,https://www.fda.gov/media/163578/download,,
Efavirenz Capsules,Bristol-Myers Squibb Co.,800-332-2056,50mg (NDC 0056-0470-30),New,9/28/22,,"Product available until March 31, 2023.",,,Antiviral,To be Discontinued,9/28/22,9/28/22,9/28/22,,,,,,,
Efavirenz Capsules,Bristol-Myers Squibb Co.,800-332-2056,200mg (NDC 0056-0474-92),New,9/28/22,,"Product available until March 31, 2023.",,,Antiviral,To be Discontinued,9/28/22,9/28/22,9/28/22,,,,,,,
Efavirenz Tablets,"Mylan Specialty, a Viatris Company",800-796-9526,600 mg (NDC 0378-2233-93),New,11/2/21,,,,,Antiviral,To be Discontinued,,,11/2/21,,,,,,,
Enalaprilat Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2.5mg/2mL, vial (NDC 0143-9786-10)",Revised,10/13/22,This presentation is currently available.,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,,3/29/19,,,,,,,
Enalaprilat Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1.25mg/mL, vial  (NDC 0143-9787-10)",Revised,10/13/22,This presentation is currently available.,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,,3/29/19,,,,,,,
"Epinephrine Injection, 0.1 mg/mL","Hospira, Inc., a Pfizer company",844-646-4398,1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4933-01),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pulmonary/Allergy,Current,,,4/27/12,,,,,https://www.fda.gov/media/165564/download,,
"Epinephrine Injection, 0.1 mg/mL","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"0.1mg/mL, 10mL, (NDC 76329-3318-1)",Revised,4/6/23,Available,,,,Cardiovascular;Pulmonary/Allergy,Current,,,4/27/12,,,,,,,
"Epinephrine Injection, Auto-Injector","Mylan Specialty, a Viatris Company",800-796-9526,0.3 mg EpiPen® (NDC 49502-500-02); Authorized Generic (NDC 49502-102-02),Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,5/9/18,,,,,,,
"Epinephrine Injection, Auto-Injector","Mylan Specialty, a Viatris Company",800-796-9526,0.15 mg EpiPen® (NDC 49502-501-02); Authorized Generic (NDC 49502-101-02),Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,5/9/18,,,,,,,
"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.15 mg/0.15 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1695-49)",Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,5/9/18,,,,,,,
"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.3 mg/0.3 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1694-49)",Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,5/9/18,,,,,,,
"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.3 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-023-01)",Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,5/9/18,,,,,,,
"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.15 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-022-01)",Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,5/9/18,,,,,,,
"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.1 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-021-01)",Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,5/9/18,,,,,,,
"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.3 mg/mL epinephrine injection, USP, auto-injector (NDC 0093-5986-27)",Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,12/7/18,,,,,,,
"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.3 mg single-dose, pre-filled syringes (NDC 78670-130-02))",Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,12/7/18,,,,,,,
"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.15 mg single-dose, pre-filled syringes (NDC 78670-131-02)",Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,12/7/18,,,,,,,
"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.15 MG Epinephrine Injection, USP auto-injector (NDC 0093-5985-27)",Revised,12/13/22,,,Available,,Pulmonary/Allergy,Resolved,12/13/22,,12/7/18,,,,,,,
Epoprostenol Sodium for Injection and Sterile Diluent for Epoprostenol Sodium for Injection,Teva,800-545-8800,NDC 0703-9258-09 ( 2 x 50 mL vials Sterile Diluent),New,9/12/22,,Product is available with an expected supply duration until AUG' 2022.  No future production expected for an extended period.,,,,To be Discontinued,9/12/22,9/12/22,9/12/22,,,,,,,
Epoprostenol Sodium for Injection and Sterile Diluent for Epoprostenol Sodium for Injection,Teva,800-545-8800,"NDC 0703-1985-01 (0.5 mg/vial (500,000 ng))",New,9/12/22,,Product is unavailable and no future production expected for an extended period.,,,,To be Discontinued,9/12/22,9/12/22,9/12/22,,,,,,,
Epoprostenol Sodium for Injection and Sterile Diluent for Epoprostenol Sodium for Injection,Teva,800-545-8800,"NDC 0703-1995-01 (1.5 mg/vial (1,500,000 ng))",New,9/12/22,,Product is unavailable and no future production expected for an extended period.,,,,To be Discontinued,9/12/22,9/12/22,9/12/22,,,,,,,
Eptifibatide Injection,Teva Pharmaceuticals,800-545-8800,"0.75 mg/mL, 75 mg, 100 mL/Vial (NDC 0703-1179-01)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Cardiovascular,To be Discontinued,9/13/22,9/13/22,9/13/22,,,,,,,
Ergotamine Tartrate and Caffeine (Cafergot) Tablets,Sandoz,800-525-8747,1mg/100mg (NDC 0781-5405-01),New,7/2/20,,,,,Neurology,To be Discontinued,,,7/2/20,,,,,,,
Ertapenem Injection,"Merck Sharp & Dohme Corp. a subsidiary of Merck and Co., Inc.",800-672-6372,1g (NDC 0006-3843-71),New,8/2/22,,,,,Anti-Infective,To Be Discontinued,8/2/22,8/2/22,8/2/22,,,,,,,
Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 3.5 g tube (NDC 17478-070-35),Revised,3/1/23,Not available,No new manufacturing of product,,,Ophthalmology; Pediatric,Current,,,7/6/22,,,,,,,
Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 1 g tube (unit dose) (NDC17478-070-31),Revised,3/1/23,Not available,No new manufacturing of product,,,Ophthalmology; Pediatric,Current,,,7/6/22,,,,,,,
Erythromycin Ophthalmic Ointment,Padagis US LLC,763-732-0225,"Erythromycin 0.5% Ophthalmic Ointment 1 gram, 50-count (00574-4024-50)",Revised,8/1/22,Available and shipping,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,,7/6/22,,,,,https://www.cdc.gov/std/treatment/drugnotices/erythromycin-ophthalmic.htm,,
Erythromycin Ophthalmic Ointment,Padagis US LLC,763-732-0225,"Erythromycin 0.5% Ophthalmic Ointment 3.5 gram, 1-count (00574-4024-35)",Revised,8/1/22,Available and shipping,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,,7/6/22,,,,,https://www.cdc.gov/std/treatment/drugnotices/erythromycin-ophthalmic.htm,,
Erythromycin Ophthalmic Ointment,Bausch Health,800-321-4576,"Erythromycin Ophthalmic Ointment USP, 0.5% 3.5 g in 1 tube (NDC 24208-910-55)",Revised,8/1/22,Limited availability. Manufacturing and distribution is ongoing. Increase in demand orders will be taken on a case-by-case basis.,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,,7/6/22,,,,,https://www.cdc.gov/std/treatment/drugnotices/erythromycin-ophthalmic.htm,,
Erythromycin Ophthalmic Ointment,Padagis US LLC,763-732-0225,"Erythromycin 0.5% Ophthalmic Ointment 3.5 gram, 24-count (00574-4024-39)",Revised,8/1/22,Available and shipping,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,,7/6/22,,,,,https://www.cdc.gov/std/treatment/drugnotices/erythromycin-ophthalmic.htm,,
Erythromycin Ophthalmic Ointment,Bausch Health,800-321-4576,"Erythromycin Ophthalmic Ointment USP, 0.5% 1 g in carton of 50 (NDC 24208-910-19)",Revised,8/1/22,Limited availability. Manufacturing and distribution is ongoing. Increase in demand orders will be taken on a case-by-case basis.,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,,7/6/22,,,,,https://www.cdc.gov/std/treatment/drugnotices/erythromycin-ophthalmic.htm,,
Esomeprazole Sodium for Injection,"Mylan Institutional, a Viatris company",800-796-9526,"40 mg vial, box of 10 (NDC 67457-392-99)",New,9/16/21,,,,,Gastroenterology;Pediatric,To be Discontinued,,,9/16/21,,,,,,,
Ethacrynate Sodium Injection,Bausch Health,800-321-4576,"50 mg, vial (NDC 68682-012-27)",New,2/24/23,,"Marketed by Oceanside Pharmaceuticals, a division of Bausch Health U.S.  Current Inventory run out 4/1/23. No further manufacturing is scheduled.",,,Cardiovascular; Pediatric,To be Discontinued,2/24/23,2/24/23,2/24/23,,,,,,,
Ethacrynate Sodium Injection,Bausch Health,800-321-4576,"50 mg, vial (NDC 68682-012-50), Novaplus",New,2/24/23,,"Marketed by Oceanside Pharmaceuticals, a division of Bausch Health U.S.  Current Inventory run out 4/1/23. No further manufacturing is scheduled.",,,Cardiovascular; Pediatric,To be Discontinued,2/24/23,2/24/23,2/24/23,,,,,,,
Ethacrynate Sodium Injection,Bausch Health,800-321-4576,"Sodium Edecrin® 50 mg, vial (NDC 25010-210-27)",New,2/24/23,,Current Inventory run out 4/1/23. No further manufacturing is scheduled.,,,Cardiovascular; Pediatric,To be Discontinued,2/24/23,2/24/23,2/24/23,,,,,,,
Ethambutol Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,400mg  (NDC 0555-0923-02),New,11/5/21,,,,,Anti-Infective,To be Discontinued,,,11/5/21,,,,,,,
Ethinyl Estradiol / Norethindrone Acetate and Ferrous Fumarate Tablets,"Allergan Sales, LLC",800-678-1605,Cartons of 5 blister cards (NDC 0430-0540-50),New,4/5/23,,,,,Reproductive,To be Discontinued,4/5/23,4/5/23,4/5/23,,,,,,,
Etodolac Tablets,Sandoz,800-525-8747,400 mg 100 ct (NDC 0185-0675-01),New,2/14/23,,Discontinuation of the manufacture of the product,,,Analgesia/Addiction,To be Discontinued,2/14/23,2/14/23,12/8/22,,,,,,,
Etodolac Tablets,Sandoz,800-525-8747,500 mg 100 ct (NDC 0185-0687-01),New,12/8/22,,Discontinuation of the manufacture of the product,,,Analgesia/Addiction,To be Discontinued,12/8/22,12/8/22,12/8/22,,,,,,,
Etodolac Tablets,Sandoz,800-525-8747,400 mg 1000 ct (NDC 0185-0675-10),New,2/14/23,,Discontinuation of the manufacture of the product,,,Analgesia/Addiction,To be Discontinued,2/14/23,2/14/23,12/8/22,,,,,,,
Etomidate Injection,"Caplin Steriles, Ltd.",,"20 mg per 10 mL, Single dose vial, (NDC 65219-445-10)",Revised,3/31/23,Backordered. Next release April 2023.,Marketed by Fresenius Kabi; Check wholesalers for inventory,,,Anesthesiology,Current,,,10/5/22,,,,,https://www.fda.gov/media/164122/download,,
Etomidate Injection,"Caplin Steriles, Ltd.",,"40 mg per 20 mL, Single dose vial, (NDC 65219-445-20)",Revised,3/31/23,Backordered. Next release April 2023.,Marketed by Fresenius Kabi,,,Anesthesiology,Current,,,10/5/22,,,,,https://www.fda.gov/media/164122/download,,
Etomidate Injection,"Caplin Steriles, Ltd.",,"2 mg/mL, 10 mL vial (NDC 25021-674-10)",Revised,3/31/23,Available,Marketed by Sagent,,,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Caplin Steriles, Ltd.",,"2 mg/mL, 20 mL vial (NDC 25021-674-20)",Revised,3/31/23,Available,Marketed by Sagent,,,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 72572-160-10)",New,10/5/22,Pending information,Distributed by Civica,,,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 72572-161-10)",New,10/5/22,Pending information,Distributed by Civica,,,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Avet Pharmaceuticals, Inc.",855-228-9470,20 mg/10mL carton of 10 (NDC 23155-160-41),Reverified,3/15/23,Product available upon request,,,,Anesthesia,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Avet Pharmaceuticals, Inc.",855-228-9470,40 mg/20 mL carton of 10 (NDC 23155-160-42),Reverified,3/15/23,Product available upon request,,,,Anesthesia,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Eugia US, LLC (formerly AuroMedics Pharma LLC) [mfd. by Eugia Pharma Specialties, Ltd.)",,"2 mg/mL, 10 mL vial (NDC 55150-221-10)",Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Eugia US, LLC (formerly AuroMedics Pharma LLC) [mfd. by Eugia Pharma Specialties, Ltd.)",,"2 mg/mL, 20 mL vial (NDC 55150-222-20)",Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,Gland Pharma Limited,,"2 mg/mL, 10 mL vial (NDC 72266-146-10)",Revised,3/17/23,Available,"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",,,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,Gland Pharma Limited,,"2 mg/mL, 20 mL vial (NDC 72266-147-10)",Revised,3/17/23,Available,"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",,,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 0143-9506-10)",New,10/5/22,Currently on backorder,,,Demand increase for the drug,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9507-10)",New,10/5/22,Currently on backorder,,,Demand increase for the drug,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 0143-9310-10), Novaplus",New,10/5/22,Pending information,,,,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9311-10), Novaplus",New,10/5/22,Pending information,,,,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"2 mg/mL, 10 mL vial (NDC 67457-902-10)",Reverified,3/28/23,Re-supply in April 2023,,,Demand increase for the drug,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"2 mg/mL, 20 mL vial (NDC 67457-903-20)",Reverified,3/28/23,Re-supply in April 2023,,,Demand increase for the drug,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"Amidate, 2 mg/mL, 10 mL vial (NDC 0409-6695-01)",Revised,3/31/23,Available,,,Other,Anesthesiology,Current,,,10/5/22,,,,,,,
Etomidate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"Amidate, 2 mg/mL, 20 mL vial (NDC 0409-6695-02)",Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesiology,Current,,,10/5/22,,,,,,,
Etoposide (Toposar) Injection,Teva,800-545-8800,NDC 0703-5653-01 (100 mg/5 mL (20 mg/mL) 5 mL Multiple-dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Etoposide (Toposar) Injection,Teva,800-545-8800,NDC 0703-5656-01 (500 mg/25 mL (20 mg/mL) 25 mL Multiple-dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Etoposide (Toposar) Injection,Teva,800-545-8800,DC 0703-5657-01 (1 gram/50 mL (20 mg/mL) 50 mL Multiple-dose Vial ),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Exenatide (BYDUREON) Extended Release for Injectable Suspension,AstraZeneca,800-236-9933,"BYDUREON® (exenatide extended-release) for injectable suspension, for subcutaneous use;  Single Dose Tray presentation; (2 mg) (NDC 0310-6520-04)",New,4/3/18,,,,,Endocrinology/Metabolism,To be Discontinued,,,4/3/18,,,,,,,
Famotidine Injection,Baxter Healthcare,888-229-0001,"Famotidine Injection premix, 20mg/50 mL in GALAXY Plastic Container (NDC 0338-5197-41)",Reverified,9/28/22,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 2 mL vial (NDC 0641-6022-25)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 4 mL vial (NDC 0641-6023-25)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 20 mL vial (NDC 0641-6021-10)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), single dose vial, PF, (NDC 63323-739-12)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"40 mg per 4 mL (10 mg per mL), mutilple dose vial, (NDC 63323-738-09)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL(10 mg per mL), multiple dose vial, (NDC 63323-738-20)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,Famotidine Injection (Solution in Multi Dose Vials : Containing Preservatives) [200 mg / 20 ml] 10PK (NDC 67457-457-20),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,Famotidine Injection (Solution in Single Dose Vials) [20 mg / 2 ml] 25PK (NDC 67457-433-22),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,"20 mg per 2 mL (10 mg per mL), single dose vial, PF, (NDC 70860-751-02 and 41)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,"200 mg per 20 mL(10 mg per mL), multiple dose vial with preservatives, (NDC 70860-751-20 and 41)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/5/20,,,,,,,
Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 100 Count (NDC 0172-5728-60),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 1000 Count (NDC 0172-5728-80),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 500 Count (NDC 0172-5728-70),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,40 MG 100 Count (NDC 0172-5729-60),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,40 MG 500 Count (NDC 0172-5729-70),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Aurobindo Pharma,732-839-9400,20 mg - 100/Bottle (NDC 65862-859-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Aurobindo Pharma,732-839-9400,40 mg - 100/Bottle (NDC 65862-860-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Alembic Pharmaceuticals,908-393-9604,20 mg Bottle of 100 counts (NDC 62332-001-31),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,20 mg Bottle of 1000 counts (NDC 62332-001-91),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 100 counts (NDC 62332-002-31),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 500 counts (NDC 62332-002-71),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 1000 counts (NDC 62332-002-91),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,"Carlsbad Technology, Inc.",,20mg 100 count (NDC 61442-121-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,"Carlsbad Technology, Inc.",,20 mg 1000 count (NDC 61442-121-10),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,"Carlsbad Technology, Inc.",,40 mg 100 count (NDC 61442-122-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Famotidine Tablets,"Carlsbad Technology, Inc.",,40 mg 1000 count (NDC 61442-122-10),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,,5/4/20,,,,,,,
Febuxostat Tablets,"Mylan, A Viatris company",800-796-9526,40mg T 30s (NDC 0378-3925-93),New,9/21/22,,,,,Rheumatology,To be Discontinued,9/21/22,9/21/22,9/21/22,,,,,,,
Febuxostat Tablets,"Mylan, A Viatris company",800-796-9526,80mg T 30s (NDC 0378-3926-93),New,9/21/22,,,,,Rheumatology,To be Discontinued,9/21/22,,9/21/22,,,,,,,
Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,40 mg (NDC 55111-796-30),New,11/22/21,,,,,Rheumatology,To be Discontinued,,,11/22/21,,,,,,,
Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,80 mg (NDC 55111-797-30),New,11/22/21,,,,,Rheumatology,To be Discontinued,,,11/22/21,,,,,,,
Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,40mg  (NDC NDC 55111-796-30),New,11/30/21,,,,,Rheumatology,To be Discontinued,,,11/30/21,,,,,,,
Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,80mg  (NDC NDC 55111-797-30),New,11/30/21,,,,,Rheumatology,To be Discontinued,,,11/30/21,,,,,,,
Fenoldopam Mesylate (Corlopam) Injection,Pfizer,844-646-4398,20 mg/2 mL (10 mg/mL) Single Dose Vial (NDC 00409-3373-02),New,8/30/22,,Discontinuation of the manufacture of the drug.,,,Cardiology,To be Discontinued,8/30/22,8/30/22,8/30/22,,,,,,,
Fenoldopam Mesylate (Corlopam) Injection,Pfizer,844-646-4398,10 mg/mL (10 mg/mL) Single Dose Vial (NDC 00409-3373-01),New,8/30/22,,Discontinuation of the manufacture of the drug.,,,Cardiology,To be Discontinued,8/30/22,8/30/22,8/30/22,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Fresenius Kabi USA,888-386-1300,50 mcg per 1 mL (50 mcg per mL) Single Dose Simplist PFS  (NDC 63323-808-11),Revised,3/31/23,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 1 mL vial(NDC 0641-6247-25),Revised,3/24/23,Unavailable,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Fresenius Kabi USA,888-386-1300,"1,000 mcg per 20 mL (50 mcg per mL) (0.05 mg per mL)  SDV (NDC 63323-806-20)",Revised,3/31/23,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Fresenius Kabi USA,888-386-1300,"2,500 mcg per 50 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-50)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Fresenius Kabi USA,888-386-1300,50 mcg per 1 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-01),Revised,3/31/23,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Fresenius Kabi USA,888-386-1300,100 mcg per 2 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-02),Revised,3/31/23,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Fresenius Kabi USA,888-386-1300,250 mcg per 5 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-05),Revised,3/31/23,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mcg/2 mL (50 mcg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1276-32),Revised,3/31/23,Next Delivery: February 2025; Estimated Recovery: March 2025,,,Other,Analgesia/Addiction;Pediatric,Current,,,,,,,,https://www.fda.gov/media/161142/download,,
Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mcg/2 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-32),Revised,3/31/23,Next Delivery: January 2024; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,,,,,,,https://www.fda.gov/media/161142/download,,
Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mcg/5 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-35),Revised,3/31/23,Next Delivery: July 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,,,,,,,https://www.fda.gov/media/161142/download,,
Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mcg/2 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-22),Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,,,,,,,https://www.fda.gov/media/161142/download,,
Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mcg/5 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-25),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,,,,,,,https://www.fda.gov/media/161142/download,,
Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,500 mcg/10 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-28),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,,,,,,,https://www.fda.gov/media/161142/download,,
Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"1,000 mcg/20 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-31)",Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: TBD,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,,,,,,,https://www.fda.gov/media/161142/download,,
Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"2,500 mcg/50 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-61)",Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,,,,,,,https://www.fda.gov/media/161142/download,,
Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 2 mL ampul (NDC 0641-6024-10),Revised,3/24/23,Unavailable,Inventory available in vial presentations.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 5 mL ampul (NDC 0641-6025-10),Revised,3/24/23,Unavailable,Inventory available in vial presentations.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL ampul (NDC 0641-6026-05),Revised,10/13/22,Currently not available,Inventory available in vial presentations.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 2 mL vial(NDC 0641-6027-25),Revised,3/24/23,Available,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 5 mL vial(NDC 0641-6028-25),Revised,3/24/23,Available,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL vial (NDC 0641-6029-25),Revised,3/24/23,Available,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL  50 mL vial(NDC 0641-6030-01),Revised,3/24/23,Available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule 10 pack (NDC 17478-0030-02),Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule; 25 pack (NDC 17478-0030-25),Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 10 pack (NDC 17478-0030-05),Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,20 mL ampule (NDC 17478-0030-20),Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 25 pack (NDC 17478-0030-55),Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction;Pediatric,Current,,,,,,,,,,
Finasteride Tablets,Mylan Pharmaceuticals Inc.,800-RXMYLAN (1-800-796- 9526),5 mg tablet (NDC 0378-5036-05)(NDC 0378-5036-77)(NDC 0378-5036-93),New,5/23/18,,,,,Urology,To be Discontinued,,,5/23/18,,,,,,,
Floxuridine for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg per vial (NDC 0143-9270-01),Revised,2/13/23,,,Available; Distributed by Cerona Therapeutics,Other,Oncology,Resolved,2/13/23,,9/16/20,,,,,,,
Fluconazole (Diflucan) Tablets,"Hospira, Inc.",844-646-4398,50 mg tablets; Bottle of 30 (NDC 00049-3410-30),New,9/15/22,,Stock anticipated to be available through October 2022; Discontinuation of the manufacture of the drug,,,Anti-Infective,To be Discontinued,9/15/22,9/15/22,9/15/22,,,,,,,
Fludarabine Phosphate Injection,Areva Pharmaceuticals,812-399-0479,50 mg/2 mL (NDC 59923-604-02),Revised,11/9/22,"Available, To order call 1-812-399-0479",,,,Oncology,Current,,,5/9/22,,,,,https://www.fda.gov/media/162383/download,,
Fludarabine Phosphate Injection,Accord Healthcare Inc.,866-941-875,50 mg/2 mL (25mg/mL) (NDC 16729-131-30),Revised,11/14/22,Product anticipated 11/21/2022,,,,Oncology,Current,,,5/6/22,,,,,https://www.fda.gov/media/163105/download,,
Fludarabine Phosphate Injection,Teva Pharmaceuticals,800-545-8800,"Lyophilized Powder for Injection, 50 mg /vial (NDC 45963-0609-55, 1 Single-Dose Vial)",Reverified,4/5/23,Available,,,,Oncology,Current,,,5/6/22,,,,,,,
Fludarabine Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mg per 2 mL (25 mg per mL), Single dose vial, PF (NDC: 63323-192-02)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesaler inventory,,Demand increase,Oncology,Current,,,5/6/22,,,,,,,
Fludrocortisone Acetate Tablets,Teva Pharmaceuticals,800-545-8800,"0.1 mg, 100 count bottle (NDC 0555-0997-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,,,12/12/18,,,,,,,
Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 100 count bottle (NDC 0115-7033-01)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,,,12/12/18,,,,,,,
Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 500 count bottle (NDC 0115-7033-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,,,12/12/18,,,,,,,
Flumazenil Injection,Mylan,800-796-9526,"0.5 mg in 5 mL (0.1 mg/mL), multi-dose vial, 10 vials (NDC 67457-447-53)",New,12/16/19,,,,,Analgesia/Addiction;Neurology;Pediatric,To be Discontinued,,,12/16/19,,,,,,,
Fluocinonide Gel 0.05%,"Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-054-15),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Fluocinonide Gel 0.05%,"Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-054-30),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Fluocinonide Gel 0.05%,"Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-054-60),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Fluocinonide Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-040-15),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Fluocinonide Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-040-30),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Fluocinonide Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-040-60),New,6/21/21,,,,,,To be Discontinued,,,6/21/21,,,,,,,
Fluocinonide Topical Solution,Teva Pharmaceuticals,800-545-8800,0.5 mg/mL  (NDC 0472-0829-02),New,8/3/21,,,,,Dermatology,To be Discontinued,,,8/3/21,,,,,,,
Fluorescein Injection,Akorn Pharmaceuticals,800-932-5676,"AK-FLUOR ((fluorescein injection, USP) 10% (NDC 17478-253-10), 5mL",Revised,12/7/22,,,Available,,Ophthalmology,Resolved,12/7/22,,5/2/22,,,,,,,
Fluorescein Injection,Akorn Pharmaceuticals,800-932-5676,"AK-FLUOR ((fluorescein injection, USP) 25% (NDC 17478-250-20), 2mL",Revised,12/7/22,,,Available,,Ophthalmology,Resolved,12/7/22,,5/2/22,,,,,,,
Fluorescein Injection,Alcon,800-268-4574,Fluorescite 5 mL in vial (NDC 0065-0092-65),Revised,12/7/22,,,Available,,Ophthalmology,Resolved,12/7/22,,5/2/22,,,,,,,
Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 1.0 mg 100 sterile strips (NDC 17478-404-01),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,,,2/6/18,,,,,,,
Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 0.6 mg 300 sterile strips (NDC 17478-403-03),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,,,2/6/18,,,,,,,
Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 100 Strips per box (ndc 17238-900-11),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,,,2/20/18,,,,,,,
Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 300 Strips per box (NDC 17238-900-30),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,,,2/20/18,,,,,,,
Fluorometholone Ophthalmic Ointment,Abbvie,800-678-1605,FML (flourometholone) Ointment 0.1% 1 TUBE in 1 CARTON  3.5 g in 1 TUBE (NDC 0023-0316-04),New,9/13/21,,,,,Ophthalmology,To be Discontinued,,,9/13/21,,,,,,,
Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 100 count bottle (NDC 0781-2823-01)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,,2/23/18,,,,,,,
Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 1000 count bottle (NDC 0781-2823-10)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,,2/23/18,,,,,,,
Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 100 count bottle (NDC 0781-2822-01)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,,2/23/18,,,,,,,
Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 1000 count bottle (NDC 0781-2822-10)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,,2/23/18,,,,,,,
Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 100 count bottle (NDC 0781-2824-01)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,,2/23/18,,,,,,,
Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 1000 count bottle (NDC 0781-2824-10)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,,2/23/18,,,,,,,
Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 30 count bottle (NDC 0781-2824-31)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,,2/23/18,,,,,,,
Fluoxetine Tablets,Teva Pharmaceuticals,800-545-8800,"20 mg, 100 count (NDC 0093-0807-01)",New,2/8/23,,Business Decision to Discontinue,,,Psychiatry,To be Discontinued,2/8/23,2/8/23,2/8/23,,,,,,,
Fluoxetine Tablets,Teva Pharmaceuticals,800-545-8800,"20 mg, 30 count (NDC 0093-0807-56)",New,2/8/23,,Business Decision to Discontinue,,,Psychiatry,To be Discontinued,2/8/23,2/8/23,2/8/23,,,,,,,
Fluoxetine Tablets,Teva Pharmaceuticals,800-545-8800,"60 mg, 30 count (NDC 0093-5262-56)",New,2/8/23,,Business Decision to Discontinue,,,Psychiatry,To be Discontinued,2/8/23,2/8/23,2/8/23,,,,,,,
Fluoxetine Tablets,Teva Pharmaceuticals,800-545-8800,"10 mg, 100 count (NDC 0093-7188-01)",New,2/8/23,,Business Decision to Discontinue,,,Psychiatry,To be Discontinued,2/8/23,2/8/23,2/8/23,,,,,,,
Fluoxetine Tablets,Teva Pharmaceuticals,800-545-8800,"10 mg, 1000 count (NDC 0093-7188-10)",New,2/8/23,,Business Decision to Discontinue,,,Psychiatry,To be Discontinued,2/8/23,2/8/23,2/8/23,,,,,,,
Fluoxetine Tablets,Teva Pharmaceuticals,800-545-8800,"10 mg, 30 count (NDC 0093-7188-56)",New,2/8/23,,Business Decision to Discontinue,,,Psychiatry,To be Discontinued,2/8/23,2/8/23,2/8/23,,,,,,,
Flurazepam Hydrochloride Capsules,"Rising Pharma Holdings, Inc.",732-917-6058,15mg C 100s (NDC 0378-4415-01),New,8/3/22,Anticipated availability: August 2023.,Delay is due to manufacturing delays at the contract manufacturing facility.,,,Neurology; Other,Current,,,8/3/22,,,,,,,
Flurazepam Hydrochloride Capsules,"Rising Pharma Holdings, Inc.",732-917-6058,30mg C 100s (NDC 0378-4430-01),New,8/3/22,Anticipated availability: August 2023.,Delay is due to manufacturing delays at the contract manufacturing facility.,,,Neurology; Other,Current,,,8/3/22,,,,,,,
Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",100 mg. 30’s count (NDC 10370-175-11),Revised,12/16/22,,,,,Psychiatry,Resolved,12/16/22,,2/5/19,,,,,,,
Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",150 mg. 30’s count (NDC 10370-176-11),Revised,12/16/22,,,,,Psychiatry,Resolved,12/16/22,,2/5/19,,,,,,,
Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 100 mg Extended Release Capsules, 30 count (NDC 0228-2848-03)",Revised,12/16/22,,,,,Psychiatry,Resolved,,,2/5/19,,,,,,,
Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 150 mg Extended Release Capsules, 30 count (NDC 0228-2849-03)",Revised,12/16/22,,,,,Psychiatry,Resolved,12/16/22,,2/5/19,,,,,,,
Fosamprenavir Calcium (Lexiva) Oral Solution,GlaxoSmithKline (ViiV Healthcare),888-825-5249,50 mg/mL Oral Solution 225 mL bottle (NDC 49702-208-53),New,1/3/23,,"The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024.",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Fosamprenavir Calcium (Lexiva) Tablets,GlaxoSmithKline (ViiV Healthcare),888-825-5249,700 mg tablet 60 count (NDC 49702-207-18),New,1/3/23,,"The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024.",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Fosphenytoin Sodium Injection,"Mylan Institutional, a Viatris company",800-796-9526,"100 mg/2 mL, package of 25 vials (NDC 67457-516-25)",New,9/3/21,,,,,Neurology;Pediatric,To be Discontinued,,,8/4/21,,,,,,,
Fosphenytoin Sodium Injection,"Mylan Institutional, a Viatris company",800-796-9526,"500 mg/10 mL, package of 10 vials (NDC 67457-517-01)",New,8/4/21,,,,,Neurology;Pediatric,To be Discontinued,,,8/4/21,,,,,,,
Furosemide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,20 mg/2mL vial (NDC 70860-302-41 and 70860-302-02),Reverified,3/24/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,40 mg/4mL vial (NDC 70860-302-42 and 70860-302-04),Reverified,3/24/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,100 mg/10mL vial (NDC 70860-302-43 and 70860-302-10),Reverified,3/24/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Sagent Pharmaceuticals,866-625-1618,20 mg/2 mL single-dose vial (NDC 25021-311-02),Reverified,3/22/23,Available.,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Sagent Pharmaceuticals,866-625-1618,40 mg/4 mL single-dose vial (NDC25021-311-04),Reverified,3/22/23,Available.,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Sagent Pharmaceuticals,866-625-1618,100 mg/10 mL single-dose vial (NDC 25021-311-10),Reverified,3/22/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Gland Pharma Limited,866-625-1618,"2 mL in 1 vial, 25 vials/carton (NDC 25021-311-02)",Reverified,7/1/22,Available,,,Demand increase for the drug,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Gland Pharma Limited,866-625-1618,"4 mL in 1 vial, 25 vials/carton (NDC 25021-311-04)",Reverified,7/1/22,Available,,,Demand increase for the drug,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Gland Pharma Limited,866-625-1918,"10 mL in 1 vial, 25 vials/carton (NDC 25021-311-10)",Reverified,7/1/22,Available,,,Demand increase for the drug,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,20 mg per 2 mL (NDC 71288-205-03),Reverified,2/13/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,40 mg per 4 mL (NDC 71288-203-05),Reverified,2/13/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,100 mg per 10 mL (NDC 71288-203-11),Reverified,2/13/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-27),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,"100 mg/10 mL (10 mg/mL) syringe, bundle of 10 (NDC 0409-1639-10)",New,9/28/22,,,,,Cardiovascular,To be Discontinued,9/28/22,9/28/22,9/28/22,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,"100 mg/10 mL (10 mg/mL) syringe, individual (NDC 0409-1639-21)",New,9/28/22,,,,,Cardiovascular,To be Discontinued,9/28/22,9/28/22,9/28/22,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,"40 mg/4 mL (10 mg/mL) syringe, bundle of 10 (NDC 0409-9631-04)",New,9/28/22,,,,,Cardiovascular,To be Discontinued,9/28/22,9/28/22,9/28/22,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,"40 mg/4 mL (10 mg/mL) syringe, individual (NDC 0409-9631-14)",New,9/28/22,,,,,Cardiovascular,To be Discontinued,9/28/22,9/28/22,9/28/22,,,,,,,
Furosemide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-02)",Revised,3/31/23,Available,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"40 mg per 4 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-04)",Revised,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-10)",Revised,3/31/23,Available,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,20 mg/2 mL single-dose vial (NDC 55150-322-25),Revised,4/4/23,Currently on backorder - next shipment April,Check wholesalers for inventory,,Demand increase for the drug,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,40 mg/4 mL single-dose vial (NDC 55150-323-25),Revised,4/4/23,"Currently on backorder, next shipment TBD",,,Delay in shipping of the drug,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,100 mg/10 mL single-dose vial (NDC 55150-324-25),Revised,4/4/23,"Currently on backorder, next shipment April",Check wholesalers for inventory,,Demand increase for the drug,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 10 mL Single Dose Glass Vial (25 x 10 mL) (NDC 36000-284-25)",Reverified,3/29/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 2 mL Single Dose Glass Vial (25 x 2 mL)(NDC 36000-282-25)",Reverified,3/29/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 4 mL Single Dose Glass Vial (25 x 4 mL)(NDC 36000-283-25)",Reverified,3/29/23,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Avet Pharmaceuticals Inc,855-228-9470,20 mg/mL (NDC 23155-473-41),Revised,10/31/22,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Avet Pharmaceuticals Inc,855-228-9470,40 mg/4mL (NDC 23155-473-42),Revised,10/31/22,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Avet Pharmaceuticals Inc,855-228-9470,100 mg/10mL (NDC 23155-473-44),Revised,10/31/22,Available,,,,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-02),Revised,3/31/23,Available,,,Other,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-04),Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial (NDC 0409-6102-10),Revised,3/31/23,Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-25),Revised,3/31/23,Available,,,Other,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-26),Revised,3/31/23,Available,,,Other,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Accord Healthcare Inc.,866-941-7875,10 mg/ml (SDV) USP;  20 mg/2 ml; 25 pk [2 ml] Vial (NDC 16729-500-08),New,3/27/23,Unavailable,Inventory on hold pending further assessment.,,Other,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Accord Healthcare Inc.,866-941-7875,10 mg/ml (SDV) USP;  40 mg/4 ml; 10 pk [4 ml] Vial (NDC 16729-501-43),New,3/27/23,Unavailable,Inventory on hold pending further assessment.,,Other,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Injection,Accord Healthcare Inc.,866-941-7875,10 mg/ml (SDV) USP;  100 mg/10 ml; 10 pk [10 ml] Vial (NDC 16729-502-43),New,3/27/23,Unavailable,Inventory on hold pending further assessment.,,Other,Cardiovascular,Current,,,4/7/20,,,,,,,
Furosemide Oral Solution,Wockhardt,800-346-6854,"10 mg/mL, 60mL (NDC 60432-0613-60)",New,4/11/22,,,,,Cardiovascular,To be Discontinued,,,4/11/22,,,,,,,
"Furosemide Oral Solution, 10 mg/mL",Wockhardt Bio AG/Morton Grove Pharmaceuticals,847-410-6929,"10 mg/mL, 4 oz. (NDC 60432-613-04)",New,5/19/22,,,,,Cardiovascular,To be Discontinued,,,5/19/22,,,,,,,
Gallium Citrate GA- 67 Injection,Lantheus Medical Imaging Inc.,800-299-3431,2mCi/ML; 3.3 mL in 1 VIAL (NDC 11994-121-06),New,10/27/22,,,,,Medical Imaging,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,https://www.fda.gov/media/162689/download
Gallium Citrate GA- 67 Injection,Lantheus Medical Imaging Inc.,800-299-3431,2mCi/ML; 4.4 mL in 1 VIAL (NDC 11994-121-08),New,10/27/22,,,,,Medical Imaging,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,https://www.fda.gov/media/162689/download
Gallium Citrate GA- 67 Injection,Lantheus Medical Imaging Inc.,800-299-3431,2mCi/ML; 6.6 mL in 1 VIAL (NDC 11994-121-13),New,10/27/22,,,,,Medical Imaging,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,https://www.fda.gov/media/162689/download
Gallium Citrate GA- 67 Injection,Lantheus Medical Imaging Inc.,,2mCi/ML; 9.9 mL in 1 VIAL (NDC 11994-121-19),New,10/27/22,,,,,Medical Imaging,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,https://www.fda.gov/media/162689/download
Gatifloxacin Ophthalmic Solution 0.5%,Abbvie,800-678-1605,ZYMAXID 0.5% 2.5mL (NDC 0023-3615-25),New,3/10/23,,Labeler Allergan. Business decision to discontinue product,,,Ophthalmology,To be Discontinued,3/10/23,3/10/23,3/10/23,,,,,,,
Gatifloxacin Ophthalmic Solution 0.5%,Abbvie,800-678-1605,ZYMAXID 0.5% 1mL (NDC 0023-3615-01),New,3/10/23,,Labeler Allergan. Business decision to discontinue product,,,Ophthalmology,To be Discontinued,3/10/23,3/10/23,3/10/23,,,,,,,
Gatifloxacin Ophthalmic Solution 0.5%,Abbvie,800-678-1605,Gatifloxacin Ophthalmic Solution 0.5% 2.5mL (NDC 60758-615-25),New,3/10/23,,Labeler Pacific Pharma. Business decision to discontinue product,,,Ophthalmology,To be Discontinued,3/10/23,3/10/23,3/10/23,,,,,,,
Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 7 Tablets in 1 Blister Pack (NDC 44004-321-07)",Revised,6/8/22,,,,,Anti-Infective,To be Discontinued,,,5/27/15,,,,,,,
Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 5 Tablets in 1 Blister Pack (NDC 44004-321-05)",Revised,6/8/22,,,,,Anti-Infective,To be Discontinued,,,5/27/15,,,,,,,
Gentamicin and Prednisolone Acetate Ophthalmic Suspension,Abbvie,800-678-1605,"PRED G® (gentamicin and prednisolone acetate ophthalmic suspension) NDC 0023-0106-05/ 1 Bottle, Dropper in 1 Carton> 5 mL in 1 Bottle, Dropper, (NDC 0023-0106-10) / 1 Bottle, Dropper in 1 Carton> 10 mL in 1 Bottle, Dropper",New,6/9/22,,,,,Ophthalmology,To be Discontinued,,,6/9/22,,,,,,,
Gentamicin Sulfate and Prednisolone Acetate Ophthalmic Ointment,Abbvie,800-678-1605,PRED-G- gentamicin sulfate 0.3% and prednisolone acetate 0.6% ointment 1 TUBE in 1 CARTON  3.5 g in 1 TUBE (NDC 0023-0066-04),New,9/13/21,,,,,Ophthalmology,To be Discontinued,,,9/13/21,,,,,,,
Gentamicin Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"80 mg per 2 mL (40 mg per mL), MDV, (NDC 63323-010-02)",Reverified,3/31/23,Available,Check wholesaler inventory,,Demand increase for the drug,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"800 mg per 20 mL (40 mg per mL), MDV, (NDC 63323-010-20)",Reverified,3/31/23,Available,Check wholesaler inventory,,Demand increase for the drug,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), Pediatric SDV, (NDC 63323-173-02)",Reverified,3/31/23,Available,Check wholesaler inventory,,Demand increase for the drug,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,80 mg/2 mL (40 mg/mL); 2 mL Single Dose Glass Fliptop Vial (NDC 00409-1207-03),Reverified,3/31/23,Next Delivery and Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,80 mg/2 mL (40 mg/mL) Single Dose Glass Fliptop Vial NovaPlus (NDC 00409-1207-25),Reverified,3/31/23,Next Delivery and Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 60 mg/50 mL, (NDC 0338-0507-41)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80 mg/50 mL, (NDC 0338-0509-41)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80mg/100 mL, (NDC 0338-0503-48)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 100 mg/50 mL, (NDC 0338-0511-41)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 100 mg/100 mL, (NDC 0338-0505-48)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 120 mg/100 mL, (NDC 0338-0507-48)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Injection,"Hikma Pharmaceuticals USA, Inc.",800-631-2174,"40 mg/mL, 2 mL vial (NDC 0143-9128-25)",New,3/23/23,This presentation is temporarily on backorder.,Additional lots will be available in the May 2023 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,,7/23/21,,,,,,,
Gentamicin Sulfate Solution,Abbvie,800-678-1605,GENOPTIC® (gentamicin sulfate) Ophthalmic solution/drops (NDC 60758-188-05) -- 5 mL in 10 mL bottle,New,6/9/22,,,,,Ophthalmology,To be Discontinued,,,6/9/22,,,,,,,
Glipizide Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",Extended-release 10 mg/1 unit (NDC 10370-746-01),New,2/9/22,,,,,Endocrinology/Metabolism,To be Discontinued,,,2/9/22,,,,,,,
Glipizide Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",Extended-release 10 mg/1 unit (NDC 10370-746-05),New,2/9/22,,,,,Endocrinology/Metabolism,To be Discontinued,,,2/9/22,,,,,,,
Glipizide Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",Extended-release 5 mg/1 unit (NDC 10370-745-01),New,2/9/22,,,,,Endocrinology/Metabolism,To be Discontinued,,,2/9/22,,,,,,,
Glipizide Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",Extended-release 5 mg/1 unit (NDC 10370-745-05),New,2/9/22,,,,,Endocrinology/Metabolism,To be Discontinued,,,2/9/22,,,,,,,
Glipizide Tablets,Teva Pharmaceuticals,800-545-8800,"5mg tablets (NDC 0591-0460-10), (NDC 0591-0460-05), (NDC 0591-0460-01)",New,5/28/20,,,,,Endocrinology/Metabolism,To be Discontinued,,,5/28/20,,,,,,,
Glipizide Tablets,Teva Pharmaceuticals,800-545-8800,"10mg tablets, (NDC 0591-0461-10), (NDC 0591-0461-01), (NDC 0591-0461-05)",New,5/28/20,,,,,Endocrinology/Metabolism,To be Discontinued,,,5/28/20,,,,,,,
Glipizide XL Tablets,Pfizer,800-533-4535,Glipizide XL 2.5 mg tablet; bottle of 30 (NDC 59762-0540-1),New,10/14/22,,Supply expected to exhaust late December 2022; Discontinuation of the manufacture of the drug.,,,Endocrinology/Metabolism,To be Discontinued,10/14/22,10/14/22,10/14/22,,,,,,,
Glipizide XL Tablets,Pfizer,800-533-4535,Glipizide XL 5 mg tablet; bottle of 500 (NDC 59762-0541-2),New,10/14/22,,Supply expected to exhaust late October 2022; Discontinuation of the manufacture of the drug.,,,Endocrinology/Metabolism,To be Discontinued,10/14/22,10/14/22,10/14/22,,,,,,,
Glipizide XL Tablets,Pfizer Pharmaceuticals,800-533-4535,Glipizide XL 5 mg tablets; bottle of 100 (NDC 59762-0541-1),New,3/8/23,,Discontinuation of the manufacture of the drug.,,,Endocrinology/Metabolism,To be Discontinued,3/8/23,3/8/23,3/8/23,,,,,,,
Glipizide XL Tablets,Pfizer Pharmaceuticals,800-533-4535,Glipizide XL 10 mg tablets; bottle of 100 (NDC 59762-0542-1),New,3/8/23,,Supply expected to exhaust late April 2023; Discontinuation of the manufacture of the drug.,,,Endocrinology/Metabolism,To be Discontinued,3/8/23,3/8/23,3/8/23,,,,,,,
Glucagon Injection,Xeris Pharmaceuticals Inc.,877-XERIS-37,"Gvoke PFS, 0.5 mg per 0.1 mL, pre-filled syringe, 1 count (NDC 72065-130-11)",New,11/8/22,,"Distribution will continue in the US until January 30, 2023 and product can be dispensed until supply is exhausted.  Gvoke HypoPen 2-Pack 0.5 MG (NDC 72065-120-12) will continue to be available for pediatric.  All other Gvoke products including Gvoke PFS 1.0 MG, Gvoke HypoPen 0.5 MG, Gvoke HypoPen 1.0 MG and Gvoke Kit will continue to be available.",,,Endocrinology/Metabolism; Gastroenterology; Pediatric,To be Discontinued,11/8/22,11/8/22,11/8/22,,,,,,,
Glucagon Injection,Xeris Pharmaceuticals Inc.,877-XERIS-37,"Gvoke PFS, 0.5 mg per 0.1 mL, pre-filled syringe, 2 count (NDC 72065-130-12)",New,11/8/22,,"Distribution will continue in the US until January 30, 2023 and product can be dispensed until supply is exhausted.  Gvoke HypoPen 2-Pack 0.5 MG (NDC 72065-120-12) will continue to be available for pediatric. All other Gvoke products including Gvoke PFS 1.0 MG, Gvoke HypoPen 0.5 MG, Gvoke HypoPen 1.0 MG and Gvoke Kit will continue to be available.",,,Endocrinology/Metabolism; Gastroenterology; Pediatric,To be Discontinued,11/8/22,11/8/22,11/8/22,,,,,,,
Glucagon Injection,Novo Nordisk,609-987-5800,"GlucaGen, 1 mg/mL, single-dose vial, pack of 10 (NDC 0597-0053-45)",New,11/18/22,,Marketed by Boehringer-Ingelheim,,,Endocrinology/Metabolism; Gastroenterology; Pediatric,To be Discontinued,11/18/22,11/18/22,11/18/22,,,,,,,
Glucagon Injection,Novo Nordisk,609-987-5800,"GlucaGen Diagnostic Kit, 1 mg/mL single-dose vial and 1 mL vial of sterile water for injection (NDC 0597-0260-10)",New,11/18/22,,Marketed by Boehringer-Ingelheim,,,Endocrinology/Metabolism; Gastroenterology; Pediatric,To be Discontinued,11/18/22,11/18/22,11/18/22,,,,,,,
Glucagon Injection,Eli Lilly and Company,800-545-5979,"Glucagon Emergency Kit, 1 mg (NDC 0002-8031-01 kit; containing 1 mg of glucagon per vial (NDC:0002-7529-01) and 1 mL of diluent per prefilled syringe (NDC 0002-7530-01))",Revised,11/18/22,,"Discontinuation of Glucagon Emergency Kit (NDA 020928; NDC 0002-8031-01; NDC 0002-7529-01). The kit distribution will be available in the US through February 2023. Glucagon will continue to be available as Baqsimi to hospitals, health systems and patients.",,,Endocrinology/Metabolism; Gastroenterology; Pediatric,To be Discontinued,10/11/22,10/11/22,10/11/22,,,,,,,
Glyburide (GLYNASE) Tablets,Pfizer Pharmaceuticals,800-533-4535,1.5 tablet; Bottle of 100 (NDC 0009-0341-01),New,1/3/23,,Discontinuation of the manufacture of the drug. Supply expected to exhaust early February 2023.,,,Endocrinology/Metabolism,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Glyburide (GLYNASE) Tablets,Pfizer Pharmaceuticals,800-533-4535,3 mg tablet; Bottle of 100 (NDC 0009-0352-01),New,1/3/23,,Discontinuation of the manufacture of the drug. Supply expected to exhaust early November 2023.,,,Endocrinology/Metabolism,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Glyburide (GLYNASE) Tablets,Pfizer Pharmaceuticals,800-533-4535,6 mg tablet; Bottle of 100 (NDC 0009-3449-01),New,1/3/23,,Discontinuation of the manufacture of the drug. Supply expected to exhaust early February 2023.,,,Endocrinology/Metabolism,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Glyburide (GLYNASE) Tablets,Pfizer Pharmaceuticals,800-533-4535,6 mg tablet; Bottle of 500 (NDC 0009-3449-03),New,1/3/23,,Discontinuation of the manufacture of the drug. Supply expected to exhaust early February 2023.,,,Endocrinology/Metabolism,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1.25 mg/250 mg 100 Count (NDC 00228-2751-11),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22,9/6/22,,,,,,,
Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2.5 mg/500 mg 100 Count (NDC 00228-2752-11),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22,9/6/22,,,,,,,
Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2.5 mg/500 mg 500 Count (NDC 00228-2752-50),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22,9/6/22,,,,,,,
Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg/500 mg 100 Count (NDC 00228-2753-11),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22,9/6/22,,,,,,,
Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg/500 mg 500 Count (NDC 00228-2753-50),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22,9/6/22,,,,,,,
Glycopyrrolate Inhalational Solution,"Sunovion Pharmaceuticals, Inc.",888-394-7377,25mcg/mL (NDCs 63402-201-00 and 63402-201-01),New,4/3/23,,,,,Pulmonary/Allergy,To be Discontinued,4/3/23,4/3/23,4/3/23,,,,,,,
Granisetron Hydrochloride Injection,Teva Pharmauceuticals,800-545-8800,"1 mg/mL, 1 mg, 1 mL/Vial (NDC 0703-7971-03)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Gastroenterology,To be Discontinued,9/13/22,9/13/22,9/13/22,,,,,,,
Granisetron Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"1 mg/mL, 4 mg, 4 mL/Vial (NDC 0703-7973-01)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Gastroenterology,To be Discontinued,9/13/22,9/13/22,9/13/22,,,,,,,
Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 1 mg, 100 Count (NDC 42806-048-01)",Reverified,2/23/21,Available,,,Other,Cardiovascular,Current,,,10/24/17,,,,,,,
Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 2 mg, 100 Count (NDC 42806-296-01)",Reverified,2/23/21,Available,,,Other,Cardiovascular,Current,,,10/24/17,,,,,,,
Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1mg tablets 100 count bottle (NDC 0591-0444-01),Revised,4/5/23,Limited Supply Available,,,,Cardiovascular,Current,,,10/24/17,,,,,,,
Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2 mg tablets 100 count bottle (NDC 0591-0453-01),Revised,4/5/23,Available,Recovery expected TBD,,,Cardiovascular,Current,,,10/24/17,,,,,,,
Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,1 mg bottles of 30 (NDC 65162-711-03); 1 mg bottles of 100 (NDC 65162-711-10),Reverified,8/17/20,Available,,,Other,Cardiovascular,Current,,,10/24/17,,,,,,,
Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,2 mg bottles of 30 (NDC 65162-713-03); 2 mg bottles of 100 (NDC 65162-713-10); 2 mg bottles of 500 (NDC 65162-713-50),Reverified,8/17/20,Available,,,Other,Cardiovascular,Current,,,10/24/17,,,,,,,
Haloperidol Decanoate Injection,Teva,800-545-8800,NDC 0703-7133-01 (500 mg/5 mL (100 mg/mL) 5 mL Multiple Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Psychiatry,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Haloperidol Decanoate Injection,Teva,800-545-8800,NDC 0703-7131-03 (100 mg/mL 10 x 1 mL Single Dose Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Psychiatry,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Haloperidol Decanoate Injection,Teva,800-545-8800,NDC 0703-7121-03 (50 mg/mL 10 x 1 mL Single Dose Vials),New,8/11/22,,Product is available with an expected supply duration until JUL 2022.  No future production expected for an extended period.,,,Psychiatry,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Haloperidol Decanoate Injection,Teva,800-545-8800,NDC 0703-7123-01 (250 mg/5 mL (50 mg/mL) 5 mL Multiple Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Psychiatry,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,0.5 mg (NDC 0378-0351-01) and (NDC 0378-0351-10),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg (NDC 0378-0257-01) and (NDC 0378-0257-10),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0214-01) and (NDC 0378-0214-10),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,5 mg (NDC 0378-0327-01) and (NDC 0378-0327-10),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-0334-01),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg (NDC 0378-0355-01),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 100 CT (NDC 68382-079-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 1000 CT (NDC 68382-079-10),Revised,11/20/19,,,Available,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 10MG 100 CT (NDC 68382-080-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 20MG 100 CT (NDC 68382-081-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-13-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-83-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count unit dose (NDC 0781-13-9113),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-13-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-83-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count bottle (NDC 0781-13-9801),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-13-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-83-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-13-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-83-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count unit dose (NDC 0781-13-9613),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-13-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-83-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count unit dose (NDC 0781-13-9713),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Haloperidol Tablets,Sandoz,800-525-8747,20 mg 100 count bottle (NDC 0781-83-9301),Revised,11/20/19,,,,,Psychiatry,Resolved,,,10/19/18,,,,,,,
Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 2,000 USP units in 1000 mL.  Product code 2B0944  (NDC 0338-0433-04)",Revised,3/29/23,Available on allocation,,,Manufacturing Delay,Hematology,Current,,,11/14/17,,,,,,,
Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 1,000 USP units in 500 mL.  Product code 2B0953 (NDC 0338-0431-03)",Revised,3/29/23,Unavailable,,,Other,Hematology,Current,,,11/14/17,,,,,,,
Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"1,000 Units/500 mL (2 Units/mL); Flexible Container (NDC 00409-7620-03)",Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: September 2023,,,Demand increase for the drug,Hematology,Current,,,11/14/17,,,,,https://www.fda.gov/media/156079/download,,
Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"2,000 Units/1000 mL (2 Units/mL); Flexible Container (NDC 00409-7620-59)",Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023,,,Demand increase for the drug,Hematology,Current,,,11/14/17,,,,,https://www.fda.gov/media/156079/download,,
Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection, 1,000 units / 500 mL (2 units / mL) in VIAFLEX Plastic Container.  Product code AHB0953U (NDC 0338-0424-18)",Revised,3/29/23,Available on allocation.,Product code AHB0953U replaces code 2B0953,,Manufacturing Delay,Hematology,Current,,,11/14/17,,,,,,,
Heparin Sodium and Sodium Chloride 0.9% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 Units/500 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-77)",Revised,3/31/23,Available,Check wholesaler for inventory,,Other,Hematology,Current,,,11/14/17,,,,,,,
Heparin Sodium and Sodium Chloride 0.9% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2,000 Units/1000 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-10)",Revised,3/31/23,4 & 5 month expiry (7/31/2023 & 8/31/2023 expiry) dating available by request.,,,Other,Hematology,Current,,,11/14/17,,,,,,,
Heparin Sodium and Sodium Chloride 0.9% Injection,B. Braun Medical Inc.,800-227-2862,"1,000 USP units in 500 mL. Product code P8721 (NDC 0264-9872-10)",Revised,3/25/22,Available. On 100% allocation.,,,Demand increase for the drug,Hematology,Current,,,11/14/17,,,,,,,
Histrelin Acetate Implant,"Endo Pharmaceuticals, Inc.",800-462-3636,Vantas 50 mg Implantation Kit (NDC 67979-500-01),Revised,9/21/21,,,,,Oncology,To be Discontinued,,,9/21/21,,,,,,,
Hydralazine Hydrochloride Injection,American Regent/Luitpold,800-645-1706,20mg/ml SDV ( NDC 0517 - 0901-25 ),Revised,6/29/21,,,Available,,Cardiovascular,Resolved,,,3/17/21,,,,,,,
Hydralazine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per mL, SDV (NDC 63323-614-01)",Revised,6/29/21,,,Available,,Cardiovascular,Resolved,,,9/8/20,,,,,,,
Hydralazine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"20 mg/mL, 1mL single dose vial  (box of 10) (NDC 17478-934-01)",Revised,6/29/21,,,,,Cardiovascular,Resolved,,,9/8/20,,,,,,,
Hydralazine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"20 mg/mL, 1mL single dose vial  (box of 25) (NDC 17478-934-15)",Revised,6/29/21,,,,,Cardiovascular,Resolved,,,9/8/20,,,,,,,
Hydralazine Hydrochloride Injection,"Mylan Institutional, a Viatris company",800-796-9526,20 mg / 1 ml] 25PK (NDC 67457-291-01),Revised,6/29/21,,,,,Cardiovascular,Resolved,,,9/8/20,,,,,,,
Hydralazine Hydrochloride Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,20 mg/mL per vial (NDC 39822-0500-4),Revised,6/29/21,,,,,Cardiovascular,Resolved,,,9/8/20,,,,,,,
Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg/25 mg (NDC 0378-2025-01),New,5/22/18,,,,,Cardiovascular,To be Discontinued,,,5/22/18,,,,,,,
Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,12.5 mg/ 20 mg (NDC 0378-2012-01),New,5/22/18,,,,,Cardiovascular,To be Discontinued,,,5/22/18,,,,,,,
Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg/ 12.5 mg (NDC 0378-1012-01),New,5/22/18,,,,,Cardiovascular,To be Discontinued,,,5/22/18,,,,,,,
Hydrochlorothiazide and Spironolactone (Aldactazide) Tablets,Pfizer,800-533-4535,50 mg tablet; bottle of 100 (NDC 0025-1021-31),New,9/8/22,,Supply expected to exhaust mid September 2022,,,Cardiovascular,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Hydrochlorothiazide and Spironolactone (Aldactazide) Tablets,Pfizer,800-533-4535,25 mg tablet; bottle of 100 (NDC 0025-1011-31),New,11/8/22,,Discontinuation of the manufacture of the drug. Supply expected to exhaust late December 2022,,,Cardiovascular,To be Discontinued,11/8/22,11/8/22,11/8/22,,,,,,,
Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution,Perrigo Pharmaceuticals,269-673-8451,Hydrocodone Bitartrate (5 mg/5 mL) and Homatropine Methylbromide (1.5 mg/5 mL)(NDC 0574-1105-16),New,6/5/18,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,,6/5/18,,,,,,,
Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 12 suppositories (NDC 59741-301-12),New,11/25/19,,,,,Other;Urology,To be Discontinued,,,11/25/19,,,,,,,
Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 24 suppositories (NDC 59741-301-24),New,11/25/19,,,,,Other;Urology,To be Discontinued,,,11/25/19,,,,,,,
Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 100 suppositories (NDC 59741-301-01),New,11/25/19,,,,,Other;Urology,To be Discontinued,,,11/25/19,,,,,,,
Hydrocortisone Sodium Succinate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,1000 mg; Single Dose ACT-O-Vial (NDC 0009-0005-01),New,3/24/23,"Limited Supply Available
Next Delivery: May 2023
Estimated Recovery: June 2023",Shortage per Manufacturer: Manufacturing Delays,,Other,Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology,Current,,,3/24/23,,,,,,,
Hydrocortisone Sodium Succinate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg; vial (NDC 0009-0825-01),New,3/24/23,"Limited Supply Available
Next Delivery: April 2023
Estimated Recovery: August 2023",Shortage per Manufacturer: Manufacturing Delays,,Other,Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology,Current,,,3/24/23,,,,,,,
Hydrocortisone Sodium Succinate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg; Single Dose ACT-O-Vial (NDC 0009-0011-04),New,3/24/23,"Limited Supply – Direct Ship Only
Next Delivery: June 2023; Estimated Recovery:  July 2023",Shortage per Manufacturer: Manufacturing Delays,,Other,Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology,Current,,,3/24/23,,,,,https://www.fda.gov/media/166443/download,,
Hydrocortisone Sodium Succinate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg; Single Dose ACT-O-Vial (NDC 0009-0011-03),New,3/24/23,"Limited Supply Available
Next Delivery: April 2023
Estimated Recovery: June 2023",Shortage per Manufacturer: Manufacturing Delays,,Other,Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology,Current,,,3/24/23,,,,,,,
Hydrocortisone Sodium Succinate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mg; Single Dose ACT-O-Vial (NDC 0009-0013-06),New,3/24/23,"Limited Supply Available
Next Delivery: April 2023
Estimated Recovery: June 2023",Shortage per Manufacturer: Manufacturing Delays,,Other,Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology,Current,,,3/24/23,,,,,,,
Hydrocortisone Sodium Succinate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mg; Single Dose ACT-O-Vial (NDC 0009-0013-05),New,3/24/23,"Limited Supply Available
Next Delivery: May 2023
Estimated Recovery: June 2023",Shortage per Manufacturer: Manufacturing Delays,,Other,Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology,Current,,,3/24/23,,,,,,,
Hydrocortisone Sodium Succinate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,500 mg; Single Dose ACT-O-Vial (NDC 0009-0016-12),New,3/24/23,"Limited Supply Available
Next Delivery and Estimated Recovery: July 2023",Shortage per Manufacturer: Manufacturing Delays,,Other,Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology,Current,,,3/24/23,,,,,,,
Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,5 mg tablet; bottle of 50 (NDC 59762-0073-1),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,10 mg tablet; bottle of 100 (NDC 59762-0074-1),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,20 mg tablet; bottle of 100 (NDC 59762-0075-1),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,Cortef 20 mg tablet; bottle of 100 (NDC 0009-0044-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,Cortef 5 mg tablet; bottle of 50 (NDC 0009-0012-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,Cortef 10 mg tablet; bottle of 100 (NDC 0009-0031-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Strides Pharma Inc.,855-273-0146,"5 mg, 50 count bottles (NDC 64380-970-25)",Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Strides Pharma Inc.,855-273-0146,"10 mg, 100 count bottles (NDC 64380-971-06)",Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Strides Pharma Inc.,855-273-0146,"20 mg, 100 count bottles (NDC 64380-972-06)",Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Amneal Pharmaceutical,866-525-7270,100mg/100 count (NDC 00115-1697-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydrocortisone Tablets,Amneal Pharmaceutical,866-525-7270,20mg/100 count (NDC 00115-1700-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/2/20,,,,,,,
Hydromorphone Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"(Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-11)                                                                                                                                                                                     Microvault",Revised,3/31/23,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"1 mg per 1 mL, Single dose vial, (NDC 63323-852-25)",Revised,3/31/23,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-853-25)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-854-10)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"10 mg per 1 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-10)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"50 mg per 5 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-15)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"500 mg per 50 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-50)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"10 MG/1ML, 10 X 1 mL Single-dose Vials (NDC 0703-0110-03)",Revised,4/5/23,Allocation,,,,Analgesia/Addiction,Current,,,11/1/17,,,,,,,
Hydromorphone Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"10 MG/1ML, 10 X 5 mL Single-dose Vials (NDC 0703-0113-03)",Revised,4/5/23,Allocation,,,,Analgesia/Addiction,Current,,,11/1/17,,,,,,,
Hydromorphone Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"10 MG/1 ML, 50 mL Single-dose Vial (NDC 0703-0018-01)",Revised,4/5/23,"Allocating Limited Supply, Recovery TBD",,,,Analgesia/Addiction,Current,,,11/1/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 1 mL vial (NDC 0641-0121-25)",Revised,10/13/22,Inventory is currently available.,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,,11/3/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0641-2341-41)",Revised,10/13/22,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,,11/3/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,0.5 mg/0.5 mL (1 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-05),Revised,3/31/23,Next Delivery and Estimated Recovery: TBD,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,1 mg/1 mL (1 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1283-31),Revised,3/31/23,Available,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,2 mg/1 mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1312-30),Revised,3/31/23,Available,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,4 mg/1 mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1304-31),Revised,3/31/23,Available,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,1 mg/1 mL (1 mg/mL); Glass Ampul (NDC 00409-2552-01),Revised,3/31/23,Next Delivery and Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,10 mg/mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-01),Revised,3/31/23,Available,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/5 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-05),Revised,3/31/23,Available,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,"Hospira, Inc., a Pfizer company",844-646-4398,500 mg/50 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-50),Revised,3/31/23,Available,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 1 mL ampule, 10 count (NDC 17478-0540-01)",Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 5 mL ampule, 10 count (NDC 17478-0540-05)",Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 50 mL vial, 10 count (NDC 17478-0540-50)",Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"(Dilaudid) 0.2 mg per 1 mL, prefilled syringe, MicroVault packaging (NDC 76045-121-11)",Revised,3/31/23,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydromorphone Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"(Dilaudid) 2 mg per 1 mL, prefilled syringe, MicroVault packaging (NDC 76045-010-11)",Revised,3/31/23,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Hydroxocobalamin Injection,SERB SA,,"Hydroxocobalamin Injection (Cyanokit) intravenous powder for solution for injection, 5 gram, vial, (NDC 11704-0370-01)",Revised,1/20/22,,,Available,,Endocrinology/Metabolism;Other,Resolved,,,4/20/21,,,,,,,
Hydroxocobalamin Injection,Teva Pharmaceuticals,800-545-8800,"Hydroxocobalamin Injection 1000MCG/ML, 1X30ML(NDC 0591-2888-30)",Revised,1/21/22,,,Available,,Endocrinology/Metabolism,Resolved,,,4/20/21,,,,,,,
Hydroxyamphetamine Hydrobromide/Tropicamide Ophthalmic Solution,Akorn Operating Company LLC,800-932-5676,"PAREMYD® Hydroxyamphetamine Hydrobromide/Tropicamide Ophthalmic Solution 1%/0.25%, fill 15 mL (NDC 17478-704-12)",New,1/31/23,,Business decision to discontinue product.,,,Ophthalmology,To be Discontinued,1/31/23,1/31/23,1/31/23,,,,,,,
Hydroxychloroquine Tablets,Sandoz,800-525-8747,200 mg 100ct (NDC 0781-5994-01),New,2/14/23,,,,,Rheumatology; Anti-Infective,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
Hydroxychloroquine Tablets,Sandoz,800-525-8747,200 mg 500ct (NDC 0781-5994-05),New,2/14/23,,,,,Rheumatology; Anti-Infective,To be Discontinued,,2/14/23,2/14/23,,,,,,,
Hydroxyprogesterone Caproate Injection,American Regent/Luitpold,800-645-1706,"Hydroxyprogesterone Caproate Injection, USP 250mg/mL 1mL Single Dose Vial (NDC 0517-1767-01)",Revised,8/2/19,,,,,Reproductive,Resolved,,,1/25/19,,,,,,,
Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,"Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml (NDC 71225-104-01)",Revised,8/2/19,,,,,Reproductive,Resolved,,,1/25/19,,,,,,,
Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single dose auto-injector 1.1mL for subcutaneous injection: (NDC 64011-247-02),Revised,8/2/19,,,,,Reproductive,Resolved,,,1/25/19,,,,,,,
Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,,,1/25/19,,,,,,,
Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Multi-dose vial 5mL for intramuscular injection: (NDC 64011-243-01),Revised,8/2/19,,,,,Reproductive,Resolved,,,1/25/19,,,,,,,
Hydroxyprogesterone Caproate Injection,Prasco Laboratories,866-525-0688,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,,,1/29/19,,,,,,,
Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,Hydroxyprogesterone Caproate Injection USP 250 mg/1 mL single-dose vial (NDC 55150-309-01),Revised,8/2/19,,,,,Reproductive,Resolved,,,1/25/19,,,,,,,
Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,"Hydroxyprogesterone Caproate Injection USP 1,250 mg/5 mL multiple-dose vial (NDC 55150-310-01)",Revised,8/2/19,,,,,Reproductive,Resolved,,,1/25/19,,,,,,,
Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,Hydroxyprogesterone Caproate Injection 250 mg/ 1 ml (NDC 71225-105-01),Revised,8/2/19,,,,,Reproductive,Resolved,,,1/25/19,,,,,,,
Hydroxypropyl (Lacrisert) Cellulose Ophthalmic Insert,"Bausch Health Americas, Inc.",800-321-4576,"Lacrisert, 5 mg per ophthalmic insert, 60 unit dose blister pack (NDC 24208-800-60)",Reverified,1/10/23,"Unavailable, Resupply expected July 2023",,,Other,Ophthalmology,Current,,,5/1/20,,,,,,,
Hydroxyzine Pamoate Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril 25 mg Capsules; 100 count bottle (NDC 0069-5410-66),New,3/28/23,,To be discontinued upon stop sale date May 2025,,,Psychiatry; Analgesic,To be Discontinued,3/28/23,3/28/23,3/28/23,,,,,,,
Hydroxyzine Pamoate Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril 50 mg Capsules; 100 count bottle (NDC 0069-5420-66),New,3/28/23,,To be discontinued upon stop sale date April 2023,,,Psychiatry; Analgesic,To be Discontinued,3/28/23,3/28/23,3/28/23,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 25 mg Capsules; 100 count bottle (NDC 0069-5410-66),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 50 mg Capsules; 100 count bottle (NDC 0069-5420-66),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 100 count (NDC 14539-674-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 500 count (NDC 14539-674-05),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 100 count (NDC 14539-675-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 500 count (NDC 14539-675-05),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,100 mg 100 count (NDC 0555-0324-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 100 count (NDC 0555-0323-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 500 count (NDC 0555-0323-04),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 100 count (NDC 0555-0302-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 500 count (NDC 0555-0302-04),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 100 count (NDC 0185-0674-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 500 count (NDC 0185-0674-05),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 100ct (NDC 00115-1803-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 500ct (NDC 00115-1803-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 100ct (NDC 00115-1804-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 500ct (NDC 00115-1804-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,,3/12/19,,,,,,,
Hyoscyamine Sulfate Injection,"Meda Pharmaceuticals Inc, A Viatris company",800-796-9526,"Levsin® Injection, 0.5mg, (NDC 0037-9001-05)",New,9/13/22,,Product will be available until stock out or expiry (October 2023).,,,Anesthesia; Gastroenterology; Urology,To be Discontinued,9/13/22,9/13/22,9/13/22,,,,,,,
Ibuprofen and Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,800 mg/26.6 mg 90 Count (NDC 0093-8107-98),New,1/25/23,,Business decision to discontinue manufacture of the drug product,,,Analgesia,To be Discontinued,1/25/23,1/25/23,1/25/23,,,,,,,
Ibutilide Fumarate Injection,"Mylan Institutional, a Viatris company",800-796-9526,"1 mg/10 mL (0.1 mg/mL), single dose vial (NDC 67457-366-10)",Reverified,3/28/23,Available,,,Other,Cardiovascular,Current,,,4/29/22,,,,,,,
Ibutilide Fumarate Injection,Pfizer Pharmaceuticals,844-646-9526,"1 mg/10 mL (0.1 mg/mL), single dose vial (NDC 0009-3794-01)",Reverified,3/31/23,Available,,,Other,Cardiovascular,Current,,,4/29/22,,,,,,,
Ibutilide Fumarate Injection,Pfizer Pharmaceuticals,844-646-4398,"1 mg/10 mL (0.1 mg/mL), single dose vial (NDC 0009-3794-22), Novaplus",Reverified,3/31/23,Available,,,Other,Cardiovascular,Current,,,4/29/22,,,,,,,
Idarubicin Hydrochloride Injection,Teva,800-545-8800,NDC 0703-4155-11 (10 mg/10 mL (1 mg/mL) 10 mL Single Dose Vial),New,8/11/22,,Product is available with an expected supply duration until JUN' 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Idarubicin Hydrochloride Injection,Teva,800-545-8800,NDC 0703-4156-11 (20 mg/20 mL (1 mg/mL) 20 mL Single Dose Vial),New,8/11/22,,Product is available with an expected supply duration until JUL' 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Idarubicin Hydrochloride Injection,Teva,800-545-8800,NDC 0703-4154-11 (5 mg/5 mL (1 mg/mL) 5 mL Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Ifosfamide Injection,Teva,800-545-8800,NDC 0703-3427-11 (1 g/20 mL (50 mg/mL) Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Ifosfamide Injection,Teva,800-545-8800,NDC 0703-3429-11 (3 g/60 mL (50 mg/mL) Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Imipenem and Cilastatin for Injection,HQ Specialty Pharma,201-857-8290,"500 mg per vial, single dose vial, sterile powder (NDC 44567-0705-10)",Revised,6/8/22,,,Available,,Anti-Infective,Resolved,,,5/22/15,,,,,,,
Imipenem and Cilastatin for Injection,Merck Sharp & Dohme Corp.,800-672-6372,500 mg  imipenem  equivalent  and  500 mg  cilastatin  equivalent  and  20 mg  sodium bicarbonate as a buffer in trays of 25 vials (NDC 0006-3516-59),Revised,6/8/22,,,Available,,Anti-Infective,Resolved,,,6/16/15,,,,,,,
Imipenem and Cilastatin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"250 mg/250 mg per vial, single dose vial, sterile powder (NDC 63323-349-25)",Revised,6/8/22,,,Available,,Anti-Infective,Resolved,,,5/22/15,,,,,,,
Imipenem and Cilastatin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg/500 mg per vial, single dose vial, sterile powder (NDC  63323-322-25)",Revised,6/8/22,,,Available,,Anti-Infective,Resolved,,,5/22/15,,,,,,,
Imipramine Tablets,Sandoz,800-525-8747,10 mg 100 ct (NDC 0781-1762-01),New,2/28/22,,,,,Psychiatry,To be Discontinued,,,2/28/22,,,,,,,
Imipramine Tablets,Sandoz,800-525-8747,25 mg 100 ct (NDC 0781-1764-01),New,2/28/22,,,,,Psychiatry,To be Discontinued,,,2/28/22,,,,,,,
Imipramine Tablets,Sandoz,800-525-8747,25 mg 1000 ct (NDC 0781-1764-10),New,2/28/22,,,,,Psychiatry,To be Discontinued,,,2/28/22,,,,,,,
Imipramine Tablets,Sandoz,800-525-5747,50 mg 100 ct (NDC 0781-1766-01),New,2/28/22,,,,,Psychiatry,To be Discontinued,,,2/28/22,,,,,,,
Imipramine Tablets,Sandoz,800-525-8747,50 mg 1000 ct (NDC 0781-1766-10),New,2/28/22,,,,,Psychiatry,To be Discontinued,,,2/28/22,,,,,,,
Indigotindisulfonate Sodium Injection,American Regent/Luitpold,800-645-1706,Indigo Carmine injection 5mL ampule (NDC 0517-0375-05),Reverified,3/28/23,"Out of Stock, no plans to manufacture until sometime in 2023",,,Shortage of an active ingredient,Medical Imaging,Current,,,8/23/22,,,,,,,
Indigotindisulfonate Sodium Injection,Provepharm SAS,610-601-8600,"Bludigo [Indigotindisulfonate Sodium Injection, USP] 0.8% (40mg/5ml)] (NDC 81284-315-05)",New,10/13/22,Available,,,Other,Medical Imaging,Current,,,8/23/22,,,,,,,
Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 100s (NDC 0378-0143-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 1000s (NDC 0378-0143-10)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 100s (NDC 0378-0147-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 500s (NDC 0378-0147-05)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Indomethacin Injection,Hospira,844-646-4398,1 mg Single Dose Vial (NDC 0409-1113-01),New,8/15/22,,Limited supply available. Product expected to exhaust by November 2022,,,Pediatric; Cardiovascular,To be Discontinued,8/15/22,8/15/22,8/15/22,,,,,,,
Indomethacin Injection,Navinta LLC,609-883-1135,1 mg per vial (NDC 68382-470-01),New,8/17/22,,Navinta has made a business decision to discontinue this product.,,,Pediatric; Cardiovascular,To be Discontinued,8/17/22,8/17/22,8/17/22,,,,,,,
Insulin Lispro (Humalog Mix50/50),Eli Lilly and Company,800-545-5979,"Humalog (Insulin Lispro) Mix50/50, 10ml vial (NDC 0002-7512-01)",New,6/30/22,,,,,,To be Discontinued,,,6/30/22,,,,,,,
"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Powder for Injection (Interferon alfa-2b), 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent (NDC 0085-4350-01)",New,4/23/21,,,,,Antiviral,To be Discontinued,,,4/23/21,,,,,,,
"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Powder for Injection (Interferon alfa-2b), 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent (NDC 0085-4351-01)",New,4/23/21,,,,,Antiviral,To be Discontinued,,,4/23/21,,,,,,,
"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Powder for Injection (Interferon alfa-2b), 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01)",New,4/23/21,,,,,Antiviral,To be Discontinued,,,4/23/21,,,,,,,
"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4350-01),New,9/12/19,,,,,Antiviral;Oncology,To be Discontinued,,,9/12/19,,,,,,,
"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent ((NDC 0085-4351-01)),New,9/12/19,,,,,Antiviral;Oncology,To be Discontinued,,,9/12/19,,,,,,,
"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01),New,9/12/19,,,,,Antiviral;Oncology,To be Discontinued,,,9/12/19,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-64), 320 mg/1 mL, INJECTION, SOLUTION, IV 10 BOTTLE, PLASTIC in 1 BOX > 100 mL in 1 BOTTLE, PLASTIC",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-17), 320 mg/1 mL, VISIPAQUE INJECTION, SOLUTION, IV VISIPAQUE 320mgI/ml USB 10x100 VIAL ml USA",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2222-17), 270 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 320 mg Iodine/mL: 100 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-383-10)",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 320 mg Iodine/mL: 200 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-383-70)",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 320 mg Iodine/mL: 50 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-383-05)",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 320 mg Iodine/mL: 150 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-383-50)",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 270 mg Iodine/mL: 100 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-381-10)",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 270 mg Iodine/mL: 150 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-381-50)",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-23), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Not currently in production. Please contact GE Healthcare at CustServContrastgenemail@ge.com to inquire about future availability of this presentation.,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-62), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Not currently in production. Please contact GE Healthcare at CustServContrastgenemail@ge.com to inquire about future availability of this presentation.,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-66), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Not currently in production. Please contact GE Healthcare at CustServContrastgenemail@ge.com to inquire about future availability of this presentation.,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-67), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Not currently in production. Please contact GE Healthcare at CustServContrastgenemail@ge.com to inquire about future availability of this presentation.,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2222-16), 270 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2222-19), 270 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2222-21), 270 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-16), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-19), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-21), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/12/22,,,Available,,Medical Imaging,Resolved,10/12/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-94), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-93), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-95), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-38), 240 mg/1 mL, INJECTION, SOLUTION, IT",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1401-52), 140 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,Available,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-86), 300 mg/1 mL, INJECTION, SOLUTION, IT",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-87), 300 mg/1 mL, INJECTION, SOLUTION, IT",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-88), 300 mg/1 mL, INJECTION, SOLUTION, IT",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-42), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-90), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-85), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-84), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-82), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-87), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-86), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-59), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-65), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-61), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-63), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/19/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-62), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-66), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-76), 350 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-69), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-91), 350 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, IV OMNIPAQUE 350mgI/ml USB 10x100 ml USA",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1411-10), 180 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, ORAL OMNIPAQUE 180mgI/ml VIAL10x 10 ml USA",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-68), 300 mg/1 mL, INJECTION, SOLUTION, IV",Revised,10/27/22,,"Please contact GE Healthcare’s Medical Affairs team by emailing medical.affairs@ge.com or by calling +1 800 654 0118 (option 2, then 3) to answer any questions relating to changes in concentration or approved indications when using an alternate presentation.",,,Medical Imaging,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1411-20), 180 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, ORAL OMNIPAQUE 180mgI/ml VIAL10x 20 ml USA",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-72),300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-89), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-48), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1416-12), 12 mg/1 mL, SOLUTION, ORAL",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1415-09), 9 mg/1 mL, SOLUTION, ORAL",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-34), 240 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-30), 240 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-35), 240 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-33), 240 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-53), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-10), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,Iohexol (Omnipaque)180mgI/ml VIAL10x 20 ml USA (NDC 0407-1411-20),New,2/21/23,,"Please contact GE Healthcare’s Medical Affairs team by emailing medical.affairs@ge.com or by calling +1 800 654 0118 (option 2, then 3) to answer any questions relating to changes in concentration or approved indications when using an alternate presentation.",,,Medical Imaging,To be Discontinued,2/21/23,2/21/23,10/27/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,Iohexol (Omnipaque) 240mgI/ml USB 10x150 ml USA (NDC 0407-1412-34),New,2/21/23,,"Please contact GE Healthcare’s Medical Affairs team by emailing medical.affairs@ge.com or by calling +1 800 654 0118 (option 2, then 3) to answer any questions relating to changes in concentration or approved indications when using an alternate presentation.",,,Medical Imaging,To be Discontinued,2/21/23,2/21/23,10/27/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,Iohexol (Omnipaque) 240mgI/ml USB 10x200 ml USA (NDC 0407-1412-35),New,2/21/23,,"Please contact GE Healthcare’s Medical Affairs team by emailing medical.affairs@ge.com or by calling +1 800 654 0118 (option 2, then 3) to answer any questions relating to changes in concentration or approved indications when using an alternate presentation.",,,Medical Imaging,To be Discontinued,2/21/23,2/21/23,10/27/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,Iohexol (Omnipaque) 300mgI/ml USB 10x 75 ml USA (NDC 0407-1413-62),New,2/21/23,,"Please contact GE Healthcare’s Medical Affairs team by emailing medical.affairs@ge.com or by calling +1 800 654 0118 (option 2, then 3) to answer any questions relating to changes in concentration or approved indications when using an alternate presentation.",,,Medical Imaging,To be Discontinued,2/21/23,2/21/23,10/27/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,Iohexol (Omnipaque) 300mgI/ml USB 10x200 ml USA (NDC 0407-1413-66),New,2/21/23,,"Please contact GE Healthcare’s Medical Affairs team by emailing medical.affairs@ge.com or by calling +1 800 654 0118 (option 2, then 3) to answer any questions relating to changes in concentration or approved indications when using an alternate presentation.",,,Medical Imaging,To be Discontinued,2/21/23,2/21/23,10/27/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,Iohexol (Omnipaque) 300mgI/ml USB 10x125 ml USA (NDC 0407-1413-69),New,2/21/23,,"Please contact GE Healthcare’s Medical Affairs team by emailing medical.affairs@ge.com or by calling +1 800 654 0118 (option 2, then 3) to answer any questions relating to changes in concentration or approved indications when using an alternate presentation.",,,Medical Imaging,To be Discontinued,2/21/23,2/21/23,10/27/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,Iohexol (Omnipaque) 350mgI/ml USB 10x125 ml USA (NDC 0407-1414-95),New,2/21/23,,"Please contact GE Healthcare’s Medical Affairs team by emailing medical.affairs@ge.com or by calling +1 800 654 0118 (option 2, then 3) to answer any questions relating to changes in concentration or approved indications when using an alternate presentation.",,,Medical Imaging,To be Discontinued,2/21/23,2/21/23,10/27/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-98), 350 mg/1 mL, OMNIPAQUE INJECTION,  SOLUTION, IV OMNIPAQUE 350mgI/ml USB PH10x500ml USA",Revised,10/27/22,,"Please contact GE Healthcare’s Medical Affairs team by emailing medical.affairs@ge.com or by calling +1 800 654 0118 (option 2, then 3) to answer any questions relating to changes in concentration or approved indications when using an alternate presentation.",,,Medical Imaging,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-72), 350 mg/1 mL OMNIPAQUE INJECTION,  SOLUTION, IV OMNIPAQUE 350mgI/ml USB IBP 10x500ml USA",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-88), OMNIPAQUE 350 mg/1 mL, INJECTION, SOLUTION, IV  10 BOTTLE, PLASTIC in 1 BOX > 500 mL in 1 BOTTLE, PLASTIC",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-48), 350 mg/1 mL, INJECTION, SOLUTION, IV 10 BOTTLE, PLASTIC in 1 BOX > 500 mL in 1 BOTTLE, PLASTIC",Revised,11/18/22,,,,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-10), 240 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, IV OMNIPAQUE 240mgI/ml VIAL10x 10 ml USA",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-20), 240 mg/1 mL, OMNIPAQUE INJECTION,  SOLUTION, IV OMNIPAQUE 240mgI/ml VIAL10x 20 ml USA",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-89), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,11/18/22,,,Available,,Medical Imaging,Resolved,11/18/22,,5/9/22,,,,,,,
Iomeprol Injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  400, 56 X 100 ML (NDC 0270-7400-16)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol Injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  400, 30 X 200 ML (NDC 0270-7400-20)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol Injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  300, 10 X 200 ML (NDC 0270-7300-20)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol Injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  400, 6 X 500 ML (NDC 0270-9400-03)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 400, 10 X 100 ML (NDC 0270-7400-10)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  350, 6 X 500 ML (NDC 0270-9350-06)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 350, 10 X 200 ML (NDC 0270-7350-20)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 300, 6 X 500 ML (NDC 0270-9300-06)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 400, 9 X 500 ML (NDC 0270-9400-01)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 350, 9 X 500 ML (NDC 0270-9350-09)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  350, 30 X 150 ML (NDC 0270-7350-15)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  400, 6 X 500 ML (NDC 0270-9400-06)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  300, 56 X 100 ML (NDC 0270-7300-10)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  250, 56 X 100 ML (NDC 0270-7250-10)",Revised,12/27/22,,,Available,,Medical Imaging,Resolved,12/27/22,,7/14/22,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 41% (Isovue 200), 10x50mL vial, (NDC 0270-1314-30)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 41% (Isovue 200M), 10x20mL vial, (NDC 0270-1411-25)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 51% (IsoVue 250),  10x150mL bottle, (NDC 0270-1317-09)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 51% (IsoVue 250),  10x50mL bottle, (NDC 0270-1317-05)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 51% (IsoVue 250 PBP),  10x200mL bottle, (NDC 0270-1317-41)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 61% (IsoVue 300), 10x75mL bottle, (NDC 0270-1315-47)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 61% (IsoVue 300 PBP), 6x500mL bottle, (NDC 0270-1315-98)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 61% (IsoVue 300 PBP), 10x200mL bottle, (NDC 0270-1315-41)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 76% (IsoVue 370 PBP), 6x500mL bottle, (NDC 0270-1316-98)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 76% (IsoVue 370 PBP), 10x200mL bottle, (NDC 0270-1316-41)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,,7/1/21,,,,,,,
Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 300 mg Iodine per mL; 10 VIAL, GLASS in 1 CARTON; > 100 mL in 1 VIAL, GLASS (NDC 50419-344-10)",Revised,10/31/22,,,Available,,Medical Imaging,Resolved,10/31/22,,5/26/22,,,,,,,
Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 300 mg Iodine per mL; 10 VIAL, GLASS in 1 CARTON; > 150 mL in 1 VIAL, GLASS  (NDC 50419-344-15)",Revised,10/31/22,,,Available,,Medical Imaging,Resolved,10/31/22,,5/26/22,,,,,,,
Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 300 mg Iodine per mL; 10 VIAL, GLASS in 1 CARTON; > 50 mL in 1 VIAL, GLASS (NDC 50419-344-05)",Revised,10/31/22,,,Available,,Medical Imaging,Resolved,10/31/22,,5/26/22,,,,,,,
Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 370 mg Iodine per mL: 10 VIAL, GLASS in 1 CARTON; > 50 mL in 1 VIAL, GLASS (NDC 50419-346-05)",Revised,10/31/22,,,Available,,Medical Imaging,Resolved,10/31/22,,5/26/22,,,,,,,
Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 370 mg Iodine per mL: 10 VIAL, GLASS in 1 CARTON; > 100 mL in 1 VIAL, GLASS  (NDC 50419-346-10)",Revised,10/31/22,,,Available,,Medical Imaging,Resolved,10/31/22,,5/26/22,,,,,,,
Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 370 mg Iodine per mL: 10 VIAL, GLASS in 1 CARTON; > 150 mL in 1 VIAL, GLASS  (NDC 50419-346-15)",Revised,10/31/22,,,Available,,Medical Imaging,Resolved,10/31/22,,5/26/22,,,,,,,
Isoniazid Injection,Sandoz,800-525-8747,10 mL (100 mg/mL) Multiple dose vial (NDC 0781-3056-70),Reverified,4/5/23,"Unavailable, resupply TBD",,,Requirements related to complying with good manufacturing practices,Anti-Infective,Current,,,2/4/21,,,,,,,
Itraconazole Oral Solution,Janssen Research and Development,800-526-7736,"SPORANOX, 10mg/1ml 150ml Bottle (NDC 50458-295-15 )",New,3/21/23,,Business decision to discontinue manufacturing of this product.,,,Anti-Infective; Other,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Itraconazole Oral Solution,Janssen Research and Development,800-526-7736,10gm/1ml 150ml Bottle (NDC 10147-0150-1),New,3/21/23,,Distributed by Patriot Pharmaceuticals. Business decision to discontinue manufacturing of this product.,,,Anti-Infective; Other,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
IV Fat Emulsion,Fresenius Kabi USA,888-386-1300,"Smoflipid injectable emulsion, USP, 20% (0.2 grams per mL) (20 grams per 100 mL) (NDC 63323--820-00)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Fresenius Kabi USA,888-386-1300,"Smoflipid injectable emulsion, USP, 20% (0.2 grams per mL) (50 grams per 250 mL) (NDC 63323--820-74)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Fresenius Kabi USA,888-386-1300,"Smoflipid injectable emulsion, USP, 20% (0.2 grams per mL) (100 grams per 500 mL) (NDC 63323-820-50)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Fresenius Kabi USA,888-386-1300,"Smoflipid injectable emulsion, USP, 20%, PBP (0.2 grams per mL) (200 grams per 1000 mL) (NDC 63323-820-10)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 100 mL, Product Code EADB9520, (NDC 0338-9540-05)",Revised,3/29/23,Available,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 1000 mL, Product Code EADB9524, (NDC 0338-9540-08)",Revised,3/29/23,Available,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 250 mL, Product Code EADB9521, (NDC 0338-9540-06)",Revised,3/29/23,Available,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 500 mL, Product Code EADB9523, (NDC 0338-9540-07)",Revised,3/29/23,Available,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 100 mL, Product Code 2B6061, (NDC 0338-0519-58)",Revised,3/29/23,Available on allocation; Recovery Q2 2023,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 250 mL, Product Code 2B6062, (NDC 0338-0519-09)",Revised,3/29/23,Available on allocation,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 1000 mL, Pharmacy Bulk Package, Product Code 2B6064, (NDC 0338-0519-14)",Revised,3/29/23,Available on allocation.,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 500 mL, Product Code 2B6063, (NDC 0338-0519-13)",Revised,3/29/23,Available on allocation,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 30% IV Fat Emulsion, 500 mL, Pharmacy Bulk Package, Product Code 2B6065, (NDC 0338-0520-13)",Revised,3/29/23,Available on allocation,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,B. Braun Medical Inc.,800-227-2862,"Nutrilipid (20% IV Fat Emulsion) in 1,000mL Bag Catalog S4600 (NDC 00264-4460-00)",Revised,4/6/23,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,B. Braun Medical Inc.,800-227-2862,Nutrilipid (20% IV Fat Emulsion) in 500mL Bag Catalog S4601 (NDC 0264-4460-10),Revised,4/6/23,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
IV Fat Emulsion,B. Braun Medical Inc.,800-227-2862,Nutrilipid (20% IV Fat Emulsion) in 250mL Bag Catalog S4603 (NDC 00264-4460-30),Revised,4/6/23,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,,10/25/21,,,,,,,
Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg/mL, 5 mL vial (NDC 0143-9509-10)",Revised,12/21/22,This presentation is on backorder.,Recovery: TBD,,Shortage of an active ingredient,Anesthesia,Current,,,2/28/18,,,,,,,
Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 10 mL vial (NDC 0143-9508-10)",Revised,12/21/22,This presentation is on backorder.,Recovery: TBD,,Shortage of an active ingredient,Anesthesia,Current,,,2/28/18,,,,,,,
Ketamine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,200 mg / 20 mL (NDC 55150-438-10),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/16/18,,,,,,,
Ketamine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,500 mg / 10 mL (NDC 55150-439-10),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/16/18,,,,,,,
Ketamine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1000 mg / 10 mL (NDC 55150-440-10),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/16/18,,,,,,,
Ketamine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05),Revised,3/31/23,Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2024,,,Other,Anesthesia,Current,,,2/16/18,,,,,,,
Ketamine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10),Revised,3/31/23,Next Delivery: February 2025; Estimated Recovery: March 2025,,,Other,Anesthesia,Current,,,2/16/18,,,,,,,
Ketamine Injection,Par Pharmaceutical,800-828-9393,"10 mg/mL, 20 mL MDV (NDC 42023-113-10)",Revised,3/24/23,This presentation is on backorder.,Recovery: TBD,,Shortage of an active ingredient,Anesthesia,Current,,,2/20/18,,,,,,,
Ketamine Injection,Par Pharmaceutical,201-802-4000,"100 mg/mL, 5 mL MDV (NDC 42023-115-10)",Revised,3/24/23,This presentation is on backorder.,Recovery: TBD,,Shortage of an active ingredient,Anesthesia,Current,,,2/20/18,,,,,,,
Ketamine Injection,Par Pharmaceutical,201-802-4000,"50 mg/mL, 10 mL MDV (NDC 42023-114-10)",Revised,3/24/23,This presentation is on backorder.,Recovery: TBD,,Shortage of an active ingredient,Anesthesia,Current,,,2/20/18,,,,,,,
Ketoprofen Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"200 mg, extended release, 100 count bottle (NDC 0378-8200-01)",Revised,11/8/22,,,Available,,Analgesia/Addiction;Rheumatology,Resolved,11/8/22,,8/3/18,,,,,,,
Ketoprofen Capsules,"Misemer Pharmaceutical, Inc.",662-993-9635,"25 mg, 100 count bottle (NDC 0276-0504-10)",Revised,11/8/22,,Marketed by Sterling-Knight Pharmaceuticals LLC,Available,,Analgesia/Addiction;Rheumatology,Resolved,11/8/22,,8/3/18,,,,,,,
Ketoprofen Capsules,"Misemer Pharmaceutical, Inc.",662-993-9635,"50 mg, 100 count bottle (NDC 0276-0506-10)",Revised,11/8/22,,Marketed by Sterling-Knight Pharmaceuticals LLC,Available,,Analgesia/Addiction;Rheumatology,Resolved,11/8/22,,8/3/18,,,,,,,
Ketorolac Tromethamine Injection,Baxter Healthcare,888-229-0001,"Ketorolac Tromethamine Injection, USP, 30 mg/ mL.  Single dose glass flip top vial - 25 units per carton (NDC 0338-0072-25)",Reverified,3/29/23,"Limited Supply, Recovery Q3 2023",FOR INTRAVENOUS AND INTRAMUSCULAR USE. 30mg/mL (1 mL fill volume/ 2 mL container),,Third-party Supplier Issue,Analgesia/Addiction,Current,,,6/6/18,,,,,,,
Ketorolac Tromethamine Injection,Gland Pharma Limited,609-250-7990,"30 mg/mL, 1 mL vial (NDC 72266-118-25)",Reverified,3/10/23,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/6/18,,,,,,,
Ketorolac Tromethamine Injection,Gland Pharma Limited,609-250-7990,"30 mg/mL, 2 mL vial (NDC 72266-119-25)",Reverified,3/10/23,Available,,,Available,Analgesia/Addiction,Current,,,6/6/18,,,,,,,
Ketorolac Tromethamine Injection,Fresenius Kabi USA,888-386-1300,"15 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-107-10)",Revised,3/10/23,Backordered. Next release not available at this time.,Check wholesaler for inventory.,,,Analgesia/Addiction,Current,,,3/23/18,,,,,,,
Ketorolac Tromethamine Injection,Fresenius Kabi USA,888-386-1300,"30 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-104-10)",Revised,3/31/23,Available,Check wholesaler for inventory.,,,Analgesia/Addiction,Current,,,3/23/18,,,,,,,
Ketorolac Tromethamine Injection,Fresenius Kabi USA,888-386-1300,"60 mg per 2 mL, Single Dose, Simplist Syringe, (NDC 76045-105-20)",Revised,3/31/23,Available,Check wholesaler for inventory,,,Analgesia/Addiction,Current,,,3/23/18,,,,,,,
Ketorolac Tromethamine Injection,Baxter Healthcare,888-229-0001,"Ketorolac Tromethamine Injection, USP, 15 mg/mL. Single dose glass flip top vial. 10 units per carton (NDC 0338-0069-10)",Reverified,3/29/23,Available,,,,Analgesia/Addiction,Current,,,6/6/18,,,,,,,
Ketorolac Tromethamine Injection,Fresenius Kabi USA,888-386-1300,"15 mg per mL, Single Dose Amber Vial, (NDC 63323-161-01)",Revised,3/31/23,Available,Check wholesaler for inventory,,Manufacturing delays,Analgesia/Addiction,Current,,,3/23/18,,,,,,,
Ketorolac Tromethamine Injection,Fresenius Kabi USA,888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-01)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,,,3/23/18,,,,,,,
Ketorolac Tromethamine Injection,Fresenius Kabi USA,888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-02)",Revised,3/31/23,Backordered. Next release May 2023.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,,,3/23/18,,,,,,,
Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,15 mg/mL vial (NDC 70860-700-01 and 70860-700-02),Reverified,3/10/23,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,,3/23/18,,,,,,,
Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,30 mg/mL vial (NDC 70860-701-01 and 70860-701-03),Reverified,3/10/23,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,,3/23/18,,,,,,,
Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,60 mg/mL vial (NDC 70860-701-02 and 70860-701-04),Reverified,3/10/23,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,,3/23/18,,,,,,,
Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 15MG/ML 25X1ML (NDC 25021-700-01),Reverified,3/22/23,Backordered. Estimated availability TBD,,,Manufacturing delays,Analgesia/Addiction,Current,,,3/26/18,,,,,,,
Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X2ML (NDC 25021-701-02),Reverified,3/22/23,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,,3/26/18,,,,,,,
Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X1ML (NDC 25021-701-01),Reverified,3/22/23,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,,3/26/18,,,,,,,
Ketorolac Tromethamine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,15 mg/mL (15 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3793-01),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,,3/26/18,,,,,,,
Ketorolac Tromethamine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,30 mg/mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3795-01),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,,3/26/18,,,,,,,
Ketorolac Tromethamine Injection,"Hospira, Inc., a Pfizer company",844-646-4398,60 mg/2 mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3796-01),Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,,3/26/18,,,,,,,
Ketorolac Tromethamine Injection,Virtus Pharmaceuticals,888-843-3593,30MG/ML (NDC 69543-0386-25),New,3/26/18,Available,,,Other,Analgesia/Addiction,Current,,,3/26/18,,,,,,,
Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"15 mg/mL, 1 mL vial (NDC 0641-6041-25)",Reverified,10/13/22,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/6/18,,,,,,,
Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 1 mL vial (NDC 0641-6042-25)",Reverified,10/13/22,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/6/18,,,,,,,
Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 2 mL vial (NDC 0641-6043-25)",Reverified,10/13/22,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/6/18,,,,,,,
Lactulose Solution,Wockhardt Bio AG/Morton Grove Pharmaceuticals,847-410-6929,"10 g/15 mL- (NDC 60432-037-08) [8 oz (237 mL)], (NDC 60432-037-32) [32 oz (946 mL)], (NDC 60432-038-16) [16 oz (473 mL)] and (NDC 60432-038-64) [64 oz (1892 mL)]",New,5/26/22,,,,,Gastroenterology,To be Discontinued,,,5/26/22,,,,,,,
Lactulose Solution,Torrent Pharma Inc.,908-280-3333,10 g/15 mL (ORAL) 8 oz (NDC 13668580-08) || 16 oz. (NDC 13668-580-10) || 32 oz (NDC 13668-580-12),New,6/9/22,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,,6/9/22,,,,,,,
Lactulose Solution,Torrent Pharma Inc.,908-280-3333,10 g / 15 mL (ORAL-RECTAL) 8 oz (NDC 13668-574-08) || 16 oz (NDC 13668-574-10) || 32 oz (NDC 13668-574-12),New,6/9/22,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,,6/9/22,,,,,,,
Lamivudine and Tenofovir Disoproxil Fumarate Tablets,"Celltrion, Inc.",201-988-4615,300 mg; 300 mg (NDC 72606-002-01),New,9/1/21,,,,,Antiviral,To be Discontinued,,,9/1/21,,,,,,,
Lamivudine and Zidovudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine and Zidovudine Tablets 150mg and 300mg (NDC 0378-5180-91),New,3/16/18,,,,,Antiviral,To be Discontinued,,,3/16/18,,,,,,,
Lamivudine Oral Solution,GlaxoSmithKline,888-825-5249,5 mg/mL 240 mL bottle (NDC 0173-0663-00),New,10/27/22,,"This product discontinuation is a business-related decision. The anticipated date that GSK will cease distribution of the product is approximately March, 2023.",,,Antiviral,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,
Lamivudine Tablets,GlaxoSmithKline,888-825-5249,100 mg tablets (NDC 0173-0662-00),New,10/27/22,,"This product discontinuation is a business-related decision. The anticipated date that GSK will cease distribution of the product is approximately March, 2023.",,,Antiviral,To be Discontinued,10/27/22,10/27/22,10/27/22,,,,,,,
Lamivudine; Zidovudine (Combivir) Tablets,GlaxoSmithKline (ViiV Healthcare),888-825-5249,150 mg; 300 mg tablets 60 count (NDC 49702-202-18),New,,,"The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024.",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Lanoxin (digoxin) Tablets,Concordia Pharmaceuticals Inc.,866-243-5382,Lanoxin (digoxin) 187.5 mcg (0.1875 mg) tablets; 100-count bottles (NDC 59212-245-55),New,5/22/18,,,,,Cardiovascular,To be Discontinued,,,5/22/18,,,,,,,
Leucovorin Calcium for Injection,Teva,800-545-8800,NDC 0703-5140-01 (100 mg/vial Single-Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Pediatric,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Leucovorin Calcium for Injection,Teva,800-545-8800,NDC 0703-5145-01 (350 mg/vial Single-Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Pediatric,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,"Mylan Institutional, a Viatris company",800-796-9526,100 mg vial (NDC 67457-528-10),Reverified,3/28/23,Re-supply in May 2023,,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,"Mylan Institutional, a Viatris company",800-796-9526,200 mg vial (NDC 67457-529-20),Reverified,3/28/23,Re-supply in May 2023,,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,"Mylan Institutional, a Viatris company",800-796-9526,350 mg vial (NDC 67457-530-35),Reverified,3/28/23,Re-supply in May 2023,,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,500mg vial (NDC 25021-828-50),Revised,3/22/23,Backordered. Availability March 2023,,,Manufacturing delay,Oncology;Pediatric,Current,,,10/19/18,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,"100mg/vial, 20mL (NDC 0703-5140-01)",Revised,1/9/23,Unavailable,Recovery TBD,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,http://www.sppirx.com/,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,350mg/vial 30mL (NDC 0703-5145-01),Revised,1/9/23,Unavailable,Recovery TBD,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,http://www.sppirx.com/,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Fresenius Kabi USA,888-386-1300,200 mg SDV (NDC 63323-710-50),Revised,3/31/23,Available,Check wholesalers for inventory.,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,http://www.sppirx.com/,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Fresenius Kabi USA,888-386-1300,500 mg SDV (NDC 63323-711-00),Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Manufacturing delay,Oncology;Pediatric,Current,,,,,http://www.sppirx.com/,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,50 mg vial (NDC 25021-813-10),Revised,3/22/23,Backordered. Estimated availability May 2023,,,Over selling forecast,Oncology;Pediatric,Current,,,,,http://www.sppirx.com/,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,100mg vial (NDC 25021-814-30),Revised,3/22/23,Allocation. Availability March 2023,,,Demand increase,Oncology;Pediatric,Current,,,,,http://www.sppirx.com/,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,200mg vial (NDC 25021-815-30),Revised,3/22/23,Backorder. Estimated availability late March/early April 2023,,,Over selling forecast,Oncology;Pediatric,Current,,,,,http://www.sppirx.com/,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,350mg vial (NDC 25021-816-30),Revised,3/22/23,Available. On allocation.,,,Demand increase,Oncology;Pediatric,Current,,,,,http://www.sppirx.com/,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Fresenius Kabi USA,888-386-1300,"100 mg per 10 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-10)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Manufacturing Delay,Oncology;Pediatric,Current,,,,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,Fresenius Kabi USA,888-386-1300,"500 mg per 50 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-50)",Revised,3/31/23,Backordered. Next release not available at this time,Check wholesalers for inventory.,,Manufacturing Delay,Oncology;Pediatric,Current,,,,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg, 10 mL vial (NDC 0143-9555-01)",Revised,2/9/23,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing and will be available in the March 2023 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg, 20 mL vial (NDC 0143-9554-01)",Revised,2/9/23,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"200 mg, 30 mL vial (NDC 0143-9553-01)",Revised,2/9/23,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,,,,,,
Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"350 mg, 50 mL vial (NDC 0143-9552-01)",Revised,2/9/23,This presentation is temporarily on backorder.,,,Demand increase for the drug,Oncology;Pediatric,Current,,,,,,,,,,
Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-4273,Eligard 22.5 mg (NDC 62935-223-05),Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-4273,Eligard 30 mg (NDC 62935-303-30),Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Eligard 45 mg (NDC 62935-453-45),Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Fensolvi 45 mg (NDC 62935-153-50),Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Eligard 7.5 mg Kit (NDC 62935-753-75),Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 3 Months, 30mg (NDC 0074-9694-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 3 Months 22.5 mg PDS Kit (NDC 0074-3346-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,Lupron Depot 6 Months 45mg PDS Kit (NDC 0074-3473-03),Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 1 Month 7.5 mg PDS Kit (NDC 0074-3642-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 4 Months 30 mg PDS Kit (NDC 0074-3683-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 1 Month 3.75 mg PDS Kit (NDC 0074-3641-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 3 Months 11.25 mg PDS Kit (NDC 0074-3663-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 11.25 mg PDS Kit (NDC 0074-2282-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 15 mg PDS Kit (NDC 0074-2440-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 7.5 mg PDS Kit (NDC 0074-2108-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 3 Months, 11.25mg (NDC 0074-3779-03)",Revised,10/24/22,,,Available,,Endocrinology/Metabolism;Oncology,Resolved,10/24/22,,7/24/20,,,,,,,
Levoleucovorin Calcium Pentahydrate Injection,Ingenus Pharmaceuticals LLC,866-321-5031,10 mg/1mL (NDC 50742-494-17),New,12/10/21,,,,,Oncology;Pediatric,To be Discontinued,,,12/10/21,,,,,,,
Levoleucovorin Calcium Pentahydrate Injection,Ingenus Pharmaceuticals LLC,866-321-5031,10 mg 1mL (NDC 50742-495-25),New,12/10/21,,,,,Oncology;Pediatric,To be Discontinued,,,12/10/21,,,,,,,
Levoleucovorin Injection,Sandoz,800-525-8747,175 mg/17.5 mL (10 mg/mL) (NDC 0781-3201-94 ),New,5/5/22,,,,,Oncology;Pediatric,To be Discontinued,,,5/5/22,,,,,,,
Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 5 mL (NDC 0591-3012-26)",New,4/27/18,,,,,Anesthesia,To be Discontinued,,,4/27/18,,,,,,,
Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 30 mL (NDC 0591-3012-30)",New,4/27/18,,,,,Anesthesia,To be Discontinued,,,4/27/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/500 mL (4mg/mL) in VIAFLEX Plus container. Product code 2B0973 (NDC 0338-0409-03)",Reverified,3/29/23,Available,,,,Cardiovascular,Current,,,10/25/17,,,,,,,
Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/250 mL (8mg/mL) in VIAFLEX Plus container. Product code 2B0962 (NDC 0338-0411-02)",Reverified,3/29/23,Available on allocation,,,Demand increase,Cardiovascular,Current,,,10/25/17,,,,,,,
Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.8% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5982 (NDC 00264-9598-20),Reverified,5/6/21,Product available,,,Other,Cardiovascular,Current,,,10/25/17,,,,,,,
Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5942 (NDC 00264-9594-20),Reverified,5/6/21,Product available,,,Other,Cardiovascular,Current,,,10/25/17,,,,,,,
Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 500mL Excel Plastic container P5941 (NDC 00264-9594-10),Reverified,5/6/21,Product available,,,Other,Cardiovascular,Current,,,10/25/17,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57)",Revised,3/31/23,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57)",Revised,3/31/23,Backordered. Next release May 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02)",Revised,3/31/23,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10)",Revised,3/31/23,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80)",Revised,3/31/23,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89)",Revised,3/31/23,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57)",Revised,3/31/23,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/5 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-02),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31)",Revised,3/31/23,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/5 mL (1%; 10 mg/mL); Ansyr Plastic Syringe (NDC 0409-9137-05),Revised,3/31/23,Next Delivery: August 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,https://www.fda.gov/media/165564/download,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,20 mg/2 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-32),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"200 mg/20 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-01, pack of 25; NDC 0409-4276-16, individual)",Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,300 mg/30 mL (1%; 10 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4279-02),Revised,3/31/23,Next Delivery: July 2023; Estimated Recovery: June 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"500 mg/50 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-02; NDC 0409-4276-17, individual)",Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: December 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,40 mg/2 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-01),Revised,3/31/23,Available,,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,200 mg/10 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-02),Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/5 mL (1%; 10 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4904-34),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,https://www.fda.gov/media/165564/download,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg/5 mL (2%; 20 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4903-34),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,https://www.fda.gov/media/165564/download,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg/5 mL (2%; 20 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-2066-05),Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: December 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"400 mg/20 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-01, pack of 25; NDC 0409-4277-16, individual)",Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"1,000 mg/50 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-02)",Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,200 mg/5 mL (4%; 40 mg/mL); Glass Ampul (NDC 0409-4283-01),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Xylocaine Cardiac 100 mg/5 mL (2%; 20 mg/mL); Ansyr Plastic Syringe (NDC 0409-1323-05),Revised,3/31/23,Next Delivery: August 2023; Estimated Recovery: December 2024,,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,https://www.fda.gov/media/165564/download,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"2%, 5mL Luer-Jet Prefilled Syringe (NDC 76329-3390-1)(old NDC 0548-3390-00)",Revised,4/6/23,Available,,,,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97)",Revised,3/31/23,Backordered. Next release not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17)",Revised,3/31/23,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57)",Revised,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10)  - NDC discontinued",Revised,3/31/23,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20) - NDC discontinued",Revised,3/31/23,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50) - NDC discontinued",Revised,3/31/23,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97)",Revised,3/31/23,Backordered. Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mg/50 mL (0.5%; 5 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4275-01),Revised,3/31/23,Next Delivery and Estimated Recovery: December 2024,,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,250 mg/50 mL (0.5%; 5 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4278-01),Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: September 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 2 mL Ampoule (NDC 55150-158-72),Revised,4/4/23,Currently on backorder - next shipment April,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 5 mL Ampoule (NDC 55150-159-74),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesia,Current,,,2/20/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 2 mL Ampoule (NDC 55150-160-72),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesia,Current,,,2/20/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 2 mL Single Dose Vial (NDC 55150-161-02),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 5 mL Single Dose Vial (NDC 55150-162-05),Revised,4/4/23,Currently on backorder - next shipment in April,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 30 mL Single Dose Vial (NDC 55150-163-30),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesia,Current,,,2/20/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 2 mL Single Dose Vial (NDC 55150-164-02),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 5 mL Single Dose Vial (NDC 55150-165-05),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,2/20/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc., a Pfizer company",844-646-4398,300 mg/20 mL (1.5%; 15 mg/mL); Glass Ampul (NDC 0409-4776-01),Revised,3/31/23,Available,,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 10 mL Multi Dose Vial (NDC 55150-251-10),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,6/13/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 20 mL Multi Dose Vial (NDC 55150-252-20),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,6/13/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 10 mL Multi Dose Vial (NDC 55150-254-10),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,6/13/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 20 mL Multi Dose Vial (NDC 55150-255-20),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,6/13/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 5 mL vial, Preservative Free (NDC 0143-9595-25)",Revised,3/24/23,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing and will be available in the May timeframe. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,,6/13/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 5 mL vial, Preservative Free (NDC 0143-9594-25)",Revised,3/24/23,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing and will be available in the May timeframe. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,,6/13/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 50 mL vial, Preserved (NDC 0143-9577-10)",Revised,3/24/23,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing and will be available in the May timeframe. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,,6/13/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 50 mL vial, Preserved (NDC 0143-9575-10)",Revised,3/24/23,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing and will be available in the April timeframe. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,,6/13/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Spectra Medical Devices, Inc.",978-657-0889 ext. 5231,1% 5 mL ampule (NDC 65282-1605-1),Revised,1/7/22,Available,,,Other,Anesthesia,Current,,,6/14/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% MDV 1000mg/50mL (NDC 55150-256-50),Revised,4/4/23,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,6/13/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,"Huons Co., Ltd. (South Korea)", intbiz@huons.com,"Methylparaben Free Lidocaine HCl Injection, USP 1% 50mg/5mL (Vial) (NDC 73293-0001-2)",New,9/6/22,Available,,,Demand increase for the drug,Anesthesia,Current,,,7/14/18,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Sintetica US,"844-425-3131, SinteticaCS@eversana.com",1% 2 mL ampoule (NDC 83090-001-10),Revised,3/29/23,Available,,,Other,Anesthesia; Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Sintetica US,"844-425-3131, SinteticaCS@eversana.com",1% 5 mL ampoule (NDC 83090-002-10),Revised,3/29/23,Available,,,Other,Anesthesia; Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Sintetica US,"844-425-3131, SinteticaCS@eversana.com",1% 10 mL ampoule (NDC 83090-003-10),Revised,3/29/23,Available,,,Other,Anesthesia; Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Sintetica US,"844-425-3131, SinteticaCS@eversana.com",2% 2 mL ampoule (NDC 83090-004-10),Revised,3/29/23,Available,,,Other,Anesthesia; Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Sintetica US,"844-425-3131, SinteticaCS@eversana.com",2% 5 mL ampoule (NDC 83090-005-10),Revised,3/29/23,Available,,,Other,Anesthesia; Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Sintetica US,"844-425-3131, SinteticaCS@eversana.com",2% 10 mL ampoule (NDC 83090-006-10),Revised,3/29/23,Available,,,Other,Anesthesia; Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection,Sintetica US,"844-425-3131, SinteticaCS@eversana.com",4% 5 mL ampoule (NDC 83090-007-10),Revised,3/29/23,Available,,,Other,Anesthesia; Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"2.5 g/50 mL (0.5%; 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3177-01)",Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"200 mg/20 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-01)",Revised,3/31/23,Next Delivery: November 2023; Estimated Recovery: June 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"300 mg/30 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-02)",Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2024,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"500 mg/50 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3178-03)",Revised,3/31/23,Next Delivery: September 2023; Estimated Recovery: June 2024,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"75 mg/5 mL (1.5%; 1:200,000); Glass Ampul (NDC 0409-1209-01)",Revised,3/31/23,Next Delivery: July 2023; Estimated Recovery: June 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"450 mg/30 mL (1.5%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3181-01)",Revised,3/31/23,Next Delivery: December 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"400 mg/20 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-01)",Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"600 mg/30 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-02)",Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2024,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"1 g/50 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-03)",Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: June 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc., a Pfizer company",844-646-4398,"400 mg/20 mL (2%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3183-01)",Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,,2/22/12,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% w/EPI 10 mL, 100 mg MDV (NDC 63323-482-17)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% w/EPI 10 mL, 100 mg SDV, MPF (NDC 63323-487-17)",Revised,3/31/23,Backordered. Next release not available at this time.,,,Manufacturing delay,Anesthesia;Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 1.5% w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-488-17)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-489-17)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 0.5% w/EPI 10 mL, 10 mg MDV (NDC 63323-481-57)",Revised,3/31/23,Backordered. Next release May 2023.,,,,Anesthesia; Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% w/EPI 20 mL, 200 mg MDV (NDC 63323-482-27)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia; Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% w/EPI 50 mL, 500 mg MDV (NDC 63323-482-57)",Revised,3/31/23,Backordered. Next release April 2023.,,,,Anesthesia; Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% w/EPI 20 mL, 400 mg MDV (NDC 63323-483-27)",Revised,3/31/23,Backordered. Next release May 2023.,,,Demand increase for the drug,Anesthesia; Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 2% w/EPI 50 mL, 1 g MDV (NDC 63323-483-57)",Revised,3/31/23,Backordered. Next release June 2023.,,,Demand increase for the drug,Anesthesia; Pediatrtic,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 1% w/EPI 30 mL, 300 mg, SDV MPF (NDC 63323-487-37)",Revised,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Anesthesia; Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kabi USA,888-386-1300,"Xylocaine 1.5% w/EPI 30 mL, 450 mg, SDV, MPF (NDC 63323-488-37)",Revised,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Anesthesia; Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,Fresenius Kasbi USA,888-386-1300,"Xylocaine 2% w/EPI 20 ml, 400 mg SDV, MPF (NDC 63323-489-27)",Revised,3/31/23,Backordered. Next release April 2023.,,,,Anesthesia; Pediatric,Current,,,10/14/16,,,,,,,
Lidocaine Patch 5%,"Endo Pharmaceuticals, Inc.",800-642-3636,LIDODERM (NDC 63481-687-06),New,1/25/23,,Permanent discontinuation on 1/18/2023,,,Analgesia,To be Discontinued,1/25/23,1/25/23,1/25/23,,,,,,,
Lindane Shampoo 1%,Wockhardt Bio A.G.,847-410-6929,"60 mL, (NDC 60432-834-60)",New,6/22/22,,,,,Other,To be Discontinued,,,6/22/22,,,,,,,
Linezolid Injection,Teva Pharmaceuticals,800-545-8800,"600 mg/300 mL, 300 mL/Bag (NDC 0703-9060-33)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Anti-Infective,To be Discontinued,9/13/22,9/13/22,9/13/22,,,,,,,
Liothyronine Sodium Injection,Par Sterile Products LLC,800-828-9393,"10 mcg/mL (NDC 42023-120-06, 42023-120-01)",New,2/23/23,,,,,Endocrinology/Metabolism,To be Discontinued,2/23/23,2/23/23,2/23/23,,,,,,,
Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 5mcg tablets (NDC 0378-3611-01),New,3/28/18,,,,,Endocrinology/Metabolism,To be Discontinued,,,3/28/18,,,,,,,
Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 25mcg tablets (NDC 0378-3612-01),New,3/28/18,,,,,Endocrinology/Metabolism,To be Discontinued,,,3/28/18,,,,,,,
Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2.5 mg (NDC 0378-2072-01); 5 mg (NDC 0378-2073-01); 5 mg (NDC 0378-2073-10); 10 mg (NDC 0378-2074-01); 10 mg (NDC 0378-2074-10); 20 mg (NDC 0378-2075-01); 20 mg (NDC 0378-2075-10); 30 mg (NDC 0378-2077-01); 40 mg (NDC 0378-2076-01; 40 mg (NDC 0378-2076-05,New,4/11/18,,,,,Cardiovascular,To be Discontinued,,,4/11/18,,,,,,,
Lithium Oral Solution,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,8 mEq/5 mL 500 mL bottle (NDC 0054-3527-63),Revised,1/30/23,,Discontinued,,,Psychiatry,To be Discontinued,1/30/23,1/30/23,5/6/20,,,,,,,
Lixisenatide (ADLYXIN) Injection,Sanofi,800-633-1610,Adlyxin™ (lixisenatide) injection 10mcg (NDC 00024-5745-02)  3mL single patient use pen Starter Pack: Contains 1 single-patient-use prefilled green pen of ADLYXIN 10 mcg (50 mcg/mL and delivers 14 doses of 10 mcg) (NDC 0024-5741-01) and 1 single-patient-use prefilled burgundy pen of ADLYXIN 20 mcg (100 mcg/mL and delivers 14 doses of 20 mcg) (NDC 0024-5740-00),New,2/3/23,,Product expiry date is 9/30/2023 (Marketing End Date),,,Endocrinology/Metabolism,To be Discontinued,2/3/23,2/3/23,2/3/23,,,,,,,
Lixisenatide (ADLYXIN) Injection,Sanofi,800-633-1610,Adlyxin™ (lixisenatide) injection 20mcg (NDC 00024-5747-02) 3mL single patient use pen Maintenance Pack NDC: Contains 2 single-patient-use prefilled burgundy pens for ADLYXIN 20 mcg (100 mcg/mL and delivers 14 doses of 20 mcg) (NDC 0024-5740-00),New,2/3/23,,Product expiry date is 9/30/2023 (Marketing End Date),,,Endocrinology/Metabolism,To be Discontinued,2/3/23,2/3/23,2/3/23,,,,,,,
Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 1 mL vial (NDC 0641-6001-25)",Revised,10/13/22,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing and will be available in the October - November 2022 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,,9/5/18,,,,,,,
Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 10 mL vial (NDC 0641-6000-10)",Revised,10/13/22,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,,9/5/18,,,,,,,
Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 1 mL vial (NDC 0641-6003-25)",Revised,10/13/22,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,,9/5/18,,,,,,,
Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 10 mL vial ((NDC 0641-6002-10)",Revised,10/13/22,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,,9/5/18,,,,,,,
Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 1 mL vial (NDC 0641-6044-25)",Revised,10/13/22,This presentation is temporarily on backorder.,Additional lots are scheduled for manufacturing and will be available in the October - November 2022 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,,9/5/18,,,,,,,
Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 10 mL vial (NDC 0641-6046-10)",Revised,10/13/22,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,,9/5/18,,,,,,,
Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 1 mL vial (NDC 0641-6045-25)",Revised,10/13/22,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,,9/5/18,,,,,,,
Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 10 mL vial (NDC 0641-6002-10)",Revised,10/13/22,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,,9/5/18,,,,,,,
Lorazepam Injection,"Hospira, Inc., a Pfizer company",844-646-4398,2 mg/mL; Carpuject Luer Lock Glass Syringe  (NDC 00409-1985-30),Revised,3/17/23,Available,,,Other,Neurology,Current,,,5/3/18,,,,,,,
Lorazepam Injection,"Hospira, Inc., a Pfizer company",844-646-4398,2 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6778-02),Revised,3/17/23,Discontinued,,,Discontinuation of the manufacture of the drug,Neurology,Current,,,5/3/18,,,,,,,
Lorazepam Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"LORAZEPAM INJECTION, USP, C IV [2 mg/ mL](NDC 76329-8261-1)",Reverified,4/6/23,Backorder due to the increase in demands,,,Other,Neurology,Current,,,5/3/18,,,,,,,
Lorazepam Injection,Akorn Pharmaceuticals,800-932-5676,Lorazepam Injection 2 mg/mL (NDC 17478-040-01),Revised,3/1/23,Not available,No new manufacturing of product,,,Neurology,Current,,,9/5/18,,,,,,,
Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 1000 count bottle (NDC 0527-1394-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,,,11/25/19,,,,,,,
Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 1000 count bottle (NDC 0527-1395-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,,,11/25/19,,,,,,,
Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 1000 count bottle (NDC 0527-1396-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,,,11/25/19,,,,,,,
Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 1000 count bottle (NDC 0527-1397-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,,,11/25/19,,,,,,,
Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 100 count bottle (NDC 0527-1394-01)",Revised,6/13/22,,,Available,,Psychiatry,Resolved,,,11/25/19,,,,,,,
Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 100 count bottle (NDC 0527-1395-01)",Revised,6/13/22,,,Available,,Psychiatry,Resolved,,,11/25/19,,,,,,,
Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 100 count bottle (NDC 0527-1396-01)",Revised,6/13/22,,,Available,Other,Psychiatry,Resolved,,,11/25/19,,,,,,,
Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 100 count bottle (NDC 0527-1397-01)",Revised,6/13/22,,,Available,,Psychiatry,Resolved,,,11/25/19,,,,,,,
Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count bottle (NDC 0591-0369-01)",Revised,6/14/22,,,Available,,Psychiatry,Resolved,,,11/25/19,,,,,,,
Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 count bottle (NDC 0591-0371-01)",Revised,6/14/22,,,Available,,Psychiatry,Resolved,,,11/25/19,,,,,,,
Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 count bottle (NDC 0591-0372-01)",Revised,6/14/22,,,Available,,Psychiatry,Resolved,,,11/25/19,,,,,,,
Lutetium Lu 177 Dotatate (LUTATHERA) Injection,"Advanced Accelerator Applications USA, Inc.",862-778-8300,"Lutathera® (lutetium Lu 177 dotatate) injection, for intravenous use 10 mCi/mL; Colorless Type I glass 30 mL single-dose vial containing 7.4 GBq (200 mCi) ± 10% of lutetium Lu 177 dotatate (NDC 69488-003-01)",Revised,8/1/22,,,Available,,Oncology,Resolved,8/1/22,,5/12/22,,,,,,,
Lutetium Lu 177 Vipivotide Tetraxetan (Pluvicto) Injection,"Advanced Accelerator Applications USA, Inc.",862-778-8300,"PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) injection, for intravenous use  27 mCi/mL; Colorless Type I glass 30 mL single-dose vial containing 7.4 GBq (200 mCi) ± 10% of lutetium Lu 177 vipivotide tetraxetan (NDC 69488-010-61)",Revised,4/4/23,Availability: Limited; Estimated Duration of Supply Shortage: Approximately three months,"There are challenges in meeting demand and no therapeutic equivalents are available. 
For more information, please see the attached:",,Other,Oncology,Current,,,3/7/23,,,,,https://www.fda.gov/media/165964/download,,
Mannitol Injection,B. Braun Medical Inc.,800-227-2862,20% 500 mL Excel Bag L5781 (NDC 0264-7578-20),New,6/10/22,Product on allocation for contracted customers,,,Other,Renal,Current,,,9/23/21,,,,,,,
Mannitol Injection,"Fresenius Kabi USA, LLC",888-386-1300,25% (12.5 grams per 50 mL)(250 mg per mL) Single dose vial (NDC 63323-024-25),Reverified,3/31/23,Backordered. Next release April 2023.,,,Demand increase for the drug,Renal,Current,,,9/23/21,,,,,,,
Mannitol Injection,"Hospira, Inc., a Pfizer company",844-646-4398,12.5 g/50 mL (25%); Single Dose Glass Fliptop Vial (NDC 0409-4031-01),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Renal,Current,,,9/23/21,,,,,,,
Mannitol Injection,Baxter Healthcare,888-229-0001,"10% OSMITROL Injection (10% Mannitol Injection, USP) 500 mL Viaflex Plastic Container Product Code 2D5613Q (NDC 0338-0535-03)",Reverified,3/29/23,Available,,,,Renal,Current,,,9/23/21,,,,,,,
Mannitol Injection,Baxter Healthcare,888-229-0001,"20% OSMITROL Injection (20% Mannitol Injection, USP) 500 mL Viaflex Plastic Container Product Code 2D5633Q (NDC 0338-0357-03); 250 mL Viaflex Plastic Container Product Code 2D5632Q (NDC 0338-0357-02)",Reverified,3/29/23,Available,,,,Renal,Current,,,9/23/21,,,,,,,
Mannitol Injection,"ICU Medical, Inc.",877-946-7747,"20% Mannitol Injection, USP 500 mL (Legacy Hospira NDC 0409-7715-03)(ICU Medical NDC 0990-7715-03)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Renal,Current,,,9/23/21,,,,,,,
Mannitol Injection,"ICU Medical, Inc.",877-946-7747,"20% Mannitol Injection, USP 250 mL (Legacy Hospira NDC 0409-7715-02)(ICU Medical NDC 0990-7715-02)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Renal,Current,,,9/23/21,,,,,,,
Maraviroc (Selzentry) Tablets,GlaxoSmithKline (ViiV Healthcare),888-825-5249,25 mg tablet 120 count (NDC 49702-233-08),New,1/3/23,,"The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024.  Selzentry 150mg (49702-223-18), Selzentry 300 mg (49702-224-18) and Selzentry Oral Solution (49702-260-55) will still be available.",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Maraviroc (Selzentry) Tablets,GlaxoSmithKline (ViiV Healthcare),888-825-5249,75 mg tablet 120 count (NDC 49702-235-08),New,1/3/23,,"The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024.  Selzentry 150mg (49702-223-18), Selzentry 300 mg (49702-224-18) and Selzentry Oral Solution (49702-260-55) will still be available.",,,Antiviral,To be Discontinued,1/3/23,1/3/23,1/3/23,,,,,,,
Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,718-276-8607,"12.5mg tablets, 100 count (NDC 42806-012-01)",New,2/28/18,,,,,Gastroenterology,To be Discontinued,,,2/28/18,,,,,,,
Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"12.5mg tablets, 1000 count (NDC 42806-012-10)",New,2/28/18,,,,,Gastroenterology,To be Discontinued,,,2/28/18,,,,,,,
Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 100 count (NDC 42806-014-01)",New,2/28/18,,,,,Gastroenterology,To be Discontinued,,,2/28/18,,,,,,,
Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 1000 count (NDC 42806-014-10)",New,2/28/18,,,,,Gastroenterology,To be Discontinued,,,2/28/18,,,,,,,
Medroxyprogesterone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-6801-01 (150 mg/mL 1 mL Single-Dose Vial),New,8/11/22,,Product is currently  unavailable and no future production expected for an extended period.,,,Reproductive,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Medroxyprogesterone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-6801-04 (150 mg/mL  25 x 1 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Reproductive,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Megestrol Acetate Oral Suspension,Wockhardt Bio AG/Morton Grove Pharmaceuticals,847-410-6929,"40 mg/mL (NDC 60432-126-08) [8 oz (240 mL)], (NDC 60432-126-16) [1 Pint (480 mL)]",New,5/26/22,,,,,Endocrinology/Metabolism,To be Discontinued,,,5/26/22,,,,,,,
Megestrol Acetate Suspension,Par Pharmaceutical,"800-828-9393, option 5 then option 2","125mg/1ml, 150ml Bottle (NDC 49884-230-69)",New,12/1/21,,,,,Endocrinology/Metabolism,To be Discontinued,,,12/1/21,,,,,,,
Meloxicam Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,7.5 mg tablets (NDCs 0597-0029-01 and 0597-0029-94),New,11/1/21,,,,,Analgesia/Addiction,To be Discontinued,,,11/1/21,,,,,,,
Meloxicam Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,15 mg tablets (NDCs 0597-0030-01 and 0597-0030-56),New,11/1/21,,,,,Analgesia/Addiction,To be Discontinued,,,11/1/21,,,,,,,
Memantine Hydrochloride Extended-Release Capsules,"ANI Pharmaceuticals, Inc.",800-434-1121,14mg tablets(NDCs 43975-264-03 and 43975-264-09),New,4/8/22,,,,,Neurology,To be Discontinued,,,4/8/22,,,,,,,
Memantine Hydrochloride Extended-Release Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",28mg  (NDCs 10370-349-09 and 10370-349-11),New,10/11/22,,,,,Neurology,To be Discontinued,10/11/22,10/11/22,10/11/22,,,,,,,
Memantine Hydrochloride Extended-Release Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",21mg  (NDC 10370-348-11),New,10/11/22,,,,,Neurology,To be Discontinued,10/11/22,10/11/22,10/11/22,,,,,,,
Memantine Hydrochloride Extended-Release Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",14mg  (NDCs 10370-347-09 and 10370-347-11),New,10/11/22,,,,,Neurology,To be Discontinued,10/11/22,10/11/22,10/11/22,,,,,,,
Memantine Hydrochloride Extended-Release Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",7mg  (NDC 10370-346-11),New,10/11/22,,,,,Neurology,To be Discontinued,10/11/22,10/11/22,10/11/22,,,,,,,
Memantine Hydrochloride Extended-Release Capsules,ANI Pharmaceuticals,800-434-1121,7mg capsules (NDC 43975-242-03),New,11/1/22,,,,,Neurology,To be Discontinued,11/1/22,11/1/22,11/1/22,,,,,,,
Memantine Hydrochloride Extended-Release Capsules,ANI Pharmaceuticals,800-434-1121,21mg capsules (NDC 43975-243-03),New,11/1/22,,,,,Neurology,To be Discontinued,11/1/22,11/1/22,11/1/22,,,,,,,
Memantine Hydrochloride Extended-Release Capsules,ANI Pharmaceuticals,00-434-1121,28mg capsules (NDCs 43975-266-03 and 43975-266-09),New,11/1/22,,,,,Neurology,To be Discontinued,11/1/22,11/1/22,11/1/22,,,,,,,
Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,300 mg/30 mL (10 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-1036-30),Revised,6/10/22,,,,,Anesthesia,To be Discontinued,,,7/26/21,,,,,,,
Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,400 mg/20 mL (20 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-1067-20),Revised,6/10/22,,,,,Anesthesia,To be Discontinued,,,7/26/21,,,,,,,
Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,450 mg/30 mL (15 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-1041-30),Revised,6/10/22,,,,,Anesthesia,To be Discontinued,,,7/26/21,,,,,,,
Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 0409-1038-50),Revised,6/10/22,,,,,Anesthesia,To be Discontinued,,,7/26/21,,,,,,,
Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine) 1% (500 mg per 50 mL), (10 mg per mL), MDV, (NDC 63323-0283-57)",Revised,3/10/23,Backordered. Next release March 2023.,,,,Anesthesia,Current,,,7/14/21,,,,,,,
Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine) 2% (1,000 mg per 50 mL), (20 mg per mL), MDV, (NDC 63323-0296-57)",Revised,3/10/23,Available,Check wholesaler inventory,,,Anesthesia,Current,,,7/14/21,,,,,,,
Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine MPF) 1% (300 mg per 30 mL), (10 mg per mL), SDV, (NDC 63323-0260-37)",Revised,3/10/23,Backordered. Next release March 2023.,Check wholesaler inventory,,,Anesthesia,Current,,,7/14/21,,,,,,,
Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine MPF) 1.5% (450 mg per 30 mL), (15 mg per mL), SDV, (NDC 63323-0293-37)",Revised,3/10/23,Backordered. Next release April 2023.,Check wholesaler inventory,,Manufacturing delay,Anesthesia,Current,,,7/14/21,,,,,,,
Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine MPF) 2% (400 mg per 20 mL), (20 mg per mL), SDV, (NDC 63323-0294-27)",Revised,3/10/23,Backordered. Next release April 2023.,Check wholesaler inventory,,Manufacturing delay,Anesthesia,Current,,,7/14/21,,,,,,,
Mesalamine (CANASA®)  Suppositories,Allergan,800-678-1605,"1 gm, Rectal Suppositories, 42 suppositories in 1 box (NDC 58914-501-42)",New,7/30/20,,,,,Gastroenterology,To be Discontinued,,,7/30/20,,,,,,,
Metaxalone Tablets,Pfizer Pharmaceuticals,800-533-4535,Skelaxin 800 mg tablet; Bottle of 100 (NDC 60793-136-01),New,2/25/22,,,,,Musculoskeletal,To be Discontinued,,,2/25/22,,,,,,,
Metaxalone Tablets,Pfizer Pharmaceuticals,800-533-4535,Skelaxin 800 mg tablet; Bottle of 500 (NDC 60793-136-05),New,2/25/22,,,,,Musculoskeletal,To be Discontinued,,,2/25/22,,,,,,,
Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,750mg tablets (NDC 2037-577-10) and (NDC 62037-577-01 ),New,6/24/20,,,,,Endocrinology/Metabolism,To be Discontinued,,,6/24/20,,,,,,,
Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,500mg tablets (NDC 62037-571-01) and (NDC 62037-571-10),New,6/24/20,,,,,Endocrinology/Metabolism,To be Discontinued,,,6/24/20,,,,,,,
Methadone Hydrochloride Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Methadone Hydrochloride Injection (Solution in Multi Dose Vials) [200 mg / 20 ml](NDC 67457-217-20),Revised,6/8/21,,,Available,,Analgesia/Addiction;Anesthesia,Resolved,,,4/25/18,,,,,,,
Methadone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Methadone Hydrochloride Injection USP, 200 mg/20 mL (10 mg/mL) , 20 mL multidose vials (NDC 17478-380-20)",Revised,6/8/21,,,Available,,Analgesia/Addiction;Anesthesia,Resolved,,,4/25/18,,,,,,,
Methamphetamine Hydrochloride Tablets,"Mayne Pharma, Inc.",844-825-8500,"5 mg, bottle of 100 (NDC 68308-115-01)",New,3/17/23,Currently unavailable. Estimated shortage duration: September 2023,,,Manufacturing delay,Psychiatry,Current,,,3/17/23,,,,,,,
Methamphetamine Hydrochloride Tablets,"Hikma Pharmaceuticals USA, Inc.",800-631-2174,"5 mg, bottle of 100 (NDC 0054-0389-25)",New,3/17/23,Currently unavailable,,,Other,Psychiatry,Current,,,3/17/23,,,,,,,
Methamphetamine Hydrochloride Tablets,"Key Therapeutics, Inc.",888-981-8337,"Desoxyn 5 mg, bottle of 100 (NDC 70868-820-05)",New,3/17/23,Available,,,,Psychiatry,Current,,,3/17/23,,,,,,,
Methimazole Tablets,Pfizer Pharmaceuticals,800-533-4535,Tapazole 5 mg tablets; bottle of 100 (NDC 60793-104-01),New,11/5/21,,,,,Endocrinology/Metabolism,To be Discontinued,,,11/5/21,,,,,,,
Methimazole Tablets,Pfizer Pharmaceuticals,800-533-4535,Tapazole 10 mg tablets; bottle of 100 (NDC 60793-105-01),New,11/5/21,,,,,Endocrinology/Metabolism,To be Discontinued,,,11/5/21,,,,,,,
Methocarbamol Injection,"Mylan Specialty, a Viatris Company",800-796-9526,100 mg/mL (NDC 67457-273-10),New,5/9/22,,,,,Analgesia/Addiction,To be Discontinued,,,5/9/22,,,,,,,
Methohexital Sodium (Brevital) Injection,Par Pharmaceutical,800-828-9393,"500 mg/vial, 50 mL multiple dose vial, box of 1 (NDC 42023-105-01)",Revised,11/15/21,,,Available,,Anesthesia,Resolved,,,5/21/21,,,,,,,
Methotrexate Injection,Hikma Pharmaceuticals USA Inc.,800-631-2174,1 gram per vial  (NDC 0143-9830-01),New,3/15/23,Temporarily on backorder.,Additional lots will be available in the March 2023 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,Hikma Pharmaceuticals USA Inc.,800-631-2174,"25 mg/mL, 2 mL vial (NDC 0143-9519-10)",New,3/15/23,Temporarily on backorder.,Additional lots will be available in the March 2023 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,Teva Pharmaceuticals,800-545-8800,50 mg/2 mL (25 mg/mL) 2 mL Single-Dose Vial (NDC 0703-3671-01),Reverified,4/5/23,Unavailable; Estimated Resupply in June 2023,,,Other,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,Teva Pharmaceuticals,800-545-8800,250 mg/10 mL (25 mg/mL) 10 mL Single-Dose Vial (NDC 0703-3675-01),Reverified,4/5/23,Unavailable; Estimated Resupply in July 2023,,,Other,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,Teva Pharmaceuticals,800-545-8800,1 g/40 mL (25 mg/mL) 40 mL Single-Dose Vial  (NDC 0703-3678-01),Reverified,4/5/23,Limited Supply Available; Estimated Full Recovery in June 2023,,,Other,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/2 mL (25 mg/mL) Multiple Dose Vial  (NDC 61703-0350-38),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Limited Supply Available. Weekly releases.,,Demand Increase for the drug,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/2 mL  (25 mg/mL) Glass Fliptop Vial Novaplus® (NDC 61703-0350-10),Revised,3/31/23,"Next Delivery: May 2023; Estimated Recovery: September 2023


Estimated recovery: September 2023",,,Demand Increase for the drug,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,1 g/40 mL (25 mg/mL) Single Dose Glass Fliptop Vial (NDC 61703-0408-41),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: September 2023,Limited Supply Available. Weekly releases.,,Demand Increase for the drug,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,1 g/40 mL (25 mg/mL) Single Dose Glass Fliptop Vial Novaplus® (NDC 61703-0408-25),Revised,3/31/23,Next Delivery: July 2023; Estimated Recovery: September 2023,Limited Supply Available. Weekly releases.,,Demand Increase for the drug,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,1 g/40 mL (25 mg/mL) Single-Dose Vial PREMIERProRx® (NDC 61703-0124-40),Revised,3/31/23,Next Delivery: July 2023; Estimated Recovery: September 2023,,,Demand Increase for the drug,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,"Fresenius Kabi USA, LLC",888-386-1300,1g per vial; single dosage vial; (NDC 63323-122-50),Reverified,3/31/23,Backordered. Next release May 2023.,,,Demand Increase for the drug,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,"Fresenius Kabi USA, LLC",888-386-1300,250 mg per 10 mL (25 mg per mL); vial; (NDC 63323-123-10),Reverified,3/31/23,Backordered. Next release May 2023.,,,Demand Increase for the drug,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,Accord Healthcare Inc.,"866-941-7875, option 2",50 mg/2 mL (25 mg/mL) Single Dose Vial  (NDC 16729-277-30),New,3/14/23,Inventory on Hold Pending Further Assessment,,,Other,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,Accord Healthcare Inc.,"866-941-7875, option 2",250 mg/10 mL  (25 mg/mL) Single Dose Vial  (NDC 16729-277-03),New,3/14/23,Inventory on Hold Pending Further Assessment,,,Other,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methotrexate Injection,Accord Healthcare Inc.,"866-941-7875, option 2",1 g/40 mL (25 mg/mL) Single Dose Vial (NDC 16729-277-35),New,3/14/23,Inventory on Hold Pending Further Assessment,,,Other,Rheumatology; Oncology,Current,,,3/13/23,,,,,,,
Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 100s (16729-030-01),Revised,11/15/22,No additional lots are anticipated at this time.,,,API procurement delay,Cardiovascular,Current,,,8/30/18,,,,,,,
Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 500s (16729-030-16),Revised,11/15/22,No additional lots are anticipated at this time.,,,API procurement delay,Cardiovascular,Current,,,8/30/18,,,,,,,
Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 100s (16729-031-01),Revised,11/15/22,No additional lots are anticipated at this time.,,,API procurement delay,Cardiovascular,Current,,,8/30/18,,,,,,,
Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 500s (16729-031-16),Revised,11/15/22,No additional lots are anticipated at this time.,,,API procurement delay,Cardiovascular,Current,,,8/30/18,,,,,,,
Methyldopa Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,250 mg (NDC 0378-0611-01),Revised,10/8/21,,,,,Cardiovascular,To be Discontinued,,,10/8/21,,,,,,,
Methyldopa Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,500 mg (NDC 0378-0421-01),Revised,10/8/21,,,,,Cardiovascular,To be Discontinued,,,10/8/21,,,,,,,
Methylphenidate Hydrochloride Extended Release Tablets,Patriot Pharmaceuticals LLC,800-631-5273,18 mg (NDC 10147-0685-1),New,12/9/22,,Last expiry August 2025; Discontinuation of the manufacture of the drug product.,,,Psychiatry,To be Discontinued,12/9/22,12/9/22,12/9/22,,,,,,,
Methylphenidate Hydrochloride Extended Release Tablets,Patriot Pharmaceuticals LLC,800-631-5273,27 mg (NDC 10147-0688-1),New,12/9/22,,Last expiry July 2025; Discontinuation of the manufacture of the drug product.,,,Psychiatry,To be Discontinued,12/9/22,12/9/22,12/9/22,,,,,,,
Methylphenidate Hydrochloride Extended Release Tablets,Patriot Pharmaceuticals LLC,800-631-5273,36 mg (NDC 10147-0686-1),New,12/9/22,,Last expiry October 2025; Discontinuation of the manufacture of the drug product.,,,Psychiatry,To be Discontinued,12/9/22,12/9/22,12/9/22,,,,,,,
Methylphenidate Hydrochloride Extended Release Tablets,Patriot Pharmaceuticals LLC,800-631-5273,54 mg (NDC 10147-0687-1),New,12/9/22,,Last expiry September 2025; Discontinuation of the manufacture of the drug product.,,,Psychiatry,To be Discontinued,12/9/22,12/9/22,12/9/22,,,,,,,
Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0045-01 (400 mg/10 mL (40 mg/mL) 10 mL Multiple-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0043-01 (200 mg/5 mL (40 mg/mL) 5 mL Multiple-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0063-01 (400 mg/5 mL (80 mg/mL) 5 mL Multiple-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0031-01 (40 mg/mL 1 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0031-04 (40 mg/mL 25 x 1 mL Single-Dose Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0051-01 (80 mg/mL 1 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0051-04 (80 mg/mL 25 x 1 mL Single-Dose Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Methylprednisolone Acetate Injection,"Par Pharmaceutical, Inc.",800-828-9393,"400 mg/5 mL (80 mg/mL), 5 mL multiple dose vial, box of 1 (NDC 42023-240-01)",New,6/16/22,Available,,,,Rheumatology,Current,,,6/16/22,,,,,,,
Methylprednisolone Acetate Injection,Sagent Pharmaceuticals,866-625-1618,40MG/ML 1X10ML (NDC 25021-820-010),Reverified,3/22/23,Available,,,,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Sagent Pharmaceuticals,866-625-1618,40MG/ML 1X5ML (NDC 25021-820-05),Reverified,3/22/23,Available.,,,,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Sagent Pharmaceuticals,866-625-1618,80MG/ML 1x5ML (NDC 25021-821-05),Reverified,3/22/23,Available,,,,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Amneal Pharmaceutical,866-525-7270,"40mg/mL, 1 single-dose vial (NDC 70121-1573-01)",Revised,3/17/23,Available,,,,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Amneal Pharmaceutical,866-525-7270,"40 mg/mL, 25 single-dose vials (NDC 70121-1573-05)",Revised,3/17/23,Available,,,,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Amneal Pharmaceutical,866-525-7270,"80 mg/mL, 1 single-dose vials (NDC 70121-1574-01)",Revised,3/17/23,Available,,,,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Amneal Pharmaceutical,866-525-7270,"80 mg/mL, 25 single-dose vials (NDC 70121-1574-05)",Revised,3/17/23,Available,,,,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Northstar,972-446-4800,"40mg/ml, 1ml/1 vial X 25 (NDC 16714-088-25)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Northstar,972-446-4800,"40mg/ml, 1ml/1 vial (NDC 16714-088-01)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Northstar,972-446-4800,200mg/5ml (40mg/ml) (NDC 16714-089-01),New,12/15/21,Out of Stock,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Northstar,972-446-4800,"80mg/ml, 1ml/1 vial X 25 (NDC 16714-472-25)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Northstar,972-446-4800,"80mg/ml, 1ml/1 vial (NDC 16714-472-01)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Northstar,972-446-4800,"400mg/5ml (80mg/ml), 5ml/1 vial (NDC 16714-473-01)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Northstar,972-446-4800,400mg/10ml (40mg/ml) (NDC 16714-090-01),New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,400 mg/10 mL (40 mg/mL) 10 mL Multiple-Dose Vial (NDC 0703-0045-01),Revised,1/9/23,Unavailable,Recovery TBD,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,400 mg/5 mL (80 mg/mL) 5 mL Multiple-Dose Vial(NDC 0703-0063-01),Revised,1/9/23,Unavailable,Recovery TBD,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,200 mg/5 mL (40 mg/mL) 5 mL Multiple-Dose Vial(NDC 0703-0043-01),Revised,1/9/23,Unavailable,Recovery TBD,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,40 mg/mL 1 mL Single-Dose Vial (NDC 0703-0031-01),Revised,1/9/23,Unavailable,Recovery TBD,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,80 mg/mL 1 mL Single-Dose Vial(NDC 0703-0051-01),Revised,1/9/23,Unavailable,Recovery TBD,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,40 mg/mL 25 x 1 mL Single-Dose Vial (NDC 0703-0031-04 40),Revised,1/9/23,Unavailable,Recovery TBD,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,80 mg/mL 25 x 1 mL Single-Dose Vial(NDC 0703-0051-04),Revised,1/9/23,Unavailable,Recovery TBD,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,20 mg/mL; Multidose Vial (NDC 0009-0274-01),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Multidose Vial (NDC 0009-0280-02),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Multidose Vial (NDC 0009-0280-03),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Multidose Vial (NDC 0009-0280-51),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Multidose Vial (NDC 0009-0280-52),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Multidose Vial (NDC 0009-0306-02),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Multidose Vial (NDC 0009-0306-12),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Single-dose Vial (NDC 0009-3073-01),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Single-dose Vial (NDC 0009-3073-03),Reverified,3/31/23,Available,,,Demand increase for the drug,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3073-22),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3073-23),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial (NDC 0009-3475-01),Reverified,3/31/23,Available,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial (NDC 0009-3475-03),Reverified,3/31/23,Available,,,Demand increase for the drug,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3475-22),Reverified,3/31/23,Next Delivery and Estimated Recovery: July 2023,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3475-23),Reverified,3/31/23,Next Delivery and Estimated Recovery: July 2023,,,Other,Rheumatology,Current,,,12/15/21,,,,,,,
Methylprednisolone Tablets,Pfizer,800-533-4535,32 mg tablet; Bottle of 25 (NDC 0009-0176-01),New,9/12/22,,Discontinuation of the manufacture of the drug.,,,Rheumatology,To be Discontinued,9/12/22,9/12/22,9/12/22,,,,,,,
Methylprednisolone Tablets,Sandoz,800-525-8747,4 mg 100 ct (NDC 0781-5022-01),New,2/14/23,,,,,Neurology,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
Methylprednisolone Tablets,Sandoz,800-525-8747,4 mg 21 ct (NDC 0781-5022-07),New,2/14/23,,,,,Neurology,To be Discontinued,2/14/23,2/14/23,2/14/23,,,,,,,
Methylprednisolone Tablets,Teva Pharmaceuticals,800-545-8800,4 mg tablets (NDC 0591-0790-01),New,12/5/19,,,,,Neurology,To be Discontinued,,,12/5/19,,,,,,,
Metoclopramide Tablets,Par Pharmaceutical,800-828-9393,"10 mg, 500S (NDC 49884-0689-01",New,7/6/21,,,,,Gastroenterology,To be Discontinued,,,7/6/21,,,,,,,
Metoclopramide Tablets,Par Pharmaceutical,800-828-9393,"10 mg, 500S (NDC 49884-0689-05)",New,7/6/21,,,,,Gastroenterology,To be Discontinued,,,7/6/21,,,,,,,
Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,50 mg tablets (NDCs 0591-0462-01 and 0591-0462-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,,,12/16/19,,,,,,,
Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,100 mg tablets (NDCs 0591-0463-01 and 0591-0463-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,,,12/16/19,,,,,,,
Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets 1 x 100 bottle (NDC 0025-1821-31),New,10/13/21,,,,,Anti-Infective,To be Discontinued,,,10/13/21,,,,,,,
Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets 1 x 50 bottle (NDC 0025-1821-50),New,10/13/21,,,,,Anti-Infective,To be Discontinued,,,10/13/21,,,,,,,
Metronidazole Gel,"Tolmar, Inc.",800-525-8747,"1%, 60g tube (NDC 0781-7080-35)",New,2/16/23,,,,,Dermatology,To be Discontinued,2/16/23,2/16/23,2/16/23,,,,,,,
Metronidazole Gel,"Tolmar, Inc.",800-525-8747,"1%, 55g pump (NDC 0781-7080-55)",New,2/16/23,,,,,Dermatology,To be Discontinued,2/16/23,2/16/23,2/16/23,,,,,,,
Metronidazole Injection,B. Braun Medical Inc.,800-227-2862,500 mg/100 mL (5 mg/mL) NDC 0264-5535-32 (Product code D5353-5224),New,1/13/22,Available. On allocation.,,,Demand increase for the drug,Anti-Infective,Current,,,1/13/22,,,,,,,
Metronidazole Injection,Baxter Healthcare,888-229-0001,"500 mg/100 mL in VIAFLEX Plastic Container. Product Code 2B3421, (NDC 0338-1055-48)",Reverified,3/29/23,Available,,,,Anti-Infective,Current,,,1/13/22,,,,,,,
Metronidazole Injection,Sagent Pharmaceuticals,866-625-1618,5mg/ml 500mg per 100mL bag in 24 pack (NDC 25021-113-82),Reverified,3/22/23,Available,,,Demand increase for the drug,Anti-Infective,Current,,,1/13/22,,,,,,,
Metronidazole Injection,"Hospira, Inc., a Pfizer company",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 0409-7811-37),Reverified,3/31/23,Available,,,Other,Anti-Infective,Current,,,1/13/22,,,,,,,
Metronidazole Injection,"Hospira, Inc.",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 0409-7811-24),Revised,8/17/22,,Discontinuation of the manufacture of the drug. Replaced with NDC 00409-0152-24,,,Anti-Infective,To be Discontinued,8/17/22,8/17/22,1/13/22,,,,,,,
Metronidazole Injection,"Hospira, Inc., a Pfizer company",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 0409-0152-24),Reverified,3/31/23,Available,,,Other,Anti-Infective,Current,,,1/13/22,,,,,,,
Metronidazole Injection,Gland Pharma Limited,TBD,100 mL Single Dose Bag (NDC 47335-993-01),New,4/11/22,Lots are anticipated in April; with additional inventory arriving in May.,,,Other,Anti-Infective,Current,,,1/13/22,,,,,,,
Metronidazole Injection,Pfizer Pharmaceuticals,844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 0409-7811-37),New,4/6/23,,Supply expected to exhaust late May/early June 2023; Discontinuation of the manufacture of the drug,,,Anti-Infective,To be Discontinued,4/6/23,4/6/23,4/6/23,,,,,,,
Metronidazole Vaginal Gel,"Tolmar, Inc.",877-986-5627,"0.75%, 70g tube (NDC 0781-7077-87)",New,11/28/22,,Discontinued. No longer available for orders starting December 2022.,,,Anti-Infective,To be Discontinued,11/28/22,11/28/22,11/28/22,,,,,,,
Midazolam Injection,WG Critical Care,888-493-0861,50mg/50mL (1mg/mL) in 0.9% Sodium Chloride single-dose bag  (NDC 44567-610-10),Reverified,10/3/22,Available,,,,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,WG Critical Care,888-493-0861,100mg/100mL (1mg/mL) in 0.9% Sodium Chloride single-dose bag  (NDC 44567-611-10),Reverified,10/3/22,Available,,,,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Akorn Pharmaceuticals,800-932-5676,10 ML Vial - Pack of 10 (NDC 17478-0524-10),Revised,3/1/23,Not available,No new manufacturing of product,,,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Fresenius Kabi USA,888-386-1300,"1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Fresenius Kabi USA,888-386-1300,"2 mg/mL, 2 mL prefilled syringe, 24 count (NDC 76045-0001-20)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Fresenius Kabi USA,888-386-1300,"1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Fresenius Kabi USA,888-386-1300,"1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Fresenius Kabi USA,888-386-1300,"5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Fresenius Kabi USA,888-386-1300,"5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Fresenius Kabi USA,888-386-1300,"5 mg/mL, 1 mL prefilled syringe, 24 count (NDC 76045-0002-10)",Revised,3/31/23,3 month expiry (6/30/2023 expiry) dating available by request.,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Fresenius Kabi USA,888-386-1300,"5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 10 mL vial, 10 count (NDC 00641-6056-10)",Revised,8/26/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 2 mL vial, 25 count (NDC 00641-6057-25)",Revised,8/26/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 5 mL vial, 10 count (NDC 0641-6059-25)",Revised,8/26/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 1 mL vial, 25 count (NDC 00641-6061-25)",Revised,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 10 mL vial, 10 count (NDC 00641-6060-10)",Revised,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,"Hospira, Inc., a Pfizer company",844-646-4398,2 mg/2mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-17),Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: March 2024,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,"Hospira, Inc., a Pfizer company",844-646-7398,5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-05),Revised,3/31/23,Available,,,Other,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,"Hospira, Inc., a Pfizer company",844-646-4398,5 mg/mL (5 mg/mL)  Single Dose Glass Fliptop Vial (NDC 00409-2308-01),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2023,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,https://www.fda.gov/drugs/drug-shortages/search-list-extended-use-dates-assist-drug-shortages,,
Midazolam Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/10 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-05),Revised,3/31/23,Available,,,Other,Anesthesia;Neurology,Current,,,4/2/20,,,,,https://www.fda.gov/drugs/drug-shortages/search-list-extended-use-dates-assist-drug-shortages,,
Midazolam Injection,"Hospira, Inc., a Pfizer company",844-646-4398,10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2308-02),Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: September 2023,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,https://www.fda.gov/drugs/drug-shortages/search-list-extended-use-dates-assist-drug-shortages,,
Midazolam Injection,"Hospira, Inc., a Pfizer company",844-646-4398,25 mg/5 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-03),Revised,3/31/23,Available,,,Other,Anesthesia;Neurology,Current,,,4/2/20,,,,,https://www.fda.gov/drugs/drug-shortages/search-list-extended-use-dates-assist-drug-shortages,,
Midazolam Injection,"Hospira, Inc., a Pfizer company",844-646-4398,10 mg/10 mL (1 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2587-05),Revised,3/31/23,Limited Supply Available. Next Delivery: July 2023; Estimated Recovery: September 2023,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,50 mg per 10 mL Multi-Dose Vial (NDC 70860-601-10),Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,25 mg per 5 mL Multi-Dose Vial (NDC 70860-601-05),Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,25 mg per 5 mL Multi-Dose Vial (NDC 47781-589-17),Reverified,3/10/23,No stock available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,50 mg per 10 mL Multi-Dose Vial (NDC 47781-589-91),Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,2 mg per 2 mL Single Dose Vial (NDC 70860-600-02),Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,2 mg per 2 mL Single Dose Vial (NDC 47781-588-68),Reverified,3/10/23,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Avet Pharmaceuticals Inc,855-228-9470,50 mg/10mL vial (NDC 23155-601-42),Revised,10/31/22,Available,,,Other,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Avet Pharmaceuticals Inc,855-228-9470,25 mg/5mL vial (NDC 23155-601-41),Revised,10/31/22,Available,,,Other,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Midazolam Injection,Avet Pharmaceuticals Inc,855-228-9470,2 mg/2mL vial (NDC 23155-600-41),Revised,10/31/22,Available; On allocation due to increased demand,,,Other,Anesthesia;Neurology,Current,,,4/2/20,,,,,,,
Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,15mg tablets (NDC 0591-2469-15),New,5/29/18,,,,,Psychiatry,To be Discontinued,,,5/29/18,,,,,,,
Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,30mg tablets (NDC 0591-2470-15),New,5/29/18,,,,,Psychiatry,To be Discontinued,,,5/29/18,,,,,,,
Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,45mg tablets (NDC 0591-2471-15),New,5/29/18,,,,,Psychiatry,To be Discontinued,,,5/29/18,,,,,,,
Misoprostol Tablets,Lupin,800-466-1450,100-mcg tablets Bottles of 60 (NDC 43386-160-06),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Lupin,800-466-1450,100-mcg tablets Bottles of 120 (NDC 43386-160-12),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Lupin,800-466-1450,200-mcg tablets Bottles of 60 (NDC 43386-161-06),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Lupin,800-466-1450,200-mcg tablets Bottles of 100 (NDC 43386-161-01),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 60 (NDC 59762-5007-1),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 120 (NDC 59762-5007-2),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 60 (NDC 59762-5008-1),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; 10x10 blister (NDC 0025-1451-34),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 60 (NDC 0025-1451-60),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 100 (NDC 0025-1461-31),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 60 (NDC 0025-1461-60),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 100 (NDC 59762-5008-2),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,,12/28/20,,,,,,,
Mitoxantrone Injection,Teva,800-545-8800,NDC 0703-4685-01 (20 mg/10 mL (2 mg/mL) Multiple Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Neurology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Mitoxantrone Injection,Teva,800-545-8800,NDC 0703-4680-01 (25 mg/12.5 mL (2 mg/mL) Multiple Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Neurology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Mitoxantrone Injection,Teva,800-545-8800,NDC 0703-4686-01 (30 mg/15 mL (2 mg/mL) Multiple Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Neurology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Mometasone Furoate Monohydrate Nasal Spray,Merck Sharp & Dohme Corp.,800-672-6372,50 mcg (NDC 0085-1288-01),New,6/9/21,,,,,Pulmonary/Allergy,To be Discontinued,,,6/9/21,,,,,,,
Montelukast Sodium Chewable Tablet,Sandoz,800-525-8747,"4 mg  (NDCs 0781-5554-05, 0781-5554-06, 0781-5554-13, 0781-5554-31, 0781-5554-64, 0781-5554-92)",New,10/12/21,,,,,Pulmonary/Allergy,To be Discontinued,,,10/12/21,,,,,,,
Montelukast Sodium Chewable Tablet,Sandoz,800-525-8747,"5 mg  (NDCs 0781-5555-05, 0781-5555-06, 0781-5555-13, 0781-5555-31, 0781-5555-64, 0781-5555-92)",New,10/12/21,,,,,Pulmonary/Allergy,To be Discontinued,,,10/12/21,,,,,,,
Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,4 mg  (NDCs 0093-7424-98 and 0093-7424-56),New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,,,7/28/20,,,,,,,
Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,5 mg  (NDCs 0093-7425-98 and 0093-7425-56),New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,,,7/28/20,,,,,,,
Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,"10 mg (NDCs 0093-7426-10, 0093-7426-56, and 0093-7426-98)",New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,,,7/28/20,,,,,,,
Montelukast Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-5201-93),New,3/20/18,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,,3/20/18,,,,,,,
Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-2658-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"30 mg, 100s (NDC 0378-2659-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"60 mg, 100s (NDC 0378-2660-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100s (NDC 0378-2661-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg, 100s (NDC 0378-2662-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,,5/8/18,,,,,,,
Morphine Sulfate Injection,Fresenius Kabi USA,888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-452-01)",Revised,3/31/23,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Morphine Sulfate Injection,Fresenius Kabi USA,888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-454-01)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Morphine Sulfate Injection,Fresenius Kabi USA,888-386-1300,"5 mg per 1 mL, Single dose vial, (NDC 63323-455-01)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Morphine Sulfate Injection,Fresenius Kabi USA,888-386-1300,"10 mg per 1 mL, Single dose vial, (NDC 63323-451-01)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Morphine Sulfate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"30 mg/30 mL (1 mg/1 mL) Single-Dose (Preservative-Free PCA Vial), (NDC 76329-1912-1)",Reverified,4/6/23,Available,,,,Analgesia/Addiction,Current,,,12/6/18,,,,,,,
Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6125-25)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,,11/3/17,,,,,,,
Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"8 mg/mL, 1 mL vial (NDC 0641-6126-25)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,,11/3/17,,,,,,,
Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-6127-25)",Revised,4/8/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Analgesia/Addiction,Current,,,11/3/17,,,,,,,
Morphine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,2 mg/mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1890-01),Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: September 2023,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,https://www.fda.gov/media/128550/download,,
Morphine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,4 mg/mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1891-01),Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,https://www.fda.gov/media/128550/download,,
Morphine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,8 mg/mL (8 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1892-01),Revised,3/31/23,Available,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,https://www.fda.gov/media/128550/download,,
Morphine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,10 mg/mL (10 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1893-01),Revised,3/31/23,Available,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,https://www.fda.gov/media/128550/download,,
Morphine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,5 mg/10 mL (0.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3814-12),Revised,3/31/23,Available,,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,https://www.fda.gov/media/128550/download,,
Morphine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,10 mg/10 mL (1 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3815-12),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,https://www.fda.gov/media/128550/download,,
Morphine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"1,000 mg/20 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-03)",Revised,3/31/23,Next Delivery and Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,https://www.fda.gov/media/128550/download,,
Morphine Sulfate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"2,500 mg/50 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-05)",Revised,3/31/23,Next Delivery and Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,,10/31/17,,,,,https://www.fda.gov/media/128550/download,,
Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 1 mg/mL, 10 mL ampul (NDC 0641-6019-10)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,,11/3/17,,,,,,,
Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 0.5 mg/mL, 10 mL ampul (NDC 0641-6020-10)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,,11/3/17,,,,,,,
Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 10 mg/mL, 20 mL ampul (NDC 0641-6039-01)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,,11/3/17,,,,,,,
Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 25 mg/mL, 20 mL ampul (NDC 0641-6040-01)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,,11/3/17,,,,,,,
Morphine Sulfate Injection,Fresenius Kabi USA,888-386-1300,"2 mg per 1 mL, Single-use prefilled syringe, micro vault packaging (NDC 76045-004-11)",Revised,3/31/23,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Morphine Sulfate Injection,Fresenius Kabi USA,888-386-1300,"4 mg per 1 mL, Single-use prefilled syringe, micro vault packaging (NDC 76045-005-11)",Revised,3/31/23,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,,10/31/17,,,,,,,
Moxetumomab pasudotox-tdfk (Lumoxiti) Injection,AstraZeneca AB (AstraZeneca),800-236-9933,1 mg vial (NDC 0310-4700-01),New,1/10/23,,"The planned permanent discontinuation of moxetumomab pasudotox-tdfk) for injection from the U.S. market is August 31, 2023.",,,Oncology,To be Discontinued,1/10/23,1/10/23,1/10/23,,,,https://www.fda.gov/media/164425/download,,,https://www.fda.gov/media/164425/download
Moxifloxacin (Moxeza) Ophthalmic Solution,Novartis,888-669-6682,"5mg/mL, 3mL in 1 bottle, (NDC 0065-0006-03)",New,7/2/21,,,,,Ophthalmology,To be Discontinued,,,7/2/21,,,,,,,
Moxifloxacin Tablets,Torrent Pharmaceuticals Limited,908-280-3333,"400mg tablets, bottle of 30 (NDC 13668-201-30)",New,3/28/23,,Business decision to discontinue manufacture of this product.,,,Anti-Infective,To be Discontinued,3/28/23,3/28/23,3/28/23,,,,,,,
Moxifloxacin Tablets,Torrent Pharmaceuticals Limited,908-280-3333,"400mg tablets, bottle of 100 (NDC 13668-201-01)",New,3/28/23,,Business decision to discontinue manufacture of this product.,,,Anti-Infective,To be Discontinued,3/28/23,3/28/23,3/28/23,,,,,,,
Moxifloxacin Tablets,Torrent Pharmaceuticals Limited,908-280-3333,"400mg tablets, bottle of 500 (NDC 13668-201-05)",New,3/28/23,,Business decision to discontinue manufacture of this product.,,,Anti-Infective,To be Discontinued,3/28/23,3/28/23,3/28/23,,,,,,,
Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 10 mL Single Dose Dual Glass Fliptop Vials (NDC 61703-0434-82),Reverified,11/28/22,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,,,,,,,,
Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 2 x 50 mL Pharmacy Bulk Package Dual Glass Fliptop Vials (NDC 61703-0422-83),Reverified,11/28/22,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,,,,,,,,
Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Pediatric; Single Dose Glass Fliptop Vial (NDC 61703-0421-53),Reverified,11/28/22,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,,,,,,,,
Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Pediatric, Multiple Vitamins for Injection. Single Dose package. (NDC 54643-5646-1)",Revised,4/5/23,"Limited availability, on allocation","Distributed by Baxter
Customer Service Number 888-229-0001",,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,,,,,,https://www.nutritioncare.org/Guidelines_and_Clinical_Resources/Product_Shortages/2020_Parenteral_Nutrition_Multivitamin_Product_Shortage_Considerations/,,
Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Adult, Multiple Vitamins for Injection. Single dose package. (NDC 54643-5649-1)",Revised,4/5/23,"Limited availability, on allocation","Distributed by Baxter
Customer Service Number 888-229-0001",,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,,,,,,https://www.nutritioncare.org/Guidelines_and_Clinical_Resources/Product_Shortages/2020_Parenteral_Nutrition_Multivitamin_Product_Shortage_Considerations/,,
Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Adult, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5650-2)",Revised,4/5/23,Limited Availability,"Distributed by Baxter
Customer Service Number 888-229-0001",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,,,,,,https://www.nutritioncare.org/Guidelines_and_Clinical_Resources/Product_Shortages/2020_Parenteral_Nutrition_Multivitamin_Product_Shortage_Considerations/,,
Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Pediatric, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5647-0)",Revised,4/5/23,Limited Availability,"Distributed by Baxter
Customer Service Number 888-229-0001",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,,,,,,https://www.nutritioncare.org/Guidelines_and_Clinical_Resources/Product_Shortages/2020_Parenteral_Nutrition_Multivitamin_Product_Shortage_Considerations/,,
Mycophenolic Sodium Delayed-Release Tablets,Lupin Pharmaceuticals,866-587-4617,180mg (NDC 70748-217-16),New,4/6/23,,,,,Anti-Infective,To be Discontinued,4/6/23,4/6/23,4/6/23,,,,,,,
Mycophenolic Sodium Delayed-Release Tablets,Lupin Pharmaceuticals,866-587-4617,360mg (NDC 70748-218-16),New,4/6/23,,,,,Anti-Infective,To be Discontinued,4/6/23,4/6/23,4/6/23,,,,,,,
Nafcillin Injection,Pfizer Pharmaceuticals,800-533-4535,1 g; Single Dose Vial (Powder)(NDC 0409-3713-01),New,10/20/21,,,,,Anti-Infective,To be Discontinued,,,10/20/21,,,,,,,
Nafcillin Injection,Pfizer Pharmaceuticals,800-533-4535,2 g; Single Dose Vial (Powder)(NDC 0409-3714-01),New,10/20/21,,,,,Anti-Infective,To be Discontinued,,,10/20/21,,,,,,,
Nafcillin Injection,Pfizer Pharmaceuticals,800-533-4535,10 g per Pharmacy Bulk Package; Pharmacy Bulk Vial (Powder)(NDC 0409-3715-01),New,10/20/21,,,,,Anti-Infective,To be Discontinued,,,10/20/21,,,,,,,
Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-3124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,,,12/23/19,,,,,,,
Nafcillin Sodium Injection,Sandoz,800-525-8747,2 gram vial packaged in 10s (NDC 0781-3125-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,,,12/23/19,,,,,,,
Nafcillin Sodium Injection,Sandoz,800-525-8747,Pharmacy Bulk Package bottle (NDC 0781-3126-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,,,12/23/19,,,,,,,
Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-9124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,,,12/23/19,,,,,,,
Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9224-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,,,12/23/19,,,,,,,
Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9225-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,,,12/23/19,,,,,,,
Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3128-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,,,12/23/19,,,,,,,
Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3129-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,,,12/23/19,,,,,,,
Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 1 mL Glass Ampul (NDC 00409-1463-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,,,10/11/19,,,,,,,
Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/mL; 1 mL Glass Ampul (NDC 00409-1465-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,,,10/11/19,,,,,,,
Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1464-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,,,10/11/19,,,,,,,
Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/10 mL (20 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1467-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,,,10/11/19,,,,,,,
Naratriptan Hydrochloride Tablets,GlaxoSmithKline,888-825-5249,1 mg 9-count blisterpack (NDC 0173-0561-00),New,4/7/22,,,,,Neurology,To be Discontinued,,,4/7/22,,,,,,,
Naratriptan Hydrochloride Tablets,GlaxoSmithKline,888-825-5249,2.5 mg 9-count blisterpack (NDC 0173-0562-00),New,4/7/22,,,,,Neurology,To be Discontinued,,,4/7/22,,,,,,,
Nateglinide Tablets,Par Pharmaceuticals Inc.,"800-828-9393, option 5 then option 2","60mg, 100’s count bottle (NDC 49884-984-01)",New,10/7/22,,,,,Endocrinology/Metabolism,To be Discontinued,10/7/22,10/7/22,10/7/22,,,,,,,
Nateglinide Tablets,Par Pharmaceuticals Inc.," 800-828-9393, option 5 then option 2","120mg 100s, 100 ‘s count bottle (NDC 49884-985-01)",New,10/7/22,,,,,Endocrinology/Metabolism,To be Discontinued,10/7/22,10/7/22,10/7/22,,,,,,,
Nebivolol Hydrochloride Tablets,Abbvie,800-678-1605,"BYSTOLIC® (nebivolol) tablets, NDC 0456-1420-30 (30 tablets in 1 bottle)",New,6/9/22,,,,,Cardiovascular,To be Discontinued,,,6/9/22,,,,,,,
Nedocromil Sodium Ophthalmic Solution,Allergan,800-678-1605,2% (NDC 0023-8842-05),New,5/18/22,,,,,Ophthalmology,To be Discontinued,,,5/18/22,,,,,,,
Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,50 mg 100 Tablets (NDC 0093-7178-01),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,,9/18/20,,,,,,,
Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,100 mg 60 Tablets (NDC 0093-1024-06),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,,9/18/20,,,,,,,
Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,150 mg 60 Tablets (NDC 0093-7113-06),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,,9/18/20,,,,,,,
Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,200 mg 60 Tablets (NDC 0093-1025-06),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,,9/18/20,,,,,,,
Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,250 mg 60 Tablets (NDC 0093-1026-06),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,,9/18/20,,,,,,,
Neomycin Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, 100 tablets (NDC 0093-1177-01)",Reverified,4/5/23,Available,Delay in shipping of drug,,Other,Anti-Infective,Current,,,11/16/22,,,,,,,
Neomycin Sulfate Tablets,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"500 mg, 100 tablets (NDC 39822-0310-5)",Revised,2/10/23,Unavailable,,,Delay in shipping of drug,Anti-Infective,Current,,,11/16/22,,,,,,,
Nesiritide Powder (NATRECOR) for Injection,Janssen Pharmaceuticals,800-526-7736,1.5 mg (NDC 65847-205-25),New,2/5/18,,,,,Cardiovascular,To be Discontinued,,,2/5/18,,,,,,,
Nevirapine (Viramune) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,200 mg tablets (NDC 0597-0046-60),New,5/29/20,,,,,Antiviral,To be Discontinued,,,5/29/20,,,,,,,
Nevirapine Oral Suspension,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,50mg/5mL (NDC 0597-0047-24),New,10/1/21,,,,,Antiviral,To be Discontinued,,,10/1/21,,,,,,,
Nizatidine Capsules,Teva Pharmaceuticals,800-545-8800,"300 mg, 30 count bottle (NDC 0591-3138-30)",Reverified,4/5/23,Available,,,Other,Gastroenterology,Current,,,3/27/20,,,,,,,
Nizatidine Capsules,Teva Pharmaceuticals,800-545-8800,"150 mg, 60 count bottle (NDC 0591-3137-60)",Reverified,4/5/23,Available,,,Other,Gastroenterology,Current,,,3/27/20,,,,,,,
Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"300 mg, 30 count bottle (NDC 68462-0426-30)",New,3/27/20,Unavailable,,,,Gastroenterology,Current,,,3/27/20,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Nizatidine+Capsules&st=d&tab=tabs-2,,
Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"150 mg, 60 count bottle (NDC 68462-0425-60)",New,3/27/20,Unavailable,,,,Gastroenterology,Current,,,3/27/20,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Nizatidine+Capsules&st=d&tab=tabs-2,,
Norepinephrine Bitartrate Injection,Teva,800-545-8800,NDC 0703-1153-03 (4 mg/4 mL (1 mg/mL) 10 Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Cardiology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Norepinephrine Bitartrate Injection,Teva,800-545-8800,NDC 0703-1153-83 (4 mg/4 mL (1 mg/mL) 10 Vials) PREMIERProRx®,New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Cardiology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Norethindrone (NOR QD) Tablets,Allergan,800-678-1605,"Nor QD, 0.35 mg norethindrone, Tablets, (NDC  52544-235-28)",New,2/23/18,,,,,Reproductive,To be Discontinued,,,2/23/18,,,,,,,
Nystatin and Triamcinolone Acetonide Cream,Teva Pharmaceuticals,800-545-8800,"0.1%  (NDCs 0472-0150-15, 0472-0150-30, 0472-0150-60)",New,4/8/22,,,,,Dermatology,To be Discontinued,,,4/8/22,,,,,,,
Nystatin and Triamcinolone Acetonide Ointment,Teva Pharmaceuticals,800-545-8800,"0.1%  (NDCs 0472-0155-15, 0472-0155-30, 0472-0155-60)",New,4/8/22,,,,,Dermatology,To be Discontinued,,,4/8/22,,,,,,,
Nystatin Ointment,Sandoz,800-525-8747,15 g tube (NDC 0168-0007-15 ),New,6/3/22,,,,,Dermatology,To be Discontinued,,,6/3/22,,,,,,,
Nystatin Ointment,Sandoz,800-525-8747,30 g tube (NDC 0168-0007-30 ),New,6/3/22,,,,,Dermatology,To be Discontinued,,,6/3/22,,,,,,,
Nystatin Ointment,Torrent Pharmaceuticals Limited,908-280-3333,"100,000 units/gm (NDCs 13668-534-01 and 13668-534-02)",New,3/21/23,,,,,Dermatology,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Octreotide Acetate Injection,Teva,800-545-8800,NDC 0703-3343-01 (5000 mcg/5 mL (1000 mcg/mL) 5 mL Multiple Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Octreotide Acetate Injection,Teva,800-545-8800,"NDC 0703-3321-04 (500 mcg/mL, 25 x 1 mL Single Dose Vials)",New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Octreotide Acetate Injection,Teva,800-545-8800,NDC 0703-3333-01 (1000 mcg/5 mL (200 mcg/mL) 5 mL Multiple Dose Vial),New,8/11/22,,Product is available with an expected supply duration until JUL 2022.  No future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Octreotide Acetate Injection,Teva,800-545-8800,NDC 0703-3311-04 (100 mcg/mL 1 mL Single Dose Vial 25 Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Octreotide Acetate Injection,Teva,800-545-8800,NDC 0703-3301-04 (50 mcg/mL 1 mL Single Dose Vial 25 Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Olanzapine and Fluoxetine (Symbyax) Capsules,Eli Lilly and Co.,800-545-5979,12mg/50mg per capsule (NDC Package Code 0002-3234-30),New,7/15/20,,,,,Psychiatry,To be Discontinued,,,7/15/20,,,,,,,
Olanzapine and Fluoxetine (Symbyax) Capsules,Eli Lilly and Co.,800-545-5979,6mg/50mg per capsule (NDC Package Code 0002-3233-30),New,7/15/20,,,,,Psychiatry,To be Discontinued,,,7/15/20,,,,,,,
Olopatadine Hydrochloride Nasal Spray,Novartis Pharmaceuticals,888-669-6682,"PATANASE (olopatadine hydrochloride) nasal spray, 665 mcg  (NDC 0078-0834-30) 1 BOTTLE in 1 CARTON (0078-0834-30) > 240 SPRAY, METERED in 1 BOTTLE",New,6/21/22,,,,,Pulmonary/Allergy,To be Discontinued,,,6/21/22,,,,,,,
Olopatadine Hydrochloride Nasal Spray,Novartis Pharmaceuticals,888-669-6682,"Olopatadine hydrochloride nasal spray, 665 mcg (NDC 61314 320-01) 1 BOTTLE in 1 CARTON (61314-320-01) > 30500 uL in 1 BOTTLE",New,6/21/22,,,,,Pulmonary/Allergy,To be Discontinued,,,6/21/22,,,,,,,
Ombitasvir; Paritaprevir; Ritonavir (Technivie) Tablets,Abbvie,800-255-5162,212.5mg; 75mg; 50mg (NDC 0074-3082-28),New,5/22/18,,,,,Antiviral,To be Discontinued,,,5/22/18,,,,,,,
Omeprazole and Sodium Bicarbonate Powder for Suspension,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",20mg and 1680mg  (NDC 49884-268-11),New,6/28/22,,,,,Gastroenterology,To be Discontinued,,,6/28/22,,,,,,,
Omeprazole and Sodium Bicarbonate Powder for Suspension,Endo Pharmaceuticals. Inc.,"800-828-9393, option 5, then option 2",40mg and 1680mg  (NDC 49884-269-11),New,6/28/22,,,,,Gastroenterology,To be Discontinued,,,6/28/22,,,,,,,
Omeprazole and Sodium Bicarbonate Powder for Suspension,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",20mg; 1680mg  (NDCs 49884-268-52 and 49884-268-11),New,2/2/22,,,,,Gastroenterology,To be Discontinued,,,2/2/22,,,,,,,
Omeprazole and Sodium Bicarbonate Powder for Suspension,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",40mg; 1680mg (NDCs 49884-269-11 and 49884-269-52),New,2/2/22,,,,,Gastroenterology,To be Discontinued,,,2/2/22,,,,,,,
Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"2 mg/mL , 20 mL vials (NDC 23155-549-31)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"PPRX 2 mg/mL , 2 mL Vial, 25 pack (NDC 23155-548-42)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"PPRX 2 mg/mL , 2 mL Vial, 10 pack (NDC 23155-548-41)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, amber vial, 4 mg per 2 mL (NDC 63323-373-02)",Revised,4/25/22,Available,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Multi dose, amber vial, 40 mg per 20 mL (NDC 63323-374-20)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, Simplist syringe, 4 mg per 2 mL (NDC 76045-103-20)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9890-01)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"2 mg/mL, 2 mL vial, 25 count (NDC 55150-125-02)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"2 mg/mL , 2 mL Vial (NDC 23155-547-41)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-4759-01),Revised,4/25/22,,,,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 2 mL vial (NDC 0641-6078-25)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-4755-03),Revised,4/25/22,,,,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1120-12),Revised,10/6/21,,,,,Gastroenterology,To be Discontinued,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"2 mg/mL, 20 mL vial, 1 count (NDC 55150-126-20)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Apotex Corp.,800-706-5575,Ondansetron 2mg/mL 2mL vials Box of 25 vials (NDC 60505-6130-05),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,40mg/20mL EA 1 Vial (NDC 25021-782-20),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,4mg/2mL PK 25 Vials (NDC 25021-777-02),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,2 mg/mL 2mL vial (NDC 70860-776-02),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,2 mg/mL 20mL vial (NDC 70860-777-20),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,"2 mg/mL, 2 mL vial (NDC 72266-123-25)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,"2 mg/mL, 20 mL vial (NDC 72266-124-01)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Ondansetron Hydrochloride Injection,Baxter Healthcare,800-229-0001,"Ondansetron Injection, USP (2 mg/mL) 2 mL Single Use Glass Vial (25 x 2 mL) (NDC 36000-012-25)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,,4/11/18,,,,,,,
Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Eloxatin 50 mg/10 mL vial (NDCs 0024-0590-10),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Eloxatin 100 mg/20 mL vial (NDC 0024-0591-20),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Eloxatin 200 mg/40 mL vial (NDC 0024-0592-40),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Winthrop Oxaliplatin 50 mg/10 mL vial (NDC 0955-1725-10),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Winthrop Oxaliplatin 100 mg/20 mL vial (NDC 0955-1727-20),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Winthrop Premier Oxaliplatin 50 mg/10 mL vial (NDC 0955-1731-10),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Winthrop Premier Oxaliplatin 100 mg/20 mL vial (NDC 0955-1733-20),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Oxaprozin Tablets,Sandoz,800-525-8747,600 mg 100 ct (NDC 0185-0141-01),New,3/17/23,,Discontinuation of the manufacture of the product,,,Analgesia/Addiction,To be Discontinued,3/17/23,3/17/23,3/17/23,,,,,,,
Oxcarbazepine Oral Suspension,Novartis Pharmaceuticals Corporation,888-669-6682,300mg/5mL (NDC 0781-6270-43),New,8/8/22,,,,,Neurology,To Be Discontinued,8/8/22,8/8/22,8/8/22,,,,,,,
Oxybutynin Chloride Syrup,"Lannett Company, Inc.",215-333-9000 ext: 4,5 mg per 5 mL (syrup) (NDC 54838-510-80),New,12/13/22,Currently out of stock; targeting to restock around mid-January 2023,Vendor supply disruption for inactive ingredient,,Shortage of inactive ingredient,Antispasmodic; Anticholinergic,Current,,,12/13/22,,,,,,,
Oxybutynin Chloride Syrup,Wockhardt,800-346-6854,"5mg/5mL, 473mL (NDC 60432-0092-16)",New,4/11/22,,,,,Urology,To be Discontinued,,,4/11/22,,,,,,,
Oxytocin Injection,Fresenius Kabi USA,888-386-1300,100 USP Units per 10 mL (10 USP units per mL); Multiple dose vial; (NDC 63323-012-10),Revised,3/31/23,Backordered. Next release May 2023.,Check wholesalers for inventory,,Manufacturing delay,Anesthesia; Urology; Other,Current,,,9/23/22,,,,,,,
Oxytocin Injection,Fresenius Kabi USA,888-386-1300,300 USP Units per 30 mL (10 USP Units per mL); Multiple dose vial; (NDC 63323-012-30),Revised,3/31/23,Backordered. Next release May 2023.,Check wholesalers for inventory,,Manufacturing delay,Anesthesia; Urology; Other,Current,,,9/23/22,,,,,,,
Oxytocin Injection,Fresenius Kabi USA,888-386-1300,10 USP Units per mL (10 USP units per mL); (NDC 63323-012-01)( NDC 63323-0012-11),Revised,3/31/23,Available,Check wholesalers for inventory,,Manufacturing delay,Anesthesia; Urology; Other,Current,,,9/23/22,,,,,,,
Oxytocin Injection,Par Pharmaceuticals,800-828-9393,"Pitocin: Packages of six 50 mL Pharmacy Bulk Packages, each containing 10 units of oxytocin per mL (total = 500 units of oxytocin per vial), (NDC 42023-130-06)",Reverified,2/14/23,Limited availability,Limited supply due to increased demand,,,Anesthesia; Urology; Other,Current,,,9/23/22,,,,,,,
Oxytocin Injection,Par Pharmaceuticals,800-828-9393,"Pitocin: Packages of twenty-five oversized 1-mL vials, each containing 10 units of oxytocin, (NDC 42023-116-25)",Reverified,2/14/23,Limited availability,Limited supply due to increased demand,,,Anesthesia; Urology; Other,Current,,,9/23/22,,,,,,,
Oxytocin Injection,Par Pharmaceuticals,800-828-9393,"Pitocin: Packages of twenty-five 10 mL multiple-dose vial, each containing 10 units of oxytocin per mL (total = 100 units of oxytocin per vial) (NDC 42023-116-02)",Reverified,2/14/23,Limited availability,Limited supply due to increased demand,,,Anesthesia; Urology; Other,Current,,,9/23/22,,,,,,,
Paclitaxel Injection (protein-bound particles),Bristol Myers Squibb Co.,877-417-1523,"100 mg, single dose vial (NDC 24979-710-51); marketed by TWi Pharmaceuticals, Inc.",Revised,2/8/23,,,Available,,Oncology,Resolved,2/8/23,,10/5/21,,,,,,,
Paclitaxel Injection (protein-bound particles),Bristol Myers Squibb Co.,877-417-1523,"Abraxane® 100 mg, single dose vial (NDC 68817-134-50)",Revised,2/8/23,,,Available,,Oncology,Resolved,2/8/23,,10/5/21,,,,,,,
"Paclitaxel Injection, USP",Mylan Institutional,800-796-9526,"100 mg in 16.7 mL (6 mg/mL), multi-dose vial (NDC 67457-449-17)",New,11/22/19,,,,,Oncology,To be Discontinued,,,7/3/19,,,,,,,
Palifermin (Kepivance) Lyophilized Powder for Injection,Swedish Orphan Biovitrum AB,866-773-5274,"6.25mg/vial, 3-pack, (NDC 66658-112-03)",New,2/10/23,Currently not available; Estimated recovery in October 2023,,,Regulatory delay,Other,Current,,,2/10/23,,,,,,,
Palifermin (Kepivance) Lyophilized Powder for Injection,Swedish Orphan Biovitrum AB,866-773-5274,"6.25mg/vial, 6-pack, (NDC 66658-112-06)",New,2/10/23,Currently not available; Estimated recovery in October 2023,,,Regulatory delay,Other,Current,,,2/10/23,,,,,,,
Paliperidone (INVEGA) Extended Release Tablets,Janssen Research and Development LLC,800-526-7736,INVEGA 1.5 mg 30 Tabs (NDC 50458-554-01),New,2/3/23,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,2/3/23,2/3/23,2/3/23,,,,,,,
Paliperidone (INVEGA) Extended Release Tablets,Janssen Research and Development LLC,800-526-7736,INVEGA 1.5 mg 10 blister pack (NDC 50458-554-10),New,2/3/23,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,2/3/23,2/3/23,2/3/23,,,,,,,
Paliperidone Extended Release Tablets,Janssen Research and Development LLC,800-JANSSEN (1-800-526-7736),"1.5 mg 30 Tabs, (NDC 10147-0951-3)",New,11/23/22,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Paliperidone Extended Release Tablets,Janssen Research and Development LLC,800-JANSSEN (1-800-526-7736),"3 mg 30 Tabs, (NDC 10147-0952-3)",New,11/23/22,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Paliperidone Extended Release Tablets,Janssen Research and Development LLC,800-JANSSEN (1-800-526-7736),"6 mg 30 Tabs, (NDC 10147-0953-3)",New,11/23/22,,Discontinuation of the manufacture of the drug.,,,Psychaitry,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Paliperidone Extended Release Tablets,Janssen Research and Development LLC,800-JANSSEN (1-800-526-7736),"9 mg 30 Tabs, (NDC 10147-0954-3)",New,11/23/22,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Pantoprazole Sodium for Injection,Sandoz,800-525-8747,"40 mg, Package of 10 vials (NDC 0480-4111-03)",Reverified,4/5/23,Limited Supply,Marketed by Teva,,Demand increase in the drug,Gastroenterology,Current,,,6/4/19,,,,,,,
Pantoprazole Sodium for Injection,Sandoz,800-525-8747,"40 mg, package of 10 vials (NDC 65219-433-15)",Reverified,4/5/23,Limited supply,Marketed by Fresenius Kabi,,Demand increase for the drug,Gastroenterology,Current,,,6/4/19,,,,,,,
Pantoprazole Sodium for Injection,Sandoz,800-525-8747,"40 mg, 10 vials (NDC 72572-550-10)",Reverified,4/5/23,Available,Marketed by Civica,,,Gastroenterology,Current,,,6/4/19,,,,,,,
Pantoprazole Sodium for Injection,Sandoz,800-525-8747,"40 mg, 10 vials (NDC 0781-3232-95)",Reverified,4/5/23,Limited Availability,,,Demand increase for the drug,Gastroenterology,Current,,,6/4/19,,,,,,,
Pantoprazole Sodium for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,"40 mg, 10 vials (NDC 62756-129-44)",Revised,4/5/22,Available,,,Other,Gastroenterology,Current,,,6/4/19,,,,,,,
Pantoprazole Sodium for Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"40 mg, 10 vials (NDC 55150-202-10)",Revised,4/4/23,Currently on backorder - next shipment April,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,,5/28/19,,,,,,,
Pantoprazole Sodium for Injection,"Hospira, Inc., a Pfizer company",800-533-4535,"40 mg, 10 vials (NDC 0008-0923-55)",Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,,5/28/19,,,,,,,
Pantoprazole Sodium for Injection,"Hospira, Inc., a Pfizer company",800-533-4535,"40 mg, 25 vials (NDC 0008-0923-60)",Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,,5/28/19,,,,,,,
Pantoprazole Sodium for Injection,"Hospira, Inc., a Pfizer company",800-533-4535,"40 mg, 10 vials (NDC 0008-4001-10; PremierProRx)",Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,,5/28/19,,,,,,,
Pantoprazole Sodium for Injection,"Hospira, Inc., a Pfizer company",800-533-4535,"40 mg, 25 vials (NDC 0008-4001-25; PremierProRx)",Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,,5/28/19,,,,,,,
Pantoprazole Sodium for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg, 10 vials (NDC 0143-9284-10)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Gastroenterology,Current,,,6/4/19,,,,,,,
Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,25mcg Cartridge: (NDC 68875-0202-1); Carton: (NDC 68875-0202-2) (contains 2 cartridges),Revised,12/6/21,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,,9/11/19,,,,,https://www.fda.gov/media/131077/download,,
Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,50mcg   Cartridge: (NDC 68875-0203-1); Carton: (NDC 68875-0203-2) (contains 2 cartridges),Revised,12/6/21,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,,9/11/19,,,,,https://www.takeda.com/49d169/siteassets/en-us/home/newsroom/natpara/dhcp-alt-rx-adjusted-100-mcg-dosing-plan.pdf,,
Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,75mcg   Cartridge: (NDC 68875-0204-1); Carton: (NDC 68875-0204-2) (contains 2 cartridges),Revised,12/6/21,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,,9/11/19,,,,,https://www.fda.gov/media/131077/download,,
Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,100mcg   Cartridge: (NDC 68875-0205-1); Carton: (NDC 68875-0205-2) (contains 2 cartridges),Revised,12/6/21,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,,9/11/19,,,,,https://www.takeda.com/49d169/siteassets/en-us/home/newsroom/natpara/dhcp-alt-rx-adjusted-100-mcg-dosing-plan.pdf,,
Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 200 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4347-01)",New,2/28/18,,,,,Oncology,To be Discontinued,,,2/28/18,,,,,,,
Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 300 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4348-01)",New,2/28/18,,,,,Oncology,To be Discontinued,,,2/28/18,,,,,,,
Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 600 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4349-01)",New,2/28/18,,,,,Oncology,To be Discontinued,,,2/28/18,,,,,,,
Pentamidine Isethionate (Nebupent) For Inhalation Solution,"Fresenius Kabi USA, LLC",888-386-1300,"300 mg per vial, SDV, PF (NDC 63323-877-15)",Revised,9/13/19,,,,,Anti-Infective,Resolved,,,8/2/19,,,,,,,
Pentostatin Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"10 mg, single dose vial (NDC 0409-0801-01)",Reverified,3/31/23,Available,,,Other,Oncology,Current,,,3/22/22,,,,,https://www.fda.gov/media/162946/download,,
Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 100s (NDC 0378-0357-01)",New,5/8/18,,,,,Cardiovascular,To be Discontinued,,,5/8/18,,,,,,,
Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 500s (NDC 0378-0357-05)",New,5/8/18,,,,,Cardiovascular,To be Discontinued,,,5/8/18,,,,,,,
Phenobarbital Oral Solution,Torrent Pharma Inc.,908-280-3333,1 pint 473mL (NDC 16571-330-16),New,11/25/19,,,,,Neurology,To be Discontinued,,,11/25/19,,,,,,,
Physostigmine Salicylate Injection,Akorn Pharmaceuticals,800-932-5676,"Physostigmine Salicylate Injection, USP  1mg/mL (10amps/box, 2mL each) (NDC 17478-510-02)",Revised,3/1/23,Not available,No new manufacturing of product,,,Neurology,Current,,,2/21/19,,,,,,,
Pindolol Tablets,Sun Pharmaceutical Industries Inc.,800-818-4555,"Pindolol Tablets, 5mg and 10mg (100 count bottles)(NDC 57664-655-88, 57664-656-88)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,,2/21/20,,,,,,,
Pindolol Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Pindolol 5mg Tabs 100s (NDC 0378-0052-01),Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,,2/21/20,,,,,,,
Pindolol Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Pindolol 10mg Tabs 100s (NDC 0378-0127-01),Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,,2/21/20,,,,,,,
Pindolol Tablets,Bayshore Pharmaceuticals,973-315-1819,5 mg/ 100 count (NDC 76385-131-01),Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,,2/21/20,,,,,,,
Pindolol Tablets,Bayshore Pharmaceuticals,973-315-1819,10 mg/ 100 count (NDC 76385-132-01),Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,,2/21/20,,,,,,,
Pindolol Tablets,"ANI Pharmaceuticals, Inc.",800-434-1121,"5 mg: Bottles of 100 tablets, (NDC 62559-560-01)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,,2/21/20,,,,,,,
Pindolol Tablets,"ANI Pharmaceuticals, Inc.",800-434-1121,"10 mg; Bottles of 100 tablets, (NDC 62559-561-01)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,,2/21/20,,,,,,,
Pindolol Tablets,"Nostrum Laboratories, Inc.",816-841-4636,"5 mg, Bottle of 100 tablets (NDC 29033-028-01)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,,2/21/20,,,,,,,
Pindolol Tablets,"Nostrum Laboratories, Inc.",816-841-4636,"10 mg, Bottle of 100 tablets (NDC 29033-029-01)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,,2/21/20,,,,,,,
Pioglitazone Hydrochloride Tablets,Sandoz,800-525-8747,15 mg/1 (NDC 0781-5420-64),New,1/10/22,,,,,Endocrinology/Metabolism,To be Discontinued,,,1/10/22,,,,,,,
Pioglitazone Hydrochloride Tablets,Sandoz,800-525-8747,30 mg/1 (NDC 0781-5421-10),New,1/10/22,,,,,Endocrinology/Metabolism,To be Discontinued,,,1/10/22,,,,,,,
Pioglitazone Hydrochloride Tablets,Sandoz,800-525-8747,45 mg/1 (NDC 0781-5422-10),New,1/10/22,,,,,Endocrinology/Metabolism,To be Discontinued,,,1/10/22,,,,,,,
Pioglitazone/Metformin HCl (ACTOPLUS MET®) Tablets,Takeda Pharmaceuticals USA Inc.,877-825-3327,15mg/500mg tablet (NDC 64764-0155-60),New,10/18/21,,,,,Endocrinology/Metabolism,To be Discontinued,,,10/18/21,,,,,,,
Piroxicam Capsules,"Pfizer, Inc.",800-533-4535,Feldene 10 mg capsules; Bottle of 100 (NDC 0069-3220-66),New,4/4/23,,Supply expected to exhaust late May 2023; Discontinuation of the manufacture of the drug,,,Analgesia,To be Discontinued,4/4/23,4/4/23,4/4/23,,,,,,,
Polymyxin B Sulfate and Trimethoprim Sulfate Ophthalmic Solution,"Allergan Sales, LLC",800-678-1605,"10,000 units/mL; 1 mg/mL (NDC 0023-7824-10)",New,8/8/22,,,,,Ophthalmology,To Be Discontinued,8/8/22,8/8/22,8/8/22,,,,,,,
Potassium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3294-51)",Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,6/10/19,,,,,https://www.fda.gov/media/158385/download,,
Potassium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"40 mEq/20 mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 00409-8183-01)",Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,6/10/19,,,,,https://www.fda.gov/media/158385/download,,
Potassium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3294-25), Novaplus",Revised,3/31/23,Limited Supply Available. Next Delivery: January 2024; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,6/10/19,,,,,,,
Potassium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"40 mEq/20 mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 0409-8183-25), Novaplus",Revised,3/31/23,Next Delivery and Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,6/10/19,,,,,,,
Potassium Acetate Injection,"Exela Pharma Sciences, LLC",828-758-5474,Potassium Acetate Inj. 40mEq (2mEq/ml) 20mL (NDC 51754-2001-4),Revised,5/16/22,Product shipped to and available in wholesalers. Additional shipment end of May 2022. Increased supply available in mid-June.,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,6/10/19,,,,,,,
Potassium Chloride Concentrate Injection,B. Braun Medical Inc.,800-227-2862,(2 mEq K /mL) 250mL bulk package Catalog# S9402-11(NDC 0264-1940-20),Revised,4/6/23,Inventory depleted.,Discontinuation of manufacturing,,Discontinuation of manufacturing,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,10 mEq/5 mL (2 mEq/mL) Single Dose Glass Fliptop Vial (NDC 0409-6635-01),Reverified,3/31/23,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,20 mEq/10 mL (2 mEq/mL) Single Dose Plastic Fliptop Vial (NDC 0409-6651-06),Reverified,3/31/23,Limited Supply Available. Next Delivery: June 2023; Estimated Recovery: December 2023,,,Demand Increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,40 mEq/20 mL (2 mEq/mL) Single Dose Plastic Fliptop Vial (NDC 00409-6653-05),Reverified,3/31/23,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,Fresenius Kabi USA,888-386-1300,"60 mEq per 30 mL (2 mEq per mL), Multi dose, plastic vial, (NDC 63323-967-30)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,Fresenius Kabi USA,888-386-1300,"10 mEq per 5 mL(2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-05)",Revised,3/31/23,Available,Check wholesalers for inventory,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,Fresenius Kabi USA,888-386-1300,"20 mEq per 10 mL (2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-10)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,Fresenius Kabi USA,888-386-1300,"40 mEq per 20 mL (2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-20)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,10 mEq/100 mL in VIAFLEX Plastic Container; Product Code 2B0826 (NDC 0338-0709-48),Reverified,3/29/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,10 mEq/50 mL in VIAFLEX Plastic Container; Product Code 2B0821 (NDC 0338-0705-41),Reverified,3/29/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,20 mEq/100 mL in VIAFLEX Plastic Container; Product Code 2B0827 (NDC 0338-0705-48),Reverified,3/29/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,20 mEq/50 mL in VIAFLEX Plastic Container; Product Code 2B0822 (NDC 0338-0703-41),Reverified,3/29/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,40 mEq/100 mL in VIAFLEX Plastic Container; Product Code 2B0824 (NDC 0338-0703-48),Reverified,3/29/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,29.8 g/L (20 mEq) 50 mL (NDC 14789-107-08),Revised,3/22/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,29.8 g/L (40 mEq) 100 mL (NDC 14789-107-16),Revised,3/22/23,Backordered. Next release not available at this time.,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,14.9 g/L (20 mEq) 100 mL (NDC 14789-108-16),Revised,3/22/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,14.9 g/L (10 mEq) 50 mL (NDC 14789-108-08),Revised,3/22/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,7.45 g/L ( 10 mEq) 100 mL (NDC 14789-109-16),Revised,3/22/23,Available,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 20 mEq/50 mL (Legacy Hospira NDC 0409-7077-14) (ICU Medical NDC 0990-7077-14)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 10 mEq/100 mL (Legacy Hospira NDC 0409-7074-26) (ICU Medical NDC 0990-7074-26)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 10 mEq/50 mL (Legacy Hospira NDC 0409-7075-14) (ICU Medical NDC 0990-7075-14)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 20 mEq/100 mL (Legacy Hospira NDC 0409-7075-26) (ICU Medical NDC 0990-7075-26)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 40 mEq/100 mL (Legacy Hospira NDC 0409-7077-26) (ICU Medical NDC 0990-7077-26)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,,,
Potassium Chloride Concentrate Injection,B. Braun Medical Inc.,800-227-2862,Concentrated Potassium Chloride Injection USP 250 mL Plastic Bag P9402 (NDC 0264-1944-20),Revised,4/6/23,Available. On 125% on allocation to existing customers.,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,11/2/21,,,,,https://www.fda.gov/media/163184/download,,
Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",0.375mg (NDC 10370-251-11),New,12/16/21,,,,,Neurology,To be Discontinued,,,12/16/21,,,,,,,
Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",0.75mg (NDC 10370-252-11),New,12/16/21,,,,,Neurology,To be Discontinued,,,12/16/21,,,,,,,
Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",1.5mg (NDC 10370-253-11),New,12/16/21,,,,,Neurology,To be Discontinued,,,12/16/21,,,,,,,
Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",2.25mg (NDC 10370-305-11),New,12/16/21,,,,,Neurology,To be Discontinued,,,12/16/21,,,,,,,
Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",3mg (NDC 10370-254-11),New,12/16/21,,,,,Neurology,To be Discontinued,,,12/16/21,,,,,,,
Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",3.75mg (NDC 10370-306-11),New,12/16/21,,,,,Neurology,To be Discontinued,,,12/16/21,,,,,,,
Prednicarbate Ointment,Sandoz,800-525-8747,0.1% (NDCs 0168-0410-15 and 0168-0410-60),New,3/16/23,,,,,Dermatology,To be Discontinued,3/16/23,3/16/23,3/16/23,,,,,,,
Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (Pred Forte) (NDC 11980-180-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,,,3/15/19,,,,,,,
Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,,,3/15/19,,,,,,,
Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (NDC 60758-119-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,,,3/15/19,,,,,,,
Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (NDC 60758-119-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,,,3/15/19,,,,,,,
Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 5mL in 1 bottle (NDC 61314-637-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,,,3/15/19,,,,,,,
Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 10mL in 1 bottle (NDC 61314-637-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,,,3/15/19,,,,,,,
Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 15mL in 1 bottle (NDC 61314-637-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,,,3/15/19,,,,,,,
Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,,,3/15/19,,,,,,,
Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (NDC 60758-119-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,,,3/15/19,,,,,,,
Prednisolone Sodium Phosphate Oral Solution,Wockhardt Bio AG/Morton Grove Pharmaceuticals,847-410-6929,15 mg/5mL (NDC 60432-212-08) (8 fl oz.),New,5/26/22,,,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,,5/26/22,,,,,,,
Pregabalin Capsules,Teva Pharmaceuticals,800-545-8800,100 mg 90 count (NDC 00228-2859-09),New,11/23/22,,Allocating Product until stock on hand is depleted,,,Neurology,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Pregabalin Capsules,Teva Pharmaceuticals,800-545-8800,150 mg 90 Count (NDC 00228-2860-09),New,11/23/22,,Allocating Product until stock on hand is depleted,,,Neurology,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Pregabalin Capsules,Teva Pharmaceuticals,800-545-8800,200 mg 90 Count (NDC 00228-2861-09),New,11/23/22,,Allocating Product until stock on hand is depleted,,,Neurology,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Pregabalin Capsules,Teva Pharmaceuticals,800-545-8800,225 mg 90 Count (NDC 00228-2862-09),New,11/23/22,,Allocating Product until stock on hand is depleted,,,Neurology,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Pregabalin Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 90 Count (NDC 00228-2856-09),New,11/23/22,,Allocating Product until stock on hand is depleted,,,Neurology,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Pregabalin Capsules,Teva Pharmaceuticals,800-545-8800,300 mg 90 Count (NDC 00228-2863-09),New,11/23/22,,Allocating Product until stock on hand is depleted,,,Neurology,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Pregabalin Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 90 Count (NDC 00228-2857-09),New,11/23/22,,Allocating Product until stock on hand is depleted,,,Neurology,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Pregabalin Capsules,Teva Pharmaceuticals,800-545-8800,75 mg 90 Count (NDC 00228-2858-09),New,11/23/22,,Allocating Product until stock on hand is depleted,,,Neurology,To be Discontinued,11/23/22,11/23/22,11/23/22,,,,,,,
Procainamide Hydrochloride Injection,Pfizer,844-646-4398,"1,000 mg/2 mL (500 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 0409-1903-01)",New,8/30/22,,Discontinuation of the manufacture of the drug.,,,Cardiology,To be Discontinued,8/30/22,8/30/22,8/30/22,,,,,,,
Procardia Capsules,Pfizer Pharmaceuticals,800-533-4353,10 mg capsule; Bottle of 100 (NDC 0069-2600-66),New,5/10/21,,,,,Cardiovascular,To be Discontinued,,,5/10/21,,,,,,,
ProHance® (Gadoteridol) Injection,Bracco Diagnostics,877-272-2269,"279.3 mg/mL, 5 x 10 mL pre-filled syringe, (NDC 0270-1111-16)",New,6/1/21,,,,,Medical Imaging,To be Discontinued,,,6/1/21,,,,,,,
ProHance® (Gadoteridol) Injection,Bracco Diagnostics,877-272-2269,"279.3 mg/mL, 5 x 17 mL pre-filled syringe, (NDC 0270-111-45)",New,6/1/21,,,,,Medical Imaging,To be Discontinued,,,6/1/21,,,,,,,
Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL vial (NDC 0641-0928-25)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/1/22,,3/23/17,,,,,,,
Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL ,1 mL vial (NDC 0641-0929-25)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/1/22,,3/23/17,,,,,,,
Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL ampul (NDC 0641-1495-35)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/2/22,,3/23/17,,,,,,,
Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 1 mL ampul (NDC 0641-1496-35)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/1/22,,3/23/17,,,,,,,
Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL vial (NDC 0641-6084-25)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/1/22,,3/23/17,,,,,,,
Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL ,1 mL vial (NDC 0641-6085-25)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/1/22,,3/23/17,,,,,,,
Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL ampul (NDC 0641-6082-25)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/1/22,,3/23/17,,,,,,,
Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL, 1 mL ampul (NDC 0641-6083-25)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/1/22,,3/23/17,,,,,,,
Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"25 mg/mL, Carton of 25 ampuls (NDC 39822-5525-3)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/1/22,,3/23/17,,,,,,,
Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"50 mg/mL, Carton of 25 ampuls (NDC 39822-5550-6)",Revised,12/1/22,,,Available,,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Resolved,12/1/22,,3/23/17,,,,,,,
"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 1 vial Single-Dose (NDC 0703-2191-01)",New,12/19/19,,,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,,12/19/19,,,,,,,
"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL Injection, 1 Vial Single-Dose (NDC 0703-2201-01)",New,12/19/19,,,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,,12/19/19,,,,,,,
"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 25 in 1 tray (NDC 0703-2191-04)",New,12/19/19,,,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,,12/19/19,,,,,,,
"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL, 25 in 1 tray (NDC 0703-2201-04)",New,12/19/19,,,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,,12/19/19,,,,,,,
Promethazine Tablets,Sandoz,800-525-8747,25 mg 1000 ct (NDC 0781-1830-10),New,12/8/22,,Discontinuation of the manufacture of the product,,,Urology,To be Discontinued,12/8/22,12/8/22,12/8/22,,,,,,,
Promethazine Tablets,Sandoz,800-525-8747,25 mg 100 ct (NDC 0781-1830-01),New,12/8/22,,Discontinuation of the manufacture of the product,,,Urology,To be Discontinued,12/8/22,12/8/22,12/8/22,,,,,,,
Promethazine Tablets,Sandoz,800-525-8747,50 mg 100 ct (NDC 0781-1832-01),New,12/8/22,,Discontinuation of the manufacture of the product,,,Urology,To be Discontinued,12/8/22,12/8/22,12/8/22,,,,,,,
Propafenone Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",150mg (NDCs 0603-5448-21 and 0603-5448-25),New,2/2/22,,,,,Cardiovascular,To be Discontinued,,,2/2/22,,,,,,,
Propafenone Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",225mg (NDCs 0603-5449-21 and 0603-5449-25),New,2/2/22,,,,,Cardiovascular,To be Discontinued,,,2/2/22,,,,,,,
Propafenone Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",300mg (NDC 0603-5450-21),New,2/2/22,,,,,Cardiovascular,To be Discontinued,,,2/2/22,,,,,,,
Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 10X100ML VL (NDC 0591-2136-68),Revised,11/21/22,,,Discontinuance of Manufacturing,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 20X50ML VL (NDC 0591-2136-51),Revised,11/21/22,,,Discontinuance of Manufacturing,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 25X20ML VL (NDC 0591-2136-95),Revised,11/21/22,,,Discontinuance of Manufacturing,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0209-10),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0234-20),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,1000 mg/100 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0248-10),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Avet Pharmaceuticals Inc,855-228-9470,200 mg/20mL (pack 10) (NDC 23155-235-41),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Avet Pharmaceuticals Inc,855-228-9470,200 mg/20mL (pack of 20) (NDC 23155-235-44),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Avet Pharmaceuticals Inc,855-228-9470,500 mg/50 mL (pack of 20) (NDC 23155-345-42),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Avet Pharmaceuticals Inc,855-228-9470,"1,000 mg/100 mL (pack of 10) (NDC 23155-345-13)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-30),Revised,11/21/22,,,"Please note that Propofol 200 mg/20 mL (10 mg/mL) Single Patient Use Glass Fliptop Vial NDC 00409-4699-30 has been discontinued, but replaced with NDC  00409-6010-25. This was an NDC change only, so no supply or patient impact will occur from this discontinuation.",,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-33),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,1000 mg/100 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-24),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"1000 mg per 100 mL (10 mg per mL), single patient use only, 100 mL (NDC 63323-269-65)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,200mg per 20ml (NDC 25021-608-20),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 10X100ML VL (NDC 0591-2136-68),Revised,3/14/22,,,,,Anesthesia,To be Discontinued,,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,200mg/20mL  10ct (NDC 43598-265-58),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"200mg/20mL vial, individual (NDC 43598-265-20)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,500mg/50mL  20ct (NDC 43598-548-21),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"500mg/50mL vial, individual (NDC 43598-548-50)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 20X50ML VL (NDC 0591-2136-51),Revised,3/14/22,,,,,Anesthesia,To be Discontinued,,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 25X20ML VL (NDC 0591-2136-95),Revised,3/14/22,,,,,Anesthesia,To be Discontinued,,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL), single patient use only, 10 mL (NDC 63323-269-10)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL (10 mg per mL), single patient use only, 20 mL (NDC 63323-269-29)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL (10 mg per mL), single patient use only, 50 mL (NDC 63323-269-50)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,500mg per 50ml (NDC 250-21-608-50),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,1000mg per 100ml (NDC 25021-608-51),Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 20 mL vial (NDC 0641-6194-10)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 50 mL vial (NDC 0641-6195-20",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 100 mL vial (NDC 0641-6196-10",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"1000mg/100mL vial, 10ct (NDC 43598-549-10)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"1000mg/100mL vial, individual (NDC 43598-549-52)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"200mg/20mL vial, 25ct (NDC 43598-265-25)",Revised,11/21/22,,,,,Anesthesia,Resolved,11/21/22,,4/10/20,,,,,,,
Protamine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mg per 5 mL (10 mg per mL), single dose vial, preservative free,  (NDC 63323-229-05)",Revised,10/14/22,,Check wholesaler inventory,Available,,Hematology,Resolved,10/14/22,,4/20/21,,,,,,,
Protamine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"250 mg per 25 mL (10 mg per mL), single dose vial, preservative free, (NDC 63323-229-30)",Revised,10/14/22,,Check wholesaler inventory,Available,,Hematology,Resolved,10/14/22,,4/20/21,,,,,,,
Quinapril and Hydrochlorothiazide Tablets,Pfizer Pharmaceuticals,800-533-4535,Accuretic 10 mg/12.5 mg tablets; bottle of 90 (NDC 0071-0222-23),Reverified,3/31/23,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril and Hydrochlorothiazide Tablets,Pfizer Pharmaceuticals,800-533-4535,Accuretic 20 mg/12.5 mg tablets; bottle of 90 (NDC 0071-0220-23),Reverified,3/31/23,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril and Hydrochlorothiazide Tablets,Pfizer Pharmaceuticals,800-533-4535,Accuretic 20 mg/25 mg tablets; bottle of 90 (NDC 0071-0223-23),Reverified,3/31/23,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril and Hydrochlorothiazide Tablets,Aurobindo Pharma,866-850-2876,"10-12.5mg, 90 count bottle (NDC 65862-0161-90)",New,1/19/23,Discontinued,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril and Hydrochlorothiazide Tablets,Aurobindo Pharma,866-850-2876,"20-12.5mg, 90 count bottle (NDC 65862-0162-90)",New,1/19/23,Discontinued,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril and Hydrochlorothiazide Tablets,Aurobindo Pharma,866-850-2876,"50mg/325mg/40mg, 90 count bottle (NDC 65862-0163-90)",New,1/19/23,Discontinued,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,"Solco Healthcare US, LLC",866-931-9829,5MG/90ct (NDC 43547-410-09),New,1/19/23,Not available. Long-term backorder for all NDCs. No estimated release date at this time.,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,"Solco Healthcare US, LLC",866-931-9829,10MG/90ct (NDC 43547-411-09),New,1/19/23,Not available. Long-term backorder for all NDCs. No estimated release date at this time.,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,"Solco Healthcare US, LLC",866-931-9829,20MG/90ct (NDC 43547-412-09),New,1/19/23,Not available. Long-term backorder for all NDCs. No estimated release date at this time.,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,"Solco Healthcare US, LLC",866-931-9829,40MG/90ct (NDC 43547-413-09),New,1/19/23,Not available. Long-term backorder for all NDCs. No estimated release date at this time.,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,"Lupin Pharmaceuticals, Inc.",866-587-4617,5 mg (NDC 68180-556-09),New,1/19/23,Unavailable,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,"Lupin Pharmaceuticals, Inc.","Lupin Pharmaceuticals, Inc.",10 mg (NDC 68180-557-09),New,1/19/23,Unavailable,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,"Lupin Pharmaceuticals, Inc.",866-587-4617,20 mg (NDC 68180-558-09),New,1/19/23,Unavailable,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,"Lupin Pharmaceuticals, Inc.",866-587-4617,40 mg (NDC 68180-554-09),New,1/19/23,Unavailable,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"5 mg, 90 count bottle (NDC 65862-0617-90)",New,1/19/23,Discontinued,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"10 mg, 90 count bottle (NDC 65862-0618-90)",New,1/19/23,Discontinued,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"20 mg, 90 count bottle (NDC 65862-0618-90)",New,1/19/23,Discontinued,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"40 mg, 90 count bottle (NDC 65862-0620-90)",New,1/19/23,Discontinued,,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,Accupril 40 mg tablets; bottles of 90 (NDC 0071-0535-23),Reverified,3/31/23,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,Accupril 10 mg tablets; bottles of 90 (NDC 0071-0530-23),Reverified,3/31/23,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,Accupril 20 mg tablets; bottles of 90 (NDC 0071-0532-23),Reverified,3/31/23,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Quinapril Hydrochloride Tablets,Pfizer Pharmaceuticals,800-533-4535,Accupril 5 mg tablets; bottles of 90 (NDC 0071-0527-23),Reverified,3/31/23,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Cardiology,Current,,,1/19/23,,,,,,,
Ranolazine Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,500 mg  (NDC 45963-418-50),New,7/6/20,,,,,Cardiovascular,To be Discontinued,,,7/6/20,,,,,,,
Ranolazine Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,1000 mg  (NDC 45963-419-50),New,7/6/20,,,,,Cardiovascular,To be Discontinued,,,7/6/20,,,,,,,
Ranolazine Extended-Release Tablets,"Gilead Sciences, Inc.",800-445-3235,"500 mg (NDCs 61958-1003-1, 61958-1003-2, and 61958-1003-3)",Revised,1/13/23,,,,,Cardiovascular,To be Discontinued,12/22/22,12/22/22,12/22/22,,,,,,,
Ranolazine Extended-Release Tablets,"Gilead Sciences, Inc.",800-445-3235,"1000 mg (NDCs 61958-1004-1, 61958-1004-2, and 61958-1004-3)",Revised,1/13/23,,,,,Cardiovascular,To be Discontinued,12/22/22,12/22/22,12/22/22,,,,,,,
Remifentanil Injection,"Mylan, a Viatris Company",800-796-9526,ULTIVA 1 mg (NDC 67457-198-03),Reverified,3/28/23,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/28/22,,,,,,,
Remifentanil Injection,"Mylan, a Viatris Company",800-796-9526,ULTIVA 2 mg (NDC 67457-198-05),Reverified,3/28/23,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/28/22,,,,,,,
Remifentanil Injection,"Mylan, a Viatris Company",800-796-9526,ULTIVA 5 mg (NDC 67457-198-10),Reverified,3/28/23,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/28/22,,,,,,,
Remifentanil Injection,Hikma Pharmaceuticals,800-631-2174,1 mg/vial (NDC 0143-9391-10),Revised,8/26/22,This presentation is on backorder. Product will be available September 2022,,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/28/22,,,,,,,
Remifentanil Injection,Hikma Pharmaceuticals,800-631-2174,2 mg/Vial (NDC 0143-9392-10),Revised,8/26/22,This presentation is on backorder. Product will be available September 2022,,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/28/22,,,,,,,
Remifentanil Injection,Hikma Pharmaceuticals,800-631-2174,5 mg/mL (NDC 0143-9393-10),Revised,8/26/22,Currently available,,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/28/22,,,,,,,
Remifentanil Injection,Fresenius Kabi USA,888-386-1300,"1 mg per vial, SDV (NDC 63323-723-03)",Reverified,3/31/23,Backordered. Next release April 2023.,Check wholesaler inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/28/22,,,,,,,
Remifentanil Injection,Fresenius Kabi USA,888-386-1300,"2 mg per vial, SDV (NDC 63323-724-05)",Revised,3/10/23,Available,Check wholesaler inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/28/22,,,,,,,
Remifentanil Injection,Fresenius Kabi USA,888-386-1300,"5 mg per vial, SDV (NDC 63323-725-10)",Revised,3/31/23,Available,Check wholesaler inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,,6/28/22,,,,,,,
Repaglinide Tablets,Sandoz,800-525-8747,1mg tablets (NDC 0781-5149-01),New,2/2/18,,,,,Endocrinology/Metabolism,To be Discontinued,,,2/2/18,,,,,,,
Rifampin (Rifadin) Capsules,Sanofi-Aventis,800-633-1610; Option 7,150 mg capsules (NDC 0068-0510-30),New,6/15/20,,,,,Anti-Infective,To be Discontinued,,,6/15/20,,,,,,,
Rifampin (Rifadin) Capsules,Sanofi-Aventis,800-633-1610; Option 7,300 mg capsules (NDC 0068-0508-60),New,6/15/20,,,,,Anti-Infective,To be Discontinued,,,6/15/20,,,,,,,
Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,150 mg Bottles of 30 (NDC 61748-015-30),New,9/12/22,,Discontinuation of manufacture of the drug.,,,,To be Discontinued,9/12/22,9/12/22,9/12/22,,,,,,,
Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 30 (NDC 61748-018-30),New,9/12/22,,Discontinuation of manufacture of the drug.,,,,To be Discontinued,9/12/22,9/12/22,9/12/22,,,,,,,
Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 60 (NDC 61748-018-60),New,9/12/22,,Discontinuation of manufacture of the drug.,,,,To be Discontinued,9/12/22,9/12/22,9/12/22,,,,,,,
Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 100 (NDC 61748-018-01),New,9/12/22,,Discontinuation of manufacture of the drug.,,,,To be Discontinued,9/12/22,9/12/22,9/12/22,,,,,,,
Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,150 mg (NDC 42806-801-30),Reverified,1/11/23,Available,,,Other,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,150 mg (NDC 42806-801-01),Reverified,1/11/23,Available,,,Other,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,300 mg (NDC 42806-799-30),Reverified,1/11/23,Available,,,Other,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,300 mg (NDC 42806-799-60),Reverified,1/11/23,Available,,,Other,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,300 mg (NDC 42806-799-01),Reverified,1/11/23,Available,,,Other,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,300 mg (NDC 42806-799-05),Reverified,1/11/23,Available,,,Other,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,Lupin,866-587-4617,150 mg - Bottles of 30 (NDC 68180-658-06),Reverified,3/31/23,Available,,,,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,Lupin,866-587-4617,300 mg - Bottles of 30 (NDC 68180-659-06),Reverified,3/31/23,Available,,,,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,Lupin,866-587-4617,300 mg - Bottles of 60 (NDC 68180-659-07),Reverified,3/31/23,Available,,,,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,150 mg Bottles of 30 (NDC 61748-015-30),Revised,3/1/23,Not available,No new manufacturing of product,,,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 30 (NDC 61748-018-30),Revised,3/1/23,Not available,No new manufacturing of product,,,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 60 (NDC 61748-018-60),Revised,3/1/23,Not available,No new manufacturing of product,,,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 100 (NDC 61748-018-01),Revised,3/1/23,Not available,No new manufacturing of product,,,Anti-Infective,Current,,,12/22/21,,,,,,,
Rifampin Injection,Fresenius Kabi USA,888-386-1300,"600 mg per vial, PF, Lyophilized powder (NDC 63323-351-20)",Revised,3/31/23,Available,Check wholesaler inventory,,,Anti-Infective,Current,,,2/17/21,,,,,,,
Rifampin Injection,Sanofi,800-633-1610,"600 mg/10 mL, Lyophilized powder (NDC 0068-0597-01)",Revised,6/22/21,Available,,,Requirements related to complying with good manufacturing practices,Anti-Infective,Current,,,2/17/21,,,,,,,
Rifampin Injection,"Mylan Institutional, a Viatris company",800-796-9526,"600 mg, (Lyophilizate in Single Dose Vials) (NDC 67457-445-60)",Reverified,3/28/23,Unavailable,Re-supply April 2023,,Demand increase for the drug,Anti-Infective,Current,,,2/17/21,,,,,,,
Rifampin/Isoniazid (Rifamate) Capsules,Sanofi-Aventis,800-633-1610; Option 7,150 mg/300 mg capsules (NDC 0068-0509-60),New,6/15/20,,,,,Anti-Infective,To be Discontinued,,,6/15/20,,,,,,,
Rifampin/Isoniazid/Pyrazinamide (Rifater) Tablets,Sanofi-Aventis,800-633-1610; Option 7,150 mg/300 mg/120 mg tablets (NDC 0088-0576-41),New,6/15/20,,,,,Anti-Infective,To be Discontinued,,,6/15/20,,,,,,,
Rifapentine Tablets,Sanofi,800-633-1610 Option 7,"Rifapentine (Piftin) Tablets, 150 mg (NDC 0088-2102-24)",Reverified,3/14/23,Intermittent supply,,,Demand increase for the drug,Anti-Infective,Current,,,3/25/20,,,,,,,
Risankizumab-rzaa Injection,Abbvie,800-255-5162,75 mg/0.83 mL Prefilled Syringe (NDC numbers 0074-2042-01 and 0074-2042-02),New,9/20/22,,,,,Rheumatology,To be Discontinued,9/20/22,9/20/22,9/20/22,,,,,,,
Risedronate Sodium Tablets,Allergan Sales LLC,800-678-1605,30 mg (NDC 0430-0470-15),New,5/9/22,,,,,Musculoskeletal,To be Discontinued,,,5/9/22,,,,,,,
Risedronate Tablets,Allergan Sales LLC,800-678-1605,5 mg tablets (NDC 0430-0471-15),New,12/9/19,,,,,Musculoskeletal,To be Discontinued,,,12/9/19,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 3 mg (NDC 50458-330-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 2 mg (NDC 50458-320-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 1 mg (NDC 50458-300-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.5 mg (NDC 50458-302-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-01),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,,5/24/18,,,,,,,
Ritonavir Oral Solution,Abbvie Inc.,800-633-9110,"80mg/mL, 240mL bottle (NDC 0074-1940-63)",New,2/1/23,,Discontinuation,,,Antiviral,To be Discontinued,2/1/23,2/1/23,2/1/23,,,,,,,
Rocuronium Bromide Injection,"Fresenius Kabi USA, LLC",888-386-1300 ,"50 mg per 50 mL (10 mg per mL), multiple dose vial, (NDC 63323-426-05)",New,2/15/23,Backordered. Next release March 2023.,,,Demand increase for the drug,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL), multiple dose vial, (NDC 63323-426-10)",New,2/15/23,1 month expiry (3/31/2023 expiry) dating available by request.  Next release April 2023.,,,Demand increase for the drug,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,"XGen Pharmaceuticals DJB, Inc.",866-390-4411,"50 mg/5mL, box of 10 (NDC 39822-4200-2)",New,2/15/23,Intermittent availability until October 2023 then steady supply,Tamarang is the application holder and X-Gen is the distributor/labeler,,Demand increase for the drug,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,"XGen Pharmaceuticals DJB, Inc.",866-390-4411,"100 mg/10mL, box of 10 (NDC 39822-4200-6)",New,2/15/23,Intermittent availability until October 2023 then steady supply,Tamarang is the application holder and X-Gen is the distributor/labeler,,Demand increase for the drug,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Sagent Pharmaceuticals,866-625-1618,50 mg/5mL Pk 10 Vials (NDC 25021-662-05),Reverified,3/22/23,Backordered. Availability: April 2023,,,Other,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Sagent Pharmaceuticals,866-625-1618,100 mg/10mL Pk 10 Vials (NDC 25021-662-10),Reverified,3/22/23,Unavailable,,,Other,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,"Mylan Institutional, a Viatris Company",800-796-9526,50 mg/5 mL solution in multi-dose vials (preservative-free) (NDC 67457-228-05),Reverified,3/28/23,Available,,,,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Sandoz Inc.,800-525-8747,"10 mg/mL 10 mL vials, box of 10 (NDC 0781-3220-95)",Reverified,4/5/23,Intermittent Supply until Expected Recovery in July 2023,,,Other,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Sandoz Inc.,800-525-8747,"10 mg/mL 5 mL vials, box of 10 (NDC 0781-3220-92)",Reverified,4/5/23,Intermittent Supply until Expected Recovery in July 2023,,,Other,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/5 mL (10 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-9558-05),Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: December 2023,"Check Wholesaler for Availability 
Shortage per Manufacturer: Manufacturing Delay",,Other,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mg/5 mL (10 mg/mL); 5 mL Multiple Dose Glass Fliptop Vial NovaPlus (NDC 00409-9558-49),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg/10 mL (10 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9558-10),Revised,3/31/23,Limited Supply Available. Next Delivery: June 2023; Estimated Recovery: December 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mg/10 mL (10 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial NovaPlus (NDC 00409-9558-50),Revised,3/31/23,Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Almaject,866-770-3024,50mg/5mL multidose vial (NDC 72611-756-01),New,2/27/23,Available,Gland is the application holder and Almaject is the distributor/labeler,,,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Almaject,866-770-3024,100mg/10mL multidose vial (NDC 72611-757-01),New,2/27/23,Unavailable,Gland is the application holder and Almaject is the distributor/labeler,,,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Hikma Pharmaceuticals USA Inc.,800-631-2174,"10 mg/mL, 5 mL vial (NDC 0143-9250-10)",New,2/24/23,This presentation is temporarily on backorder.,Additional lots will be available in the March 2023 timeframe. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Hikma Pharmaceuticals USA Inc.,800-631-2174,"10 mg/mL, 10 mL vial (NDC 0143-9251-10)",New,2/24/23,This presentation is temporarily on backorder.,Additional lots will be available in the March - April 2023 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Baxter Healthcare,888-229-0001,"50 mg / 5 mL (5 mg / mL), Multiple Dose Vial, Product Code RCM0050 (NDC 04306-6007-10)",Revised,3/29/23,"Limited Supply, Recovery Q3 2023",Tamarang is the application holder and Baxter is the distributor/labeler,,Demand Increase,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Baxter Healthcare,888-229-0001,"100 mg /10 mL (10 mg / mL), Multiple Dose Vial, Product Code RCM0100 (NDC 04306-6013-10)",Revised,3/29/23,Available,Tamarang is the application holder and Baxter is the distributor/labeler,,Demand Increase,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,100mg/10mL (NDC 55150-226-10),Revised,4/4/23,Available,,,,Anesthesia,Current,,,2/15/23,,,,,,,
Rocuronium Bromide Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,50mg/5mL (NDC 55150-225-05),Revised,4/4/23,Available,Check wholesalers for inventory,,Available,Anesthesia,Current,,,2/15/23,,,,,,,
Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.2% (2mg/mL), 10mL, 10 vials (NDC 70069-061-10)",Revised,1/20/23,Available,,,,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.2% (2mg/mL), 10mL, 25 vials (NDC 70069-061-25)",Revised,1/20/23,Available,,,,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.2% (2mg/mL), 20mL, 10 vials (NDC 70069-062-10)",Revised,1/20/23,Available,,,,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.2% (2mg/mL), 20mL, 25 vials (NDC 70069-062-25)",Revised,1/20/23,Available,,,,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,"0.2% 2mg/mL 10x100mL (NDC 25021-671-66), Novaplus",Reverified,3/22/23,Available,Marketed by Sagent Pharmaceuticals,,,Anesthesia,Current,,,3/27/18,,,,,,,
Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,"0.2% 2mg/mL 10x200mL (NDC 25021-671-67), Novaplus",Reverified,3/22/23,Available,Marketed by Sagent Pharmaceuticals,,,Anesthesia,Current,,,3/27/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.5% (5 mg/mL), 30 mL, 1 vial (NDC 70069-064-01)",Revised,1/20/23,Available,,,,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.5% (5 mg/mL), 30 mL, 10 vials (NDC 70069-064-10)",Revised,1/20/23,Available,,,,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.5% (5 mg/mL), 30 mL, 25 vials (NDC 70069-064-25)",Revised,1/20/23,Available,,,,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"0.5% 5mg/mL, 30mL, 1 Vial (NDC 17478-0081-30)",Revised,3/1/23,Not available,No new manufacturing of product,,,Anesthesia,Current,,,3/27/18,,,,,,,
Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,0.2% 2mg/mL 10x100mL (NDC 25021-671-82),Reverified,3/22/23,Available,Marketed by Sagent Pharmaceuticals,,,Anesthesia,Current,,,3/27/18,,,,,,,
Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,0.2% 2mg/mL 10x200mL (NDC 25021-671-87),Reverified,3/22/23,Available,Marketed by Sagent Pharmaceuticals,,,Anesthesia,Current,,,3/27/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/10 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-10),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/12/22,3/26/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-20),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22,3/26/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9301-30),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22,3/26/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/20 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9302-20),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22,3/26/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-10),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22,3/26/18,,,,,,,
Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-20),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22,3/26/18,,,,,,,
Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.2% 20 mL Single Dose Vials (NDC 55150-195-20),Revised,4/4/23,Available,Sporadic availability expected.,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.2% 100 mL Single Dose Infusion Bottles (NDC 55150-196-99),Revised,4/4/23,Available,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 20 mL Single Dose Vials (NDC 55150-197-20),Revised,4/4/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-198-30),Revised,4/4/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.75% 20 mL Single Dose Vials (NDC 55150-199-20),Revised,4/4/23,Available,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 10 mL Single Dose Vials (NDC 55150-200-10),Revised,4/4/23,Currently on backorder - next shipment in April,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 20 mL Single Dose Vials (NDC 55150-201-20),Revised,4/4/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-10)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-20)",Revised,3/31/23,Backordered. Next release not available at this time.,,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-286-20)",Revised,3/31/23,Backordered. Next release not available at this time.,,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-287-20)",Revised,3/31/23,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Plastic Ampule, Sterile-Pak (63323-288-10)",Revised,3/31/23,Backordered. Next release not available at this time.,,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-288-20)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Free Flex Bag (NDC 63323-285-61)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Free Flex Bag (NDC 63323-285-63)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-285-65)",Revised,3/31/23,Available,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-285-64)",Revised,3/31/23,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"5 mg per mL / 0.5% (500 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-286-00)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"5 mg per mL / 0.5% (1,000 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-286-63)",Revised,3/31/23,Backordered. Next release May 2023.,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Single Dose Vial (NDC 63323-285-13)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Single Dose Vial (NDC 63323-285-23)",Revised,3/31/23,Available,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Single Dose Vial (NDC 63323-286-35)",Revised,3/31/23,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Single Dose Vial (NDC 63323-286-23)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Single Dose Vial (NDC 63323-287-21)",Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Single Dose Vial (NDC 63323-288-11)",Revised,3/31/23,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Single Dose Vial (NDC 63323-288-21)",Revised,3/31/23,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,Fresenius Kabi USA,888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Sterile-Pack, Single Dose Vial (NDC 63323-286-31)",Revised,3/31/23,Backordered. Next release not available at this time.,,,,Anesthesia,Current,,,3/23/18,,,,,,,
Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,500 mg per 100 mL (5 mg per mL 0.5%) (NDC 25021-652-82 ),Reverified,3/22/23,Available,Marketed by Sagent Pharmaceuticals,,,Anesthesia,Current,,,3/27/18,,,,,,,
Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,"1,000 mg per 200 mL (5 mg per mL 0.5%) (NDC 25021-652-87)",Reverified,3/22/23,Available,Marketed by Sagent Pharmaceuticals,,,Anesthesia,Current,,,3/27/18,,,,,,,
Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"0.2%, 40 mg/20 mL (2 mg/mL) single dose vial (NDC 43066-015-10)",Revised,3/29/23,Available,,,Demand increase,Anesthesia,Current,,,12/22/20,,,,,,,
Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"0.5%, 100 mg/20 mL (5 mg/mL) single dose vial (NDC 43066-019-10)",Revised,3/29/23,Available,,,Demand increase,Anesthesia,Current,,,12/22/20,,,,,,,
Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"0.5%, 150 mg/30 mL (5 mg/mL) single dose vial (NDC 43066-023-10)",Revised,3/29/23,Limited supply; Recovery April 2023,,,Demand increase,Anesthesia,Current,,,12/22/20,,,,,,,
Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"1%, 200 mg/20 mL (10 mg/mL) single dose vial (NDC 43066-027-10)",Revised,3/29/23,Available,,,Demand increase,Anesthesia,Current,,,12/22/20,,,,,,,
Rosuvastatin Calcium Tablets,Sandoz,800-525-8747,5 mg (NDC 0781-5400-92),New,6/16/22,,,,,Cardiovascular,To be Discontinued,,,6/16/22,,,,,,,
Rosuvastatin Calcium Tablets,Sandoz,800-525-8747,10 mg (NDC 0781-5401-92),New,6/16/22,,,,,Cardiovascular,To be Discontinued,,,6/16/22,,,,,,,
Rosuvastatin Calcium Tablets,Sandoz,800-525-8747,20 mg (NDC 0781-5402-92),New,6/16/22,,,,,Cardiovascular,To be Discontinued,,,6/16/22,,,,,,,
Rosuvastatin Calcium Tablets,Sandoz,800-525-8747,40 mg (NDC 0781-5403-31),New,6/16/22,,,,,Cardiovascular,To be Discontinued,,,6/16/22,,,,,,,
Samarium SM 153 Lexidronam  (Quadramet) Injection,Lantheus Medical Imaging INC,800-362-2668,150mCi (NDC 11994-016-01),New,10/28/21,,,,,Oncology,To be Discontinued,,,10/28/21,,,,,,,
Saquinavir Mesylate (Invirase) 200mg Capsules,"Genentech, Inc",877-436-3683,200 mg capsules (NDC 0004-0245-15),New,2/6/18,,,,,Antiviral,To be Discontinued,,,2/6/18,,,,,,,
Saxagliptin and Metformin Hydrochloride XR Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,"Saxagliptin/Metformin HCl (Kombiglyze® ) XR tablets 2.5 mg/1000mg; 60 tablets, film-coated, extended release in 1 bottle, plastic (NDC 0310-6125-60)",New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Saxagliptin and Metformin Hydrochloride XR Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,"Saxagliptin/Metformin HCl (Kombiglyze® ) XR tablets 5 mg/500mg; 30 tablets, film coated, extended release in 1 bottle, plastic (NDC 0310-6135-30)",New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Saxagliptin and Metformin Hydrochloride XR Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,"Saxagliptin/Metformin HCl (Kombiglyze® ) XR tablets 5 mg/1000mg; 30 tablets, film coated, extended release in 1 bottle, plastic (NDC 0310-6145-30)",New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Saxagliptin and Metformin Hydrochloride XR Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,"Saxagliptin/Metformin HCl (Kombiglyze® ) XR tablets 5 mg/1000mg; 7 tablets in 1 blister pack/1 carton, film coated, extended release (NDC 0310-6145-95)",New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Saxagliptin Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,"Saxagliptin (Onglyza®) 2.5 mg film-coated tablets; 30 in 1 bottle, plastic (NDC 0310-6100-30)",New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Saxagliptin Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,"Saxagliptin (Onglyza®) 2.5 mg film-coated tablets; 90 in 1 bottle, plastic (NDC 0310-6100-90)",New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Saxagliptin Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,Saxagliptin (Onglyza®) 2.5 mg film-coated tablets; 7 tablets in 1 blister pack/1 carton (NDC 0310-6100-95),New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Saxagliptin Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,"Saxagliptin (Onglyza®) 5 mg film-coated tablets; 30 in 1 bottle, plastic (NDC 0310-6105-30)",New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Saxagliptin Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,"Saxagliptin (Onglyza®) 5 mg film-coated tablets; 90 in 1 bottle, plastic (NDC 0310-6105-90)",New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Saxagliptin Tablets,AstraZeneca Pharmaceuticals LP,800-236-9933,Saxagliptin (Onglyza®) 5 mg film-coated tablets; 7 tablets in 1 blister pack/1 carton (NDC 0310-6105-95),New,3/21/23,,"The reason for the permanent discontinuation is an AZ business decision, and not due to any safety or efficacy-related concerns for the drug.",,,Endocrinology/Metabolism,To be Discontinued,3/21/23,3/21/23,3/21/23,,,,,,,
Sclerosol Intrapleural Aerosol,Lymol Medical Corp.,781-935-0004,Sclerosol 4 GM (NDC 63256-100-30),Revised,6/14/22,,,,,Pulmonary/Allergy,To be Discontinued,,,2/16/17,,,,,,,
Scopolamine Transdermal System,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/3 days 24s (NDC 0378-6470-44),Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,,,8/27/18,,,,,,,
"Selenium Sulfide Lotion, 2.5%",Wockhardt,800-346-6854,4 fl oz (118 mL) (NDC 60432-528-04),New,6/13/22,,,,,Dermatology,To be Discontinued,,,6/13/22,,,,,,,
Semaglutide (Ozempic) Injection,"Novo Nordisk, Inc.",866-696-4090 and press 0  ,"Ozempic® semaglutide injection, 0.25 mg / 0.5mg  2 mg/1.5mL (NDC 0169-4132-12)",Revised,4/5/23,To be discontinued,"Transition to Ozempic® semaglutide injection, 0.25 mg / 0.5mg
2 mg/3mL",,,Endocrinology/Metabolism,Current,,,8/23/22,,,,,,,
Semaglutide (Ozempic) Injection,"Novo Nordisk, Inc.",866-696-4090 and press 0  ,"Ozempic® semaglutide injection, 1 mg (NDC 0169-4130-13)",Revised,4/5/23,Currently available,,,,Endocrinology/Metabolism,Current,,,8/23/22,,,,,,,
Semaglutide (Ozempic) Injection,"Novo Nordisk, Inc.",866-696-4090 and press 0  ,"Ozempic® semaglutide injection, 2 mg (NDC 0169-4772-12)",Revised,4/5/23,Currently available,,,,Endocrinology/Metabolism,Current,,,8/23/22,,,,,,,
Semaglutide (Ozempic) Injection,"Novo Nordisk, Inc.",866-696-4090 and press 0,"Ozempic® semaglutide injection, 0.25 mg / 0.5mg 2 mg/3mL (NDC 0169-4181-13)",Revised,4/5/23,Currently available,,8/23/22,,Endocrinology/Metabolism,Current,,,,,,,,,,
Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-493-4689,0.25 mg / 0.5mL (NDC 0169-4525-14),Revised,1/3/23,Available,,,,Endocrinology/Metabolism,Current,,,3/31/22,,,,,,,
Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-493-4689,0.5 mg / 0.5mL (NDC 0169-4505-14),Revised,1/3/23,Available,,,,Endocrinology/Metabolism,Current,,,3/31/22,,,,,,,
Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-496-4689,1 mg / 0.5mL (NDC 0169-4501-14),Revised,1/3/23,Available,,,,Endocrinology/Metabolism,Current,,,3/31/22,,,,,,,
Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-496-4689,1.7 mg / 0.75mL (NDC 0169-4517-14),Revised,1/3/23,Available,,,,Endocrinology/Metabolism,Current,,,3/31/22,,,,,,,
Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-496-4689,2.4 mg / 0.75mL (NDC 0169-4524-14),Revised,1/3/23,Available,,,,Endocrinology/Metabolism,Current,,,3/31/22,,,,,,,
"Sertraline Hydrochloride Oral Solution, USP",Aurobindo Pharma,866-850-2876,"20mg/ml, 60ml  (NDC 16714-601-02)",Revised,4/13/21,,,Northstar Rx label. Product Distributed by McKesson:  +1 (972) 446-4800,,Psychiatry,Resolved,,,5/26/20,,,,,,,
Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 30 count (NDC 16729-215-10)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 90 count (NDC 16729-215-15)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 500 count (NDC 16729-215-16)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","50 mg, 90 count (NDC 16729-216-15)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","50 mg, 500 count (NDC 16729-216-16)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","100 mg, 90 count (NDC 16729-217-15)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","100 mg, 500 count (NDC 16729-217-16)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 30 count (NDC 65862-011-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 100 count (NDC 65862-011-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 500 count (NDC 65862-011-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 30 count (NDC 65862-012-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 100 count (NDC 65862-012-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 500 count (NDC 65862-012-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 30 count (NDC 65862-013-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 100 count (NDC 65862-013-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 500 count (NDC 65862-013-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 30 count (NDC 16714-611-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 100 count (NDC 16714-611-04)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 500 count (NDC 16714-611-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 1000 count (NDC 16714-611-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 30 count (NDC 16714-612-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 100 count (NDC 16714-612-04)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 500 count (NDC 16714-612-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 1000 count (NDC 16714-612-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 30 count (NDC 16714-613-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 100 count (NDC 16714-613-04)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 500 count (NDC 16714-613-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 1000 count (NDC 16714-613-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 25 mg; Bottle of 30 tablets (NDC 0049-4960-30); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 50 mg; Bottle of 30 tablets (NDC 0049-4900-30); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 50 mg; Blister of 10 tablets (NDC 0049-4900-41); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 100 mg; Bottle of 30 tablets (NDC 0049-4910-30); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 100 mg; Blister of 10 tablets (NDC 0049-4910-41); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Viatris,800-796-9526,25 mg; Bottle of 30 tablets (NDC 59762-6347-1); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Viatris,800-796-9526,50 mg; Bottle of 30 tablets (NDC 59762-6443-1); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Viatris,800-796-9526,100 mg; Bottle of 30 tablets (NDC 59762-5160-1); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Viatris,800-796-9526,100 mg; Bottle of 100 tablets (NDC 59762-5160-2); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 30 count (NDC 68180-351-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 90 count  (NDC 68180-351-09)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 1000 count (NDC 68180-351-03)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 30 count (NDC 68180-352-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 90 count (NDC 68180-352-09)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 500 count (NDC 68180-352-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 5000 count (NDC 68180-352-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 30 count (NDC 68180-353-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 90 count (NDC 68180-353-09)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 500 count (NDC 68180-353-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 5000 count (NDC 68180-353-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 30 count (NDC 69097-833-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 90 count (NDC 69097-833-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 500 count (NDC 69097-833-12)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 30 count (NDC 69097-834-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 500 count (NDC 69097-834-12)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 30 count (NDC 69097-835-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 500 count (NDC 69097-835-12)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 30 count (NDC 76282-212-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 60 count (NDC 76282-212-60)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 90 count (NDC 76282-212-90)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 100 count (NDC 76282-212-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 180 count (NDC 76282-212-18)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 500 count (NDC 76282-212-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 30 count (NDC 76282-213-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 60 count (NDC 76282-213-60)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 90 count (NDC 76282-213-90)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 100 count (NDC 76282-213-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 180 count (NDC 76282-213-18)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 500 count (NDC 76282-213-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 30 count (NDC 76282-214-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 60 count (NDC 76282-214-60)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 90 count (NDC 76282-214-90)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 100 count (NDC 76282-214-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 180 count (NDC 76282-214-18)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 500 count (NDC 76282-214-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,,5/29/20,,,,,,,
Sildenafil Citrate (REVATIO),Novitium Pharma LLC,845-652-0377,"10 mg/mL, (NDC 70954-168-10)",Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,,,5/21/19,,,,,,,
Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/12.5 mL; vial (NDC 0069-0338-01),Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,,,5/21/19,,,,,,,
Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,20 mg; tablets (NDC 0069-4190-68),Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,,,5/21/19,,,,,,,
Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/mL (powder); bottle (NDC 0069-0336-21),Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,,,5/21/19,,,,,,,
Silodosin Capsules,Sandoz,800-525-8747,4 mg 30ct (NDC 0781-2623-31),New,12/8/22,,Discontinuation of the manufacture of the product,,,Urology,To be Discontinued,12/8/22,12/8/22,12/8/22,,,,,,,
Silodosin Capsules,Sandoz,800-525-8747,8 mg 30ct (NDC 0781-2624-31),New,12/8/22,,Discontinuation of the manufacture of the product,,,Urology,To be Discontinued,12/8/22,12/8/22,12/8/22,,,,,,,
Silodosin Capsules,Sandoz,800-525-8747,8 mg 90ct (NDC 0781-2624-92),New,12/8/22,,Discontinuation of the manufacture of the product,,,Urology,To be Discontinued,12/8/22,12/8/22,12/8/22,,,,,,,
Simeprevir Capsules,Janssen Pharmaceuticals,800-526-7736,150mg capsules (NDC 59676-225-28),New,5/23/18,,,,,Antiviral,To be Discontinued,,,5/23/18,,,,,,,
Simvastatin (Zocor) Tablets,Merck Sharp & Dohme Corp.,800-637-2579,5 mg Tablets bottles of 30 (NDC 0006-0726-31),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,,2/6/18,,,,,,,
Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,5 mg (NDC 0093-7152-98),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,,2/6/18,,,,,,,
Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,10 mg (NDCs 0093-7153-93 / 0093-7153-56 / 0093-7153-19 / 0093-7153-31 / 0093-7153-10),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,,2/6/18,,,,,,,
Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,20 mg (NDCs 0093-7154-93 / 0093-7154-56 / 0093-7154-31 / 0093-7154-19 / 0093-7154-10),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,,2/6/18,,,,,,,
Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,40 mg (NDCs 0093-7155-93 / 0093-7155-56 / 0093-7155-31 / 0093-7155-19 / 0093-7155-10),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,,2/6/18,,,,,,,
Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,80 mg (NDCs 0093-7156-98 / 0093-7156-93 / 0093-7156-56 / 0093-7156-19 / 0093-7156-10),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,,2/6/18,,,,,,,
Simvastatin Tablets,Merck Sharp & Dohme Corp.,800-672-6372,80 mg (NDCs 0006-0543-31 and 0006-0543-54),New,7/27/21,,,,,Cardiovascular,To be Discontinued,,,7/27/21,,,,,,,
Sincalide (Kinevac) Lyophilized Powder for Injection,Bracco Diagnostics,877-272-2269,Supplied in packages of 10 single dose vials containing 5 mcg of sincalide per vial (NDC 0270-0556-15),Reverified,7/16/21,Available,,,Delay in shipping of the drug,Medical Imaging;Other,Current,,,3/1/17,,,,,,,
Sodium Acetate Injection,Fresenius Kabi USA,888-386-1300,32.8% 400 mEq 100mL PBP (NDC 63323-0032-00),Revised,3/31/23,Backordered. Next release not available at this time.,,,Manufacturing delay,Total Parenteral Nutrition,Current,,,3/23/16,,,,,,,
Sodium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mEq/50 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3299-05),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,2/3/16,,,,,https://www.fda.gov/media/158385/download,,
Sodium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,200 mEq/100 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3299-06),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,2/3/16,,,,,https://www.fda.gov/media/158385/download,,
Sodium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,40 mEq/20 mL (2 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 0409-7299-73),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,2/3/16,,,,,https://www.fda.gov/media/158385/download,,
Sodium Acetate Injection,Milla Pharmaceuticals,833-251-8463,100 mEq/50 mL (2 mEq/mL) (NDC 69784-230-20),Reverified,12/3/21,Available,,,Other,Total Parenteral Nutrition,Current,,,3/23/16,,,,,,,
Sodium Acetate Injection,Milla Pharmaceuticals,833-251-8463,200 mEq/100 mL (2 mEq/mL) (NDC 69784-231-20),Reverified,12/3/21,Available,,,Other,Total Parenteral Nutrition,Current,,,3/23/16,,,,,,,
Sodium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,200 mEq/100 mL (2 mEq/mL) Pharmacy Bulk Package Glass Fliptop Vial NovaPlus (NDC 0409-3299-25),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition,Current,,,2/3/16,,,,,,,
Sodium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mEq/50 mL (2 mEq/mL) Pharmacy Bulk Package Glass Fliptop Vial NovaPlus (NDC 0409-3299-26),Revised,3/31/23,Next Delivery: November 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition,Current,,,2/3/16,,,,,,,
Sodium Acetate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,40 mEq/20 mL (2 mEq/mL) Single Dose Plastic Fliptop Vial NovaPlus (NDC 0409-7299-25),Revised,3/31/23,Next Delivery and Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition,Current,,,2/3/16,,,,,,,
Sodium Bicarbonate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,2.5 mEq/5 mL (0.5 mEq/mL) Fliptop Vial (4.2% Concentration) (NDC 0409-5555-02),Revised,3/31/23,Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,3/1/17,,,,,,,
Sodium Bicarbonate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,2.5 mEq/5 mL (0.5 mEq/mL) Fliptop Vial Novaplus®  (4.2% Concentration) (NDC 0409-5555-01),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,3/1/17,,,,,,,
Sodium Bicarbonate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,44.6 mEq/50 mL (0.9 mEq/mL) LifeShield™ ABBOJECT™ Glass Syringe (7.5% concentration) (NDC 0409-4916-14),Revised,3/31/23,Next Delivery and  Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,3/1/17,,,,,https://www.fda.gov/media/165564/download,,
Sodium Bicarbonate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mEq/50 mL (1 mEq/mL) Single Dose Glass Fliptop Vial (8.4% concentration) (NDC 0409-6625-14) (old NDC 0409-6625-02),Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,3/1/17,,,,,https://www.fda.gov/media/158477/download,,
Sodium Bicarbonate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mEq/50 mL (1 mEq/mL) Single Dose Vial Novaplus® (8.4% concentration) (NDC 0409-6625-35),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,3/1/17,,,,,,,
Sodium Bicarbonate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Pediatric 10 mEq/10 mL (1 mEq/mL) LifeShield® ABBOJECT® Glass Syringe (8.4% Concentration) (NDC 0409-4900-14),Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,3/1/17,,,,,https://www.fda.gov/media/165564/download,,
Sodium Bicarbonate Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154,10 mEq/10 mL (NDC 2551754-5011-04),New,1/31/22,Currently on backorder,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,7/24/17,,,,,,,
Sodium Bicarbonate Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154,"5 mEq/10 mL, 4.2%, (NDC 51754-5012-04)",New,1/31/22,On backorder,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,7/24/17,,,,,,,
Sodium Bicarbonate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,Infant 5 mEq/10 mL (0.5 mEq/mL) ABBOJECT® Glass Syringe (4.2% Concentration) (NDC 0409-5534-14) (old NDC 0409-5534-34),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: March 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,3/1/17,,,,,https://www.fda.gov/media/165564/download,,
Sodium Bicarbonate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mEq/50 mL (1 mEq/mL) LifeShield® ABBOJECT® Glass Syringe (8.4% Concentration) (NDC 0409-6637-14),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: September 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,3/1/17,,,,,https://www.fda.gov/media/165564/download,,
Sodium Bicarbonate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"Sodium Bicarbonate Inj. USP, 8.4%, 50mL Luer-Jet Prefilled Syringe, (NDC 0548-3352-00), (new NDC 76329-3352-1)",Reverified,4/6/23,Backorder due to the increase in demands,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,3/1/17,,,,,,,
Sodium Bicarbonate Injection,Fresenius Kabi USA,888-386-1300,"4.2% Single dose vial, 2.5 mEq per 5 mL (0.5 mEq per mL) (42 mg per mL)(NDC 63323-083-05)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,7/24/17,,,,,,,
Sodium Bicarbonate Injection,Fresenius Kabi USA,888-386-1300,"8.4% Single dose vial, 50 mEq per 50 mL (1 mEq per mL)  (84 mg per mL)(NDC 63323-089-50)",Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,7/24/17,,,,,,,
Sodium Bicarbonate Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154,"8.4%, 50mL (NDC 51754-5001-05)",Revised,1/31/22,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,,7/24/17,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 50 mL (Legacy Hospira NDC 0409-7984-13)(ICU Medical NDC 0990-7984-13)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 50 mL 4-1 (Legacy Hospira NDC 0409-7984-36)(ICU Medical NDC 0990-7984-36)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 100 mL (Legacy Hospira NDC 0409-7984-37)(ICU Medical NDC 0990-7984-37)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 100 mL (Legacy Hospira NDC 0409-7984-23)(ICU Medical NDC 0990-7984-23)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 25 mL (Legacy Hospira NDC 0409-7984-20)(ICU Medical NDC 0990-7984-20)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 50 mL Fleboflex Plastic Container (115 units/carton)(NDC 79672-613-01)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 100 mL Fleboflex Plastic Container (70 units/carton)(NDC 79672-613-02)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 250 mL Fleboflex Plastic Container (28 units/carton)(NDC 79672-613-03)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 500 mL Fleboflex Plastic Container (20 units/carton)(NDC 79672-613-04)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 1000 mL Fleboflex Plastic Container (10 units/carton)(NDC 79672-613-05)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 500 mL (Legacy Hospira (NDC 0409-7983-03)(ICU Medical NDC 0990-7983-03)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 1000 mL (Legacy Hospira NDC 0409-7983-09)(ICU Medical NDC 0990-7983-09)",Reverified,3/31/23,On allocation,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,1000 mL Excel Bag L8000 (NDC 0264-7800-00),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,500 mL Excel Bag L8001 (NDC 0264-7800-10),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,250 mL Excel Bag L8002 (NDC 0264-7800-20),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,1000 mL E3 Bag E8000 (NDC 0264-7800-09),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,100 mL PAB Bag S8004-5264 (NDC 0264-1800-32),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,50 mL PAB Bag S8004-5384 (NDC 0264-1800-31),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,25 mL PAB Bag S8004-5410 (NDC 0264-1800-36),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Hospira, Inc., a Pfizer company",844-646-4398,50 mL ADD-Vantage™ Flexible Container (NDC 00409-7101-66),Reverified,3/31/23,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,https://www.fda.gov/media/158041/download,,
Sodium Chloride 0.9% Injection Bags,"Hospira, Inc., a Pfizer company",844-646-4398,100 mL ADD-Vantage™ Flexible Container (NDC 00409-7101-67),Reverified,3/31/23,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,https://www.fda.gov/media/158041/download,,
Sodium Chloride 0.9% Injection Bags,"Hospira, Inc., a Pfizer company",844-646-4398,250 mL ADD-Vantage™ Flexible Container (NDC 00409-7101-02),Reverified,3/31/23,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,https://www.fda.gov/media/158041/download,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 100 mL Fleboflex Plastic Container (70 units/carton)(NDC 76297-001-21)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 250 mL Fleboflex Plastic Container (28 units/carton)(NDC 76297-001-31)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 500 mL Fleboflex Plastic Container (20 units/carton)(NDC NDC 76297-001-01)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 1000 mL Fleboflex Plastic Container (10 units/carton)(NDC NDC 76297-001-41)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 50 mL Fleboflex Plastic Container (115 units/carton)(NDC 76297-001-11)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Fresenius Kabi USA,888-386-1300,"0.9% (450 mg per 50 mL), (9 mg per mL), Single Dose freeflex bag, 50 mL, (NDC: 63323-623-53)",Revised,3/31/23,Available,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Fresenius Kabi USA,888-386-1300,"0.9% (900 mg per 100 mL), (9 mg per mL), Single Dose freeflex bag, 100 mL, (NDC: 63323-623-61)",Revised,3/31/23,Available,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Fresenius Kabi USA,888-386-1300,"0.9% (2,250 mg per 250 mL), (9 mg per mL), Single dose freeflex bag, 250 mL, (NDC: 63323-623-74)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Fresenius Kabi USA,888-386-1300,"0.9% (4,500 mg per 500 mL), (9 mg per mL), Single dose freeflex bag, 500 mL, (NDC: 63323-623-75)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Fresenius Kabi USA,888-386-1300,"0.9% (9,000 mg per 1,000 mL), (9 mg per mL), Single dose freeflex bag, 1,000 mL, (NDC: 63323-623-76)",Revised,3/31/23,Backordered. Next release April 2023.,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL VIAFLEX Plastic Container, Quad Pack; Product Code 2B1302; (NDC 0338-0049-18)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL VIAFLEX Plastic Container, Product Code 2B1306 (NDC 0338-0049-41)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL VIAFLEX Plastic Container, Product Code 2B1307 (NDC 0338-0049-48)",Revised,3/29/23,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B1308 (NDC 0338-0049-31)",Revised,3/29/23,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"250 mL VIAFLEX Plastic Container, Product Code 2B1322Q (NDC 0338-0049-02)",Revised,3/29/23,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"500 mL VIAFLEX Plastic Container, Product Code 2B1323Q (NDC 0338-0049-03)",Revised,3/29/23,Limited supply; Recovery August,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"1000 mL VIAFLEX Plastic Container, Product Code 2B1324X (NDC 0338-0049-04)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"25 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B1300 (NDC 0338-0049-10)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B1301 (NDC 0338-0049-11)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B1309 (NDC 0338-0049-38)",Revised,3/29/23,Limited supply; Recovery Q2,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"250 mL VIAFLO Plastic Container, Product Code UE1322D (NDC 0338-9543-02)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"1000 mL VIAFLO Plastic Container, Product Code UE1324D (NDC 0338-9543-06)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"500 mL VIAFLO Plastic Container, Product Code UE1323D (NDC 0338-9543-04)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL MINI-BAG Plus Container, Quad Pack, Product Code 2B0042 (NDC 0338-0553-11)",Revised,3/29/23,Available,,,Manufacturing delay,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL MINI-BAG Plus Container, Single Pack, Product Code EZPB0042 (NDC 0338-9151-30)",Revised,3/29/23,Supply available on allocation,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL MINI-BAG Plus Container, Single Pack, Product Code EZPB0043 (NDC 0338-9159-30)",Revised,3/29/23,"Limited Supply on Allocation, Recovery 2023",,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL MINI-BAG Plus Container, Quad Pack, Product Code 2B 0043 (NDC 0338-0553-18)",Revised,3/29/23,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"250 mL VIAFLO Plastic Container, Product Code UE1322D (NDC 0338-9543-02)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"500 mL VIAFLO Plastic Container, Product Code UE1323D (NDC 0338-9543-04)",Revised,3/29/23,Available,,,,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"1000 mL VIAFLO Plastic Container, Product Code UE1324D (NDC 0338-9543-06)",Revised,3/29/23,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 150 mL (Legacy Hospira NDC 0409-7983-61) (ICU Medical NDC 0990-7983-61)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Gastroenterology; Other; Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 250 mL (Legacy Hospira NDC 0409-7983-02) (ICU Medical NDC 0990-7983-02)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Demand increase for the drug,Gastroenterology; Other; Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 500 mL (Legacy Hospira NDC 0409-7983-55) (ICU Medical NDC 0990-7983-55)",Reverified,3/31/23,Available,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,,Gastroenterology; Other; Pediatric,Current,,,12/10/21,,,,,,,
Sodium Chloride 14.6% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mEq per 20 mL (2.5 mEq per mL), Single dose plastic flip top vial, (NDC 63323-090-20)",New,4/5/22,Backordered. Next release June 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,4/5/22,,,,,,,
Sodium Chloride 14.6% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mEq per 40 mL (2.5 mEq per mL), Single dose plastic flip top vial, (NDC 63323-090-40)",New,4/5/22,Backordered. Next release June 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,4/5/22,,,,,,,
Sodium Chloride 14.6% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,14.6% 100 mEq/40 mL (2.5 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-6660-75),Revised,3/31/23,Next Delivery: January 2024; Estimated Recovery: March 2024,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,4/5/22,,,,,,,
Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,30 mL vials (NDC 63323-0093-30),Reverified,3/31/23,Available,Check wholesaler inventory.,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,,,,,,,,,
Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mL vials (NDC 63323-0095-61),Reverified,3/31/23,Available,Check wholesaler inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,,,,,,,,,
Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,200 mL vials (NDC 63323-0088-63),Reverified,3/31/23,Backordered. Next release not available at this time.,Check wholesaler inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,,,,,,,,,
Sodium Chloride 23.4% Injection,"Hospira, Inc., a Pfizer company",844-646-4398,400 mEq/100 mL (4 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-1141-02),Reverified,3/17/23,Limited Supply Available. Next Delivery: March 2023; Estimated Recovery: December 2024,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,,,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Medefil, Inc.",630-682-4600,"Sodium Chloride Injection, USP, 0.9%, in a plastic syringe (10 mL) (NDC 64253-202-30)",Revised,10/3/22,Available,,,Available,Other,Current,,,8/2/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (18 mg per 2 mL)(9 mg per mL) (NDC 63323-186-02)",Reverified,3/31/23,Available,Check wholesalers for inventory,,Increase in Demand,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (90 mg per 10 mL)(9 mg per mL) (NDC 63323-186-10)",Reverified,3/31/23,Available,Check wholesalers for inventory,,Demand increase,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (180 mg per 20 mL)(9 mg per mL) (NDC 63323-186-20)",Reverified,3/31/23,Available,Check wholesalers for inventory,,Demand increase,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose tear top vial, 0.9%, (900 mg per 100 mL)(9 mg per mL) (NDC 63323-186-00)",Reverified,3/31/23,Backordered.  Next release date not available at this time.,,,Increase in Demand,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc., a Pfizer company",844-646-4398,10 mL (0.9%); Single Dose Plastic Fliptop Vial (NDC 00409-4888-10),Revised,3/31/23,Available,,,Other,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc., a Pfizer company",844-646-4398,10 mL (0.9%); Single Dose LifeShield Plastic Fliptop Vial (NDC 00409-4888-12),Revised,3/31/23,Available,,,Other,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc., a Pfizer company",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-20),Revised,3/31/23,Available,,,Other,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc., a Pfizer company",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-50),Revised,3/31/23,Available,,,Other,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.9%, 2 mL vial (NDC 0641-0497-25)",Revised,10/3/22,This presentation is temporarily on backorder.  Recovery is TBD at this time.,,,Demand increase for the drug,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes",Guerbet LLC,877-729-6679,125 mL PFS (NDC 0019-1188-81),Revised,10/3/22,"On backorder. Next batch will be available in April 2022, and the current demand can be fulfilled by May 2022.",,,Other,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes",Guerbet LLC,877-729-6679,125 mL PFS RFID Tag (NDC 0019-1188-27),Revised,10/3/22,Available; Next batch will be available May 2022.,,,Other,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Spectra Medical Devices, Inc.",978-657-0889,0.9% 10mL Ampule (NDC 65282-1510-1),Revised,10/3/22,"Currently available, in stock, Production is ongoing",,,Other,Other,Current,,,6/21/18,,,,,,,
"Sodium Chloride Injection, 0.9% Vials and Syringes","Spectra Medical Devices, Inc.",978-657-0889,0.9% 5mL Ampule (NDC 65282-1505-1),Revised,10/3/22,"Currently available, in stock, Production is ongoing",,,Other,Other,Current,,,6/21/18,,,,,,,
Sodium Phosphates Injection,"Hospira, Inc., a Pfizer company",844-646-4398,"Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL, vial (NDC 0409-7391-72)",Revised,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,9/1/21,,,,,https://www.fda.gov/media/158385/download,,
Sodium Phosphates Injection,Fresenius Kabi USA,888-386-1300,"Phosphorus 15 mmol/5 mL, Sodium 20 mEq/5 mL, vial (NDC 63323-884-06)",Revised,3/31/23,Available,Check wholesaler inventory,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,9/1/21,,,,,,,
Sodium Phosphates Injection,Fresenius Kabi USA,888-386-1300,"Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL, vial (NDC 63323-881-16)",Revised,3/31/23,Available,Check wholesaler inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,,9/1/21,,,,,,,
Somatropin (SAIZEN) Injection,"EMD Serono, Inc.",800-283-8088,Saizen Vial 5 mg (NDC 44087-1005-2),Revised,1/9/23,,Discontinuation of the manufacture of the product,,,Endocrinology/Metabolism,To be Discontinued,1/9/23,1/9/23,1/9/23,,,,,,,
Somatropin (SAIZEN) Injection,"EMD Serono, Inc.",800-283-8088,Saizen Vial 8.8 mg (NDC 44087-1088-1),Revised,1/9/23,,Discontinuation of the manufacture of the product,,,Endocrinology/Metabolism,To be Discontinued,1/9/23,1/9/23,1/9/23,,,,,,,
Somatropin (SAIZEN) Injection,"EMD Serono, Inc.",800-283-8088,"Reconstitution Kit containing 1 vial of Saizen 8.8 mg, diluent, and 1 Saizenprep Reconstitution Device (NDC 44087-0016-1)",Revised,1/9/23,,Discontinuation of the manufacture of the product,,,Endocrinology/Metabolism,To be Discontinued,1/9/23,1/9/23,1/9/23,,,,,,,
Somatropin Injection,"Novo Nordisk, Inc.",609-987-5800,Norditropin® FlexPro® 5mg/1.5mL (NDC 0169-7704-21),Revised,3/20/23,Intermittent supply. Demand met by end of June 2023.,Manufacturing delays,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,"Novo Nordisk, Inc.",609-987-5800,Norditropin® FlexPro® 10mg/1.5mL (NDC 0169-7705-21),Revised,3/20/23,Intermittent supply. Demand met by end of June 2023.,Manufacturing delays,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,"Novo Nordisk, Inc.",609-987-5800,Norditropin® FlexPro® 15mg/1.5mL (NDC 0169-7708-21),Revised,3/20/23,Intermittent supply. Demand met by end of June 2023.,Manufacturing delays,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,"Novo Nordisk, Inc.",609-987-5800,Norditropin® FlexPro®  30mg/3mL (NDC 0169-7703-21),Revised,3/20/23,Intermittent supply. Demand met by end of June 2023.,Manufacturing delays,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Sandoz,800-525-8747,Omnitrope Cartridge (somatropin) Pen 5 mg/1.5 mL (NDC 0781-3001-07),Reverified,4/5/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Sandoz,800-525-8747,Omnitrope Cartridge (somatropin) Pen 10 mg/1.5 mL (NDC 0781-3004-07),Reverified,4/5/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Eli Lilly,800-545-5979,Humatrope 12mg KIT (NDC 0002-8148-01),Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Eli Lilly,800-545-5979,Humatrope 24mg KIT (NDC 0002-8149-01),Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,5 mg/mL; Two-chamber cartridge with preservative (NDC 0013-2626-81),Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,12 mg/mL; Two-chamber cartridge with preservative (NDC 0013-2646-81),Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 0.2 mg; Two-chamber cartridge without preservative (NDC 0013-2649-02),Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 0.4 mg; Two-chamber cartridge without preservative (NDC 0013-2650-02),Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 0.6 mg; Two-chamber cartridge without preservative (NDC 0013-2651-02),Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 0.8 mg; Two-chamber cartridge without preservative (NDC 0013-2652-02),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 1.0 mg; Two-chamber cartridge without preservative (NDC 0013-2653-02),Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 1.2 mg; Two-chamber cartridge without preservative (NDC 0013-2654-02),Revised,3/31/23,Next Delivery: May 2023; Estimated Recovery: December 2023,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 1.4 mg; Two-chamber cartridge without preservative (NDC 0013-2655-02),Revised,3/31/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 1.6 mg; Two-chamber cartridge without preservative (NDC 0013-2656-02),Revised,3/31/23,Next Delivery: July 2023; Estimated Recovery: December 2023,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 1.8 mg; Two-chamber cartridge without preservative (NDC 0013-2657-02),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Pfizer Pharmaceuticals,800-533-4535,Miniquick 2.0 mg; Two-chamber cartridge without preservative (NDC 0013-2658-02),Revised,3/31/23,Next Delivery: April 2023; Estimated Recovery: December 2023,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Genentech,800-551-2231,Nutropin NuSpin 5 mg (NDC 50242-074-01),Reverified,3/14/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Genentech,800-551-2231,Nutropin NuSpin 10 mg (NDC 50242-075-01),Reverified,3/14/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Injection,Genentech,800-551-2231,Nutropin NuSpin 20 mg (NDC 50242-076-01),Reverified,3/14/23,Available,,,Other,Endocrinology/Metabolism,Current,,,1/6/23,,,,,,,
Somatropin Recombinant (Humatrope) Injection,Eli Lilly and Co.,800-545-5979,5 mg kit (NDC 0002-7335-11) contains 5 mg/mL in 1 vial (NDC 0002-7349-01) of Humatrope and 5 mL in 1 vial (NDC 0002-7336-01) of Sterile Diluent,New,7/7/20,,,,,Hematology,To be Discontinued,,,7/7/20,,,,,,,
Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 100 (NDC 0228-2803-11)",New,5/22/18,,,,,Renal,To be Discontinued,,,5/22/18,,,,,,,
Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 500 (NDC 0228-2803-50)",New,5/22/18,,,,,Renal,To be Discontinued,,,5/22/18,,,,,,,
Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 100 (NDC 0228-2672-11)",New,5/22/18,,,,,Renal,To be Discontinued,,,5/22/18,,,,,,,
Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 500 (NDC 0228-2672-50)",New,5/22/18,,,,,Renal,To be Discontinued,,,5/22/18,,,,,,,
Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 100 (NDC 0228-2673-11)",New,5/22/18,,,,,Renal,To be Discontinued,,,5/22/18,,,,,,,
Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 500 (NDC 0228-2673-50)",New,5/22/18,,,,,Renal,To be Discontinued,,,5/22/18,,,,,,,
Stavudine Capsules,Mylan Pharmaceuticals Inc.,800-496-9526,20mg capsules (NDC 0378-5041-91),New,4/30/18,,,,,Antiviral,To be Discontinued,,,4/30/18,,,,,,,
Sterile Water for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 mL vial (NDC 0641-6147-10),Revised,2/9/23,Available,,,Demand increase for the drug,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,"Hospira, Inc., a Pfizer company",844-646-4398,10 mL Single Dose Plastic Fliptop Vial (NDC 00409-4887-10),Revised,3/31/23,Available,,,Other,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,"Hospira, Inc., a Pfizer company",844-646-4398,20 mL Single Dose Plastic Fliptop Vial (NDC 00409-4887-20),Revised,3/31/23,Available,,,Other,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mL Single Dose Plastic Fliptop Vial (NDC 00409-4887-50),Reverified,3/31/23,Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023,,,Demand increase for the drug,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,"Hospira, Inc., a Pfizer company",844-646-4398,100 mL Single Dose Glass Fliptop Vial (NDC 00409-4887-99),Revised,3/31/23,Next Delivery: June 2023; Estimated Recovery: December 2023,,,Demand increase for the drug,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,Fresenius Kabi USA,888-386-1300,10 mL Vial (NDC 63323-0185-10),Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,Fresenius Kabi USA,888-386-1300,20 mL Vial (NDC 63323-0185-20),Revised,3/31/23,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,Fresenius Kabi USA,888-386-1300,50 mL Vial (NDC 63323-0185-50),Revised,3/31/23,Available,Check wholesalers for inventory,,Demand increase for the drug,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,"Medefil, Inc.",630-682-4600,10 mL in plastic syringe (NDC 64253-020-30),Revised,3/1/22,Available,,,Available; Demand Increase for the drug,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,Fresenius Kabi USA,888-386-1300,"Single Dose free flex bag, 1,000 mL fill, (NDC 63323-178-76)",Revised,3/31/23,Available,Check wholesalers for inventory,,,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,Nephron Pharmaceuticals Corporation,803-569-2800,5 mL Plastic Vials (NDC 0487-6105-01),New,2/22/22,Available,,,Other,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,American Regent/Luitpold,800-645-1706,10mL Vial (NDC 0517-3010-25),Reverified,3/28/23,Unavailable,,,Demand increase for the drug,Other,Current,,,11/23/21,,,,,,,
Sterile Water for Injection,American Regent/Luitpold,800-645-1706,20mL Vial (NDC 0517-3020-25),Reverified,3/28/23,Available,,,Demand increase for the drug,Other,Current,,,11/23/21,,,,,,,
Streptozocin (Zanosar) Sterile Powder,"ESTEVE PHARMACEUTICALS, S.A.",Amer@esteve.com or mcomasl@esteve.com,"Streptozocin powder for concentrate for solution for infusion, dosage of 1g for single-use per vial (NDC 68118-100-01)",Revised,4/4/23,Available,,,Other,Oncology,Current,,,7/12/22,,,,,https://www.fda.gov/media/166810/download,,
Streptozocin (Zanosar) Sterile Powder,Teva,800-545-8800,NDC 0703-4636-01 (1 gram Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Streptozocin (Zanosar) Sterile Powder,Teva Pharmaceuticals,800-545-8800,Streptozocin (Zanosar®) Sterile Powder: (NDC 0703-4636-01) (1 gram Single Dose Vial),Revised,4/5/23,Unavailable; Recovery TBD,,,Other,Oncology,Current,,,7/12/22,,,,,,,
Succimer (Chemet) Capsules,Recordati Rare Diseases,866-209-7604,100 mg capsules (NDC 55292-201-11),Revised,9/14/21,,,Available,,Hematology,Resolved,,,2/26/21,,,,,,,
Sucralfate Tablets,Amneal Pharmaceuticals LLC,866-525-7270,1 g - 100 tablets per bottle (NDC 69238-1656-1),New,1/9/23,Limited availability; Estimated recovery in Q3 2023,,,Other,Gastroenterology,Current,,,1/4/23,,,,,,,
Sucralfate Tablets,Amneal Pharmaceuticals LLC,866-525-7270,1 g - 500 tablets per bottle (NDC 69238-1656-5),New,1/9/23,Limited availability; Estimated recovery in Q3 2023,,,Other,Gastroenterology,Current,,,1/4/23,,,,,,,
Sucralfate Tablets,"Nostrum Laboratories, Inc.",816-841-4636,1g – 100 count (NDC 29033-003-01),New,1/4/23,Available,,,,Gastroenterology,Current,,,1/4/23,,,,,,,
Sucralfate Tablets,"Nostrum Laboratories, Inc.",816-841-4636,1g – 500 count (NDC 29033-003-05),New,1/4/23,Available,,,,Gastroenterology,Current,,,1/4/23,,,,,,,
Sucralfate Tablets,Teva Pharmaceuticals USA,800-545-8800,1g - 100 Count Bottle  (NDC 0093-2210-01),Reverified,4/5/23,Available,,,,Gastroenterology,Current,,,1/4/23,,,,,,,
Sucralfate Tablets,Teva Pharmaceuticals USA,800-545-8800,1g - 500 Count Bottle (NDC 0093-2210-05),Reverified,4/5/23,Available,,,,Gastroenterology,Current,,,1/4/23,,,,,,,
Sucralfate Tablets,Teva Pharmaceuticals USA,800-545-8800,1 g - 90 Count Bottle (NDC 0093-2210-98),Reverified,4/5/23,Available,,,,Gastroenterology,Current,,,1/4/23,,,,,,,
Sucralfate Tablets,"Allergan, Inc.",800-678-1605,1g - 100 Count Bottle  (NDC 58914-171-10),Revised,3/1/23,Available,,,Other,Gastroenterology,Current,,,1/4/23,,,,,,,
Sucralfate Tablets,"Allergan, Inc.",800-678-1605,1g - 100 Count Bottle  (NDC 59762-040-11),Revised,3/1/23,Limited availability; Estimated recovery in June 2023,,,Delay in shipping,Gastroenterology,Current,,,1/4/23,,,,,,,
Sucralfate Tablets,"Allergan, Inc.",800-678-1605,1g - 500 Count Bottle (NDC 59762-040-15),Revised,3/1/23,Limited availability; Estimated recovery in June 2023,,,Delay in shipping,Gastroenterology,Current,,,1/4/23,,,,,,,
Sufentanil Citrate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2 mL ampules in packages of 10 (NDC 17478-050-02),New,3/2/23,Unavailable,,,,Analgesia/Addiction; Pediatric,Current,,,5/3/22,,,,,,,
Sufentanil Citrate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,5 mL ampules in packages of 10 (NDC 17478-050-05),New,3/2/23,Unavailable,,,,Analgesia/Addiction; Pediatric,Current,,,5/3/22,,,,,,,
Sufentanil Citrate Injection,"Hospira, Inc., a Pfizer company",844-646-4398,50 mcg/mL Single Dose Glass Fliptop Vial (NDC 0409-3382-21),Revised,3/31/23,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,,5/3/22,,,,,,,
Sufentanil Citrate Injection,Akorn Pharmaceuticals,800-932-5676,"50 mcg/mL (NDC 17478-050-01), 1mL vial, 10 pack",Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction;Pediatric,Current,,,5/3/22,,,,,,,
Sufentanil Citrate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 mL ampules in packages of 10 (NDC 17478-050-01),Revised,3/2/23,Unavailable,,,,Analgesia/Addiction;Pediatric,Current,,,5/3/22,,,,,,,
Sufentanil Citrate Injection,Akorn Pharmaceuticals,800-932-5676,"50 mcg/mL (NDC 17478-050-02), 2mL vial, 10 pack",Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction;Pediatric,Current,,,5/3/22,,,,,,,
Sufentanil Citrate Injection,Akorn Pharmaceuticals,800-932-5676,"50 mcg/mL (NDC 17478-050-05), 5mL vial, 10 pack",Revised,3/1/23,Not available,No new manufacturing of product,,,Analgesia/Addiction;Pediatric,Current,,,5/3/22,,,,,,,
Sulfacetamide Sodium and Prednisolone Acetate Ophthalmic Ointment,Abbvie,800-678-1605,Blephamide (prednisolone acetate; sulfacetamide sodium) (NDC 11980-022-05) - 5 mL in 10 mL bottle,New,6/9/22,,,,,Ophthalmology,To be Discontinued,,,6/9/22,,,,,,,
Sulfacetamide Sodium and Prednisolone Acetate Ophthalmic Ointment,Abbvie,800-678-1605,Blephamide S.O.P. (sulfacetamide sodium 10% and prednisolone acetate 0.2%) 1 TUBE in 1 CARTON 3.5 g in 1 TUBE (NDC 0023-0313-04),New,9/13/21,,,,,Ophthalmology,To be Discontinued,,,9/13/21,,,,,,,
Sulfacetamide Sodium Solution,Abbvie,800-678-1605,Bleph-10® (sulfacetamide sodium) (NDC 11980-011-05) - 5 mL in 10 mL bottle,New,6/9/22,,,,,Ophthalmology,To be Discontinued,,,6/9/22,,,,,,,
Sulfasalazine Tablets,Chartwell Pharma,845-268-5000 Ext: 510,500 mg tablets; Bottle of 100 (NDC 23155-019-01),Revised,10/25/22,"Product Available. Distributed by Chartwell. For inquiries, call Customer Service number 845-268-5000  Ext: 510.",,,Other,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Chartwell Pharma,845-268-5000 Ext. 510,500 mg tablets; bottle of 100 (NDC 62135-960-01),Revised,10/25/22,Available,,,,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Chartwell Pharma,845-268-5000 Ext. 510,500 mg tablets; Bottle of 500 (NDC 62135-960-05),Revised,10/25/22,Available,,,,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Chartwell Pharma,845-268-5000 Ext. 510,500 mg tablets; Bottle of 1000 (NDC 62135-960-10),Revised,10/25/22,Available,,,,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Chartwell Pharma,845-268-5000 Ext. 510,500 mg tablets; Bottle of 300 (NDC 62135-960-31),Revised,10/25/22,Available,,,,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 100 (NDC 0013-0101-10),Reverified,3/31/23,Available,,,Other,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 300 (NDC 0013-0101-20/0013-0101-30),Reverified,3/31/23,Available,,,Other,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 100 (NDC 0013-0102-50),Reverified,3/31/23,Available,,,Other,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 300 (NDC 0013-0102-20/0013-0102-60),Reverified,3/31/23,Available,,,Other,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 100 (NDC 59762-0104-1/59762-0104-5),Reverified,3/31/23,Available,,,Other,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 300 (NDC 59762-0104-6),Reverified,3/31/23,Available,,,Other,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets; bottle of 100 (NDC 59762-5000-1/59762-5000-5),Reverified,3/31/23,Limited Supply Available Next Delivery: March 2023; Estimated Recovery: TBD,,,Other,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets; bottle of 300 (NDC 59762-5000-6),Reverified,3/31/23,Limited Supply Available Next Delivery and Estimated Recovery: March 2023,,,Other,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 100 Count (NDC 0093-3234-01),Revised,4/5/23,"Limited Supply Available, Recovery TBD",NDC: 0591-0796-01 has been changed to NDC: 0093-3234-01,,,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 1000 Count (NDC 0093-3234-10),Revised,4/5/23,"Unavailable, Recovery TBD",NDC: 0591-0796-10 has been changed to NDC: 0093-3234-10,,,Gastroenterology,Current,,,4/24/20,,,,,,,
Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 500 Count (NDC 0093-3234-05),Revised,4/5/23,"Unavailable, Recovery TBD",NDC: 0591-0796-05 has been changed to NDC: 0093-3234-05,,,Gastroenterology,Current,,,4/24/20,,,,,,,
Sumatriptan (Sumavel DosePro) Injection,"Endo Pharmaceuticals, Inc.",800-462-3636,Sumavel DosePro (sumatriptan injection) 6mg/0.5mL (NDC 63481-367-06),New,2/27/18,,,,,Neurology,To be Discontinued,,,2/27/18,,,,,,,
Sumatriptan Succinate Injection,Teva Pharmaceuticals,800-545-8800,6 mg/0.5 mL  (NDC 0703-7351-01),New,12/5/19,,,,,Neurology,To be Discontinued,,,12/5/19,,,,,,,
Synercid Injection,Pfizer,844-646-4398,500 mg; 10 mL Single Dose Glass Vial  (NDC 61570-260-10),New,8/30/22,,Discontinuation of the manufacture of the drug.,,,Antibiotic,To be Discontinued,8/30/22,8/30/22,8/30/22,,,,,,,
Tacrolimus Capsules,"BPI Labs, LLC",727-471-0850 ext. 275,1 mg 100 count bottle (NDC 54288-135-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Ascend Laboratories LLC.,860-667-7081,0.5 mg 100’s count (NDC 67877-278-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Ascend Laboratories LLC.,860-667-7081,1 mg 100’s count (NDC 67877-279-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Ascend Laboratories LLC.,860-667-7081,5 mg 100’s count (NDC 67877-280-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Glenmark Pharmaceuticals,888-721-7115,0.5 mg 100 count bottles (NDC 68462-685-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Glenmark Pharmaceuticals,888-721-7115,1 mg 100 count bottles (NDC 68462-686-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Glenmark Pharmaceuticals,888-721-7115,5 mg 100 count bottles (NDC 68462-687-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,0.5 mg (NDC 55111-525-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,1 mg (NDC 55111-526-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,5 mg (NDC 55111-527-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"0.5 mg, 100s (NDC 0378-2045-01)",Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"1 mg, 100s (NDC 0378-2046-01)",Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"5 mg, 100s (NDC 0378-2047-01)",Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",0.5 mg 100 count (NDC 1672904101),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",1 mg 100 count (NDC 1672904201),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",5 mg 100 count (NDC 1672904301),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 30 count (NDC 68992-3075-3),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 100 count (NDC 68992-3075-1),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 30 count (NDC 68992-3010-3),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 100 count (NDC 68992-3010-1),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 30 count (NDC 68992-3040-3),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 100 count (NDC 68992-3040-1),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,1 mg 100 count bottles (NDC 64338-721-06),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,0.5 mg 100 count bottles (NDC 64380-720-06),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,5 mg 100 count bottles (NDC 64380-722-06),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-2102-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-2103-04),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-2104-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 0.5 mg 100 count bottle (NDC 0469-0607-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 5 mg 100 count bottle (NDC 0469-0657-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 1 mg 100 count bottle (NDC 0469-0617-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 0.5 mg 30 count bottle (NDC 0469-0647-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 1 mg 30 count bottle (NDC 0469-0677-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 5 mg 30 count bottle (NDC 0469-0687-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 0.2 mg unit dose packets (NDC 0469-1230-50),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 1 mg unit dose packets (NDC 0469-1330-50),Revised,5/2/22,,,Available,,Transplant,Resolved,,,5/17/19,,,,,,,
"Talwin (Pentazocine Lactate Injection, USP, CIV)","Hospira, Inc.",844-646-4398,30 mg/mL; 1 mL glass ampul (NDC 00409-1941-01),New,4/16/18,,,,,Analgesia/Addiction,To be Discontinued,,,4/16/18,,,,,,,
Technetium Tc 99m Sulfur Colloid Injection,Sun Pharmaceutical Industries Inc.,800-221-7554,5 Vial Kit (NDC 45567-0030-1),Revised,4/29/22,,,Available,,Medical Imaging,Resolved,,,10/8/21,,,,,,,
Technetium TC-99M Mebrofenin Injection,Sun Pharmaceutical Industries Inc.,800-221-7554,5 vial kit (NDC 45567-0455-1),Revised,6/28/22,On backorder.,,,Other,Medical Imaging,Current,,,3/30/22,,,,,,,
Technetium TC-99M Mebrofenin Injection,Sun Pharmaceutical Industries Inc.,800-221-7554,30 vial kit (NDC 45567-0455-2),Revised,6/28/22,On backorder.,,,Other,Medical Imaging,Current,,,3/30/22,,,,,,,
Technetium TC-99M Mebrofenin Injection,Bracco Diagnostics,877-272-2269,"CHOLETEC- mebrofenin injection, powder, lyophilized, for solution; Kit for the Preparation of Technetium Tc 99m Mebrofenin, supplied as 10 sterile multidose reaction vials per kit. (NDC 0270-0083-20)",Reverified,9/13/22,Available,,,Delay in shipping of the drug,Medical Imaging,Current,,,3/30/22,,,,,,,
Technetium TC-99m Sodium Pertechnetate Generator,Curium US LLC,888-744-1414,"(ULTRA-TECHNEKOW V4) 1.0 Ci 69945-010-03; 1.5 Ci 69945-015-04, 2.0 Ci 69945-020-05, 2.5 Ci 69945-025-06, 3.0 Ci 69945-030-07; 3.5 Ci 69945-035-08, 5.0 Ci 69945-051-09, 6.0 Ci 69945-060-10, 7.5 Ci 79945-075-11, 11.0 Ci 69945-110-12, 14.0 Ci 69945-140-13, 16.0 Ci 69945-160-14, 19.0 Ci 69945-190-15",Revised,1/18/23,,,Available,,Medical Imaging,Resolved,1/18/23,,11/17/22,,,,,,,
Technetium TC-99m Sodium Pertechnetate Generator,"Lantheus Medical Imaging, Inc.",800-299-3431,"(Technelite) 3 Ci 11994-090-01; 4 Ci 11994-090-03, 4.5 Ci 11994-090-04, 5 Ci 11994-090-05, 6 Ci 11994-090-06, 7.5 Ci 11994-090-07, 10 Ci 11994-090-09, 12.5 Ci 11994-090-10, 15 Ci 11994-090-11, 18 Ci  11994-090-12, 20 Ci 11994-090-13, 1 Ci 11994-090-36, 2 Ci 11994-090-73, 2.5 Ci 11994-090-92, 3 Ci 11994-091-01, 4 Ci 11994-091-03, 4.5 Ci 11994-091-04, 5 Ci 11994-091-05, 6 Ci 11994-091-06, 7.5 Ci 11994-091-07, 10 Ci 11994-091-09, 12.5 CI 11994-091-10, 15 Ci 11994-091-11, 18 Ci 11994-091-12, 20 Ci 11994-091-13, 1 Ci 11994-091-36, 2 Ci 11994-091-73, 2.5 Ci 11994-091-92",Revised,1/18/23,,,Available,,Medical Imaging,Resolved,1/18/23,,11/17/22,,,,,,,
Technetium TC-99m Sodium Pertechnetate Generator,Northstar Medical Radioisotopes LLC,844-438-6659 or 608-313-8000,"(RADIOGENIX SYSTEM) 30-1153 mCi per Source Vessel / Generator, 22-30 mL vial; NDCs 71612-075-002 for 7.5Ci, 71612-120-02 for 12Ci, 71612-150-02 for 15Ci, and 71612-190-02 for 19Ci",Revised,1/18/23,,,Available,,Medical Imaging,Resolved,1/18/23,,11/17/22,,,,,,,
Technetium Tc99m Succimer Injection (DMSA),Theragnostics Inc.,617-286-7479,ROTOP DMSA (Kit for the Preparation of Technetium Tc99m Succimer Injection). One vial contains 1.74 mg powder with the active substance: 1.0 mg succimer.  Five vials included in a carton (NDC 71647-001-01),Revised,1/12/23,,,Please review the following website for more information: www.nephroscan.com,,Medical Imaging,Resolved,1/12/23,,8/7/17,,,,,,,
Telmisartan and Amlodipine (Twynsta) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",203-798-4375,"Telmisartan and Amlodipine (Twynsta) tablets 80mg/10mg, 30 count blister (NDC 0597-0127-37)",New,3/6/18,,,,,Cardiovascular,To be Discontinued,,,3/6/18,,,,,,,
Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1121,5mg capsules (NDCs 62559-920-51 and 62559-920-14),New,4/12/22,,,,,Oncology,To be Discontinued,,,4/12/22,,,,,,,
Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1211,20mg capsules (NDCs 62559-921-51 and 62559-921-14),New,4/12/22,,,,,Oncology,To be Discontinued,,,4/12/22,,,,,,,
Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1211,100mg capsules (NDCs 62559-922-51 and 62559-922-14),New,4/12/22,,,,,Oncology,To be Discontinued,,,4/12/22,,,,,,,
Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1211,140mg capsules (NDCs 62559-923-51 and 62559-923-14),New,4/12/22,,,,,Oncology,To be Discontinued,,,4/12/22,,,,,,,
Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1211,180mg capsules (NDCs 62559-924-51 and 62559-924-14),New,4/12/22,,,,,Oncology,To be Discontinued,,,4/12/22,,,,,,,
Teprotumumab-trbw,Horizon Therapeutics,866-479-6742,500 mg lyophilized powder (NDC 75987-130-15),Revised,3/31/21,Product available.,,,Other,Ophthalmology,Current,,,12/23/20,,,,,,,
Testosterone Transdermal Gel,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",25mg/2.5g  (NDC 49884-418-72),New,8/29/22,,,,,Urology,To be Discontinued,8/29/22,8/29/22,8/29/22,,,,,,,
Testosterone Transdermal Gel,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",50mg/5g  (NDC 49884-510-72),New,8/29/22,,,,,Urology,To be Discontinued,8/29/22,8/29/22,8/29/22,,,,,,,
"Testosterone Transdermal System (Film, Extended Release)",AbbVie,800-255-5162,"2 mg/day, each system contains 9.7 mg testosterone USP for delivery of 2 mg per day (NDC 0023-5990-60)",New,1/10/23,,The discontinuation is limited to only the NDCs listed.  Other NDCs of the same or similar products will continue to be available.,,,Urology,To be Discontinued,1/10/23,1/10/23,1/10/23,,,,,,,
"Testosterone Transdermal System (Film, Extended Release)",AbbVie,800-255-5162,"4 mg/day, each system contains 19.5 mg testosterone USP for delivery of 4 mg per day (NDC 0023-5992-30)",New,1/10/23,,The discontinuation is limited to only the NDCs listed.  Other NDCs of the same or similar products will continue to be available.,,,Urology,To be Discontinued,1/10/23,1/10/23,1/10/23,,,,,,,
Thallous Chloride TL 201 Injection,Lantheus Medical Imaging Inc.,800-299-3431,2mCi/ML; 5.5 mL in 1 VIAL (NDC 11994-427-11),New,10/28/22,,,,,Medical Imaging,To be Discontinued,10/28/22,10/28/22,10/28/22,,,,,,,https://www.fda.gov/media/162689/download
Thallous Chloride TL 201 Injection,Lantheus Medical Imaging Inc.,800-2993431,2mCi/ML; 7.7 mL in 1 VIAL (NDC 11994-427-15),New,10/28/22,,,,,Medical Imaging,To be Discontinued,10/28/22,10/28/22,10/28/22,,,,,,,https://www.fda.gov/media/162689/download
Thallous Chloride TL 201 Injection,Lantheus Medical Imaging Inc.,800-299-3431,2mCi/ML; 9.9 mL in 1 VIAL (NDC 11994-427-19),New,10/28/22,,,,,Medical Imaging,To be Discontinued,10/28/22,10/28/22,10/28/22,,,,,,,https://www.fda.gov/media/162689/download
Thallous Chloride TL 201 Injection,Lantheus Medical Imaging Inc.,800-299-3431,2mCi/ML; 2.2 mL in 1 VIAL (NDC 11994-427-24),New,10/28/22,,,,,Medical Imaging,To be Discontinued,10/28/22,10/28/22,10/28/22,,,,,,,https://www.fda.gov/media/162689/download
Thallous Chloride TL 201 Injection,Lantheus Medical Imaging Inc.,800-299-3431,2mCi/ML; 3.3 mL in 1 VIAL (NDC 11994-427-26),New,10/28/22,,,,,Medical Imaging,To be Discontinued,10/28/22,10/28/22,10/28/22,,,,,,,https://www.fda.gov/media/162689/download
Thallous Chloride TL 201 Injection,Lantheus Medical Imaging Inc.,800-299-3431,2mCi/ML; 4.4 mL in 1 VIAL (NDC 11994-427-28),New,10/28/22,,,,,Medical Imaging,To be Discontinued,10/28/22,10/28/22,10/28/22,,,,,,,https://www.fda.gov/media/162689/download
Thiothixene Capsules,Amneal Pharmaceutical,866-525-7270,"1 mg, 100 count bottle (NDC 60219-1673-1)",Revised,10/14/22,,,Available,,Psychiatry,Resolved,10/14/22,,4/24/19,,,,,,,
Thiothixene Capsules,Amneal Pharmaceutical,866-525-7270,"2 mg, 100 count bottle (NDC 60219-1674-1)",Revised,10/14/22,,,Available,,Psychiatry,Resolved,10/14/22,,4/24/19,,,,,,,
Thiothixene Capsules,Amneal Pharmaceutical,866-525-7270,"5 mg, 100 count bottle (NDC 60219-1675-1)",Revised,10/14/22,,,Available,,Psychiatry,Resolved,10/14/22,,4/24/19,,,,,,,
Thiothixene Capsules,Amneal Pharmaceutical,866-525-7270,"10 mg, 100 count bottle (NDC 60219-1676-1)",Revised,10/14/22,,,Available,,Psychiatry,Resolved,10/14/22,,4/24/19,,,,,,,
Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"1 mg, 100 count bottle (NDC 70954-014-10)",Revised,10/14/22,,,Available,,Psychiatry,Resolved,10/14/22,,4/24/19,,,,,,,
Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"2 mg, 100 count bottle (NDC 70954-015-10)",Revised,10/14/22,,,Available,,Psychiatry,Resolved,10/14/22,,4/24/19,,,,,,,
Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"5 mg, 100 count bottle (NDC 70954-016-10)",Revised,10/14/22,,,Available,,Psychiatry,Resolved,10/14/22,,4/24/19,,,,,,,
Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"10 mg, 100 count bottle (NDC 70954-017-10)",Revised,10/14/22,,,Available,,Psychiatry,Resolved,10/14/22,,4/24/19,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® (timolol maleate ophthalmic solution), 0.25%, 5 mL in a 7.5 mL bottle (NDC 24208-812-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® (timolol maleate ophthalmic solution), 0.5%, 5 mL in a 7.5 mL bottle (NDC 24208-813-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® (timolol maleate ophthalmic solution), 0.5%, 10 mL in a 10 mL bottle (NDC 24208-813-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,Authorized Generic Timolol Maleate Ophthalmic Solution 0.5% 5 mL in a 7.5 mL bottle (NDC 68682-813-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® in OCUDOSE® (timolol maleate) Sterile Ophthalmic Solution, 0.25% 0.3 mL in 60 individual doses (NDC 0187-1498-25)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® in OCUDOSE®  (timolol maleate) Sterile Ophthalmic Solution, 0.5% 0.3 mL in 60 individual doses (NDC 0187-1496-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Apotex Corp.,800-706-5575,Timolol Maleate Ophthalmic Solution 0.5% 2.5mL bottle (NDC 60505-1005-04),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Apotex Corp.,800-706-5575,Timolol Maleate Ophthalmic Solution 0.5% 5mL bottle (NDC 60505-1005-01),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Istalol, Timolol Maleate Ophthalmic solution 0.5% in a 7.5 mL bottle (NDC 24208-004-01)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Istalol, Timolol Maleate Ophthalmic solution 0.5% in a 10 ml bottle (NDC 24208-004-03)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Solution 0.5%,  2.5ml (NDC 68682-045-25)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Solution 0.5%, 5ml (NDC 68682-045-50)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25% 5mL (NDC 64980-513-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25%  10 mL (NDC 64980-513-01),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25% 15 mL (NDC 64980-513-15),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,FDC Limited,201-964-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 5mL (NDC 64980-514-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 10mL (NDC 64980-514-01),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 15mL (NDC 64980-514-15),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.25% OS 1x5ml BTL (NDC 60758-802-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.25% OS 1x10ml BTL (NDC 60758-802-10),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.5% OS 1x5ml BTL (NDC 60758-801-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.5% OS 1x10ml BTL (NDC 60758-801-10),Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5% 5mg/mL, 5mL, 1 Bottle/EA (NDC 17478-0288-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5%, 10mL, 1 Bottle / EA (NDC 17478-0288-11)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5%, 15mL, 1 Bottle / EA (NDC 17478-0288-12)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 5 mL bottle, (NDC 61314-227-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 10 mL bottle (NDC 61314-227-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 15 mL bottle (NDC 61314-227-15)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 5 mL bottle, ()NDC 61314-226-05",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 10 mL bottle, (NDC 61314-226-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 15 mL bottle, (NDC 61314-226-15)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,,5/29/20,,,,,,,
Tipranavir Oral Solution,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,100mg/mL (NDC 0597-0002-01),New,6/29/21,,,,,Antiviral,To be Discontinued,,,6/29/21,,,,,,,
Tirofiban Hydrochloride Injection,Medicure Pharma Inc.,888-435-2220,"5 mg/100 mL vial, 50 mcg/mL (NDC 25208-002-03)",New,2/24/23,,"The discontinuation is limited to only the NDC listed.  Tirofiban hydrochloride injection 5 mg/100 mL bag, 50 mcg/mL (NDC 25208-002-01) will continue to be available",,,Cardiovascular,To be Discontinued,2/24/23,2/24/23,2/24/23,,,,,,,
Tirzepatide Injection,Eli Lilly and Company,800-545-5979,2.5mg/0.5mL (NDC 0002-1506-80),Reverified,3/22/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Tirzepatide Injection,Eli Lilly and Company,800-545-5979,7.5mg/0.5mL (NDC 0002-1484-80),Reverified,3/22/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Tirzepatide Injection,Eli Lilly and Company,800-545-5979,12.5mg/0.5mL (NDC 0002-1460-80),Reverified,3/22/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Tirzepatide Injection,Eli Lilly and Company,800-545-5979,15mg/0.5mL (NDC 0002-1457-80),Reverified,3/22/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Tirzepatide Injection,Eli Lilly and Company,800-545-5979,10mg/0.5mL (NDC 0002-1471-80),Reverified,3/22/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Tirzepatide Injection,Eli Lilly and Company,800-545-5979,5mg/0.5mL (NDC 0002-1495-80),Reverified,3/22/23,Available,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,,12/15/22,,,,,,,
Tizanidine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",2 mg  (NDC 49884-611-53),New,6/30/21,,,,,Neurology,To be Discontinued,,,6/30/21,,,,,,,
Tizanidine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",4 mg (NDC 49884-719-53),New,6/30/21,,,,,Neurology,To be Discontinued,,,6/30/21,,,,,,,
Tizanidine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",6 mg (NDC 49884-765-53),New,6/30/21,,,,,Neurology,To be Discontinued,,,6/30/21,,,,,,,
Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,4 mg (NDC 0378-0724-19),New,11/21/19,,,,,Neurology,To be Discontinued,,,11/21/19,,,,,,,
Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0722-19),New,11/21/19,,,,,Neurology,To be Discontinued,,,11/21/19,,,,,,,
Tobramycin Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-51)",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,,,8/24/20,,,,,,,
Tobramycin Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-55), Novaplus",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,,,8/24/20,,,,,,,
Tobramycin Lyophilized Powder for Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"1.2 g, pharmacy bulk package, bottle (NDC 39822-0412-1)",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,,,8/24/20,,,,,,,
Tobramycin Lyophilized Powder for Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"1.2 g, pharmacy bulk package, pack of 6 bottles (NDC 39822-0412-6)",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,,,8/24/20,,,,,,,
Tocilizumab Injection,"Genentech, Inc",800-551-2231,"200mg/10mL, (NDC 50242-0136-01)",Revised,3/30/22,,,Available,,Rheumatology,Resolved,,,8/17/21,,,,,,,
Tocilizumab Injection,"Genentech, Inc",800-551-2231,"400mg/20mL, (NDC 50242-0137-01)",Revised,3/30/22,,,Available,,Rheumatology,Resolved,,,8/17/21,,,,,,,
Tocilizumab Injection,"Genentech, Inc",800-551-2231,"80mg/4mL, (NDC 50242-0135-01)",Revised,3/30/22,,,Available,,Rheumatology,Resolved,,,8/17/21,,,,,,,
Topotecan Injection,Teva,800-545-8800,NDC 0703-4714-01 (4 mg/4 mL (1 mg/mL) Single-Dose Vial),New,8/11/22,,Product is available with an expected supply duration until AUG 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"4 mg tablets, 100 count (NDC 16252-543-90)",New,4/18/18,,,,,Cardiovascular,To be Discontinued,,,4/18/18,,,,,,,
Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"2 mg tablets, 100 count (NDC 16252-542-90)",New,4/18/18,,,,,Cardiovascular,To be Discontinued,,,4/18/18,,,,,,,
Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"1 mg tablets, 100 count (NDC 16252-541-30)",New,4/18/18,,,,,Cardiovascular,To be Discontinued,,,4/18/18,,,,,,,
Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 30 Tablets per Bottle,  (NDC 60505-3638-3)",New,12/4/19,,,,,Hematology,To be Discontinued,,,12/4/19,,,,,,,
Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 100 Tablets per Bottle,  (NDC 60505-3638-1)",New,12/4/19,,,,,Hematology,To be Discontinued,,,12/4/19,,,,,,,
Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/1g (NDC 40085-029-80),New,3/20/18,,,,,Dermatology,To be Discontinued,,,3/20/18,,,,,,,
Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1mg/1g (NDC 40085-029-16),New,3/20/18,,,,,Dermatology,To be Discontinued,,,3/20/18,,,,,,,
Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,0.25mg/1g (NDC 40085-028-80),New,3/20/18,,,,,Dermatology,To be Discontinued,,,3/20/18,,,,,,,
Triamcinolone Acetonide Injectable Suspension,Novartis,888-669-6682,"40mg/mL vial, 1mL in 1 vial (NDC 0065-0543-01)",Reverified,3/31/23,Availability through wholesalers: not available. Estimated duration of supply shortage: 3-18 months.,There are no therapeutic equivalents.,,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,,9/27/21,,,,,,,
Triamcinolone Hexacetonide Injectable suspension,Medexus,1-855-336-3322 Option 9,"Hexatrione 2% (triamcinolone hexacetonide) Injectable suspension, 20mg/ml, 2-mL glass ampoule (NDC 59137-570-01)",Reverified,10/12/22,Available,,,,Rheumatology,Current,,,5/4/21,,,,,https://www.fda.gov/media/154709/download,,
Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 0781-5068-01)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 0781-5068-05)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 0781-5067-01)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 0781-5067-05)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 68001-0216-00)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 68001-0216-03)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 68001-0215-00)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 68001-0215-03)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,,2/23/18,,,,,,,
Trimethobenzamide Hydrochloride Capsules,Lupin,866-587-4617,"300 mg, bottle of 30 (NDC 43386-660-03)",Reverified,10/25/21,Currently unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient.,Gastroenterology,Current,,,2/16/21,,,,,,,
Trimethobenzamide Hydrochloride Capsules,Lupin,866-587-4617,"300 mg, bottle of 100 (NDC 43386-660-24)",Reverified,10/25/21,Currently unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient.,Gastroenterology,Current,,,2/16/21,,,,,,,
Trimethobenzamide Hydrochloride Capsules,Lupin,866-587-4617,"300 mg, bottle of 500 (NDC 43386-660-26)",Reverified,10/25/21,Currently unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient.,Gastroenterology,Current,,,2/16/21,,,,,,,
Trimethobenzamide Hydrochloride Capsules,Pfizer Pharmaceuticals,800-533-4535,"300 mg, bottle of 100 (NDC 61570-079-01)",Reverified,11/28/22,Discontinued,,,Discontinuation of the manufacture of the drug.,Gastroenterology,Current,,,2/16/21,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Trimethobenzamide+Hydrochloride+Capsules&st=d&tab=tabs-2,,
Trimethobenzamide Hydrochloride Capsules,Sun Pharmaceutical Industries Inc.,800-810-4555,"300 mg, bottle of 100 (NDC 53489-376-01)",Revised,10/26/21,Unavailable,,,Shortage of an active ingredient.,Gastroenterology,Current,,,2/16/21,,,,,https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Trimethobenzamide+Hydrochloride+Capsules&st=d&tab=tabs-4&panels=0,,
Trimethobenzamide Hydrochloride Capsules,Sun Pharmaceutical Industries Inc.,800-810-4555,"300 mg, bottle of 100 (NDC 53489-376-01)",New,10/26/21,,,,,Gastroenterology,To be Discontinued,,,10/26/21,,,,,,,
Umbrasilib Tosylate Tablets,"TG Therapeutics, Inc.",877-848-9462,"Umbralisib Tosylate (Ukoniq) Tablets, 200 mg (free base), 120 Tablets per bottle (NDC 73150-200-12)",Revised,5/31/22,,,,,Oncology,To be Discontinued,,,5/31/22,,,,,,,
Valproate Sodium Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,"100 mg/mL, 5 mL vial (NDC 70860-784-41)",Reverified,3/24/23,Available,,,,Neurology,Current,,,12/30/20,,,,,,,
Valproate Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg/mL, 5 mL vial (NDC 0143-9785-10)",Reverified,8/26/22,Currently on backorder.,,,Demand increase for the drug,Neurology,Current,,,12/30/20,,,,,,,
Valproate Sodium Injection,Fresenius Kabi USA,888-386-1300,500 mg per 5 mL (100 mg per mL) (NDC 63323-494-05),Revised,3/31/23,Available,Check wholesaler inventory,,Manufacturing delays,Neurology,Current,,,12/30/20,,,,,,,
Valproic Acid Oral Solution,Wockhardt,800-346-6854,"250mg/5mL, 473mL (NDC 60432-0621-16)",New,4/11/22,,,,,Neurology,To be Discontinued,,,4/11/22,,,,,,,
Vancomycin Hydrochloride for Injection,"Mylan Institutional, a Viatris company",800-796-9526,Vancomycin Hydrochloride Injection (Lyophilisate in Single Dose Vials) [250 mg] (NDC 67457-822-99),New,7/26/21,,,,,Anti-Infective,To be Discontinued,,,7/26/21,,,,,,,
Vandetanib Tablets,Sanofi,800-633-1610,Vandetanib (Caprelsa) 100mg Tablets (NDC 58468-7820-3),Revised,10/27/22,,,Available,,Oncology,Resolved,10/27/22,,7/13/22,,,,,,,
Vandetanib Tablets,Sanofi,800-633-1610,Vandetanib (Caprelsa) 300mg Tablets (NDC 58468-7840-3),Revised,10/27/22,,,Available,,Oncology,Resolved,10/27/22,,7/13/22,,,,,,,
Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 0.5 mg; bottle of 56 tablets (NDC 60505-4765-5),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,https://www.fda.gov/media/150799/download,
Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 1 mg; bottle of 56 tablets (NDC 60505-4766-6),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,https://www.fda.gov/media/150799/download,
Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 0.5 mg and 1 mg; Starter Blister Pack of 53 tablets; (NDC 60505-4767-0),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,https://www.fda.gov/media/150799/download,
Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 1 mg: Continuation Blister Pack of 56 tablets (NDC 60505-4766-5),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,https://www.fda.gov/media/150799/download,
Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix 0.5 mg; bottle of 56 (NDC 0069-0468-56),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,,
Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix 1 mg; bottle of 56 (NDC 0069-0469-56),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,,
Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix Starting wallet; 0.5 mg 1x11 1 mg FCT 3x14 BLS WL US (NDC 0069-0471-03),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,,
Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix Continuing wallet; 1 mg FCT 4x14 BLS WL US (NDC 0069-0469-03),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,,
Varenicline Tartrate (Chantix) Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","0.5 mg, 56 ‘s count bottle pack (NDC 49884-155-76)",Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,,
Varenicline Tartrate (Chantix) Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","1 mg, 56 ‘s count bottle pack (NDC 49884-156-76)",Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,,
Varenicline Tartrate (Chantix) Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2",Starter Pack (NDC 49884-944-99),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,,6/24/21,,,,,,,
Vecuronium Bromide for Injection,Teva Pharmaceuticals,800-545-8800,NDC 0703-2914-03 (10 mg (1 mg/ml when reconstituted to 10 mL) 10 x 10 mL Vials),Revised,7/20/22,,Product is temporarily unavailable and no future production expected for an extended period.,,,Anesthesia,To be Discontinued,7/20/22,7/20/22,5/6/20,,,,,,,
Vecuronium Bromide for Injection,"Hospira, Inc., a Pfizer company",844-646-4398,10 mg Single Dose Glass Fliptop Vial (NDC 00409-1632-01),Reverified,3/31/23,Available,,,Other,Anesthesia,Current,,,5/6/20,,,,,,,
Vecuronium Bromide for Injection,"Hospira, Inc.",844-646-4398,20 mg Single Dose Glass Fliptop Vial (NDC 00409-1634-01),Revised,8/30/22,,,,,Anesthesia,To be Discontinued,8/30/22,8/30/22,8/30/22,,,,,,,
Vecuronium Bromide for Injection,"Mylan Institutional, a Viatris company",800-796-9526,Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [10 mg](NDC 67457-438-10),Reverified,3/28/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,5/6/20,,,,,,,
Vecuronium Bromide for Injection,"Mylan Institutional, a Viatris company",800-796-9526,Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [20 mg](NDC 67457-475-20),Reverified,3/28/23,Available,,,Demand increase for the drug,Anesthesia,Current,,,5/6/20,,,,,,,
Vecuronium Bromide for Injection,Fresenius Kabi USA,888-386-1300,10 mg/vial (NDC 63323-781-10),Revised,3/31/23,Available,,,,Anesthesia,Current,,,5/6/20,,,,,,,
Vecuronium Bromide for Injection,Fresenius Kabi USA,888-386-1300,20 mg/vial (NDC 63323-782-20),Revised,3/31/23,Available,,,,Anesthesia,Current,,,5/6/20,,,,,,,
Vecuronium Bromide for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,10 mg (NDC 47335-931-44),Reverified,9/23/22,Available,,,,Anesthesia,Current,,,5/6/20,,,,,,,
Vecuronium Bromide for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,20 mg (NDC 47335-932-44),Reverified,9/23/22,Available,,,,Anesthesia,Current,,,5/6/20,,,,,,,
Vecuronium Bromide for Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"10 mg/vial, packages of 10 (NDC 55150-235-10)",Revised,4/4/23,Available,Sporadic availability expected.,,Available,Anesthesia,Current,,,5/6/20,,,,,,,
Vecuronium Bromide for Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"20 mg/vial, packages of 10 (NDC 55150-236-20)",Revised,4/4/23,Available,Sporadic availability expected.,,Available,Anesthesia,Current,,,5/6/20,,,,,,,
Vecuronium Bromide Injection,Teva,800-545-8800,NDC 0703-2914-03 (10 mg (1 mg/mL when reconstituted to 10 mL) 10 x 10 mL Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Anesthesia,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Verapamil Hydrochloride Tablets,Pfizer,800-533-4535,240 mg; Bottle of 100 caplets (NDC 0025-1891-31),New,9/8/22,,Supply expected to exhaust late September 2022; Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Verapamil Hydrochloride Tablets,Pfizer,800-533-4535,120 mg: Bottle of 100 caplets (NDC 0025-1901-31),New,10/14/22,,Supply expected to exhaust late November 2022; Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,10/14/22,10/14/22,10/14/22,,,,,,,
Verapamil Hydrochloride Tablets,Pfizer,800-533-4535,180 mg: Bottle of 100 caplets  (NDCs 0025-1911-31 and 0025-2818-31),New,9/8/22,,Supply expected to exhaust late May 2023; Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,9/8/22,9/8/22,9/8/22,,,,,,,
Verteporfin (Visudyne) Injection,Bausch & Lomb Incorporated,800-553-5340,15mg Vial (NDC 0187-5600-15),Revised,2/9/23,,,Available,,Ophthalmology,Resolved,2/9/23,,10/18/22,,,,,,,
Vibramycin Hyclate (Doxycycline Hyclate) for Suspension,Pfizer Pharmaceuticals,800-533-4535,25 mg/5 mL oral suspension; 1 x 60 mL bottle (NDC 0069-0970-65),New,11/16/21,,,,,Anti-Infective,To be Discontinued,,,11/16/21,,,,,,,
Vincristine Sulfate (Vincasar PFS) Injection,Teva,800-545-8800,NDC 0703-4402-11 (1 mg/mL 1 mL Single-Dose Vial),New,8/11/22,,Product is available with an expected supply duration until AUG 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22,8/11/22,,,,,,,
Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-06),New,4/16/18,,,,,Oncology,To be Discontinued,,,4/16/18,,,,,,,
Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 50 mg/5mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-09),New,4/16/18,,,,,Oncology,To Be Discontinued,,,4/16/18,,,,,,,
Vitamin A Palmitate (Aquasol A) Injection,"Casper Pharma, LLC",844-522-7737,"50,000 USP units/mL (15 mg retinol), single dose vial (NDC 70199-0026-11)",Revised,4/14/22,,,Available,,Endocrinology/Metabolism;Gastroenterology,Resolved,,,10/21/21,,,,,,,
Voriconazole Tablets,PF Prism CV,800-533-4535,50 mg tablets; Bottle of 30 (NDC 59762-0934-1),New,11/14/22,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,11/14/22,11/14/22,11/14/22,,,,,,,
Voriconazole Tablets,PF Prism CV,800-533-4535,200 mg tablets embossed with G; Bottle of 30 (NDC 59762-0936-1),New,11/14/22,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,11/14/22,11/14/22,11/14/22,,,,,,,
Zafirlukast Oral Tablets,Par Pharmaceutical,800-828-9393,"Zafirlukast 10 mg Tablets, (NDC 49884-549-02)",New,3/17/22,,,,,Pulmonary/Allergy,To be Discontinued,,,3/17/22,,,,,,,
Zafirlukast Oral Tablets,Par Pharmaceutical,800-828-9393,"Zafirlukast 20 mg Tablets, (NDC 49884-554-02)",New,3/17/22,,,,,Pulmonary/Allergy,To be Discontinued,,,3/17/22,,,,,,,
Zafirlukast Oral Tablets,Par Pharmaceutical,800-828-9393,"Accolate® Zafirlukast 10 mg Tablets, (NDC 49884-589-02)",New,3/17/22,,,,,Pulmonary/Allergy,To be Discontinued,,,3/17/22,,,,,,,
Zafirlukast Oral Tablets,Par Pharmaceutical,800-828-9393,"Accolate® Zafirlukast 20 mg Tablets, (NDC 49884-590-02)",New,3/17/22,,,,,Pulmonary/Allergy,To be Discontinued,,,3/17/22,,,,,,,
Zinc Acetate Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, bottle of 250 (NDC 57844-215-52)",Revised,5/18/21,,,Available,,Other;Pediatric,Resolved,,,12/15/20,,,,,,,
Zinc Acetate Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, bottle of 250 (NDC 57844-208-52)",Revised,5/18/21,,,Available,,Other;Pediatric,Resolved,,,12/15/20,,,,,,,
Zolmitriptan (Zomig) Tablets,IPR PHARMACEUTICALS INC,302-286-4928,"2.5 mg, blister pack of 6 tablets (NDC 64896-671-51)",New,3/3/23,,,,,Neurology,To be Discontinued,3/3/23,3/3/23,3/3/23,,,,,,,
Zolmitriptan (Zomig) Tablets,IPR PHARMACEUTICALS INC,302-286-4928,"5 mg, blister pack of 3 tablets (NDC 64896-672-50)",New,3/3/23,,,,,Neurology,To be Discontinued,3/3/23,3/3/23,3/3/23,,,,,,,
Zolmitriptan (Zomig-ZMT) Orally Disintegrating Tablets,Astrazeneca Pharmaceuticals LP,302-286-4928,"2.5 mg, blister pack of 6 tablets (NDC 64896-691-51)",New,3/3/23,,,,,Neurology,To be Discontinued,3/3/23,3/3/23,3/3/23,,,,,,,
Zolmitriptan (Zomig-ZMT) Orally Disintegrating Tablets,Astrazeneca Pharmaceuticals LP,302-286-4928,"5 mg, blister pack of 3 tablets (NDC 64896-692-50)",New,3/3/23,,,,,Neurology,To be Discontinued,3/3/23,3/3/23,3/3/23,,,,,,,
Zolpidem Tartrate (Edluar) Sublingual Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0037-6010-30),Revised,11/21/18,,,Available,,Psychiatry,Resolved,,,3/16/18,,,,,,,
Zolpidem Tartrate Oral Spray,Aytu BioPharma,855-298-8246,5 mg per spray (NDCs 69654-510-30 and 69654-510-60),New,6/13/22,,,,,Psychiatry,To be Discontinued,,,6/13/22,,,,,,,